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ABSTRACT 
Specialised mechanisms have evolved in pathogenic bacteria to enable adaptation to hostile and 
fluctuating host environments. Inducible mutagenesis, in particular, has been implicated in the 
emergence of antibiotic- and stress-resistant mutants. This thesis examined mycobacterial DNA 
metabolism with specific emphasis on the roles of multiple Y-family polymerases in the evolution of 
inter-strain variation and drug resistance in M. tuberculosis. The contribution of the nrdZ-encoded 
class II ribonucleotide reductase (RNR) to the maintenance of dNTP pools for replication and repair 
under hypoxic conditions was also explored. In addition, the co-factor requirement of NrdZ 
prompted an investigation into the biosynthesis and transport of adenosylcobalamin (AdoCbl) in M. 
tuberculosis.  
The data suggest that the mycobacterial Y-polymerases are tightly regulated and restricted to 
specialised damage-free repair or replication restart. Disruptions in individual M. smegmatis 
mc2155 DinB (pol IV) homologues resulted in novel antibiotic-resistance polymorphisms that were 
suggestive of non-redundant function. In contrast, abrogation of all error-prone polymerase activity 
failed to impair long-term competitive survival of mc2155 in vitro. Similarly, heterologous 
overexpression of M. tuberculosis pol IV homologues did not increase spontaneous mutation rates 
in wild-type mc2155, or complement damage hypersensitivity. However, treatment of M. smegmatis 
with gyrase inhibitors confirmed the differential induction of pol IV homologues in response to 
replication stalling and demonstrated elevated rates of spontaneous mutagenesis as a result of 
GyrB inhibition. 
The class II RNR does not appear to play a significant role in mycobacterial pathogenesis. 
Specifically, NrdZ was unable to substitute for the class I RNR under aerobic conditions in vitro, 
and a M. tuberculosis ΔnrdZ deletion mutant was not impaired in its ability to adapt to hypoxia in 
vitro. Similarly, infection of immunocompetent mice suggested that nrdZ is not required for the 
survival or virulence of M. tuberculosis in vivo.  
Disruptions in genes required for AdoCbl and methionine biosynthesis revealed that complex 
regulatory functions govern mycobacterial methionine and AdoCbl homeostasis. Loss of early 
(cobK) or late (cobU) stage AdoCbl biosynthetic enzymes had no effect on the growth of M. 
tuberculosis H37Rv in vitro. In contrast, deletion of the B12-independent methionine synthase 
(metE) resulted in impaired growth on solid media that could be rescued by vitamin B12 but not L-
methionine supplementation, simultaneously demonstrating the ability of M. tuberculosis to 
transport exogenous vitamin B12. Significantly, double ΔcobU/ΔmetE and ΔcobK/ΔmetE deletion 
mutants in which all predicted methionine synthase activity was eliminated, were not impaired for 
growth in liquid minimal media, suggesting that M. tuberculosis H37Rv possesses alternative 
mechanisms for methionine generation. Finally, the attenuated virulence of the ΔcobU and ΔmetE 
deletion mutants in vivo in immunocompetent mice indicated the relevance of AdoCbl biosynthesis 
to mycobacterial pathogenesis. 
 
 
  v 
ACKNOWLEDGEMENTS 
 
I am grateful to the Wellcome Trust, the Howard Hughes Medical Institute, the National 
Research Foundation, the Medical Research Council of South Africa, the National Health 
Laboratory Service (formerly the South African Institute for Medical Research), and the 
University of the Witwatersrand for financial support, and for contributing to local and 
international travel expenses. 
 
I wish to thank Dr. Clif Barry III for a rewarding period spent in his laboratory at the 
NIH/NIAID, and for collaborating on subsequent mouse experiments. 
 
I should also like to express my gratitude to Dr. Neil Stoker for advice throughout the 
course of this study. 
 
To my colleagues, a rare sense of openness has characterised my time in the Molecular 
Mycobacteriology Research Unit; I appreciate the guidance, friendship, and support of all 
those who have inevitably contributed to everything I have learnt over the past few years. 
In particular, I wish to thank Steph, my co-supervisor, for offering invaluable scientific 
advice and reasoned perspective, but equally for an infectious willingness to indulge 
theoretical flights of fancy. I must also thank Edith for her calm reassurance and advice – 
as well as steadfast fortitude in the face of my regular computer-related failings. 
 
Helena, you have facilitated every aspect of this thesis. In addition to your direct technical 
involvement, your generosity and expert counsel constitute a model of unselfish scientific 
exchange. I value our friendship.  
 
I am especially indebted to my supervisor, Professor Valerie Mizrahi, for her unfailing 
support and encouragement, and for instilling in me an appreciation of scientific thought 
both rigorous and innovative. It has been a privilege to work in her lab. Thank you, Val, for 
your continued commitment to ‘turning me into a scientist’. 
 
Finally, to my family – dad, mom, piglit, dorcas, a moose long-departed…- if anything, I 
have tended to undervalue your immense contribution and to disregard the patience and 
sacrifice that has enabled me to pursue this new obsession. Know that I have tried to 
make you proud. And to emma, who pushed me at the start, and thrills me to the end. 
 
  vi 
 
PUBLICATIONS FROM THIS THESIS 
 
Warner DF, Mizrahi V. (2003) Mechanisms of stationary-phase mutagenesis in bacteria 
and their relevance to antibiotic resistance. in Dormancy and low-growth states in 
microbial disease. Coates ARM (Ed) Cambridge University Press. Cambridge, UK. pp. 
131-159. 
 
Dawes SS, Warner DF, Tsenova L, Timm J, McKinney JD, Kaplan G, Rubin H, Mizrahi V. 
(2003) Ribonucleotide reduction in Mycobacterium tuberculosis: function and expression 
of genes encoding class Ib and class II ribonucleotide reductases. Infect. Immun. 71, 
6124-6131. 
 
Warner DF, Mizrahi V. (2004) Mycobacterial genetics in target validation. Drug Discovery 
Today: Technologies, in press. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  vii 
TABLE OF CONTENTS 
DECLARATION………………………………………………………………… iii 
ABSTRACT…………………………………………………………………...... iv  
ACKNOWLEDGEMENTS…………………………………………………….. v 
PUBLICATIONS FROM THIS THESIS……………………………………… vi 
TABLE OF CONTENTS………………………………………………………. vii 
LIST OF TABLES……………………………………………………………… xiv 
LIST OF FIGURES…………………………………………………………….. xv 
 
Chapter 1 GENERAL INTRODUCTION…………………………………. 1 
1.1 Introduction…………………………………………………………………… 2 
1.2 Antimycobacterial Chemotherapy………………………………………… 2 
 Frontline DOTS drugs…………………………………………………………… 4 
 The cost of resistance…………………………………………………………… 5 
1.3 Molecular biological approaches to drug discovery: current trends.. 7 
 Targeted gene knockout………………………………………………………… 7 
 Random (transposon) mutagenesis…………………………………………….. 8 
 Conditional mutagenesis………………………………………………………… 9 
 Comparative genomics…………………………………………………………… 9 
 Transcriptional profiling………………………………………………………….. 10 
1.4 The BCG vaccine…………………………………………………………….. 11 
 Prospects for a new vaccine…………………………………………………….. 12 
 DNA vaccines……………………………………………………………………. 14 
1.5 Antituberculous immunity………………………………………………….. 15 
 Cell-mediated immunity………………………………………………………….. 17 
 The mycobacterial cell wall in immune modulation……………………………… 18 
 Immune-mediated tissue damage……………………………………………….. 18 
1.6 Probing the in vivo environment………………………………………….. 19 
1.7 Tuberculous granulomas…………………………………………………… 20 
 Phagosome maturation arrest…………………………………………………… 21 
1.8 Intracellular survival and metabolism……………………………………. 22 
1.9 Gene regulatory pathways…………………………………………………. 24 
 The DosR dormancy regulon……………………………………………………. 24 
 Other two-component regulatory systems………………………………………. 26 
 The stringent response………………………………………………………….. 26 
  viii
 Mycobacterial σ factors………………………………………………………….. 28 
1.10 Emergence of drug resistance…………………………………………….. 28 
 Permeability and efflux…………………………………………………………… 29 
 Effective antibiotic concentrations………………………………………………. 31 
 Molecular mechanisms of resistance……………………………………………. 32 
 Rates of resistance mutations…………………………………………………… 33 
 Emergence of multidrug resistance……………………………………………… 33 
1.11 In vivo stress………………………………………………………………….. 34 
 Reactive immune effectors………………………………………………………. 37 
1.12 DNA metabolism in mycobacteria…………………………………………. 40 
 
Chapter 2 GENERAL MATERIALS AND METHODS……………………. 42 
2.1 GENERAL LABORATORY PROCEDURES……………………………….. 43 
 2.1.1 Bacterial strains and culture conditions…………………………… 43 
 2.1.2 General cloning vectors………………………………………………. 44 
2.2  TRANSFORMATION OF BACTERIA……………………………………….. 45 
 2.2.1 Chemical transformation of Escherichia coli…………………….. 45 
 2.2.2 Electroduction of Escherichia coli………………………………….. 45 
 2.2.3 Transformation of mycobacteria by electroporation……………. 46 
2.3  DNA EXTRACTION………………………………………………………. 47 
 2.3.1 Plasmid preparation from Escherichia coli……………………….. 47 
 2.3.2 Preparation of mycobacterial chromosomal DNA………………... 47 
2.4  DNA MANIPULATIONS……………………………………………………….. 48 
 2.4.1 Agarose gel electrophoresis…………………………………………. 48 
 2.4.2 Recovery of DNA fragments from agarose gels………………….. 48 
 2.4.3 Enzymatic modification of DNA……………………………………… 49 
 2.4.4 Southern blot analysis of mutant mycobacterial strains……….. 50 
2.5  DNA SEQUENCING…………………………………………………………… 51 
2.6 STATISTICAL ANALYSES……………………………………………………….. 51 
 
Chapter 3 THE MYCOBACTERIAL Y-FAMILY POLYMERASES:  
  ROLES IN GENETIC ADAPTATION AND LONG-TERM  
  SURVIVAL…………………………………………………………….. 52 
3.1 ABSTRACT……………………………………………………………………… 53 
3.2 INTRODUCTION………………………………………………………………... 54 
  ix
 3.2.1  The Y-polymerase superfamily…………………………………….. 54 
 3.2.2  Heritable mutators……………………………………………………. 55 
 3.2.3  Adaptive evolution of mutation rates……………………………… 56 
 3.2.4  SOS-inducible polymerases………………………………………… 56 
 3.2.5  Stress-induced mutagenesis and stationary-phase  
  adaptation……………………………………………………………… 57 
 3.2.6  The stationary phase in mycobacteria……………………………..58 
 3.2.7  Inducible mutagenesis in mycobacteria………………………….. 59 
 3.2.8  Aims and objectives of this study………………………………….. 61 
3.3  MATERIALS AND METHODS………………………………………………… 62 
 3.3.1  Mycobacterial strains, plasmids, and probes…………………… 62 
 3.3.2  Construction of overexpression vectors…………………………. 64 
 3.3.3  Construction of reporter probes and measurement of  
  β-galactosidase activities…………………………………………… 64 
 3.3.4  Construction of the marked and unmarked suicide delivery 
  vectors………………………………………………………………….. 66 
 3.3.5 Mutation rate (μ) assessment by fluctuation assay………………. 68 
 3.3.6 Damaging treatments of mycobacteria……………………………… 70 
 3.3.7 RNA isolation and first-strand cDNA synthesis…………………… 70 
 3.3.8 Real-Time, Quantitative RT-PCR Assay (Taqman)………………… 71 
 3.3.9 Semi-quantitative RT-PCR of the mc2155 response to gyrase  
  inhibitors……………………………………………………………….. 71 
 3.3.10 Long-term competitive survival assays…………………………… 72 
 3.3.11 Sequencing of the rpoB locus of RifR M. smegmatis mutants… 72 
3.4 RESULTS………………………………………………………………………… 74 
 3.4.1  The mycobacterial Y-family homologues………………………….74 
 3.4.2  Regulation of M. tuberculosis dinP and dinX……………………. 77 
  The M. tuberculosis pol IV homologues are not DNA damage inducible… 77 
  M. tuberculosis Rv3055 and dinX promoter regions are active in 
   M. smegmatis during stationary phase in vitro………………………….. 78 
 3.4.3  Overexpression of M. tuberculosis dinP and dinX has no  
  effect on rates of spontaneous point or frameshift  
  mutagenesis…………………………………………………………… 81 
 3.4.4 A chromosomal duplication in M. smegmatis mc2155…………. 85 
  M. smegmatis mc2155 dinP is dispensable for growth in vitro…………… 88 
  Isolation of a dinP deletion mutant lacking the duplicated region………... 89 
  x
  Transformation efficiency of the ΔDR strain……………………………… 89 
  Restoration of a wild-type dinP allele in ΔDR…………………………….. 90 
 3.4.5 M. smegmatis mc2155 EP polymerases are not required 
  for long-term survival in vitro………………………………………. 91 
  M. smegmatis Y-family polymerases are dispensable for growth 
  in vitro…………………………………………………………………….. 91 
  Loss of pol IV activity does not impair long-term competitive fitness 
  of mc2155…………………………………………………………………. 94 
  M. smegmatis dnaE2 does not confer a fitness advantage during 
  stationary phase………………………………………………………….. 96 
  M. smegmatis mc2155 does not exhibit stationary-phase mutagenesis 
  in vitro…………………………………………………………………….. 97 
  The identification of novel rpoB mutations in M. smegmatis  mc2155 
   in stationary phase………………………………………………………. 98 
 3.4.6 The Y-family polymerases in TLS………………………………….. 102 
  The M. smegmatis pol IV homologues are not required for UV tolerance.. 102 
  rpoB fingerprinting of RifR mutants from UV-irradiated cultures………….. 103 
 3.4.7 Gyrase inhibition and induced mutagenesis…………………….. 106 
  Mycobacterial Y-family polymerases are differentially induced 
  in response to gyrase inhibitors………………………………………….. 106 
  The role of Y-family polymerases in survival and mutagenesis 
  after gyrase inhibition…………………………………………………….. 107 
  Novobiocin-induced mutagenesis………………………………………… 109 
 3.4.8 The role of Rv3394c in damage protection……………………….. 110 
3.5 DISCUSSION……………………………………………………………………. 113 
  EP polymerases in Gram-positive versus Gram-negative bacteria……… 113 
  The mycobacterial SOS and damage-inducible polymerase complement. 114 
  Mycobacterial EP polymerases do not contribute to long-term fitness…... 117 
  Restricted access of mycobacterial EP polymerases to the replication 
   fork?................................................................................................. 119 
  The β clamp and mycobacterial polymerase switching………..…………. 120 
  Induced mutagenesis and gyrase inhibition………..………..…………… 122 
  The role of the Y-family homologues in the novel rpoB deletion…………. 124 
  Why so many mycobacterial pol IV homologues? ………..…………….. 126 
  A model for polymerase activity………..………..………..……………… 126 
  The evolution of drug resistance in M. tuberculosis………..……………. 132 
  Future studies………..………..………..………..………..…………….. 135 
  xi
 
Chapter 4 RIBONUCLEOTIDE REDUCTION IN MYCOBACTERIUM 
 TUBERCULOSIS…………………………………………………….. 136 
4.1 ABSTRACT………..………..………..………..………..……………………… 137 
4.2 INTRODUCTION………..………..………..………..………..………………… 137 
 4.2.1 Ribonucleotide reductases (RNRs) ………..………..………..…… 137 
 4.2.2 RNRs and adaptation to oxygen availability………..………..….. 138 
 4.2.3 The mycobacterial RNR complement………..………..…………... 139 
 4.2.4 The nrdZ-encoded class II RNR………..………..………..………… 139 
 4.2.5 Aims and objectives of this study………..………..………..…….. 141 
4.3 MATERIALS AND METHODS………..………..………..………..………..… 142 
 4.3.1 Bacterial strains and plasmids………..………..………..………… 142 
 4.3.2 Site-specific knockout of M. tuberculosis nrdZ………..……….. 142 
 4.3.3 Hydroxyurea assay………..………..………..………..………..……. 143 
 4.3.4 Wayne model conditions………..………..………..………..………. 143 
 4.3.5 Infection of mice, determination of bacterial load, and  
  survival………………………………………………………………….. 144 
4.4 RESULTS………..………..………..………..………..………………………… 145 
 4.4.1 The contribution of NrdZ to aerobic RNR activity………..…….. 145 
  The nrdZ-encoded class II RNR is dispensable for growth in vitro……… 145 
  NrdZ does not contribute to tolerance of hydroxyurea in M. tuberculosis.. 145 
 4.4.2 NrdZ is not required for adaptation to hypoxia………..……….. 147 
  The ΔnrdZ deletion mutant is not impaired for survival under  
  microaerophilia……………………………………………………………. 147 
  Loss of nrdZ does not attenuate M. tuberculosis for survival in vivo…….. 149 
 4.4.3 NrdZ and damage tolerance under microaerophilia………..….. 150 
4.5 DISCUSSION………..………..………..………..………..……………………. 152 
  The class Ib RNR is essential and provides dominant aerobic RNR 
  activity……………………………………………………………………. 152 
  Regulation of mycobacterial RNR activity………..………..………..…… 154 
  Is NrdZ dispensable for hypoxic adaptation? ………..………..………… 154 
  DNA damage under limiting oxygen………..………..………..………… 156 
  NrdZ and transmission………..………..………..………..………..……. 158 
 
 
 
  xii
Chapter 5 BIOSYNTHESIS OF ADENOSYLCOBALAMIN IN 
 MYCOBACTERIUM TUBERCULOSIS…………………………. 159 
5.1 ABSTRACT………………………….………………………………………….. 160 
5.2 INTRODUCTION………………………….………………………………….. 160 
 5.2.1  Cobalamin co-factors………………………….…………………….. 162 
 5.2.2 The AdoCbl biosynthetic pathway…………………………………. 164 
 5.2.3 The mycobacterial AdoCbl biosynthetic gene complement…. 165 
 5.2.4 Regulation of AdoCbl metabolism and transport………………. 166 
 5.2.5 Cobalamin and cobalt transporters……………………………….. 166 
 5.2.6 Aims and objectives of this study…………………………………. 168 
5.3 MATERIALS AND METHODS…………………………………………….. 169 
 5.3.1 Bacterial strains and plasmids…………………………………….. 169 
 5.3.2 Construction of the marked and unmarked suicide delivery 
 vectors…………………………………………………………………………… 169 
 5.3.3 Macrophage infections…………………………………………………. 170 
 5.3.4 Infection of mice, determination of bacterial load, and survival.. 171 
5.4 RESULTS……………………………………………………………………….. 172 
 5.4.1 Disruption of AdoCbl biosynthesis in M. tuberculosis………… 172 
  Generation of a ΔcobU deletion mutant of H37Rv………………………. 172 
  Possible B12 dysregulation in the ΔcobU mutant………………………… 173 
  M. tuberculosis cobU is not required for survival in vitro in  
  macrophage models……………………………………………………………. 175 
 5.4.2 The B12-independent methionine synthase (MetE) …………….. 176 
  Disruption of metE impairs normal growth of M. tuberculosis in vitro……. 176 
  Generation of a ΔcobU/ΔmetE double knockout mutant………………… 177 
 5.4.3 Functionality of M. tuberculosis CDC1551 MetH…………………179 
 5.4.4 Targeting an earlier step in AdoCbl biosynthesis………………. 180 
  Generation of ΔcobK  and ΔcobK/ΔmetE deletion mutants……………… 180 
  The M. tuberculosis AdoCbl and methionine biosynthetic pathway  
  mutants are not strict CNCbl auxotrophs………………………………… 180 
  Methionine supplementation does not rescue growth of  
  M. tuberculosis ΔmetE…………………………………………………………  181 
 5.4.5 M. tuberculosis ΔcobU and ΔmetE mutants are  
  attenuated in vivo…………………………………………………….. 182 
 
 
  xiii
5.5 DISCUSSSION………………………….……………………………………… 184 
  AdoCbl biosynthesis in mycobacteria…………………………………… 184 
  The mycobacterial cob genes and cobalamin homeostasis…………….. 185 
  The regulation of AdoCbl metabolism in M. tuberculosis………………… 187 
  Methionine biosynthesis in M. tuberculosis………………………………. 187 
  An alternative methionine biosynthetic pathway in M. tuberculosis?.......... 189 
  Cross-regulation of B12-dependent and B12-independent methionine  
  synthase activity? …………………………….…………………………. 191 
  The role of sulphur metabolism in the M. tuberculosis ΔmetE phenotype. 192 
  AdoCbl biosynthesis in M. tuberculosis in vivo………………………….. 194 
  Transport of vitamin B12 in mycobacteria………………………………… 195 
  An immunomodulatory role for AdoCbl? ………………………………… 196 
  Possible future studies…………………………………………………… 197 
   
APPENDICES………………………….………………………….……………………. 199 
 Appendix 1: List of abbreviations………………………………………….. 200 
 Appendix 2: Culture media…………………………………………………… 202 
REFERENCES………………………….………………………….………………….. 203 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  xiv
LIST OF TABLES 
 
Chapter 2 General materials and methods 
Table 2.1 Bacterial strains used in this study…………………………………………… 43 
Table 2.2 Plasmids used in this study…………………………………………………… 44 
 
Chapter 3 The mycobacterial Y-family polymerases: roles in genetic  
  adaptation and long-term survival 
Table 3.1  Strains used in this study……………………………………………………… 62 
Table 3.2 Plasmids used in this study…………………………………………………… 63 
Table 3.3 Probes used in this study……………………………………………………… 64 
Table 3.4 Oligonucleotide primers used in this study………………………………….. 67 
Table 3.5 Induction of M. tuberculosis pol IV homologues…………………………….. 78 
Table 3.6 Mutation rates for M. smegmatis strains overexpressing M. tuberculosis  
  dinP and dinX…………………………………………………………………… 84 
Table 3.7 rpoB mutations in Rif-resistant mutants derived from M. smegmatis  
  in LTG1………………………………………………………………………….. 99 
Table 3.8 rpoB mutations in Rif-resistant mutants derived from M. smegmatis 
  in LTG2………………………………………………………………………….. 100 
Table 3.9 rpoB mutations in Rif-resistant mutants derived from UV irradiated  
  M. smegmatis…………………………………………………………………… 104 
Table 3.10 Mutation frequencies following NVB treatment……………………………… 108 
Table 3.11 rpoB mutations in Rif-resistant mutants after treatment of M. smegmatis  
  with NVB………………………………………………………………………… 110 
Table 3.12 Y-family and EP polymerase complements and properties……………….. 115 
 
Chapter 4 Ribonucleotide reduction in Mycobacterium tuberculosis  
Table 4.1  Strains, plasmids, primers and probes used in this study………………… 142 
 
Chapter 5 Biosynthesis of adenosylcobalamin in Mycobacterium 
   tuberculosis  
Table 5.1  List of strains, plasmids and probes used in this study……………………. 169 
Table 5.2 Primers used in this study…………………………………………………….. 170 
Table 5.3  Growth characteristics of M. tuberculosis mutants containing disruptions 
  in AdoCbl and methionine biosynthetic pathway genes…………………… 186 
 
 
 
  xv
LIST OF FIGURES 
 
Chapter 3 The mycobacterial Y-family polymerases: roles in genetic  
  adaptation and long-term survival 
Figure 3.1 Sequence alignment of the mycobacterial Y-family polymerases………… 75 
Figure 3.2 Genomic organisation of the mycobacterial pol IV homologues………….. 77 
Figure 3.3 a. Nucleotide sequence alignment of dinP promoter regions……………… 79 
  b. Nucleotide sequence alignment of Rv3055 promoter regions…………. 79 
  c. Nucleotide sequence alignment of dinX promoter regions……………… 80 
Figure 3.4 Stationary-phase upregulation of M. tuberculosis pol IV homologues……. 82 
Figure 3.5 Inducible expression of the M. tuberculosis pol IV homologues………….. 83 
Figure 3.6 Construction of a dinP deletion mutant strain of M. smegmatis mc2155…. 86 
Figure 3.7 Construction of the M. smegmatis dinPKin mutant………………………… 88 
Figure 3.8 The M. smegmatis mc2155 duplicated region……………………………… 90 
Figure 3.9 M. smegmatis mc2155 pol IV and EP polymerase knockout strains……… 92 
Figure 3.10 Construction of multiple sequential pol IV deletion mutants of mc2155….. 93 
Figure 3.11 Long-term competitive growth of the mc2155 Y-family and EP    
  polymerase deletion mutants…………………………………………………. 95 
Figure 3.12 An EP polymerase-free strain (DC) of M. smegmatis mc2155……………. 97 
Figure 3.13 Rifampicin resistance frequencies of M. smegmatis strains during  
  long-term growth in vitro………………………………………………………. 98 
Figure 3.14 Deletions in the rpoB gene of M. smegmatis mc2155 conferring RifR……. 101 
Figure 3.15 Effect of UV irradiation on survival of M. smegmatis………………………. 103 
Figure 3.16 Transcriptional response of M. smegmatis dinP3 to stalled replication….. 107 
Figure 3.17 Construction of Rv3394c and Rv3395c deletion mutants of  
  M. tuberculosis H37Rv………………………………………………………… 111 
Figure 3.18 Damage survival of M. tuberculosis strains…………………………………. 112 
Figure 3.19 A model for polymerase dynamics in fast- versus slow-growing  
  organisms……………………………………………………………………….. 128 
Figure 3.20 The evolution of drug resistance in M. tuberculosis in vivo……………….. 133 
 
Chapter 4 Ribonucleotide reduction in Mycobacterium tuberculosis 
Figure 4.1 Alignment of M. tuberculosis NrdZ with other class II RNRs………………. 146 
Figure 4.2  Construction of an nrdZ deletion mutant of M. tuberculosis H37Rv………. 147 
Figure 4.3 Inhibition of M. tuberculosis strains by HU……………………………………148 
Figure 4.4 Survival of M. tuberculosis strains under hypoxia………………………….. 149 
Figure 4.5 Growth of M. tuberculosis strains in B6D2/F1 mice………………………… 150 
 
  xvi
 
Chapter 5 Biosynthesis of adenosylcobalamin in Mycobacterium 
   tuberculosis 
Figure 5.1 Structures of cobalamin co-factors and derivatives………………………… 161 
Figure 5.2 The putative M. tuberculosis adenosylcobalamin biosynthetic pathway…. 163 
Figure 5.3 Reactions catalysed by the CobU enzyme………………………………….. 172 
Figure 5.4 Construction of M. tuberculosis mutants disrupted in cobalamin and   
  methionine biosynthetic pathways……………………………………………. 174 
Figure 5.5 The vitamin B12 “shock” phenotype in M. tuberculosis ΔcobU……………. 175 
Figure 5.6 Survival of M. tuberculosis strains in murine macrophages………………. 176 
Figure 5.7 Substrate utilisation by M. tuberculosis mutants disrupted in    
  cobalamin and methionine biosynthetic pathways…………………………. 178 
Figure 5.8 Growth kinetics of M. tuberculosis strains in vitro in minimal media……… 181 
Figure 5.9 Virulence of M. tuberculosis strains in C57BL/6 mice……………………… 183 
Figure 5.10   L-Methionine biosynthesis in M. tuberculosis……………………………….. 188 
 
 
Chapter 1 
 
General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   2 
1.1 Introduction 
Tuberculosis (TB) was declared a global health emergency by the World Health 
Organisation (WHO) in 1993. Over 1.5 million people died of TB during 1999 (WHO, 
1999) and the disease currently claims approximately 2 million lives per annum, more 
than can be attributed to any other bacterial infection (Corbett et al., 2003). It is estimated 
that one-third of the world’s population is infected with the causative agent, the obligate 
human pathogen Mycobacterium tuberculosis (Dye et al., 1999; Corbett et al., 2003) and, 
based on prevailing incidence levels, a further 1000 million new infections will occur 
between 2002 and 2020, resulting in 150 million cases of active disease and 36 million 
deaths (WHO, 2004). Most initial infections are resolved by the cell-mediated immune 
response; however, TB immunity is static (Nathan & Shiloh, 2000) and a residual 
population of viable bacteria may survive for extended periods in a poorly understood 
state of clinical latency (Lillebaek et al., 2002). Spontaneous reactivation of latent TB 
infection occurs in approximately 5% of cases and is thought to account for almost half of 
all active pulmonary disease (Styblo, 1991). The massive reservoir of viable bacteria in 
the estimated 2 billion asymptomatically infected individuals worldwide is, therefore, of 
supreme importance for the epidemiology and control of TB. The potential of bacterial 
populations to occupy discrete lesions in a single host renders the disease complex, 
however (Boshoff & Barry, 2005), and targeting the intractable pathogen is further 
complicated by both the increasing emergence of multi-drug resistant (MDR) strains 
(Blower & Chou, 2004; Cohen & Murray, 2004) and the lethal synergy between M. 
tuberculosis and the human immunodeficiency virus (HIV; Selwyn et al., 1989). 
 
1.2 Antimycobacterial Chemotherapy 
The global TB control effort is focused on interrupting transmission of M. tuberculosis 
through chemotherapeutic intervention in active infectious disease. The cornerstone of 
this strategy, directly observed therapy, short course (DOTS), became official policy of the 
World Health Organisation (WHO) in 1994, although modified forms were already in 
existence (Mitchison, 1998). DOTS is predicated on the supervised administration of 
combination therapy to sputum positive patients; in addition to ensuring individual 
compliance with the drug regimen, it was hoped that political commitment to TB treatment 
and the regular evaluation of programme performance would ensure success. Where fully 
implemented by well-funded national TB control programs, DOTS has improved treatment 
outcomes and limited development of drug-resistance (Cohn et al., 1990; Kim et al., 
1997a; Reichmann, 1997; Dye et al., 1998); however, adoption of the DOTS programme 
has been slow in many areas and overall coverage remains inconsistent (Netto et al., 
   3 
1999). In addition, the efficacy of DOTS is eroded by non-compliance, the HIV pandemic 
and the emergence worldwide of drug-resistant M. tuberculosis strains (Selwyn et al., 
1989, 1992; Whalen et al., 1997; Churchyard et al., 1999; De Cock & Chaisson, 1999; 
Kenyon et al., 1999; Kimerling, 2000; Espinal et al., 2001; Espinal, 2003). Paradoxically, 
recent mathematical modelling suggests that the emergence of ‘hot zones’ of MDR-TB is 
exacerbated in areas where well-functioning control programmes exert a selective 
pressure to acquire resistance while eliminating pansensitive wild-type M. tuberculosis 
strains (Blower & Chou, 2004; Cohen & Murray, 2004). Furthermore, a significant number 
of cases remain undiagnosed and therefore untreated (Dye et al., 2002), while the use of 
frontline drugs in preventive therapy is limited primarily to high-income settings with a 
small burden of disease (American Thoracic Society, 2000). Particularly sobering is the 
observation that there are currently more cases of active disease worldwide than when 
specific effective chemotherapy for TB was first introduced (Gillespie, 2002). The 
effectiveness of DOTS in reducing the prevalence of M. tuberculosis in the human 
population is, therefore, contentious and it has been argued that control will never be 
realised through treatment of active disease alone (Enarson, 2000; Suarez et al., 2001; 
Brewer & Heymann, 2004). Significantly, no chemotherapeutic strategy exists to eradicate 
clinically latent bacteria - if all transmission were immediately blocked, it is estimated that 
millions of cases would likely emerge over the next few decades from individuals with 
undiagnosed latent TB (Kaufmann, 2000). In addition, coinfection with HIV is associated 
with an increased likelihood of developing active TB and is the most important risk factor 
for reactivation (Selwyn et al., 1989; Perlman et al., 1999). As a result, there is a dire need 
for a sterilising drug to shorten the duration of chemotherapy and ultimately eradicate the 
massive reservoir of latent bacteria, both stated priorities of the Global Alliance for TB 
Drug Development (GATB). There are few candidates in the pipeline, however, although a 
recently discovered diarylquinolone offers considerable promise as a lead compound, 
both as a result of the potential to shorten the duration of chemotherapy and because the 
novel target - the mycobacterial ATP synthase – ensures that drug-sensitive and drug-
resistant isolates are equally susceptible to its inhibitory effects (Andries et al., 2004). 
Other advances include enhancements to rifampicin activity that have yielded rifapentine, 
and the adoption of several broad-spectrum antibacterials - particularly quinolones – in the 
treatment of MDR-TB (Duncan, 2004; Duncan & Barry, 2004). Differences in drug 
susceptibilities between replicating and non-dividing bacterial cells can be profound 
(Hobby & Lenert, 1957); therefore, perhaps the greatest limitation of current therapy is the 
dependence of all front-line antituberculars on actively replicating cells for their efficacy 
(Mitchison, 1985; Jindani et al., 2003). In the hope of at least partially addressing this 
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problem, a small-molecule nitroimidazopyran active against anaerobic organisms is 
currently under development by GATB (Stover et al., 2000; Barry et al., 2004). 
 
Frontline DOTS drugs 
The current standard combination therapy requires the administration of four 
antimycobacterial drugs for a minimum period of six months – an “intensive phase” 
comprising two months isoniazid, rifampicin, and pyrazinamide therapy supplemented with 
streptomycin or ethambutol if drug resistance is likely, followed by a “continuation” or 
“consolidation” phase of a further four months of isoniazid and one other frontline drug, 
usually rifampicin were affordable (Mitchison, 1985). Each of the front-line drugs has been 
selected for its ability to target bacilli in various growth stages in disparate physiological 
states (Mitchison, 1985), with a bias towards interference in cell wall integrity. Oxidative 
activation of the isoniazid prodrug by the mycobacterial catalase-peroxidase katG yields a 
poorly understood active form that interrupts mycolic acid synthesis (Zhang et al., 1992; 
Heym et al., 1993). Similarly, pyrazinamide requires activation by the hydrolytic 
pyrazinamidase to pyrazinoic acid, which is thought to inhibit fatty acid synthesis (Zimhony 
et al., 2000) as well as mediating other specific and non-specific effects through 
intracellular acid accumulation. Ethambutol is another mycobacterial cell wall inhibitor, 
interfering in the synthesis of the arabinogalactan layer by blocking arabinose insertion. In 
contrast, rifampicin binds to the bacterial DNA-dependent RNA polymerase b subunit, 
disrupting transcription while, like other aminoglycosides, streptomycin inhibits protein 
synthesis. 
 
The actively-dividing M. tuberculosis population in the lung cavity is key to transmission 
and emergence of drug resistance (Grosset, 2003; Kaplan et al., 2003), and is the 
principal target of therapy. Bacillary replication in pulmonary cavities resembles optimal in 
vitro aerobic growth, and the effectiveness of the key frontline drugs in treating acute TB is 
manifest in the rapid bacillary clearance within the first two months of chemotherapy 
(Grosset, 2003). In fact, the greatest benefit of short-course therapy derives from the 
bactericidal activity during the intensive phase, and results largely from the early killing 
effects of isoniazid (Slayden & Barry, 2000). However, despite the demonstration that high 
concentrations accumulate in all types of lesions (Barclay et al., 1953), isoniazid activity is 
transient and monoresistance common (WHO, 2004); therefore, pyrazinamide and 
especially rifampicin are required to supplement and sustain bactericidal effects. Like 
isoniazid, both rifampicin and pyrazinamide exhibit early bactericidal activity and are able 
to clear the sputum during therapy (Mitchison, 1985; Mitchison & Nunn, 1986). 
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Pyrazinamide mediates its antimycobacterial effects at low pH and so is ideally suited to 
the elimination of bacilli inside caseous necrotic foci, but appears to confer no benefit after 
the second month of therapy (Mitchison, 1985; Wayne, 1994). Another frontline drug, 
ethambutol, which has largely replaced streptomycin in standard regimens, also displays 
high bactericidal but no sterilising activity. It is significant that, although characterised by 
potent bactericidal activities, a common theme associated with the frontline drugs is their 
non-existent (isoniazid, streptomyin, ethambutol) or diminished (rifampicin, pyrazinamide) 
sterilising capability, considered a key factor in determining treatment duration (Mitchison, 
1992). 
 
Bacilli contained within macrophage phagosomes are thought to adapt to an altered, low-
metabolic state in response to hypoxia, nutrient stress, and immune surveillance 
(Schnappinger et al., 2003). Treatment of this population is predominantly the function of 
rifampicin which is able to target slowly-metabolising organisms. Introduction of rifampicin 
in combination with pyrazinamide was responsible for the advent of short-course therapy, 
significantly decreasing the duration of the continuation, or sterilising, phase which is 
crucial to the eradication of drug-susceptible persisters and reduces reactivation risk to an 
acceptable level (Fox & Mitchison, 1975). Finally, there is an increasing awareness of the 
necessary interrelation of antimicrobial activity and host defences in determining the 
ultimate fate of tubercle bacilli (Gomez & McKinney, 2004), and evidence that elimination 
of pre-existing infection by antibiotic therapy, followed by repeated post-exposure 
vaccination, could prevent disease (Lowrie et al., 1999) suggests that immune modulation 
as an adjunct to antituberculous therapy might significantly enhance efficacy (Glassroth, 
2000). 
 
The cost of resistance 
Propagation of a pathogen is dependent on the ability to survive, reproduce, and be 
transmitted, and is encapsulated in the concept of fitness (Cohen et al., 2003). Because 
antibiotics target genes or functions essential to the bacterium at some time during the 
infection process, a fitness cost has been attached to resistance mutations (Andersson & 
Levin, 1999), and has led to the assumption that removal of antibiotic selective pressure 
will favour reversion as a result of a competitive replicative disadvantage. Although fitness 
cost determines the stability and potential reversibility of the resistance mutation (Levin, 
2002), there is increasing evidence that evolution in the absence of the selective antibiotic 
preferentially results in the acquisition of mutations that ameliorate the cost of resistance, 
rather than higher-fitness, drug-sensitive revertants (Schrag & Perrot, 1996; Björkman et 
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al., 1998, 2000; Levin et al., 2000; Reynolds, 2000; Björkholm et al., 2001; Nagaev et al., 
2001). Of course, the larger mutational target (the chromosome) favours compensatory 
evolution over reversion (the individual gene; Andersson, 2003); therefore, the ability of 
bacteria to compensate genetically for the fitness cost will dictate the frequency of 
resistant mutants within a population. In addition, evidence suggests that although the 
most fit mutants will be selected in a large population, lower-fitness, compensated 
mutants might become fixed during bottlenecks if formed at a higher rate than fitter, 
susceptible revertants (Levin et al., 2000; Maisnier-Patin et al., 2002). Moreover, 
reversibility might be further reduced where genetic linkage exists between selected and 
non-selected resistance markers (Enne et al., 2001). Although information on the relative 
fitness of MDR isolates is limited (Davies et al., 2000), there is evidence that 
compensatory mutations can restore reproductive potential in monoresistant M. 
tuberculosis strains (Sherman et al., 1996; Heym et al., 1997; Telenti et al., 1997; Li et al., 
1998; Wilson et al., 1998; Slayden & Barry, 2000). Resistance phenotypes arising from 
separate mutation events can have different fitness costs (Li et al., 1998; Billington et al., 
1999) and it has been demonstrated that clinically resistant strains are more frequently 
associated with low- than high-cost mutations (Billington et al., 1999; Sander et al., 2002). 
For example, isoniazid-resistant isolates most commonly contain a katG mutation that 
reduces prodrug activation while halving catalase-peroxidase activity (Rouse et al., 1996; 
Ramaswamy & Musser, 1998; Slayden & Barry, 2000). Furthermore, results of several 
studies investigating the effects of resistance on mycobacterial virulence (Middlebrook & 
Cohn, 1953, Ordway et al., 1995; Scorpio et al., 1997; Böttger et al., 1998; Billington et al., 
1999; Pym et al., 2002; Sander et al., 2002) are consistent with phenotypic heterogeneity 
(Li et al., 1998; Billington et al., 1999) and suggest that no direct correlation can be made 
between drug resistance and pathogenicity (Cohen et al., 2003). Significantly, there is 
evidence that relative fitness in vitro may depend not only on the particular resistance 
mutation, but also on the nature of the assay (Mariam et al., 2004). Of course, in addition 
to altering the capacity to resist a drug, any resistance mechanism might impact on the 
ability of the pathogen to interact with the host environment. The apparent absence of a 
fitness cost could, therefore, reflect an inability to detect relevant growth defects in vitro 
(Andersson, 2003). Finally, while the potential effects on the fitness of M. tuberculosis are 
crucial to epidemiological predictions of the spread of resistance, particularly MDR 
isolates (Cohen et al., 2003), recent mathematical models suggest that, provided relative 
fitness of an MDR strain remains above a defined threshold, a subpopulation of the low-
fitness MDR strain will outcompete both the drug-sensitive strains and other, less fit MDR 
strains where confronted by a functioning TB control programme (Blower & Chou, 2004; 
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Cohen & Murray, 2004). For this reason, the distribution of fitness (Cohen & Murray, 
2004) among circulating M. tuberculosis strains is considered a more accurate predictive 
measure of resistance emergence, and has led to the proposal that DOTS policies 
necessarily be supplemented with anti-MDR strategies to limit resistance amplification 
(Blower & Chou, 2004; Cohen & Murray, 2004). 
 
1.3 Molecular biological approaches to drug discovery: current trends 
Detailed guidelines for the entire drug development process, including the requirements of 
a suitable drug target, have been established by GATB (http://www.tballiance.org); 
furthermore, the elucidation by the TB Structural Genomics Consortium of selected M. 
tuberculosis protein structures should further supplement drug discovery efforts (Goulding 
et al., 2002). It is significant, however, that a large proportion of research aimed at 
identifying and validating targets is performed almost exclusively in academic laboratories 
and, although the recent availability of the complete genome sequences of two M. 
tuberculosis strains (Cole et al., 1998; Fleischmann et al., 2002) has enabled post-
genomic mycobacterial research, a function for 48% of the predicted proteins encoded by 
the M. tuberculosis genome cannot be assigned (Camus et al., 2002). The more salient 
approaches to target identification and validation are considered here briefly, although the 
use of RNA-based techniques is discussed further in subsequent sections. 
 
Targeted gene knockout 
Because target validation requires the demonstration of gene essentiality at some stage of 
the infection process, molecular biological approaches are dominated by the generation of 
mutants and phenotypic screening. Reverse genetic approaches are dominated by the 
use of targeted gene knockout to elucidate function, primarily driven by the desire to 
create rationally attenuated mutants as potential vaccine candidates (Jackson et al., 1999; 
Hondalus et al., 2000; Sambandamurthy et al., 2002, 2005) or as a means to investigate 
specific genes, particularly those encoding potential drug targets (McKinney et al., 2000; 
Tullius et al., 2003). Of course, pre-selection of the target implies that this approach is 
hypothesis-driven and therefore potentially limited by prevailing dogma or preconception. 
While techniques for targeted mutagenesis have advanced considerably in the past few 
years - in particular, the use of suicide or conditionally replicating phage or plasmid 
vectors to deliver mutant alleles (Parish & Stoker, 2000; Bardarov et al., 2002) - the 
process remains time-consuming and inapplicable to large gene sets. However, the 
precise nature of the mutation introduced assures the abrogation of gene function; in 
addition, the same techniques employed to generate the mutant can be applied in 
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complementation analysis - central to the target validation process, or to establish 
essentiality of gene function in cases in which knockout mutants cannot be recovered. 
 
Random (transposon) mutagenesis 
Although targeted gene knockout is the method of choice for investigating individual gene 
function, random mutagenesis enables the generation and analysis of a large pool of 
mutants in a single experiment, effectively combining the identification and validation 
steps. No prior knowledge of individual gene function is required, so bias inherent in target 
selection is avoided. Initially applied in the screening of mutant libraries in vitro, the 
potential of this technique was fully realised when adapted for use in vivo by the addition 
of DNA sequence tags (Hensel et al., 1995; Cox et al., 1999). The application of 
signature-tagged mutagenesis (STM; Hensel et al., 1995) in the mouse infection model 
provides a powerful means of identifying and classifying mutants based on phenotypes 
revealed throughout the infection process (Cox et al., 1999), as well as revealing and 
validating immunomodulatory or persistence genes which would otherwise be impossible 
to predict (Hisert et al., 2004). A particularly innovative tool for target identification and 
validation in M. tuberculosis is the transposon site hybridisation (TraSH) method, in which 
mutant pools can be mapped by a DNA microarray-based approach (Sassetti et al., 2001; 
Sassetti et al., 2003; Sassetti & Rubin, 2003). The TraSH method was initially used to 
identify genes required for optimal mycobacterial growth in vitro (Sassetti et al., 2001, 
2003); of the M. tuberculosis genes identified as essential, many are conserved in the M. 
leprae genome, which might be considered the minimal mycobacterial gene set, and a 
large proportion of these have no identifiable bacterial orthologs. Moreover, a significant 
proportion of essential genes as yet have no assigned function. The enormous utility of 
TraSH and related techniques for functional genomic screening during various stages of 
the infection process was confirmed by its successful application in vivo in a mouse model 
of infection (Sassetti & Rubin, 2003). Perhaps the most exciting finding of the in vivo 
study, however, was the demonstation that a significant subset of the genes required for 
growth in vivo are unique to mycobacteria and closely related species and, as such, hold 
considerable promise for new drug development. In recognition of its value as an 
information resource, the TraSH-based classifications have subsequently been added to 
the individual gene descriptions on the TubercuList WWW server  
(http://genolist.pasteur.fr/TubercuList/). Of course, the coverage of mutant libraries is 
dependent on the randomness of the insertion element and may be limited by peculiarities 
in DNA sequence (e.g. G+C content). In addition, the transposon insertion site must be 
determined and there is a risk that false conclusions may be drawn from disruptions that 
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are non-inactivating or confer polar effects on neighbouring genes. Mutants identified by 
certain randomised approaches (such as TraSH) cannot be isolated from the pool for 
further analysis in pure culture, necessitating follow-up by a targeted approach. However, 
modification of experimental models and application of TraSH in specific mutant 
backgrounds is expected to yield many more persistence targets as well as other classes 
of conditionally essential genes, genes of complementary function, and genes in related 
pathways.  
 
Conditional mutagenesis 
By definition, both targeted and random mutagenesis approaches are limited by the fact 
that the disruption – and therefore abrogation of gene function – is permanent. While this 
might not always affect the ability of a mutant to compete (or infect), there is the possibility 
that disruption ab initio is unfairly prejudicial, immediately invalidating the observed 
phenotype. A solution to this problem lies in the development of systems for conditional 
mutagenesis, perhaps allowing alternative persistence targets to be identified by switching 
genes off at a particular stage of infection. In addition, the availability of systems for 
conditional mutagenesis would facilitate the study of essential genes. Inducible expression 
of anti-sense RNA provides one possible approach, and has been validated to some 
extent in preliminary studies (Parish & Stoker, 1997). Methods for generating conditional 
knockouts are critically limited by the urgent need to identify and/or develop tightly 
regulatable promoters for use in mycobacteria. However, two recent studies have applied 
tetracycline-regulated expression systems to construct conditional deletion mutants of M. 
tuberculosis in vitro in liquid culture and macrophages (Blokpoel et al., 2005; Ehrt et al., 
2005), successfully demonstrating the  enormous potential of this technology for the 
control of mycobacterial gene expression in a variety of infection models. 
 
Comparative genomics 
Post-genomic mycobacterial research has been made possible by the completion of the 
genome sequence of the M. tuberculosis strain H37Rv in 1998 (Cole et al., 1998); in 
addition, several other mycobacterial genome-sequencing projects have subsequently 
been completed or are underway - M. bovis (Garnier et al., 2003), M. leprae (Cole et al., 
2001), M. avium, M. marinum, M. microti and M. smegmatis (http://www.sanger.ac.uk; 
http://www.tigr.org), enabling whole-genome comparisons within and between closely 
related species (Marmiesse et al., 2004). The ability to identify patterns of evolutionary 
inheritance through the analysis of homologous or paralogous gene content, or to isolate 
those genes which have been inherited/lost together, can be used to infer essentiality of a 
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host of metabolic and virulence functions, or simply to cluster genes based on 
participation in the same or related biological pathways. In addition, inter-strain genomic 
comparisons provide a more dynamic sense of genome evolution than inter-species 
analyses. The genome sequences of clinical isolates - M. tuberculosis strains CDC1551 
(Fleischmann et al., 2002) and 210 (http://www.tigr.org) - together with the genome 
sequence of the laboratory strain, H37Rv, are providing important insights into inter-strain 
variation (Fleischmann et al., 2002). Furthermore, the application of array-based 
technology enables genome-wide comparisons in the absence of whole-genome 
sequence data; for example, a recent study comparing a large subset of clinical isolates of 
M. tuberculosis with the H37Rv reference strain uncovered significant genome plasticity 
and revealed genes lost in clinical strains (Tsolaki et al., 2004). Of particular relevance is 
the potential to apply the knowledge gained from genomic studies of clinical isolates to 
further refine the list of genes comprising the essential virulence gene set, which could be 
used to restrict targets to those unique mycobacterial genes whose inactivation will not 
adversely affect normal intestinal flora – a problem that has plagued broad-spectrum 
antibiotics and is especially relevant in an HIV-prevalent context. In addition, the 
association of particular strains with host populations has been inferred from an analysis 
of clinical isolates, and could be used to elucidate the possible influences of genetic 
structure on TB prevalences, as well as uncovering the reasons for global variations in 
BCG efficacy (Hirsh et al., 2004). 
 
 
Transcriptional profiling 
Finally, a significant reduction in the duration of treatment will require the development of 
potent sterilising compounds; however, sterilising activity is difficult to measure and 
requires an appropriate model of persistence. In addition, conventional microbiological 
methods for resistance determination may be rendered inapplicable by the fact that 
persistence targets are likely not to be essential to the normal growth of the bacteria. All of 
the above considerations place an extremely high premium on the rapid development and 
validation of models for persistence in which sterilising compounds might be analysed. 
Bacterial mRNA analysis offers a real-time glimpse into the transcriptional response of the 
organism to the imposed environmental or physiological condition, and so is considered 
crucial to the identification and validation of metabolic fingerprints or sentinels associated 
with disease stage. Because RNA-based techniques are not reliant on the ability to detect 
a mutant phenotype, sentinel genes could be of particular use as surrogate markers for 
the rapid evaluation of new treatment regimens for persistent or latent TB infection. This 
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has the further potential of shortening the duration of clinical trials and thus removing a 
significant disincentive to new drug development. RNA-based analyses are, however, 
technically demanding and the results exquisitely sensitive to sample handling and 
preparation (Kendall et al., 2004a). Major technical hurdles remain to be overcome, 
particularly the current inability to extract sufficient high-quality RNA from M. tuberculosis 
in situ. In addition, the use of an appropriate standard in many situations is still to be 
satisfactorily resolved. 
 
1.4 The BCG vaccine 
TB infection and mortality rates are at current levels despite the co-ordinated delivery of 
an antitubercular vaccine - derived by serial in vitro passage of Mycobacterium bovis to 
yield a live attenuated strain, BCG (bacille Calmette-Guérin, after its discoverers) safe for 
use in humans (Behr & Small, 1999) - to approximately 100 million newborns each year 
and more people over the last seventy years than any other vaccine (Kaufmann, 2000). 
Neonatal vaccination with BCG reduces the incidence of childhood TB, particularly the 
more severe forms associated with disseminated disease (Colditz et al., 1995); however, 
despite eliciting a vigorous antigen-specific immune response in most cases, BCG offers 
limited protective efficacy against adult pulmonary TB (Fine, 1995; Behr & Small, 1997; 
Brewer, 2000; Kaufmann, 2001). Critically, vaccination with BCG is unable to prevent 
infection (Fine, 1995) - analogous to the failure of a previous M. tuberculosis infection 
itself to thwart reinfection in high-prevalence areas (van Rie et al., 1999; Sonnenberg et 
al., 2001) - and it is estimated that the variable efficacy results in prevention of only a 
small percentage of all vaccine-preventable TB fatalities (Kaufmann, 2000). Failure of 
BCG in humans is in direct contrast to the reliable protection generally afforded in animal 
models (Smith, 1985), and has been attributed to many factors thought likely to impact on 
the immunogenicity of the vaccine. These relate primarily to differences in the delivered 
strains or vaccination protocols, and include variations ascribed to continual subculturing 
with resultant chromosomal deletions and loss of antigenicity, differential viabilities of the 
attenuated strains, routes of vaccine delivery, intervals between boosts, and effective 
dose (Mahairas et al., 1996, Behr & Small, 1997; Power et al., 1998; Behr et al., 1999; 
Gordon et al., 1999; Griffin et al., 1999; Jungblut et al., 1999; Turner et al., 2000). In 
addition, pre-exposure to naturally-occurring, nonpathogenic environmental mycobacteria 
is thought to antagonise the protective efficacy of the BCG vaccine (Fine, 1995; Brandt et 
al., 2002). 
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Prospects for a new vaccine 
Precedent dictates that the global control and, ultimately, elimination of an infectious 
pathogen is dependent on the ability to prevent the acquisition of disease by susceptible 
individuals (Henderson, 1998; Enarson, 2000). The development of an effective 
prophylactic strategy for TB is therefore crucial. However, persistence of M. tuberculosis 
in the host implies a critical failure to induce maximum immune protection - a 
phenomenon profoundly realised in the post-primary reactivation and reinfection events 
that characterise high prevalence areas (van Rie et al., 1999; Sonnenberg et al., 2001) - 
and demands that a preventive vaccine induce a response superior to that evoked by M. 
tuberculosis itself (Kaufmann, 2000). Several key factors render the design of a new 
antitubercular vaccine unusual, however. For example, the prominent role of T cell-
mediated immunity in controlling M. tuberculosis infection suggests that the recruitment of 
this subset should be prioritised, especially since the contribution of B cells or antibodies 
to control of TB remains controversial (Flynn, 2004). In addition, the enormous burden of 
clinically latent bacteria raises the option of immunotherapeutic vaccination, a prospect 
given further impetus by the potentially increasing requirement for vaccine therapy of co-
HIV- or MDR-TB-infected cases (Blower & Chou, 2004; Cohen & Murray, 2004). 
Approaches to TB vaccine development are characterised by differences in the delivered 
immunogen and the response evoked. Subunit vaccines, comprising adjuvenated or 
expressed antigens, elicit strong CD4+ T cell responses and allow prior selection of 
proteins of known antigenicity, but are limited by the restricted epitopic subset and T cell 
repertoires induced. Despite positive outcomes in murine models (Horwitz et al., 1995), 
subunit vaccines have consistently proved inferior to BCG in the more susceptible guinea 
pig model (Baldwin et al., 1998; Orme et al., 2001); recently, however, an antigen 
85B/ESAT-6 fusion protein conferred protection equivalent to that afforded by BCG (Olsen 
et al., 2004). The fact that subunit vaccines are not compromised by prior exposure to 
environmental bacteria potentially recommends their use in settings in which BCG is 
ineffective; in addition, cell-free preparations are considered safer for use in 
immunocompromised individuals and may render BCG-equivalent levels of protection 
acceptable for further development. 
 
Whole bacterial vaccines, comprising live-attenuated mycobacterial strains, benefit from 
an expanded epitopic repertoire and the broad stimulation of T cell populations 
(Kaufmann, 2000), while recombinant strains expressing additional antigens or 
immunomodulators could potentiate activity. It is likely that an M. tuberculosis-derived 
vaccine will offer increased immunogenicity over BCG (Behr & Small, 1997), however 
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serious safety concerns militate against using attenuated M. tuberculosis mutants or even 
recombinant BCG strains against a background of diminished immunocompetence (Talbot 
et al., 1997; Reynes et al., 2000). Furthermore, the heterogeneous immune mechanisms 
controlling infection and maintaining latent TB are incompletely understood (Flynn, 2004). 
Critically, unlike subunit vaccines, whole bacterial vaccines must exhibit significant 
improvement over the existing strain in order to be pursued. In addition, the demand that 
an M. tuberculosis-derived vaccine be at least as safe as BCG requires mutants 
sufficiently attenuated but not impaired in their immunogenicity or ability to confer long-
term protection. Several attenuated M. tuberculosis strains offer marginal improvements 
over BCG in animal models (Jackson et al., 1999; Hondalus et al., 2000; 
Sambandamurthy et al., 2002, 2005) and, although not all have been applied in protective 
assays, the characterisation of the in vivo phenotypes associated with vaccine candidates 
has provided significant insight into the host-pathogen interactions mediating the various 
stages of disease, including the mechanisms employed by M. tuberculosis in modulating 
innate and adaptive immune responses (Hingley-Wilson et al., 2003). In particular, the 
phenotypes associated with attenuated persistence (per) or pathology (pat) of disease 
have enabled identification of novel attenuations that might be more safely exploited in 
immune-deficient backgrounds or for prophylaxis against latent infection. Attempts at 
enhancing the existing BCG strain tend towards combination vaccines, and have included 
the construction of recombinant BCG overexpressing specific mycobacterial antigens 
(Horwitz et al., 2000; Horwitz & Harth, 2003), or complemented with the primary BCG 
attenuation deletion, RD1 (Pym et al., 2003). Recently, RD1-complemented recombinant 
M. microti induced superior protective efficacy in the mouse and guinea pig models 
(Brodin et al., 2004). In addition, immunogens from a host of other organisms (Stover et 
al., 1991; Snewin et al., 2001), as well as enzymes conferring extrinsic activities (Hess et 
al., 1998), have been added to BCG with mixed efficacies. However, despite promising 
evidence of the potential of vaccine-mediated immunomodulation to maximise 
antitubercular activity (Lowrie et al., 1999), studies describing BCG strains secreting 
various cytokines have yielded disappointing results (O’Donnell et al., 1994; Kong & 
Kunimoto, 1995; Murray et al., 1996). Finally, the protacted periods inevitably required to 
assess the protective efficacy of a new pre-exposure vaccine are untenable and demand 
the identification of quantitative immunological correlates of protection (Kaufmann, 2000). 
In this respect, therapeutic vaccines constitute an attractive proposition since clinical trials 
in at-risk populations could proceed without compromising existing BCG vaccination 
programmes (Stewart et al., 2003). However, several vaccines of demonstrated efficacy 
as pre-exposure vaccines fail to reduce CFU when administered post-exposure (Turner et 
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al., 2000; Kaplan et al., 2003). Moreover, the risk that the resultant increase in immune 
activation might exacerbate pathology at sites of pre-existing infection (Moreira et al., 
2002) requires that the effects of chronic immunostimulation, particularly the potential to 
aggravate occult disease or develop Koch toxicity, be minimised (Kaplan et al., 2003). 
 
DNA vaccines 
The reliance on cell-mediated immunity for the control of mycobacterial infections 
immediately suggests DNA vaccines as potential antitubercular immunoprophylactics. 
Bacterial DNA is both a natural adjuvant and mitogen, and DNA vaccines elicit strong 
humoral and cellular immune responses, making them attractive candidates for control of 
intracellular pathogens. The contribution of B cells or antibodies to protection against M. 
tuberculosis infection is, however, controversial (Flynn, 2004) and might be less significant 
than for pathogens with an extracellular stage in their replication cycle (Huygen, 2003). 
Interaction of an unmethylated CpG-containing DNA motif with receptors on the antigen 
presenting cell surface induces a T helper type 1 (TH1) response (Klinman et al., 1996; 
Hemmi et al., 2000); in addition, both exogenous and endogenous antigen presentation 
pathways are stimulated by bacterial DNA, and vaccines can be formulated to target 
specific cellular compartments for antigen processing (Delogu et al., 2000). Nevertheless, 
the hallmark of DNA vaccines remains the strong CD8+ T cell-mediated response elicited, 
closely resembling that induced by live pathogens and unlike the CD4+ T cell response 
induced by vaccines based on protein antigens or killed pathogens (Huygen, 2003). DNA 
vaccines encoding a range of secreted, surface-associated, and cytosolic mycobacterial 
antigens have been described (Huygen et al., 1996; Tascon et al., 1996; Kamath et al., 
1999; Li et al., 1999; Lowrie et al., 1999; Tanghe et al., 1999; Huygen, 2003). Strong 
humoral, cytotoxic T lymphocyte, and TH1-based cellular immune responses have been 
reported, as well as an expansion in the epitopic repertoire of T cells in comparison with 
live M. tuberculosis or BCG (Denis et al., 1998; Tanghe et al., 2001; D’Souza et al., 2003), 
perhaps as a result subdominant epitopes (Huygen, 2003). However, none of the 
vaccines displays better protective efficacy than BCG, although coimmunisation with 
different DNA vectors in multisubunit vaccines has shown additive effects (Kamath et al., 
1999; Delogu et al., 2002). In addition, vaccination regimens combining both BCG and 
DNA hold some promise; for example, prime-boost strategies (McShane et al., 2002) and 
immunisation with BCG adjuvenated in CpG oligondeoxynucleotides (Freidag et al., 
2000). At the very least, the proven efficacy of DNA vaccines in eliciting an immune 
response (Huygen et al., 1996; Tascon et al., 1996; Lowrie et al., 1999) renders them 
useful candidates for the screening of potential protective antigens and characterisation of 
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dominant motifs, particularly in the absence of a referential framework governing the 
immunogenic potential of M. tuberculosis proteins (Kaufmann, 2000; Huygen, 2003). 
 
A common theme that has emerged is the difficulty in ascertaining the reason for a 
particular DNA vaccine’s failure. Of course, immunogenicity of the encoded peptide is 
primary, and epitopic repertoire is likely to depend on the structural integrity of the 
translated protein. However, several other variables have been implicated in determining 
relative protective efficacies (Huygen, 2003), including CpG content - specifically the 
proportion of immunostimulatory and neutralising motifs (Sato et al., 1996; Krieg et al., 
1998), the physical structure of the plasmid vector (Huygen, 2003), the dose applied and 
mode of delivery, and the transfection efficiency and amount of antigen actually 
synthesised (Gurunathan et al., 2000). Comparisons between different vaccines are also 
dependent on the experimental methodology employed, such that the virulence of the M. 
tuberculosis strain, and route and interval between final immunisation and challenge, all 
impact on the measured outcome (Huygen, 2003). In addition, the relative effectiveness of 
the immune response evoked depends on the antigen, the genetic background of the 
host, and the stage of infection – factors of particular relevance for protective versus 
therapeutic vaccination (Huygen, 2003). Finally, post-exposure DNA vaccination offers the 
prospect of modifying, or augmenting, the immune mechanisms maintaining a persistent 
M. tuberculosis infection in check  (Stewart et al., 2003; Flynn, 2004). Stimulation with 
alternative antigens might recruit additional T cell clones, thereby expanding the T cell 
repertoire or, at the very least, potentiating the existing response. However, the immune 
components interacting to contain a persistent infection are complex and modulation 
potentially fraught (Moreira et al., 2002; Taylor et al., 2003). Perhaps unsurprisingly, trials 
to date of DNA vaccines for immunotherapy of TB have proved controversial, and difficult 
to replicate (Lowrie et al., 1999; Turner et al., 2000; Repique et al., 2002). In addition, 
post-exposure vaccination might result in exacerbated Koch-type pathology (Turner et al., 
2000; Taylor et al., 2003), although this is not a DNA vaccine-specific phenomenon and is 
likely caused by excess tumour necrosis factor (TNF)-a at the infection foci (Bekker et al., 
2000; Moreira et al., 2002). 
 
1.5 Antituberculous immunity 
The tubercle bacillus is transmitted between human hosts almost exclusively through the 
respiratory tract. Airborne infectious droplet nuclei are inhaled and drawn deep into the 
lung alveoli where the bacilli lodge in terminal air spaces and are engulfed by resident 
alveolar macrophages (Rook & Bloom, 1994). Although able to destroy most potential 
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bacterial pathogens, alveolar macrophages are rendered impotent by several effective 
counter-mechanisms which enable M. tuberculosis to survive even the most potent 
antimicrobial effector functions (Russell, 2001). Unlike bacteria whose pathogenesis is 
dependent on the avoidance of phagocytosis, M. tuberculosis preferentially targets 
intracellular vacuoles and utilises multiple surface receptors to enter macrophages 
(Zimmerli et al., 1996; Schorey et al., 1997; Ernst, 1998; Aderem & Underhill, 1999), the 
choice of receptor likely determining the cellular response (Schlesinger et al., 1990; 
Wright & Silverstein, 1983). In addition, tubercle bacilli interfere in the normal maturation 
of phagosomes (Chua et al., 2004). After uptake by alveolar macrophages, intracellular 
replication of the bacilli ensues virtually unimpeded, culminating in the lysis of the infected 
cell and the subsequent engulfment of extracellular bacilli. The macrophages and 
monocytes attracted to the infection foci at this stage are equally incapable of effecting 
mycobacterial killing, and a second round of intracellular replication inside immature 
macrophages follows (Grosset, 2003). Bacillaemia enables the migration of bacteria 
inside dendritic cells (Geijtenbeek et al., 2003; Tailleux et al., 2003) to uninfected areas of 
the lung as well as extra-pulmonary organs (Monack et al., 2004). However, the onset of 
acquired cell mediated immunity is triggered by the dissemination of bacilli to extra-
pulmonary lymphoid organs, and is followed by a delayed-type hypersensitivity (DTH) 
reaction (Balasubramanian et al., 1994; Kaufmann, 2001; Grosset, 2003). In most cases, 
the cell-mediated immune response effectively controls the infection and subsequent 
dissemination; of all infected individuals approximately 5-10% develop clinical disease, 
either within one or two years of the initial infection, or later, as a result of re-infection or 
reactivation of a latent population of viable bacilli persisting after the initial containment 
(Bloom & Murray, 1992). Therefore, although initial parasitisation of the human host is 
successful, primary infection is almost invariably asymptomatic. Critically, post-primary 
disease, comprising subsequent reactivation or reinfection, results from the failure of the 
immune system to exercise sterilising immunity. Surviving intra-phagosomal bacteria are 
believed to enter a state analagous to non-replicating persistence (NRP) in vitro until 
waning host immunity leads to reactivation from latency and the onset of disease (Wayne 
& Sohaskey, 2001).  Fundamental questions therefore pertain to the ability of a population 
of viable M. tuberculosis bacilli to survive - and perhaps monitor (Boshoff & Barry, 2005) - 
the immune response, and several counterimmune and immunomodulatory mechanisms 
have been proposed. These include the evasion of active immune surveillance within 
tubercles; the localised subversion of the immune response, for example through 
interference in interferon (IFN)-g signalling (Ting et al., 1999; Noss et al., 2000; Kincaid & 
Ernst, 2003) or down-regulation of immune modulators such as interleukin (IL)-12 
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(Hickman et al., 2002; Nau et al., 2002); the possible development of phenotypic tolerance 
of immune-mediated effectors as a result of stress regulon induction or metabolic 
alteration (Stewart et al., 2003); and the activity of detoxification or damage repair 
mechanisms. In addition, occupation of non-professional phagocytes lacking MHC II 
antigen presentation has been suggested as another persistence mechanism 
(Hernandez-Pando et al., 2000). Alternatively, it has been suggested that the stable 
maintenance of a low-level persistent infection could result from the auto-modulation of 
the immune response by the host to avoid pathological damage in excess of the risk 
posed by the residual population, while simultaneously maintaining immune memory 
(Stewart et al., 2003). 
 
Cell-mediated immunity 
Protective acquired immunity to M. tuberculosis is dominated by a TH1 immune response 
mediated by CD4+ T cells and accessory CD8+, gd and CD1-restricted ab T cells, and 
characterised by the TH1 cytokines IFN-g and IL-12 (Murray, 1999; Flynn & Chan, 2001a; 
Kaufmann, 2001). Phagocytosis of M. tuberculosis bacilli by macrophages and dendritic 
cells induces a TH1 profile (Henderson et al., 1997; Ladel et al., 1997b): CD4+ T cells, 
stimulated by IL-12 and able to interact with peptides presented by Class II major 
histocompatibility (MHC) molecules, release IFN-g which in turn activates macrophages 
(Flynn & Chan, 2001a). IFN-g is a primary component of antimycobacterial immunity, 
mediating the upregulation of a large number of macrophage pathways (Ehrt et al., 2001), 
including the production by phagosome NADPH oxidase (phox) and inducible nitric oxide 
synthase (iNOS) of reactive oxygen (ROI) and nitrogen (RNI) intermediates, respectively 
(Nathan & Shiloh, 2000). Significantly, recent evidence suggests that the immune status 
of the macrophage (type-1 versus type-2) is critical to bacillary persistence, and that IFN-g 
production might dependent on the production of IL-23 rather than IL-12 (Verreck et al., 
2004). Release of IFN-g also induces expression of a vacuolar trafficking component 
required for maturation of M. tuberculosis-containing phagosomes (MacMicking et al., 
2003). Stark evidence of the importance of CD4+ T cells in protective immunity is provided 
by the pathogenic synergy between HIV and TB - it is estimated that HIV-positive PPD-
positive patients have an 8-10% annual risk of developing active tuberculosis as opposed 
to a 10% lifetime risk in HIV-negative PPD-positive individuals (Selwyn et al., 1989; 
Chaisson & Benson, 1995), while in situ analysis of lung lesions from incurable TB 
patients reveals a failure to recruit CD4+ and CD8+ T cells to cavity surfaces resulting in 
deficient macrophage activation and rampant bacillary replication (Kaplan et al., 2003). 
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The mycobacterial cell wall in immune modulation 
A significant proportion of the M. tuberculosis genome is dedicated to putative lipid 
biosynthetic functions (Cole et al., 1998). Many cell wall-associated molecules have 
potent biological activity and are likely to be prominent in modulating the innate and 
adaptive immune responses (Brennan, 2003). For example, lipoarabinomannan inhibits 
IFN-g-mediated macrophage activation in vitro (Sibley et al., 1988, 1990) and can induce 
production of TNF-a by macrophages (Chatterjee et al., 1992), while the interaction of 
mannose-capped lipoarabinomannan with dendritic cell receptors reduces 
antimycobacterial activity and stimulates the release of anti-inflammatory cytokines 
(Geijtenbeek et al., 2003; Tailleux et al., 2003). Recently, M. tuberculosis was shown to 
modulate apoptotic pathways in both macrophages and polymorphonuclear neutrophils 
(PMNs) – preventing apoptosis in infected macrophages (Sly et al., 2003), but promoting 
in vitro apoptosis of PMNs from patients with active TB (Alemán et al., 2004). The 
observation that virulent M. tuberculosis strains elicit different innate immune responses 
associated with differential infection outcomes (Manca et al., 1999b, 2001, 2004) further 
suggests that the signalling network induced by the interaction of host innate immune 
components with bacterial surface motifs might direct the subsequent course of infection 
(Stewart et al., 2003).  
 
Immune-mediated tissue damage 
A feature of TB is that the (“inappropriate”) host immune response, rather than the 
inherent toxicity of the bacillus, defines the disease (Condos et al., 1998; Schluger & Rom, 
1998; Dannenberg & Collins, 2001; Glickman & Jacobs, 2001), prompting the proposal 
that the organism’s most virulent property might be the ability to induce the destructive 
lung pathology that likely aids transmission (Flynn, 2004). Consistent with the potentially 
active dynamic established between host immunity and M. tuberculosis is the 
demonstration that the efficacy of the protective response is reduced if challenged with 
dead as opposed to live bacilli (Bloch & Segal, 1955; Orme, 1988), and that antigenic 
composition is a function of growth phase (Shi et al., 2004). Compelling evidence of the 
importance of host immune-mediated tissue damage in progression of pulmonary TB is 
provided by the pathology (pat) class of in vivo mutants (Hingley-Wilson et al., 2003), 
deficient in their ability to cause characteristic lung pathology despite exhibiting no growth 
defect in the presence of functional innate or acquired immune responses (Kaushal et al., 
2002; Steyn et al., 2002).  In particular, the observation that attenuation of virulence in pat 
mutants correlates with diminished immuno- and histopathology indicates that the 
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adaptive immune response induced by undefined, wild-type M. tuberculosis virulence 
mechanisms is the cause of typical tissue pathology and, ultimately, death. Further 
investigation of the mechanisms mediating the reduced pathology in these mutants, 
especially the potential induction of differential immunomodulatory profiles, is required to 
understand the immunopathological responses that characterise and determine disease 
progression (Hingley-Wilson et al., 2003). 
 
1.6 Probing the in vivo environment 
Recent advances in RNA-based technologies have shifted the focus of mycobacterial 
genetics to the analysis of gene expression profiles (Schnappinger et al., 2003). An 
unresolved (Kendall et al., 2004b), but fundamental assumption underlying the use of 
expression analysis to probe the in vivo environment is that the differential expression of a 
gene provides direct evidence of its utility in that environment; that is, the encoded product 
is necessary for adaptation to the given condition. Based on this assumption, sentinel 
genes can be used as surrogate markers to probe prevailing physiological or 
environmental conditions. Such markers have already been employed to provide some 
measure of the appropriateness of particular model systems (Fenhalls et al., 2002b) and 
to investigate the M. tuberculosis response to environments encountered in vitro (Betts et 
al., 2002; Fisher et al., 2002; Ohno et al., 2003; Schnappinger et al., 2003; Voskuil et al., 
2003, 2004), in mice (Shi et al., 2003; Timm et al., 2003) and in humans (Timm et al., 
2003) using samples containing relatively large numbers of bacilli. Realisation of the full 
potential of mRNA analysis tools is completely reliant on the ability to isolate RNA from 
bacteria grown in vivo; however, current studies are critically limited by a technical inability 
to extract mycobacterial RNA of sufficient quantity and quality from infected lesions in vivo 
to enable whole-genome expression profiling by microarray although analysis by RT-PCR-
based methods has yielded some insight (Timm et al., 2003). In a novel attempt to 
partially overcome the stated technical limitations, bacterial RNA extracted from isogenic 
mice that had been simultaneously infected was recently pooled for investigation (Talaat 
et al., 2004); however, in situ analysis of M. tuberculosis RNA transcripts in human lung 
tissue has demonstrated that each granuloma comprises a compact microenvironment 
characterised by a unique cytokine profile (Fenhalls et al. 2000; 2002a), therefore limiting 
the validity of pooling tissue samples from even a single individual. Clearly, a 
technological leap in RNA isolation methodologies and detection sensitivity will be 
required before expression profiling of samples obtained from the paucibacillary lesions of 
humans with latent TB infection could be considered, even at the single-gene level. 
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1.7 Tuberculous granulomas 
In the presence of a functional adaptive immune system, TB bacilli are sequestered in 
granulomas comprising differentiated macrophages and surrounded by lymphocytes and 
other immune cells maintained in complex structures by extracellular matrix components 
(Flynn & Chan, 2001a; Cosma et al., 2003). Containment of bacilli within granulomas is 
essential for restriction of disease, limiting the spread of the infection and localising 
immune cell activity. A defective immune response, for example in HIV infection, is 
characterised by impaired granuloma integrity and more disseminated and lethal forms of 
TB (Lawn et al., 2002; Frieden et al., 2003). Inside granulomas, bacilli persist within 
macrophages or are found extracellularly in the central necrotic milieu typical of caseation 
(Grosset, 2003). In approximately 90% of immunocompetent individuals, cell mediated 
immunity results in the death of the bacilli within organised necrotising caseous lesions 
that are sealed off from surrounding tissue by fibrotic capsules and may eventually calcify 
and even ossify (Styblo et al., 1969; Sutherland, 1976; Chan & Kaufmann, 1994; Enarson 
& Rouillon, 1994). In some cases, no modification of the caseous centre occurs, and 
bacilli are thought to persist extracellularly within undefined lesions in states of low 
metabolic activity (Canetti, 1955; Rees & Hart, 1961; Hu et al., 2000; Bouley et al., 2001; 
Grosset, 2003; Muñoz-Elías et al., 2005). Alternatively, in the remaining minority of cases 
(between 5-10% of infected individuals), the caseum softens, and the release of bacilli into 
the oxygen-rich lung results in the progression of infection to pulmonary cavitation and 
clinical disease (Long, 1935; Canetti, 1955; Enarson & Rouillon, 1994; Bloom & Murray, 
1992). Whatever the eventual outcome, at some time post initial infection bacilli in 
immunocompetent individuals are enclosed within granulomas likely characterised by 
hypoxia, low pH, nutrient deprivation, and awash in inhibitory organic acids (Loebel et al., 
1933; Nyka, 1967, 1974; Schnappinger et al., 2003; Boshoff & Barry, 2005). In addition, 
through the course of the infection, the tubercle bacilli probably endure continual exposure 
to ROI and RNI produced by polymorphonuclear leukocytes and macrophages recruited 
and activated by the expanding T cell population (Nathan, 1992; Nicholson et al., 1996; 
MacMicking et al., 1997b; Lau et al., 1998; Wang et al., 1998; Chan & Flynn, 1999; 
Nathan & Shiloh, 2000).  
 
While some resistance to antimicrobial defences is provided by the thick mycobacterial 
cell wall, survival in the hostile host environment – and therefore persistence of M. 
tuberculosis in the human population – is thought to depend on a number of mechanisms 
that have evolved to enable the TB bacillus to evade host immune detection, or subvert or 
detoxify antimicrobial defences. A possible codicil is provided by recent evidence 
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describing the inability of established granulomas to eradicate naïve superinfecting 
mycobacteria despite the specific, monocyte-directed trafficking of these bacilli to existing 
lesions (Cosma et al., 2004). This surprising finding suggests that, rather than the innate 
ability of M. tuberculosis to avoid host immune responses or adapt gradually to evolving 
host defence mechanisms, persistence and reinfection might be predicated on a 
fundamental inability of the host immune response to eradicate M. tuberculosis infection 
(Cosma et al., 2004). In particular, the observation that, despite a robust CD4+ T cell 
response, all intracellular bacteria are not eliminated seems to  imply a critical failure of 
that T cell subset to recognise or activate infected macrophages (Flynn, 2004), analogous 
to the decreased macrophage activation as a result of deficient CD4+ and CD8+ T cell 
recruitment to the cavity surface that has been implicated in uncontrolled human TB 
(Kaplan et al., 2003). Nevertheless, the failure of the host to exert a sterilising immunity 
requires the capacity of the bacilli to endure, in some cases for years or even decades. An 
apparently static balance is established between the host immune system and the 
pathogen’s resistance (Rees & Hart, 1961; Muñoz-Elías et al., 2005), the breakdown of 
which is evidenced in the increased incidence of reactivation disease in the face of HIV 
infection (Selwyn et al., 1989), immunosuppressive medication (Keane et al., 2001), 
malnutrition, alcohol and drug abuse, and old-age (Stead, 1967). Several possible 
bacillary survival tactics and metabolic adaptations are considered briefly below, with 
some emphasis on the types of DNA damage likely to be incurred by the bacilli during 
their occupation of granulomas, the possible mechanisms that have evolved to minimise 
or repair that damage, and the potential physiological and mutagenic consequences, 
particularly with respect to the emergence of drug resistant clinical isolates. 
 
Phagosome maturation arrest 
Persistence of M. tuberculosis hinges on its ability to survive (and replicate) in pathogen-
friendly phagosomes in unactivated macrophages for extended periods. After phagocytic 
uptake, M. tuberculosis interrupts the normal maturation pathway (Clemens & Horwitz, 
1995; Hasan et al., 1997; Via et al., 1997; Fratti et al., 2001; Fratti et al., 2003b; Chua et 
al., 2004), preventing phagosome-lysosome fusion (Armstrong & Hart, 1971; Mwandumba 
et al., 2004), and ensuring a M. tuberculosis-infected phagosome characterised by limited 
acidification and a deficiency of mature lysosomal hydrolases (Russell et al., 2002). 
Phagosome maturation arrest is a complex process, mediated primarily by the 
interference of mycobacterial lipid products in intracellular trafficking events (Chua et al., 
2004). Despite the resultant incomplete acquisition of lysosomal compartments, the 
mycobacterial phagosome is not a static organelle (Clemens & Horwitz, 1996; Sturgill-
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Koszycki et al., 1996), and recent studies have emphasised the importance of bioactive 
lipids in the mycobacterial cell envelope in continually modulating host cell membrane 
sorting and organelle biogenesis pathways (Fratti et al., 2001, 2003a, 2003b; Vergne et 
al., 2003; Chua et al., 2004). Importantly, the roles of these M. tuberculosis-derived 
glycophosholipids can be reconciled with other identified arrest mechanisms (Fratti et al., 
2003a; Vergne et al., 2003). Of course, additional strategies might also be implicated and 
the range of genotypes observed in a recent screen of mutants impaired in their ability to 
cause phagosome maturation arrest suggests that the process is likely to be multifactorial  
(Pethe et al., 2004). Numerous studies have reported different in vitro susceptibilities of M. 
tuberculosis strains to ROI (Jackett et al., 1978; Laochumroonvorapong et al., 1997; 
Manca et al., 1999a; Firmani & Riley, 2002) and RNI (Friedman et al., 1997; O’Brien et al., 
1994; Rhoades & Orme, 1997; Yu et al., 1999; Firmani & Riley, 2002). However, the 
observation that the virulence of different clinical M. tuberculosis isolates does not 
correlate with an ability to modulate the amount of NO generated within the macrophage, 
or with susceptibility to RNI in vitro or in tissue culture models (Rhoades & Orme, 1997), 
or even in vivo (Ordway et al., 1995), strongly suggests that virulence is asscociated with 
more effective interference in maturation pathways (Deretic & Fratti, 1999; Zahrt & 
Deretic, 2002). In addition, evidence of the ability of M. marinum to persist in 
phagolysosomes within granulomas (Bouley et al., 2001) indicates that mycobacteria 
might have evolved at least two adaptive strategies for intramacrophage survival. 
 
1.8 Intracellular survival and metabolism 
The development of intervention strategies to reduce progression from latent to active 
disease in the estimated 2 billion individuals already infected is key to global control of TB. 
Novel therapeutics will, however, require an understanding of the mechanisms employed 
by the tubercle bacillus to survive for extended periods in immunologically educated hosts. 
Currently, there is a critical lack of a tractable, inexpensive animal model which replicates 
all aspects of latent disease (Flynn & Chan, 2001b; Boshoff & Barry, 2005). The murine 
model, in various modified forms (McCune & Tompsett, 1956; McCune et al., 1956; de Wit 
et al., 1995) is widely employed primarily because of its economy - relative to the more 
expensive, though potentially more relevant guinea pig, rabbit, or non-human primate 
models (Boshoff & Barry, 2005) - as well as the commercial availabilty of genetically and 
immunologically well-defined mice. However, while similarly reliant on a TH1-type 
response for initial control of M. tuberculosis infection, the progression of the disease in 
mice versus humans is characterised by fundamental differences, particularly with respect 
to bacillary dissemination, granuloma formation and histopathology, and viable bacillary 
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counts during chronic persistence (McMurray et al., 1996; Dannenberg & Collins, 2001; 
Duncan & Barry, 2004). In addition, while NO and RNI are the primary effectors mediating 
immune control during persistence in the mouse model (Chan et al., 1995; MacMicking et 
al., 1997a), in vitro attempts to stimulate iNOS expression in human mononuclear 
phagocytes have proved inconclusive (Shiloh & Nathan, 2000) although 
immunohistochemical studies have readily detected iNOS expression in inflamed or 
infected sites, as well as the increased exhalation of NO by tuberculosis patients 
(Nicholson et al., 1996; Wang et al., 1998; Weinberg, 1998). Oxygen availability within 
murine granulomas, too, might differ significantly from human TB, consistent with the 
disposability of dosR for virulence in a mouse model (Parish et al., 2003a) and in contrast 
to observations in the guinea pig model (Malhotra et al., 2004).  
 
Despite the questionable relevance of existing animal and tissue culture models of 
infection to human TB (Graham & Clark-Curtiss, 1999; McKinney et al., 2001; Boshoff & 
Barry, 2005), wild-type and gene-deleted mutant mycobacterial strains have been 
profitably applied as bioprobes in several such models and in vitro to refine our 
understanding of the host environment, particularly as exists within the mycobacterial 
phagosome. Evidence suggests that persisting bacilli are metabolically active (Sever & 
Youmans, 1957; Hu et al., 2000; Bouley et al., 2001) and, in vitro, adapt sufficiently to 
long-term non-replication to re-initiate cellular division (Hampshire et al., 2004). Re-
activation and chromosomal division after long-term adaptation to starvation is suggested 
by the upregulation of genes involved in DNA repair and replication, as well as cell wall 
elongation (Hampshire et al., 2004). Several stresses have been applied to mimic the 
stimuli for entry into a state of NRP, including various models of nutrient starvation (Betts 
et al., 2002; Dahl et al., 2003), oxygen limitation (Wayne & Hayes, 1996; Boon & Dick, 
2002), stationary-phase adaptation (Hampshire et al., 2004; Voskuil et al., 2004) and 
exposure to low-dose nitric oxide (Voskuil et al., 2003). Analysis of gene expression in 
response to each of these conditions, as well as phenotypic and physiological 
characterisation, has validated the relevance of each to in vivo stress; for example, 
starvation in distilled water or PBS yields bacilli with altered morphology and acid-fast 
staining properties similar to M. tuberculosis isolated from lung lesions (Nyka, 1974), while 
oxygen-starved, stationary-phase cells are phenotypically antibiotic tolerant (Hu et al., 
1998; Wayne & Sohaskey, 2001). Conversely, bacilli harvested from chronically infected 
mice exhibit enhanced thermal resistance characteristic of stationary-phase adaptation 
(Wallace, 1961). Selective in situ analysis of RNA expression levels in murine and human 
lung tissue has corroborated some of the in vitro models (Fenhalls et al., 2002b; Shi et al., 
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2003; Timm et al., 2003; Talaat et al., 2004). Critically, the differential gene expression of 
selected M. tuberculosis genes in lung tissue sections of human TB patients has shown 
that M. tuberculosis responds to specific and variable microenvironments in vivo by 
adopting a variety of metabolic states which are probably defined primarily by host 
immune status and stage of infection (Fenhalls et al., 2002b; Kaplan et al., 2003; Timm et 
al., 2003). 
 
1.9 Gene regulatory pathways 
In an effort to identify those aspects most relevant to survival and adaptation of M. 
tuberculosis in the human host, in vitro models have tended to focus on the altered 
metabolism induced in response to hypoxia, the mechanisms employed to overcome 
nutrient starvation, and the ability of the organism to sustain and respond to structural and 
DNA damage mediated by antibacterial immune effectors such as toxic ROI and RNI. 
Comparison of the expression profiles characterising the response of M. tuberculosis to 
each of these challenges has revealed striking similarities between the transcriptomes 
induced by hypoxia, sublethal doses of nitric oxide, and macrophage infection (Sherman 
et al., 2001; Ohno et al., 2003; Schnappinger et al., 2003; Voskuil et al., 2003); in contrast, 
a distinct transcriptional profile is elicited by starvation or the stringent response (Betts et 
al., 2002; Dahl et al., 2003) indicating that both adaptation to hypoxia and starvation are 
relevant to survival in vivo, but that the relative importance of each is likely to depend on 
the stage of infection. 
 
The DosR dormancy regulon 
Accumulating evidence points to a prominent role for the DosR-DosS/DosT two-
component response regulator (DosR regulon) in mediating the response of M. 
tuberculosis to host immune effectors, particularly NO and hypoxia, and adaptation to 
persistence in the human host (Sherman et al., 2001; Ohno et al., 2003; Park et al., 2003; 
Schnappinger et al., 2003; Shi et al., 2003; Voskuil et al., 2003; Karakousis et al., 2004; 
Roberts et al., 2004). The DosR dormancy regulon comprises over 40 genes induced in 
response to non-toxic NO concentrations and hypoxia (Sherman et al., 2001; Ohno et al., 
2003; Park et al., 2003; Voskuil et al., 2003; Kendall et al., 2004a; Roberts et al., 2004) 
and is required for long-term survival of mycobacteria in vitro in a low oxygen-induced 
dormant state (Boon & Dick, 2002; Voskuil et al., 2003).  Included in the regulon are 
genes associated with anaerobic metabolism and stabilisation of cellular components. In 
addition, six dormancy genes contain UspA motifs; in E. coli, uspA expression is induced 
in response to DNA damage and during nutrient starvation (Nyström & Neidhardt, 1992, 
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1994; Ferianc et al., 1998; Diez et al., 2000; Kvint et al., 2000; Gustavsson et al., 2002), 
and disruption of uspA is associated with impaired survival under stress-induced growth 
arrest (Nyström & Neidhardt, 1993, 1994). It has been suggested (Voskuil et al., 2003) 
that the inclusion of USPs in the DosR regulon, together with the class II ribonucleotide 
reductase (nrdZ), is necessary for the synthesis and preservation of the duplicated 
chromosome characteristic of dormancy in vitro (Wayne, 1977). Although both hypoxia 
and low-dose NO cause M. tuberculosis growth arrest in vitro (Wayne & Hayes, 1996; 
Voskuil et al., 2003), evidence indicates that DosR-regulated dormancy in vivo is IFN-g-, 
and therefore NO-, dependent (Schnappinger et al., 2003; Shi et al., 2003; Karakousis et 
al., 2004). An attractive hypothesis maintains that the host-mediated sequestering of 
tubercle bacilli in encapsulated avascular granulomas induces DosR-mediated 
bacteriostasis through a shift in the balance between oxygen tension and NO 
concentration (Park et al., 2003; Voskuil et al., 2003). Consistent with this model, 
increased transcription of DosR-regulon genes within wild-type murine lungs coincides 
with onset of immunity and bacterial growth arrest, and is delayed in IFN-/- mice; in 
addition, in vivo gene expression in this model implies the NO-induced transition of M. 
tuberculosis from active growth to non-replicating persistence (Shi et al., 2003). Moreover, 
the hypervirulence of a dosR mutant in SCID mice implicates T cell-mediated immunity in 
inducing DosR regulatory mechanisms (Parish et al., 2003a). Of course, the possibility 
remains that the dominant role of NO in inducing persistence might be unique to the 
mouse model (Boshoff & Barry, 2005); although it has been suggested that the inferred 
induction of NO synthases (Nicholson et al., 1996; Wang et al., 1998; Weinberg, 1998; 
Choi et al., 2002) and the presence of anti-a-crystallin antibodies in the majority of TB 
cases (Lee et al., 1992) likely indicate that NO is active in tuberculous granulomas and 
might induce a similar response (Voskuil et al., 2003), the relevance of the DosR regulon 
to human TB is currently circumstantial. As has been pointed out (Boshoff & Barry, 2005), 
induction of DosR genes on its own is not sufficient to enable adaptation to long-term NRP 
in vitro since survival is determined by the duration of the transition through the different 
stages of metabolic shutdown (Wayne & Sohaskey, 2001). Furthermore, transcriptional 
profiling has identified components that differentiate the response to oxygen limitation 
from that induced by exposure to low-dose NO (Boshoff et al., 2004), suggesting that 
disruptions to respiratory pathways induce specific regulons (Boshoff & Barry, 2005). 
Evidence of the upregulation of DosR regulon genes in response to in vitro starvation 
(Hampshire et al., 2004) and other stresses (Kendall et al., 2004a) is consistent with the 
presence of independent signalling pathways, and raises the intriguing possibility that 
dormancy genes might be induced by other stimuli in vivo. 
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Other two-component regulatory systems 
Persistence of M. tuberculosis in the human population requires an ability to sense and 
adapt to varying, mainly hostile, conditions. Eubacterial responses to environmental 
stimuli are mediated by two-component regulatory systems (2CRs), comprising a 
membrane-bound “sensor kinase” and a “response regulator”, usually a transcription 
factor (Stock et al., 2000). In response to a particular stimulus, the sensor protein 
autophosphorylates and transfers the phosphate moiety to the effector, which then binds 
to a specific promoter sequence thereby regulating the co-ordinated transcription of a 
particular gene set; in some cases, interaction with additional 2CRs initiates a cascade of 
signalling (Hoch, 2000). Eleven paired 2CRs have been identified in the M. tuberculosis 
genome, as well as four isolated regulators and three isolated sensors (Cole et al., 1998). 
The importance of 2CRs to the ability of M. tuberculosis to sense and respond to different 
stimuli within the host is manifest in the involvement of signal transducers in both 
virulence, for example PhoP (Perez et al., 2001), and persistence, for example MprA 
(Zahrt & Deretic, 2001). Several studies have investigated the effects of 2CR abrogation 
on M. tuberculosis growth and virulence in vivo (Perez et al., 2001; Zahrt & Deretic, 2001; 
Ewann et al., 2002; Parish et al., 2003a , 2003b); however, with the exception of DosR 
(Ohno et al., 2003; Park et al., 2003; Voskuil et al., 2003; Kendall et al., 2004a; Roberts et 
al., 2004) and, to a lesser extent, MprA (He & Zahrt, 2005), the signals mediating 2CR 
induction, the regulons transcribed, and their mechanisms of action remain poorly 
understood. Nevertheless, the demonstration that mutations in different 2CRs are 
associated with both attenuation and hypervirulence is suggestive of the relevance of 
these systems to infection outcomes and, together with the demonstrated absence of 2CR 
homologues in higher organisms, recommends them as potential therapeutic targets 
(Parish et al., 2003a). Significantly, several virulence factors are included in 2CR-regulons 
(Dziejman & Mekalanos, 1995), while the mprA-encoded persistence regulator (Zahrt & 
Deretic, 2001) is located on a putative pathogenicity island absent in saprophytic 
mycobacteria (Talaat et al., 2004). The hypervirulence associated with certain 2CR 
deletions might, therefore, indicate a suppressive regulatory function during initial stages 
of infection, consistent with immune modulation and persistence of the bacilli.  
 
The stringent response 
RelA is the central regulator of the stringent response in most bacteria, catalysing the 
hyperphosphorylation of GTP to (p)ppGpp during amino acid and carbon source 
starvation (Cashel et al., 1996). Binding of the (p)ppGpp alarmone to the RNA polymerase 
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b subunit inhibits transcription of translation machinery components, stimulates amino 
acid biosynthesis and transport operons, and decreases transcription rates (Cashel et al., 
1996; Barker et al., 2001; Chang et al., 2002; Wagner, 2002; Artsimovitch et al., 2004). In 
addition, (p)ppGpp affects the global transcriptional response to changing environmental 
conditions by mediating association of alternative s factors with RNA polymerase (Jishage 
et al., 2002; Laurie et al., 2003). Accumulation of (p)ppGpp has been implicated in 
phenotypic tolerance of antibiotics (Tuomanen, 1986; Greenway & England, 1999; Keren 
et al., 2004), and in enhanced UV survival (McGlynn & Lloyd, 2000). Moreover, (p)ppGpp-
mediated inhibition of transcription in wild-type E. coli triggers toxin/antitoxin-modulated 
programmed cell death  (Aizenman, et al., 1996); induction of suicide modules in 
response to antibiotic treatment, DNA damage, oxidative and environmental stresses, is 
RelA-dependent (Sat et al., 2001, 2003; Hazan et al., 2004). In M. tuberculosis, the 
bifunctional RelMtb (Avarbock et al., 1999) has been implicated in adaptation to nutrient 
stress in vitro (Betts et al., 2002; Hampshire et al., 2004), and inactivation of RelMtb is 
associated with impaired long-term survival under starvation (Primm et al., 2000). Murine 
infection with a relMtb mutant reveals a per phenotype, characterised by an inability to 
establish long-term infection and reduced histopathology (Dahl et al., 2003). Expression of 
a number of persistence and virulence factors appears to be affected by (p)ppGpp levels, 
including members of the antigen 85 complex, the M. tuberculosis complex-associated 
immunogen esat6, the lpqH-encoded 19 kDa lipoprotein (Dahl et al., 2003), mammalian 
cell entry (mce) proteins and several polyketide synthases (Hampshire et al., 2004). In 
addition, (p)ppGpp appears to interact with the ECF s factor, sD, (Betts et al., 2002;  Dahl 
et al., 2003), and evidence suggests that a subset of stringent response genes is sD-
regulated (Raman et al., 2004). Finally, relMtb is induced in vitro in response to hypoxia 
(Sherman et al., 2001), and a murine model of dormancy recently demonstrated that 
extracellular persistence of M. tuberculosis is RelMtb-dependent (Karakousis et al., 2004). 
In vitro, microanaerobic stress elicits the regulated, sequential metabolic shut-down of 
DNA, most RNA, and protein synthesis by M. tuberculosis (Wayne, 1977; Wayne & 
Hayes, 1996; Hu et al., 1998); however, when conditions favour exit from dormancy, M. 
tuberculosis bacilli re-initiate synchronised protein and DNA synthesis almost immediately 
(Wayne, 1977; Hu et al., 1998). It has, therefore, been suggested that (p)ppGpp might 
function to effect M. tuberculosis entry into, and exit from, the nonreplicating state (Mizrahi 
et al., 2005). 
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Mycobacterial s factors 
The reversible interaction of s factors with the prokaryotic RNA polymerase core enables 
modulation of gene expression profiles according to dynamic variations in the effective s 
factor population (Manganelli et al., 2004b). The identification in M. tuberculosis of 
approximately 190 defined and putative transcriptional regulators, including s factors 
(Cole et al., 1998; Fleischmann et al., 2002), is indicative of the complexity of stress 
response regulation, quite often involving the interplay of functionally overlapping and 
redundant regulons (Manganelli et al., 2004b). Evidence suggests that a hierarchy 
characterises s factor interaction, with sH at the summit, although the recent identification 
of a putative promoter motif, upstream of sigH, regulating the RecA/LexA-independent 
DNA damage response pathway (Gamulin et al., 2004) might indicate an additional level 
of control. The prominent role of s factors in mediating physiological adaptation, 
particularly in the face of hostile immune responses, is evident in the dramatic and varying 
phenotypes of s factor mutants in vivo (Chen et al., 2000; Kaushal et al., 2002; Steyn et 
al., 2002; Manganelli et al., 2004a; Raman et al., 2004). Moreover, six of the seven 
targeted or identified s factor disruptions have revealed a role in virulence (sigA, -C, -D, -
E, -F, -H, and not sigB; Manganelli et al., 2004b), and there is evidence that the same s 
factor might mediate separate responses to distinct stages or sites of infection (Chan et 
al., 2002). A diverse range of in vitro stimuli induce s factor responses, including 
starvation (Betts et al., 2002; Dahl et al., 2003; Hampshire et al., 2004), oxidative and 
environmental stresses (DeMaio et al., 1996; Gomez et al., 1997; Hu & Coates, 1999, 
2001; Manabe et al., 1999; Manganelli et al., 1999, 2004b; Michele et al., 1999 ) and 
adaptation to intraphagosomal survival (Graham & Clark-Curtiss, 1999; Manganelli et al., 
2001; Schnappinger et al., 2003); it is expected that the advent of microarray-based 
expression profiling should facilitate identification and more precise characterisation of the 
various s factor regulons and the anti-s factors and anti-anti-s factors providing post-
translational regulation, as well as enabling the definition of specific consensus binding 
motifs (Raman et al., 2001, 2004; Kaushal et al., 2002; Manganelli et al., 2002, 2004b). 
 
1.10 Emergence of drug resistance 
Extended antibiotic chemotherapy is associated with evolution of multiple-antibiotic 
resistance in other bacteria (Baquero & Blázquez, 1997; Lipsitch et al., 2000; Livermore, 
2000), a phenomenon likely to be replicated in M. tuberculosis infection. The long duration 
of the DOTS regimen, together with the toxic side effects of the front-line drugs and the 
temptation to cease therapy as symptoms subside, leads to patient non-compliance 
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(Mitchison, 1992); furthermore, recent epidemiological evidence of the increasing 
emergence of mono- and multidrug-resistant strains suggests that effective (or actual) 
monotherapy is common (WHO, 2004). In addition, several characteristics of the in vivo 
lifestyle render M. tuberculosis a difficult target for conventional antimicrobial 
chemotherapeutics (Pablos-Mendez, 2000). Typical of pathogenic mycobacteria, the 
tubercle bacillus has a long generation time and, in response to environmental conditions, 
is able to establish latent asymptomatic infection mediated by a strictly regulated shift to 
an alternative, decreased metabolic state (Wayne, 1994; McKinney et al., 2000; 
Schnappinger et al., 2003; Voskuil, 2004). Metabolic adaptation may result in specific 
antibiotics being selectively active against discrete sub-populations (Global Alliance for TB 
Drug Development, 2001); furthermore, there is increasing evidence that infecting 
populations occupy diverse microenvironments within the host (Canetti, 1955; Canetti et 
al., 1968; Jindani et al., 1980; Mitchison, 1985; Fenhalls et al., 2002b; Kaplan et al., 2003; 
Boshoff & Barry, 2005), many of which are likely to be recalcitrant to antibiotic penetration 
or refractory to activity (Iseman & Madsen, 1991; Elliott et al., 1995). Although unproven 
for M. tuberculosis, there is also the possibility that adaptation to nutrient stress via the 
stringent response might result in phenotypic tolerance of antimicrobials (Tuomanen, 
1986; Greenway & England, 1999). Non-mutant, specialised survivor cells (“persisters”; 
Bigger, 1944) able to tolerate microbicidal antibiotics have been identified in biofilm and 
stationary-phase populations of several other bacterial pathogens and are thought to 
mimic in vivo persistence (Brooun et al., 2000; Lewis, 2001; Spoering & Lewis, 2001; 
Keren et al., 2004), perhaps mediated by the RelA-associated activity of toxin/antitoxin 
(TA)-modules (Lewis, 2000; Pedersen et al., 2002; Christensen et al., 2003). Although the 
function and regulation of the putative mycobacterial TA genes is still to be elucidated, 
resistance to several frontline antimicrobial compounds is observed during long-term in 
vitro adaptation and correlates with resistance in bacilli recovered from tuberculous 
lesions in vivo (Wayne, 1994; Wayne & Sramek, 1994; Herbert et al., 1996; Wallis et al., 
1999). In addition, recent evidence from E. coli (Balaban et al., 2004; Miller et al., 2004) 
suggests that a switch to a persistent phenotype is favoured where bactericidal antibiotics 
are ineffective against slowly- or non-dividing cells (a characteristic of current front-line 
antituberculars) and is mediated by the SOS response (Miller et al., 2004). 
 
Permeability and efflux 
Altered permeability resulting from the stationary phase-associated thickening of the cell 
wall might be relevant to antimicrobial tolerance in vivo (Cunningham & Spreadbury, 
1998). The concentration achieved by antibiotics inside bacterial cells is a function of cell 
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envelope permeability and the presence of efflux systems capable of extruding toxic 
compounds (Nikaido, 1994). M. tuberculosis is intrinsically resistant to many of the 
antibiotics and chemotherapeutics in current medical use (Jarlier & Nikaido, 1994), at 
least partially because of the relative impermeability of the mycolic acid-rich mycobacterial 
cell wall (Rastogi et al., 1981; Connell & Nikaido, 1994; Brennan & Nikaido, 1995). 
Hydrophilic diffusion is constrained by the limited number and restrictive structure of 
mycobacterial porins (Trias & Benz, 1994; Engelhardt et al., 2002); furthermore, it has 
been shown that the contribution of each of the various classes of mycolic acids to cell 
wall composition varies depending on growth phase and oxygen tension, and differs for in 
vitro versus intraphagosomal survival (Barry & Mdluli, 1996; Yuan et al., 1996, 1998). 
Reduced cell wall permeability accounts to only a certain degree for the inherent 
resistance of mycobacteria, however, and recent evidence indicates a role for efflux 
mechanisms in diminished intracellular drug accummulation (Piddock et al., 2000). 
Mycobacteria, including M. tuberculosis, contain a large number of putative drug efflux 
transporters (Cole et al., 1998; Garnier et al., 2003), including members of the major 
facilitator superfamily (MFS), as well as the multidrug and toxic extrusion, resistance-
nodulation-cell division, small multidrug resistance (SMR), and ATP-binding cassette 
(ABC) families (Li & Nikaido, 2004). Although the contribution of drug transporters to the 
intrinsic resistance of mycobacteria is uncertain, overexpression of MFS transporter 
homologues (Liu et al., 1996; Takiff et al., 1996; Ainsa et al., 1998; Silva et al., 2001), 
results in low-level resistance to fluoroquinolones, aminoglycosides and tetracyclines; 
similarly, the  M. tuberculosis-associated SMR-type pump, encoded by mmr, and the 
drrAB-encoded ABC transporter mediate resistance to several antimicrobials, including 
erythromycin and cationic dyes (De Rossi et al., 1998; Choudhuri et al., 2002). Expression 
of the efpA-encoded M. tuberculosis MFS drug transport homologue is induced after 
isoniazid treatment (Wilson et al., 1999), while disruption of specific efflux pump 
homologues renders M. smegmatis marginally more sensitive to antimycobacterials 
including isoniazid, rifamycins, fluoroquinolones, and erythromycin (Li et al., 2004); in 
addition, the partial dependence of mycobacterial b-lactam resistance on active extrusion 
has been demonstrated in a b-lactamase-deficient M. smegmatis strain (Li et al., 2004). 
Finally, removal of efflux gene regulation confers markedly increased resistance to several 
drugs, perhaps indicating a potential evolutionary mechanism for the development of 
multidrug resistance in pathogenic mycobacteria (Li et al., 2004). 
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Effective antibiotic concentrations 
Mathematical modelling has identified the pre-antibiotic bacterial population size and poor 
adherence to therapeutic regimens as crucial components determining the risk of 
developing drug resistance, as well as resistance outcomes (Lipsitch & Levin, 1998). 
There is an increased probability of selecting resistance mutations during treatment with 
one antibiotic, necessitating the use of at least two antimycobacterials in antitubercular 
therapy. However, even when adhered to, limited efficacy of one or more drugs might 
result in effective monotherapy and thereby erode the potency of the combination, a 
situation exacerbated by bacilli occupying protected compartments in which an antibiotic 
might achieve only subminimum inhibitory concentrations (Lipsitch & Levin, 1998; 
Mitchison, 1998). Parallel evolution of a single founder population into heterogeneous, 
antibiotic-resistant sub-populations within isolated loci has recently been demonstrated in 
patients undergoing active antibiotic treatment for E. coli (Low et al., 2001) and M. 
tuberculosis (Kaplan et al., 2003). Furthermore, evidence from pathogenic infections 
suggests that low-level resistant variants (such as the extended-spectrum TEM β-
lactamases) might evolve during occupation of particular niches within the host in which 
the locally available concentration of an antibiotic (subject to a chemical gradient) selects 
for the different variants (Baquero et al., 1998). In many cases, the specific antibiotic 
concentrations inhibiting the variant and wild-type strains may be extremely close, 
resulting in a narrow selective concentration range. Of course, the narrowness of the 
selective range often results in some low-level resistant mutants being considered 
clinically irrelevant; however, the ability of a given antibiotic concentration (even if very 
low) to select for a particular resistance mutation (even if almost neutral) has profound 
implications for the generation of diverse microbial populations in a single host (Baquero & 
Negri, 1997). In particular, the evolution of high-level resistant mutants may be enhanced 
in vivo in populations in which low-level resistant mutants have been selected and 
maintained in various compartments. The observation that the mutation rate for a given 
antibiotic may change depending on the effective concentration during selection, and that 
different rates and genotypes occur at discontinuous intervals along the spectrum of 
applied concentrations (Kohler et al., 1997; Zhou et al., 2000), has given rise to the 
concept “mutant prevention concentration” which has been used to assess differential 
antibiotic activities and efficacies (Dong et al., 2000; Sindelar et al., 2000). In addition, the 
correlation between antibiotic resistance levels and small increases in mutation rate is 
indicative of the stable evolution of resistant phenotypes (Gustafsson et al., 2003; 
Lindgren et al., 2003). Compelling evidence of the role of antibiotic exposure in eliciting, 
and selecting, resistance mutations is provided by the observation that naïve, wild-type M. 
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tuberculosis isolates are almost invariably antibiotic susceptible (Kochi et al., 1993). 
Preventing replication and spread of M. tuberculosis to relatively sheltered in situ 
compartments, and limiting adaptation of the organism to adverse conditions is therefore 
key, and depends heavily on frontline drugs with early bactericidal activity (Mitchison, 
1993; Herbert et al., 1996; Wallis et al., 1999). 
 
Molecular mechanisms of resistance 
Bacterial diseases generally result from the multiplication of a single infecting pathogenic 
strain (Moxon & Murphy, 1978; Rubin, 1987) that subsequently acquires resistance 
through serial mutagenesis and only rarely through horizontal genetic transfer (Moxon et 
al., 1994). This is particularly true of pathogens whose preferential occupation of specific 
environments within the host restricts the opportunities for the acquisition of novel, 
transmissible genetic elements. The typical aetiology of TB - early, acute infection 
followed by extended immune-mediated isolation and latency - suggests that a similar 
situation might apply to M. tuberculosis. Recent evidence indicates that M. tuberculosis 
infections are clonal (Gutacker et al., 2002; Warren et al., 2004), and analyses of the 
genomes of clinical and laboratory mycobacterial strains have revealed only minor roles 
for horizontal gene transfer in the macroevolution of these pathogens (Cole et al., 1998; 
Cole et al., 2001; Kato-Maeda et al., 2001; Fleischmann et al., 2002; Hirsh et al., 2004; 
Tsolaki et al., 2004). Furthermore, M. tuberculosis does not possess epigenetic 
information in the form of plasmids, and no evidence exists for its natural competence 
(Derbyshire & Bardarov, 2000), although the demonstration of RD1-mediated regulation of 
conjugal transfer in M. smegmatis indicates the functional conservation of a secretory 
apparatus among mycobacteria (Flint et al., 2004). Nevertheless, in the absence of 
evidence to the contrary, these factors likely preclude the acquisition of genetic 
information by horizontal transfer. Resistance must, therefore, arise through the 
acquisition and maintenance of spontaneous chromosomal mutations in target or 
complementary genes or, rarely, from the inactivation of a target gene by a mobile genetic 
element such as IS6110 (Dale, 1995; Lemaitre et al., 1999). Consistent with the genetic 
isolation of M. tuberculosis is the observation that all drug resistance determinants are 
chromosomally encoded (Ramaswamy & Musser, 1998). Specific mutations conferring 
monoresistance to the main antituberculous drugs have been identified in each of the 
target genes (Musser, 1995; Ramaswamy & Musser, 1998), and are identical in MDR 
strains (Morris et al., 1995): for example, rifampicin resistance correlates with mutations in 
rpoB, isoniazid with katG, inhA, oxyR, ahpC, ndh and furA mutations, streptomycin (rrs, 
rpsL), pyrazinamide (pncA, IS6110 insertion), ethambutol (embB), and fluoroquinolones 
   33 
(gyrA, gyrB). However, although the majority of mutations are associated with common 
resistance determining regions, not all drug resistant phenotypes can be mapped to 
particular alterations in target genes, but remain undefined  (Musser, 1995; Ramaswamy 
& Musser, 1998). 
 
Rates of resistance mutations 
MDR strains constitute 1%-3% of total TB isolates and, although localised ‘hot zones’ of 
greater than 5% prevalence (Pablos-Méndez et al., 2000) - or incidence (Farmer et al., 
1999) - characterise worldwide MDR-TB distribution, MDR-TB is a significant problem in 
every region under WHO surveillance (Espinal, 2003; Espinal et al., 2001; WHO, 2004). 
Based on in vitro measures of individual mutation rates to drug resistance (David, 1970), 
statistically the emergence of MDR-TB would appear to require a larger bacillary 
population than is usually present during infection. However, the assumption that the risk 
of developing multiple resistance equals the product of the individual mutation rates is 
likely an oversimplification considering the complex interplay in vivo of factors that might 
reduce treatment efficacy or increase mutagenesis, as discussed above. In addition, the 
pre-existence of heteroresistant organisms in a population prior to chemotherapy might 
accelerate emergence of drug resistance and has been reported for isoniazid and 
ethambutol (Rinder et al., 1999, 2001). Evidence from other chronic infectious pathogens, 
particularly Psuedomonas aeruginosa, indicates that a higher, stress-induced mutation 
rate could explain the apparent paradox (Alonso et al., 1999), and it has been shown that 
antibiotics independently select for mutator strains in vivo (Oliver et al., 2000; Gustafsson 
et al., 2003). Furthermore, in vitro evidence from M. smegmatis suggests that, in a 
stationary phase-associated hypermutable state, mutant antagonism between 
streptomycin- and rifampicin-resistance mutations enhances acquisition of resistance to 
both (Karunakaran & Davies, 2000). The applicability of this observation to M. tuberculosis 
infection is uncertain, but has fuelled research into the role of stationary-phase 
mutagenesis and mutator polymerases in the evolution of drug resistance in mycobacteria 
(Boshoff et al., 2003). 
 
Emergence of multidrug resistance 
Infection with M. tuberculosis strains resistant to the two most commonly used frontline 
anti-TB drugs, isoniazid and rifampicin, is defined as multidrug-resistant TB (MDR-TB) 
and often culminates in incurable disease (Heifets & Cangelosi, 1999). Latest WHO 
estimates indicate that over 300 000 new cases of MDR-TB emerge worldwide each year, 
the most common pathway to multidrug resistance apparently beginning with 
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monoresistance to isoniazid or streptomycin (WHO, 2004). The prevalence of strains 
resistant to these single drugs correlates with those areas exhibiting the highest levels of 
multidrug resistance and, together with double isoniazid/streptomycin, triple 
isoniazid/streptomycin/rifampicin and quadruple isoniazid/streptomycin/rifampicin/ 
ethambutol resistant cases accounts for about 85% of resistance globally. Moreover, the 
“super strains” resistant to at least three of the four frontline TB drugs make up 79% of all 
MDR-TB cases. Treatment of MDR-TB is expensive, and the so-called “DOTS Plus” 
strategies that have been recommended for high-prevalence areas (Farmer & Kim, 1998; 
Gupta et al., 2001), comprise combinations of second-line drugs that are more expensive, 
more toxic, and less effective than the drugs used in standard therapy (Iseman, 1993). 
Furthermore, the observation that MDR-TB prevalences coincide with HIV infection rates 
is suggestive of a positive correlation between multidrug resistance and HIV seropositivity 
(Gillespie, 2002), although the identification of HIV as an independent risk factor for MDR-
TB is contentious (WHO, 2004). Characteristic features of HIV/TB-associated clinical 
disease might, however, favour the emergence of resistance and it has been suggested 
that the relationship be closely monitored (WHO, 2004). It is likely, for example, that a 
functional immune system is required to potentiate drug activity and prevent resistance 
evolution (Gillespie, 2002; Gomez & McKinney, 2004) and that the large bacterial 
populations associated with immunocompromised individuals provide an expanded subset 
for selection and transmission of rare mutation events. Furthermore, factors implicated in 
effective monotherapy in immunocompetent individuals might be exacerbated in the 
absence of a functioning immune response. For example, uncontrolled replication and 
dissemination resulting in extra-pulmonary foci, pulmonary cavitation, and empyema could 
produce drug-inaccessible compartments. In addition, drug absorbtion might be 
compromised by HIV-associated clinical diseases such as gastrointestinal complaints 
arising from other chronic infections. Finally, the increase in TB incidence in high HIV-
prevalence areas might indirectly lead to the spread increased spread of both susceptible 
and MDR strains; although potentially slower to emerge in immunocompetent individuals, 
infection with MDR strains might result in huge burdens of disease in the future (Gillespie, 
2002). 
 
1.11 In vivo stress 
Pathogens are expected to encounter and adapt to many stresses during colonisation of 
the host. Occupation of an immature phagosomal compartment partially shields M. 
tuberculosis from the macrophage’s most potent antimicrobial defence mechanisms, 
including acid, oxygenated lipids, fatty acids, lytic enzymes, and ROI and RNI (Aderem & 
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Underhill, 1999), enabling intraphagosomal replication during the early stages of infection. 
Even where maturation is stalled, however, the bacilli are exposed to a slight decrease in 
phagosomal pH (Deretic & Fratti, 1999), and the transcriptional response of M. 
tuberculosis to acid stress in vitro involves several genes involved in lipid metabolism, 
including icl, and the peroxynitrite reductase/peroxidase components ahpC and ahpD 
(Fisher et al., 2002). The glyoxylate shunt enzyme isocitrate lyase, encoded by icl, 
enables alternative energy production through the metabolism of fatty acids and is 
required for survival in macrophages and persistence in a mouse model of latent TB 
(McKinney et al., 2000). Induction of icl is associated with limiting oxygen levels in vitro 
(Wayne & Sohaskey, 2001) and entry into macrophages (Graham & Clark-Curtiss, 1999; 
Honer Zu Bentrup et al., 1999); in addition, icl expression was recently detected in a 
mouse model (Timm et al., 2003) and, according to tissue pathology, within macrophages 
in human tuberculous lung samples (Fenhalls et al., 2002b; Timm et al., 2003), all of 
which suggests that in vitro acid stress might mimic aspects of the in vivo environment. 
However, icl is also induced in vitro in a long-term nutrient starvation model (Hampshire et 
al., 2004), and in activated murine and human macrophages as part of a cohort of genes 
required for b-oxidation of fatty acids, likely indicating a switch to alternative 
(gluconeogenic) carbon metabolism in the phagosome (Dubnau et al., 2002; 
Schnappinger et al., 2003). Several genes potentially involved in fatty acid metabolism are 
common to both in vitro acid stress and intraphagosomal adaptation in vitro and in vivo 
(Dubnau et al., 2002; Fisher et al., 2002; Schnappinger et al., 2003), prompting the 
suggestion that low pH signals to M. tuberculosis the need to prepare for extended 
intraphagosomal survival (Fisher et al., 2002). M. tuberculosis is also likely to sustain 
damage to surface structures mediated by several antimicrobial defences including 
alveolar surfactant - a mild detergent with antibacterial activity, toxic peptides and proteins 
like granulysin (Dieli et al., 2001), and toxic free fatty acids secreted by macrophages 
within the mycobacterial phagosome and in the external environment (Akaki et al., 2000). 
Evidence for cell surface damage is provided by the upregulation in resting macrophages 
of M. tuberculosis genes associated with SDS treatment and cell wall maintenance 
(Schnappinger et al., 2003), including some involved in lipid biosynthesis and 
modification, as well as the sigE-encoded extracellular function (ECF) s factor, essential 
for M. tuberculosis virulence in mice (Manganelli et al., 2004a) and implicated in survival 
of M. tuberculosis in macrophages (Manganelli et al., 2001) and in the in vitro response to 
detergent-induced surface stress, heat shock, and thiol-specific oxidation (Manganelli et 
al., 1999, 2002). 
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Hypoxia is an antimicrobial mechanism generally associated with inflammation and 
impaired vascularisation. As discussed above, induction of DosR in response to both 
hypoxic and NO-mediated signalling is considered relevant to latent infection 
(Schnappinger et al., 2003; Voskuil et al., 2003; Voskuil, 2004). A switch to anaerobic 
pathways and reduced energy generation characterises M. tuberculosis respiration inside 
the phagosome, with repression of genes encoding subunits of NADH dehydrogenase 
(NDH)-I, the ubiquinol-cytochrome C complex, and ATP synthase, and induction of 
alternative electron transporters including nitrate and fumarate reductases (Schnappinger 
et al., 2003). Components of NDH-1 are also downregulated in response to low pH (Fisher 
et al., 2002); in the murine phagosome, however, the partially compensating ndh-encoded 
NDH-2 is upregulated which might indicate adaptation to a low-energy intraphagosomal 
state, or a requirement for NAD+ regeneration for the proposed b-oxidation reactions 
(Schnappinger et al., 2003). Expression of a-crystallin, a chaperonin encoded by hspX 
and included in the DosR dormancy regulon (Sherman et al., 2001; Boon & Dick, 2002; 
Ohno et al., 2003; Park et al., 2003; Voskuil et al., 2003), is strongly induced in vitro on 
entry into stationary phase (Yuan et al., 1996; Timm et al., 2003), and in response to 
hypoxia (Yuan et al., 1996; Sherman et al., 2001) and nitric oxide (Garbe et al., 1999; 
Ohno et al., 2003; Voskuil et al., 2003). The upregulation of hspX in activated 
macrophages (Yuan et al., 1998; Schnappinger et al., 2003), in vivo in mouse lungs 
(Schnappinger et al., 2003; Timm et al., 2003; Voskuil et al., 2003), and in lung specimens 
from human TB patients (Timm et al., 2003) might be in response to hypoxia or to NO, 
although the delayed expression in IFN-g-/- mice (Shi et al., 2003) indicates likely NO 
mediation; in any event, upregulation of hspX under these various conditions suggests 
that similar stresses are imposed on M. tuberculosis in vivo. Moreover, members of the 
mbt operon are induced during microaerophilic growth in vitro (Bacon et al., 2004), and in 
quiescent and activated macrophages (Schnappinger et al., 2003). 
 
M. tuberculosis is also likely to be deprived of nutrients and essential elements in its 
occupation of the phagosome and in granulomas. Recent in vitro models of starvation 
have identified broad metabolic adjustments thought likely to apply during persistence in 
vivo (Betts et al., 2002; Hampshire et al., 2004), and suggest that glucose deficiency and 
an abundance of fatty acids characterise the phagosome of activated macrophages 
(Boshoff & Barry, 2005); for example, genes involved in β-oxidation, the glyoxylate shunt, 
gluconeogenesis, amino acid/amine degradation, RNA synthesis and modification, and 
DNA transcription are induced in response to nutrient stress, while carbon degradative 
pathways, de novo ATP generation, and purine/pyrimidine synthesis are downregulated. 
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In addition, sulphur appears to be required for maintenance of redox balance and for 
translation initiation, and a number of genes required for sulphur metabolism are 
upregulated during starvation in vitro (Hampshire et al., 2004). Reduced intraphagosomal 
iron availability has been described (De Voss et al., 2000; Gold et al., 2001) and, in a 
mouse model, iron limitation was associated with growth arrest at sites of infection (Timm 
et al., 2003). In addtion, iron-scavenging siderophores are upregulated by M. tuberculosis 
in murine macrophages (Schnappinger et al., 2003) although this might be in response to 
oxidative stress (discussed below). Iron restriction is thought (Timm et al., 2003) to result 
from the downregulation of transferrin receptor expression in response to macrophage 
activation by cytokines (Mulero & Brock, 1999; Kim & Ponka, 2000) or from reduced 
intersection of mature mycobacterial phagosomes with iron-containing vesicles (Schaible 
et al., 1998; MacMicking et al., 2003). Decreased Mg2+ levels in the mycobacterial 
phagosome have also been reported, and are associated with increased M. tuberculosis 
acid sensitivity (Buchmeier et al., 2000). Gluconeogenesis is essential for virulence of M. 
bovis (Collins et al., 2002) and M. bovis BCG (Liu et al., 2003) in animal models, and 
expression of M. tuberculosis pckA (required for gluconeogenesis; Liu et al., 2003) is 
elevated in a mouse infection, consistent with reduced glucose availability in vivo (Timm et 
al., 2003). Transmission of aerosolised M. tuberculosis also incurs external environmental 
stresses such as nutrient starvation, exposure to UV/sunlight (to which it is particularly 
sensitive), dehydration, and temperature fluctuations (Corper & Cohn, 1933; Stewart et 
al., 2002). 
 
Reactive immune effectors 
M. tuberculosis is expected to sustain a variety of potentially DNA–damaging assaults in 
vivo (Mizrahi & Andersen, 1998; Boshoff et al., 2001), primarily from host-generated 
antimicrobial ROI and RNI (Adams et al., 1997; MacMicking et al., 1997a; Rich et al., 
1997; Akaki et al., 2000; Nathan & Shiloh, 2000). Furthermore, the observation that M. 
tuberculosis is much more sensitive to acidic pH than other mycobacterial species 
(Gomes et al., 1999) suggests that the bacilli might incur DNA damage in phagosomes, 
probably mediated by RNI generated from acidified nitrite (Stuehr & Nathan, 1989; 
Sturgill-Koszycki et al., 1994; Oh & Straubinger, 1996; Foster & Moreno, 1999). DNA is a 
biological target for RNI and ROI (Wink et al., 1991; Burney et al., 1999), and interaction 
with toxic radicals is mutagenic (Zhuang et al., 2000). Furthermore, damage to cellular 
components required for the protection or propagation of DNA can indirectly affect 
chromosomal integrity, while detoxification reactions might themselves yield endogenous 
damaging adducts (Nathan & Shiloh, 2000). Additional endogenous reactive intermediates 
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are also likely to be generated by the switch between aerobic and anaerobic metabolism, 
and from the partial reduction of terminal electron acceptors during respiration (Boshoff & 
Barry, 2005). Although the relevance of tissue culture and animal models of infection to 
human TB is uncertain (Graham & Clark-Curtiss, 1999; McKinney et al., 2001; Boshoff & 
Barry, 2005), there is increasing evidence that the in vivo environment is DNA damaging 
(Boshoff et al., 2003; Sassetti & Rubin, 2003; Schnappinger et al., 2003). However, the 
expression and activities of putative detoxification and damage repair components in M. 
tuberculosis remains largely undefined (Mizrahi & Andersen, 1998; Mizrahi et al., 2000, 
2005; Boshoff et al., 2001; Boshoff & Barry, 2005) though it is likely that, as in other 
organisms, some of the mechanisms implicated in antioxidant and antinitrosative defence 
function primarily to enable oxidative metabolism or in homeostatic signalling networks, 
but fulfil a vital role in tolerance of host immune effectors (Zahrt & Deretic, 2002; Nathan, 
2003). 
 
Exposure of M. tuberculosis to potent oxidative agents in vitro results in minimal 
differential gene expression (Deretic et al., 1995; Lee & Horwitz, 1995; Sherman et al., 
1995; Garbe et al., 1996; Boshoff et al., 2003) and has been attributed to the impaired 
ability of the organism to mount a coherent oxidative stress response as a result of a 
natural deficiency in the soxRS and oxyR regulons (Deretic et al., 1995; Sherman et al., 
1995; Dhandayuthapani et al., 1996; Garbe et al., 1996). Some oxidative stress response 
genes contained within the OxyR and SoxRS regulons in other bacteria are, however, 
expressed in M. tuberculosis in the absence of the central regulators, including the 
peroxiredoxin AhpC (Chen et al., 1998; Bryk et al., 2000; Springer et al., 2001; 
Schnappinger et al., 2003), superoxide dismutase (Wieles et al., 1995; Weldingh et al., 
1998; Harth & Horwitz, 1999), thioredoxin (Raman et al., 2004), and the KatG catalase-
peroxidase (Manca et al., 1999a; Master et al., 2001; Ng et al., 2004). A key question, 
though, pertains to the regulation (and therefore biological relevance) of many of the 
detoxifying mechanisms during NRP in vivo; for example, although superoxide dismutase 
levels decline in dormancy in vitro and after onset of the immune response in a mouse 
model, elevated ahpD expression has been identified as a marker for NRP (Wayne & Lin, 
1982; Wayne, 1994; Hu et al., 1999; Shi et al., 2003; Voskuil, 2004). Damage repair is 
essential for the virulence and survival of other intracellular pathogens (Buchmeier et al., 
1993; Spek et al., 2001); however, despite resulting in damage hypersensitivity in vitro, 
inactivation of mycobacterial alkylation reversal (alkA::ogt; Durbach et al., 2003) and 
recombinational repair (recA; Sander et al., 2001, 2003) pathways does not attenuate in 
vivo survival. Although it is possible that nitrosative or oxidative stresses do not induce 
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cytotoxic DNA damage in the mouse model, the virulence of isolates of the W-Beijing 
genotype (Rad et al., 2003) is similarly not impaired by the characteristic deficiency in 
elimination of damaged nucleotide pools (as a result of a mutT mutation) and/or in repair 
of alkylation damage (ogt) in these strains, nor do W strains exhibit a mutator phenotype 
(Werngren & Hoffner, 2003). It seems likely, therefore, that other repair pathways might 
preferentially function in mycobacteria; for example, a Ku-ligase system for DSB repair by 
nonhomologous end-joining (NHEJ) was recently characterised in M. tuberculosis (Weller 
et al., 2002; Della et al., 2004) and might provide a possible alternative to homologous 
recombination for repair of such lesions (Mizrahi et al., 2005). In addition, M. tuberculosis 
contains homologues of a putative DNA repair system highly conserved in thermophilic 
Archaea and predicted to function in translesion synthesis (TLS) (Makarova et al., 2002). 
Several base excision repair (BER) enzymes have also been identified that are required 
for growth in vivo (Sassetti & Rubin, 2003) but not in vitro under optimal conditions 
(Sassetti et al., 2003) implying a role in virulence. Furthermore, mycobacteria including M. 
leprae possess several conserved Fpg/Nei-family DNA glycosylases (Cole et al., 1998, 
2001; Mizrahi & Andersen, 1998; Fleischmann et al., 2002); although the in vivo role of 
these homologues in BER remains uncertain, the activity of purified M. tuberculosis Fpg in 
repair of oxidised DNA (especially 8-oxo-G) was recently demonstrated (Guo et al., 2004). 
Together with evidence that resistance to nitrosative stress in M. smegmatis is dependent 
on a functional uracil DNA glycosylase (Ung; Venkatesh et al., 2003), the demonstration 
that inactivation of proteasomal components (mpa and paf) and the uvrB-encoded 
excinuclease subunit is associated with elevated susceptibility to iNOS-generated RNI 
(Darwin et al., 2003), is suggestive of the increased importance of excision-based 
mechanisms such as BER and nucleotide excision repair (NER) in damage tolerance in 
mycobacteria (Mizrahi et al., 2005). Moreover, the upregulation of uvrB and several other 
DNA repair genes in response to certain damaging agents only, indicates that the type of 
lesion might determine the repair mechanism invoked (Boshoff et al., 2003). 
 
Other mechanisms implicated in resistance against oxidative and nitrosative stress 
include the DosR-regulated a-crystallin (Garbe et al., 1999; Ehrt et al., 1997; Ruan et al., 
1999; Sherman et al., 2001; Bryk et al., 2002; Ouellet et al., 2002), while some of the 
physical properties characteristic of mycobacteria have been implicated in the subversion 
of toxic ROI (Chan et al., 1989; Chan et al., 1991; Chan & Kaufmann, 1994; Barry & 
Mdluli, 1996; Flynn & Chan, 2001a). In addition, mycobacteria in a low oxygen-induced 
dormant state are highly resistant to mitomycin C (Peh et al., 2001), suggesting that some 
protection of chromosomal DNA is provided by the NO- or hypoxia-mediated induction of 
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M. tuberculosis UspA-like genes as part of the DosR regulon (Sherman et al., 2001; Ohno 
et al., 2003; Park et al., 2003; Voskuil et al., 2003). Finally, it has been suggested that 
several small molecules might act as biological traps for reactive intermediates, although 
their relevance in mycobacterial oxidative and nitrosative defence is unknown (Nathan & 
Shiloh, 2000). 
 
1.12 DNA metabolism in mycobacteria 
The mutational mechanisms underlying inter-strain variation and the adaptive evolution of 
drug resistance in M. tuberculosis are not well understood. However, it was hypothesised 
that the complex and variable environments encountered by M. tuberculosis during host 
colonisation and throughout the infective process might impose excessive demands on 
normal genetic regulatory systems. Furthermore, the likelihood that sub-clinical 
mycobacterial populations might be maintained in a state of prolonged stationary phase - 
either as a consequence of the specific ecological niche inhabited, or as a result of host 
immune effectors or antibiotic drugs - suggested that inducible mutator systems might 
function to enable adaptation and competitive survival. In particular, the presence of 
multiple genes encoding putative error-prone or Y-family DNA polymerases in sequenced 
mycobacterial genomes was strongly supportive of the idea that mycobacteria might 
possess the genetic means to modulate mutagenesis. This thesis aimed, therefore, to 
investigate mechanisms of mycobacterial DNA metabolism with specific emphasis on the 
role of multiple Y-family polymerases in genetic adaptation to stress. In addition, the role 
of the class II (oxygen-independent) ribonucleotide reductase (RNR) in the supply and 
maintenance of dNTP pools for replication and repair under hypoxia (also likely to prevail 
during long-term persistence in vivo) was considered. The vitamin B12 dependence of the 
class II RNR further demanded an investigation into the biosynthesis and transport of 
cobalamin (vitamin B12), as well as the cobalamin requirements of other vitamin B12-
dependent isozymes. A similar methodology characterised the approach to each question 
and involved the construction of mutant strains with altered complements of genes of 
interest, and the phenotypic characterisation of the mutants, in terms of viability, survival, 
damage tolerance, and mutagenesis, where applicable. Although the thesis comprises 
three separate studies, the central hypothesis underlying the work presented is that, while 
dependent on genes with differential regulatory and functional mechanisms, as well as co-
factor requirements, the metabolic pathways under investigation - genetic adaptation by 
chromosomal mutagenesis, dNTP pool maintenance for DNA synthesis or repair under 
hypoxic conditions, and biosynthesis of cobalamin for the vitamin B12-dependent class II 
RNR - collectively enable M. tuberculosis to adapt to the complex and fluctuating host 
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environment. In summary, Chapter 3 explores the role of the mycobacterial Y-family 
polymerases in adaptive mutagenesis and long-term competitive fitness, with particular 
emphasis on the mycobacterial DinB (pol IV) homologues. The possible mutagenic 
consequences associated with the use of alternative gyrase inhibiting antibiotics for the 
treatment of M. tuberculosis infections are also considered. In Chapter 4, the contribution 
of the oxygen-independent class II RNR to hypoxic adaptation and virulence is assessed. 
Finally, in Chapter 5, the cobalamin requirement of M. tuberculosis is investigated in 
strains containing disruptions in the cobalamin biosynthetic pathway, or selectively 
manipulated to force utilisation of vitamin B12-dependent isozymes. The role of cobalamin 
biosynthesis in the virulence of M. tuberculosis is also assessed. 
 Chapter 2 
 
General materials and methods 
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2.1 GENERAL LABORATORY PROCEDURES 
All general procedures and DNA manipulations were performed according to standard 
protocols (Sambrook et al., 1989; Sambrook & Russell, 2001). All culturing and molecular 
biological manipulations of mycobacteria were performed according to Jacobs et al. 
(1991), Larsen (2000), and Parish & Stoker (2001). 
 
2.1.1 Bacterial strains and culture conditions 
All bacterial strains used in this study were stored at -70oC in 30% glycerol (v/v) and are 
detailed in Table 2.1. 
 
Escherichia coli. All Escherichia coli strains were grown overnight at 37oC in Luria-
Bertani broth (LB) with vigorous shaking (300-400 rpm) in a New Brunswick Series 25 
Incubator Shaker, or on solid Luria-Bertani agar (LA). Antibiotics were added where 
appropriate. 
Mycobacterium smegmatis. Unless otherwise indicated, all M. smegmatis strains were 
cultured in Middlebrook 7H9 medium (Difco) supplemented with 10% (v/v) ADC (Merck), 
0.2% glycerol, and 0.10 % Tween80 (7H9M-ADC) or on Middlebrook 7H10 medium 
(Difco) supplemented with 10% (v/v) OADC (Merck) (7H10M-OADC).  
Mycobacterium tuberculosis. All culturing of M. tuberculosis strains was performed in a 
Biosafety Level 3 laboratory. Manipulations of bacilli were performed in a Class II flow 
cabinet at negative pressure (170 kPa). Unless otherwise indicated, all strains were grown 
at 37oC in Middlebrook 7H9 medium supplemented with 10% (v/v) ADC (Merck), 0.2% 
glycerol and 0.05% Tween 80 (7H9M-ADC; Jacobs et al., 1991) in roller bottles or as 
Table 2.1 Bacterial strains used in this study 
Strain Genotype/markers Reference/source 
Escherichia coli   
DH5α supE44 ΔlacU169 (F80 lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 
Hanahan (1983)/ 
Promega 
GM161 dam-4 supE44 hsdS1 E. R. Dabbs 
Mycobacterium smegmatis    
mc2155 ept-1, efficient plasmid transformation mutant of mc26 Snapper et al., 1990 
Mycobacterium tuberculosis    
H37Rv ATCC 25618 
London School of 
Hygiene and 
Tropical Medicine 
CDC1551  H. Boshoff 
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stirred cultures, or on solid Middlebrook 7H10 agar (Difco) supplemented with 10% (v/v) 
OADC (Merck) (7H10M-ADC).  
Antibiotics. For E. coli, liquid and solid media contained ampicillin (Amp) at a 
concentration of 200 μg/ml, kanamycin (Km) at 50 μg/ml, and hygromycin (Hyg) at 200 
μg/ml. Antibiotics were included at the following concentrations for M. smegmatis and M. 
tuberculosis strains, respectively: Km, 25 μg/ml and 10 μg/ml; rifampicin (Rif), 200 μg/ml 
and 2 μg/ml; and Hyg at 50 μg/ml for both mycobacterial species. 
Supplements. For counterselection of E. coli and mycobacterial clones harbouring the 
sacB gene, sucrose (Suc) was added to solid media to a final concentration of 5% (w/v) 
and 2% (w/v), respectively. For β-galactosidase activity (blue-white selection), 50 μl X-gal 
(5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside; 20 mg/ml in dimethyl formamide) was 
included in 25 ml plates. 
 
2.1.2 General cloning vectors 
The general plasmids used are detailed in Table 2.2. Constructs specific to particular 
studies are detailed in the relevant chapter. 
 
 
 
 
Table 2.2 Plasmids used in this study 
Plasmid Description Reference/source 
p2NIL Cloning vector; KmR Parish & Stoker, 2000 
pAINT E. coli-Mycobacterium integrating shuttle vector; KmR Boshoff & Mizrahi, 2000 
pBluescriptKS(+) Cloning vector; AmpR Stratagene 
pGEM3Z(+)f Cloning vector; AmpR Promega 
pGEM ®-T Easy PCR cloning vector; AmpR Promega 
pCR®2.1-TOPO® PCR cloning vector; AmpR KmR Invitrogen 
pGOAL17 Plasmid carrying lacZ and sacB genes as a PacI cassette; AmpR Parish & Stoker, 2000 
pGOAL19 Plasmid carrying hyg, lacZ and sacB genes as a PacI cassette; AmpR Parish & Stoker, 2000 
pIJ963 Plasmid carrying hyg as a BamHI-BglII cassette; Amp
R 
HygR Blondelet-Rouault et al., 1997 
pOLYG E. coli-Mycobacterium multicopy shuttle vector, HygR O’Gaora et al., 1997 
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2.2  TRANSFORMATION OF BACTERIA  
 
2.2.1 Chemical transformation of Escherichia coli 
Preparation of E. coli with rubidium chloride buffers 
All E. coli cells were prepared with rubidium chloride buffers, according to a procedure 
obtained from Dr. P. Stolt. Briefly, a saturated culture of cells was used to inoculate Psi 
broth at a 1/100 dilution. The culture was grown to an OD600 of 0.6-0.7. The bacteria were 
chilled on ice for 15-30 minutes, harvested (1100 x g for 15 min at 4oC), and then 
resuspended in RF-1 (30 mM potassium acetate, 100 mM rubidium chloride, 10 mM 
calcium chloride, 50 mM manganese chloride, 15% glycerol v/v, pH 5.8)  at 1/3 of the 
original volume. After 0.5-2 hours on ice, cells were harvested again, resuspended in RF-
2 (10 mM MOPS, 75 mM calcium chloride, 10 mM rubidium chloride, 15 % glycerol v/v, 
pH 6.5) at 1/12.5 of the original culture volume, and left on ice for 15-30 minutes. Cell 
aliquots were then dispensed into pre-chilled 1.5 ml microcentrifuge tubes, and flash-
frozen in an ethanol bath at -70oC. Cells were thawed on ice when required. 
Transformation with plasmid DNA 
Competent cells (100-200 μl) were incubated with up to 1.0 μg DNA on ice for 1 hour, and 
then heat shocked for 90 seconds at 42 oC in a microcentrifuge tube. After chilling on ice 
for 1-2 minutes, 4 volumes of 2-TY were added to the cells, which were then  incubated 
for 1 hour at 37oC. Cells were plated on LA containing the appropriate antibiotics, and 
incubated overnight at 37 oC (Sambrook et al., 1989; Sambrook & Russell, 2001) or, in the 
case of large or PacI cassette-containing (Parish & Stoker, 2000) constructs, for two days 
at 30 oC. 
 
2.2.2 Electroduction of Escherichia coli  
Electrocompetent E. coli cells were prepared according the protocol set out in the Bio-Rad 
Gene Pulser manual. Briefly, 50 ml 2TY was inoculated with 1/100 volume of a saturated 
culture of E. coli DH5α and grown at 37oC with vigorous shaking (300-400 rpm) until an 
OD600 of 0.6 was reached. Cells were placed on ice for 20 minutes and then harvested 
(1500 x g for 5 min). Cell pellets were resuspended in 50 ml ice-cold 10% glycerol, 
harvested as before, and washed again in 25ml and finally 1ml 10% glycerol. After the 
final wash, cells were resuspended in a final volume of 500 μl 10% glycerol and used 
immediately. For electroductions, a portion of a M. smegmatis colony was dispersed into 
20 μl 1% glycerol and mixed with 100 μl electrocompetent DH5α cells. The mixture was 
transferred into an electroporation cuvette and pulsed once at 200 W, 35 μF, 2.5 kV. The 
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cells were rescued by the addition of 800 μl 2TY and incubated for I hour at 37oC before 
plating on LA containing the appropriate selective antibiotics. 
 
2.2.3 Transformation of mycobacteria by electroporation 
All electroporations of M. smegmatis and M. tuberculosis were performed according to 
Larsen (2000), Gordhan & Parish (2001). 
Mycobacterium smegmatis. 100 ml cultures were grown overnight from a 1/100 dilution 
of saturated culture at 37oC with shaking at 100 rpm. Cells were harvested by 
centrifugation (1100 x g for 10 minutes at 4oC) and washed three times in 10% glycerol 
(v/v)pre-chilled at 4oC. After the final wash, cells were resuspended in 2 ml 10% glycerol  
and used immediately. 400 μl aliquots were incubated briefly on ice with 50-1000 ng of 
plasmid DNA in microcentrifuge tubes. The cells were then transferred into pre-chilled 
electroporation cuvettes with 0.2 cm electrode gap, and pulsed once in a GenePulserTM 
(Bio Rad) set at 2.5 kV, resistance 1000 W, capacitance 25 μF. Immediately after pulsing, 
1 ml Middlebrook 7H9M-ADC was added to the cells which were transferred to a clean 
microcentrifuge tube and incubated for two hours at 37 oC. Electroporation reactions were 
plated on solid Middlebrook 7H10 agar containing the appropriate antibiotics and 
supplements and incubated for 3 days at 37oC or 5 days at 30 oC. 
Mycobacterium tuberculosis. Electroporation competent M. tuberculosis cells were 
prepared according to essentially the same method as that described or M. smegmatis, 
except that all manipulations were performed at room temperature (Wards & Collins, 
1996). Briefly, 300 ml stirred or rolling cultures were inoculated from freezer stocks, and 
grown with aeration for approximately 7 days until an OD600 of 0.8-1.0 was achieved. At 
least 6 hours before harvesting, glycine (30% w/v) was added to the cultures to a final 
concentration of 1.5% (w/v). Cells were harvested by centrifugation (1100 x g) for 15 
minutes and then washed twice in 10% glycerol (v/v) before resuspending in 5 ml 10% 
glycerol.  Cells were divided into 400 μl aliquots in electroporation cuvettes with 0.2 cm 
electrode gaps, and pulsed once in a GenePulserTM (Bio Rad) set at 2.5 kV, resistance 
1000 W, capacitance 25 μF. After pulsing, the cells were rescued in 1 ml Middlebrook 
7H9M-ADC and incubated overnight at 37oC without shaking. Electroporation reactions 
were plated on solid Middlebrook 7H10 agar containing the appropriate antibiotics and 
supplements and incubated for 21-28 days at 37oC. 
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2.3 DNA EXTRACTION 
 
2.3.1 Plasmid preparation from Escherichia coli 
Small-scale preparation for screening cloned plasmids. Aliquots of saturated 
overnight cell cultures were transferred into 1.5 ml microcentrifuge tubes. Cells were 
pelleted by centrifugation at room temperature (15000 x g for 30 seconds), the 
supernatant discarded, and the cells lysed by alkaline lysis. Briefly, cells were 
resuspended in 100 μl Lysis Solution I (0.5 M Glucose, 50 mM Tris-HCl pH 8.0, 10mM 
EDTA), to which 200 μl Lysis Solution II (0.2 M NaOH, 1% SDS) was then added and 
gently mixed. After 5 minutes on ice, 150 μl Lysis Solution III (3 M Potassium Acetate, pH 
5.5) was added and, after gentle mixing, centrifuged at 9000 x g for 5 minutes in a 
Heraeus microcentrifuge at 4oC. The supernatant was isolated and treated with RNaseA 
(50 μg/ml) for 15 minutes at 42oC. DNA was precipitated by adding 350 μl isopropanol, 
incubating at room temperature for 10 minutes, and then centrifuging for 10 minutes at 
15000 x g. After discarding the supernatant, the DNA pellet was washed once in ice-cold 
70% ethanol and dried at 42oC in a vacuum centrifuge (SpeedVac, Savant, Farmingdale, 
NY, USA). DNA was then resuspended in 10-20 μl sterile water for immediate digestion by 
restriction enzyme, or was further purified by phenol/chloroform (1:1 v/v) extraction in 400 
μl sterile water followed by a chloroform/isoamyl alcohol (24:1 v/v) extraction. DNA was 
then re-precipitated by adding 1/10 volume sodium acetate buffer (pH 5.3) and 2.5 
volumes 100% ice-cold ethanol. After 30 minutes incubation at -20oC, precipitated DNA 
was collected by centrifugation at 15000 x g at 4oC, before a final ice-cold 70% ethanol 
wash and drying in a vacuum centrifuge. 
Large-scale plasmid preparation. Cultures were grown overnight at 37oC in 100 ml LB, 
with shaking at 300-400 rpm. Cells were harvested by centrifugation in a Beckmann J2-21 
centrifuge using a JA-20 rotor for 10 minutes at 1100 x g and 4oC. The remainder of the 
extraction procedure was the same as for the small-scale preparation described above, 
except that volumes were increased by a factor of 10. 
 
2.3.2 Preparation of mycobacterial chromosomal DNA 
Chromosomal DNA was isolated from M. tuberculosis and M. smegmatis using a modified 
CTAB (cetyltrimethylammonium bromide; ICN Biomedicals, Aurora, Ohio) method 
(Larsen, 2000). Mycobacterial cells were heat killed by incubating at 95oC for 5 minutes. 
Cells were harvested by centrifugation at 13000 x g for 30 seconds in microcentrifuge 
tubes, and resuspended in 500 μl TE buffer (pH 8.0) with 50 μl lysosyme (10 mg/ml). After 
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1-2 hours at 37oC, 70 μl 10% SDS and 6 μl proteinase K (10 mg/ml) were added and the 
samples incubated for an additional 2 hours at 65 oC before the addition of 100 μl 5M 
NaCl and 80 μl CTAB/NaCl solution (10% CTAB prepared in 0.7M NaCl). After a further 
10 minutes incubation, the solution was extracted with chloroform/isoamyl alcohol (24:1 
v/v) and the DNA precipitated with an equal volume isopropanol. The DNA precipitate was 
collected by centrifugation at 9000 x g and washed with 70% ice-cold ethanol, then 
vacuum dried and resuspended in sterile water. 
 
2.4 DNA MANIPULATIONS 
 
2.4.1 Agarose gel electrophoresis 
Standard electrophoretic techniques were used (Sambrook et al., 1989; Sambrook & 
Russell, 2001). Gels (0.8-2%) were prepared in 1xTAE from agarose powder (SeaKem). 
Low melting agarose powder (SeaPlaque GTG) was used for preparative gel 
electrophoresis of DNA. For the separation of low molecular weight DNA fragments (£ 
1kb), 4% gels were prepared using NuSieve® GTG® agarose (Cambrex Bio Science 
Rockland, Rockland, ME, USA). Gels were electrophoresed in a Hoefer HE 33 minigel 
horizontal submarine unit (Pharmacia Biotech, California, USA) at 75-100 volts. DNA 
molecular weight markers were from Roche Biochemicals (BMI-BMVI). 
 
2.4.2 Recovery of DNA fragments from agarose gels 
Agarase digestion of low melting temperature agarose gels 
DNA was isolated from low melting temperature agarose gels as per manufacturer’s 
instructions (Roche Biochemicals). Briefly, DNA fragments were excised from low melting 
agarose gels and heated for 10 minutes at 75oC in 1 x agarase buffer. The tube was 
transferred to a 45oC heating block, and incubated with 1 unit agarase enzyme per 100 μl 
for one hour. The mixture was chilled on ice for 15 minutes, then centrifuged (9000 x g for 
10 minutes at 4oC). The supernatant was isolated, and DNA recovered by ethanol 
precipitation before drying and resuspending in sterile water at a final concentration of 0.1-
1 μg DNA/μl. 
Recovery of DNA fragments by the GeneClean® II glass milk procedure 
DNA was isolated as per manufacturer’s instructions (Qbiogene). Briefly, weighed gel 
slices containing the fragment of interest were melted at 65oC for 15 minutes with 3 
volumes sodium iodide solution. 5 μl freshly resuspended glass milk was added, and DNA 
allowed to adhere by incubating at room temperature for 10 minutes. The glass milk was 
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then collected by centrifugation and washed with 700 μl New Wash solution. Finally, the 
pellet was air dried at room temperature for 10-20 minutes, and the DNA eluted in 10-15 
μl sterile water. The glass milk was pelleted by centrifugation at 13000 x g for 
approximately 30 seconds, and the supernatant aspirated and transferred to a clean 
microcentrifuge tube. 
 
2.4.3 Enzymatic modification of DNA  
Restriction digests. All restriction enzymes were obtained from Roche Molecular 
Biochemicals, Amersham, or New England Biolabs, Inc. Up to 1 μg plasmid DNA was 
digested in 10 μl reactions for 1 hour at 37oC (unless manufacturer’s instructions indicated 
otherwise) with the appropriate buffer. Mycobacterial chromosomal DNA (up to 5μg) was 
digested overnight at 37oC (unless manufacturer’s instructions indicated otherwise). 
Blunt-ending of 5’ overhangs using the Klenow fragment of E. coli DNA polymerase 
I. Klenow enzyme and dNTPs were supplied by Roche Molecular Biochemicals. Reactions 
were performed in 10-20μl according to manufacturer’s instructions, and incubated for 30 
minutes at 37oC. 
Dephosphorylation of vector DNA. Calf intestinal (CIP) and shrimp (SAP) alkaline 
phosphatases were supplied by Roche Molecular Biochemicals. Reactions were 
performed according to the manufacturer’s instructions for 30 minutes at 37oC. DNA 
treated with CIP was purified by phenol/chloroform extraction and ethanol precipitation, 
whereas SAP was inactivated by heat denaturation at 65oC for 15 minutes. 
Ligations of DNA fragments. All DNA ligations were performed using the Epicentre® 
Fast-LinkTM ligation kit as per the manufacturer’s instructions. For cloning of plasmid 
constructs, vector and insert DNA were used at a maximum total amount of 200 ng/10 μl 
reaction. Approximately 1-5 μl of the ligation reaction was used to transform 100-200 μl 
competent E. coli cells. 
Polymerase chain reaction (PCR). Oligonucleotide primers are listed in the materials 
and methods sections specific to each chapter. All standard PCR reactions were 
performed using the Roche FastStart Taq DNA Polymerase kit (Roche Molecular 
Biochemicals). For PCR of fragments required for knockout constructs, or for sequencing 
reactions, the Expand High Fidelity PCR System (Roche Molecular Biochemicals) was 
used. Standard 20 or 50 μl PCR reactions in 1 x supplied reaction buffer contained 5-100 
ng plasmid or genomic DNA, 0.5-1.0 μM of each of the forward and reverse primers, 10 
μM of each dNTP, 1.5 mM MgCl2, and 10% DMSO or supplied GC-RICH solution. Cycling 
parameters were as follows: denaturation at 94oC for 5 minutes, 30 cycles of denaturation 
(94oC for 60 seconds), annealing (50-65oC for 60 seconds), and extension (72oC for 60 
 50 
seconds), followed by a final extension at 72oC for 7 minutes. PCR reactions were 
performed in an Eppendorf Mastercycler gradient. For construction of knockout or 
expression vectors, gel purified PCR products (2.4.2) were cloned into pGEM®-T Easy or 
TOPO 2.1 PCR cloning vectors (Table 2.2) according to manufacturer’s instructions and 
sequenced before subsequent manipulations. 
 
2.4.4 Southern blot analysis of mutant mycobacterial strains 
Radiolabelling of probes. All probes for Southern blots were labelled using a random 
prime labelling technique. Briefly, probe DNA was dissolved in 14 μl sterile water and then 
heat-denatured at 96oC for 10 minutes before rapid cooling on ice. The DNA was then 
labelled with [α32P]-dCTP using the Random Primed Labelling Kit (Roche Biochemicals) 
according to the manufacturer’s instructions. The labelling reaction was terminated by the 
addition of 50 μl 1 x TE buffer (pH 8.0), and labelled DNA separated from unincorporated 
nucleotides by passing through two pre-equilibrated G-25 Sephadex spin columns poured 
in 1 ml disposable syringes plugged with sterile glass wool. The purified probe was 
collected by centrifugation of the columns at 4400 x g for 3 minutes in an IEC clinical 
centrifuge. The purified probe was used immediately for Southern analysis, or stored at -
20 oC for a maximum of 1 day. 
Electroblotting. Chromosomal DNA (1-5 μg) digested with the appropriate restriction 
enzyme was separated by agarose gel electrophoresis (0.8-1.0%). The DNA was 
depurinated by soaking the gel in 0.25M HCl for 15 minutes, then denatured by soaking in 
0.5M NaOH/1.5M NaCl solution for 15-20 minutes. The gel was briefly equilibrated in 1 x 
TBE buffer, overlayed with HybondTM-N nylon membrane, and sandwiched between two 
layers of pre-soaked 3MM Whatman filter and two sponges in a TE 22 Transphor 
cassette. The cassette was then inserted into a TE 22 Mini Transphor unit (Hoefer) and 
the DNA transferred at 0.5A for 2 hours at 4oC. The DNA was then cross-linked to the 
nylon membrane by irradiation in a UV Stratalinker 1800 at 1200 mJ/cm2. 
Hybridisation. After cross-linking, membranes were incubated in pre-hybridisation 
solution (0.5% SDS; 6 x SSC; 5 x Denhardts; 50% deionised formamide) containing 10 
μg/ml heat-denatured salmon-sperm DNA (Roche) at 42 oC for 2 hours in roller bottles in 
a Techne Hybridiser HB-1. The radiolabelled probe was denatured at 96oC for 10 minutes 
and added to the pre-hybridisation buffer, and hybridisation allowed to occur overnight 
(12-16 hours) at 42 oC. The hybridisation buffer was then removed, and the filters washed 
twice in the hybridisation bottles with 2 x SSC; 0.1 % SDS for 15 minutes at 42oC, then 
once with 0.5 x SSC; 0.1% SDS for 15 minutes at 42oC, followed by one wash with 0.1 x 
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SSC; 0.1% SDS for 15 minutes at 42oC, and finally a wash with 0.1 x SSC; 1% SDS for 30 
minutes at 65oC. The membranes were then exposed to X-ray film at -70oC.  
 
2.5 DNA SEQUENCING 
All sequencing was performed off-site by Inqaba Biotech on a Spectrumedix 2410 
Capillary Electrophoresis automated DNA sequencer using Big Dye Terminator V3.1 
software from ABI for result analysis. 
 
2.6 STATISTICAL ANALYSES 
The statistical significance of differences between data sets was determined using 
GraphPad InStat® software. Analysis of mutation rates from fluctuation assay data was 
performed on a set of Microsoft Office Excel spreadsheets developed by E. Machowski, L. 
Machowski & S. Barichievy (unpublished) using algorithms adapted from Rosche and 
Foster (2000) and is described in Chapter 3. 
 Chapter 3 
 
The mycobacterial Y-family polymerases: roles in genetic 
adaptation and long-term survival 
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3.1  ABSTRACT 
SOS-inducible Y-family DNA polymerases have been implicated in the adaptive evolution 
of antibiotic- and stress-resistant mutants of pathogenic bacteria. In mycobacteria, 
induced base substitution mutagenesis to rifampicin and streptomycin resistance is 
dependent on DnaE2, a novel C-family polymerase. However, mycobacterial genomes 
encode several DinB (pol IV)-like Y-family members suggesting an alternative role in 
adaptation. Neither dinP- or dinX-encoded pol IV homologue is upregulated in the 
mycobacterial damage response. In contrast, M. smegmatis contains an additional pol IV 
homologue that is SOS-inducible. Disruption of all three pol IV homologues had no effect 
on the damage hypersensitivity of a M. smegmatis dnaE2 deletion mutant, suggesting the 
dispensability of these polymerases in tolerance of UV-induced damage. Furthermore, 
overexpression of M. tuberculosis dinP and dinX did not increase spontaneous point or 
frameshift mutation rates in wild-type mc2155 and did not restore damage tolerance in the 
hypersensitive mutant. Similarly, abrogation of all identifiable pol IV or EP polymerase 
activity in M. smegmatis mc2155 failed to impair long-term competitive survival. Treatment 
of M. smegmatis with ofloxacin and novobiocin confirmed the differential induction of the 
pol IV homologues in response to replication stalling and, significantly, showed that 
elevated rates of spontaneous mutagenesis to rifampicin resistance are associated with 
GyrB inhibition. Genotypic analysis of these and other damage- and stress-induced 
rifampicin-resistant mutants identified a novel rpoB polymorphism that appears to be 
restricted to strains lacking one or more pol IV homologue. In combination, the data 
suggest that the mycobacterial pol IV homologues might not be individually redundant, but 
do not participate in adaptive mutagenesis. Rather, regulatory mechanisms might have 
evolved in mycobacteria to restrict Y-polymerase activity to error-free repair or replication 
restart in times of stress. Finally, attempts to disrupt dinP in M. smegmatis mc2155 
confirmed the presence of a duplicated chromosomal region. Furthermore, during the 
construction of an M. smegmatis deletion mutant lacking both copies of dinP, a mutant 
strain was fortuitously generated which appeared to have lost the duplicated region. The 
deletion mutation was found to have no discernable effect either on the growth rate of the 
organism or on its transformation efficiency, arguing against an association between the 
duplication in mc2155 and its ept phenotype. Site-specific re-introduction of a wild-type 
dinP allele into this deletion mutant resulted in the creation of a strain isogenic to mc2155 
but lacking the duplicated region. 
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3.2  INTRODUCTION 
The heavy reliance on chemotherapeutic intervention in active, infectious disease renders 
the global TB control effort especially vulnerable to the emergence of drug resistant M. 
tuberculosis strains. Furthermore, the observation (Boshoff et al., 2003; Mizrahi et al., 
2005) that measured rates of antibiotic resistance of M. tuberculosis in vitro (David, 1970; 
David & Newman, 1971; Boshoff et al., 2003) do not correlate with the rapid emergence of 
MDR-TB clinical isolates worldwide (Espinal et al., 2000, 2003; WHO, 2004; Blower & 
Chou, 2004; Cohen & Murray, 2004) implies that a number of factors might act in 
combination to reduce treatment efficacy or increase mutation rates during parasitism of 
the human host. Considerable attention has recently been focused on the potential roles 
of stationary-phase and stress-induced mutagenesis in bacterial adaptation (Zambrano et 
al., 1993; Taddei et al., 1995; Kasak et al., 1997; Zinser & Kolter, 1999; McKenzie et al., 
2000; Bhamre et al., 2001; Bull et al., 2001; Sung & Yasbin, 2002; Bjedov et al., 2003; 
Sung et al., 2003; Tegova et al., 2004; Tenaillon et al., 2004). In particular, the association 
of inducible mutation pathways with the emergence of drug-resistance isolates of 
pathogenic bacteria (Phillips et al., 1987; Ysern et al., 1990; Riesenfeld et al., 1997; Ren 
et al., 1999; Alonso et al., 1999; Oliver et al., 2000; Björkholm et al., 2001; Denamur et al., 
2002; Visser, 2002) is considered especially relevant to the generation of antibiotic- and 
stress-resistance mutations in M. tuberculosis, whose microevolution within the hostile 
host environment is driven by genetic rearrangement and point mutations (Ramaswamy & 
Musser, 1998; Gutacker et al., 2002). In most bacterial systems studied to date, 
adaptation to environmental stress is predicated on the activity of SOS-inducible, error-
prone (EP) repair polymerases of the Y polymerase superfamily (McKenzie et al., 2001; 
Yeiser et al., 2002; Sung et al., 2003; Tegova et al., 2004). Members of the Y-family likely 
evolved to promote mutation avoidance and damage tolerance through a specialised 
ability to replicate across a variety of DNA lesions; however, the flipside of this ability is 
that the very properties enabling translesion synthesis (TLS) are implicated in 
mutagenesis (Friedberg et al., 2001, 2002; Yang, 2003; Kunkel, 2004; Tippin et al., 
2004b).  
 
3.2.1 The Y-polymerase superfamily 
Efficient DNA replication requires both high speed and high fidelity (Friedberg et al., 
2002). Despite the presence of multiple DNA repair systems in most bacteria (Eisen & 
Hanawalt, 1999), some potentially replication-blocking DNA lesions escape detection, 
necessitating rapid TLS polymerase-mediated bypass (Goodman, 2002; Friedberg et al., 
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2002, 2003; Tippin et al., 2004b). Although it now seems obvious that specialised DNA 
polymerases might have evolved to replicate across lesions, the discovery that the 
replicative flexibility they provide can incur error rates two to four orders of magnitude 
greater than those of replicative polymerases (Kunkel, 2004) demanded a redefinition of 
traditional concepts of DNA synthesis fidelity. Moreover, the fact that many of these 
polymerases are upregulated in response to stress suggests a potential role in induced 
mutagenesis (Friedberg et al., 2001; 2002). Most TLS polymerases fall into the Y-
polymerase superfamily comprising a wide range of structurally-related proteins present in 
bacteria, archaea and eukaryotes (Ohmori et al., 2001). Of these, the DinB subfamily – 
represented by E. coli pol IV (Wagner et al., 1999) - is the most widespread (Ohmori et al., 
2001). Members of the Y-family catalyse low-fidelity synthesis on non-substrate templates 
such as undamaged DNA or non-cognate lesions, lack intrinsic 3’®5’ proofreading 
exonuclease activity, adopt a distributive mode of DNA replication, and are able to support 
TLS of DNA lesions which might block replication by members of the other polymerase 
families (Friedberg et al., 2001, 2002; Goodman, 2002). In particular, the identification of 
EP Y-family repair polymerases has raised significant questions pertaining to the 
structural relation of members of this family to the other main DNA polymerases, the 
features enabling faithful bypass of DNA lesions but low-fidelity synthesis of undamaged 
or non-cognate DNA and, finally, the co-ordination at a replication fork of multiple different 
polymerase classes (Friedberg et al., 2001, 2002; Yang, 2003; Kunkel, 2004). Although Y-
family polymerases share little sequence homology with the other polymerase families, 
structural analyses have confirmed a similar overall architecture (Ling et al., 2001; Silvian 
et al., 2001; Trincao et al., 2001; Zhou et al., 2001; Yang, 2003). Critically, the active site 
of Y-family polymerases is sufficiently flexible to allow bypass of lesions that might distort 
replicative polymerase geometry, but with a consequent reduction in stringency (Ling et 
al., 2001; Friedberg et al., 2002; Yang, 2003; Kunkel, 2004). 
 
3.2.2 Heritable mutators 
Mutation rates can be modified by heritable and environment-dependent mechanisms 
(Metzgar & Wills, 2000). Heritable mutator mechanisms are independent of the 
environment and are often associated with mutations in DNA replication or repair genes 
that confer constitutive mutator phenotypes (Horst et al., 1999). Alternatively, specific 
regions of a genome may perturb DNA polymerase activity, resulting in replication 
slippage errors comprising single-motif insertion and deletion events (InDels) (Kunkel & 
Bebenek, 2000). Such hotspots of mutation are typically associated with “contingency 
genes” encoding strongly selected structures such as surface antigens or 
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restriction/modification systems (Moxon et al., 1994; Field et al., 1999; Moxon & Wills, 
1999). The inherent sequence repetition, together with evidence for frequent InDels in 
mycobacterial PE and PPE genes, for example, is suggestive of repeat expansions and 
contractions at these loci (Brosch et al., 2001; Banu et al., 2002). Small proportions of 
heritable mutators characterise commensal and chronic pathogenic bacterial populations 
in vivo, consistent with the idea that an elevated mutation rate may promote adaptation to 
the fluctuating host environment (Matic et al., 1997; Taddei et al., 1997b; Oliver et al., 
2000; Björkholm et al., 2001; Denamur et al., 2002; Visser, 2002). However, the 
deleterious consquences of a constitutive mutator phenotype (Boe et al., 2000) ensure 
that maintenance of the mutator allele depends on genetic linkage to the resultant 
beneficial mutation (Boe et al., 2000; Visser, 2002) and, in general, regaining the wild-type 
genotype is essential to the long-term survival of the population (Giraud et al., 2001a, 
2001b). 
 
3.2.3 Adaptive evolution of mutation rates 
Inducible (environment-dependent) mutators, on the other hand, act in a genome-wide 
manner to increase mutation rates specifically in response to applied stress (Metzgar & 
Wills, 2000). Those cells that survive produce progeny cells with normal mutation rates, 
thereby reducing the risk of unchecked mutagenesis. Whereas the acquisition of a 
mutator phenotype is a random event, it has been proposed that inducible mutagenesis is 
an adaptive response that has evolved by second-order selection to modulate mutation 
rates while limiting the costs associated with a constitutive mutator phenotype (Metzgar & 
Wills, 2000; Radman et al., 2000; Tenaillon et al., 2001, 2004). Alternatively, the 
pleiotropic hypothesis holds that stress-induced mutagenesis merely reflects the inevitable 
consequence of molecular constraints on survival mechanisms (Tenaillon et al., 2004). 
Whatever the selective force governing their evolution, the selection of inducible mutator 
mechanisms is inferred from the negative correlation between stress-induced 
mutagenesis and constitutive mutators, as well as by the observation that, where stresses 
are frequent or of long duration, inducible mutators are selected as efficiently as mutator 
alleles (Bjedov et al., 2003). 
3.2.4 SOS-inducible polymerases 
While MMR-deficient strains constitute nearly all identified natural mutators (LeClerc et al., 
1996; Matic et al., 1997), several environment-dependent mutator systems have been 
implicated in induced mutagenesis (Taddei et al., 1995, 1997a; Hughes & Andersson, 
1997; Bridges, 1998; Bjedov et al., 2003). Of these, the well-characterised E. coli SOS 
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response is considered the prototype. Significantly, the SOS regulon includes the EP 
repair polymerases, pol V (UmuD’C) and pol IV (DinB) (Kenyon & Walker, 1980; Bagg et 
al., 1981; Walker et al., 2000; Courcelle et al., 2001). Pol V provides the dominant TLS 
activity following DNA damage in E. coli (Rangarajan et al., 1999), the fidelity of synthesis 
depending on the nature of the lesion (Reuven et al., 1999; Tang et al., 1999, 2000; Maor-
Shoshani et al., 2003a). In particular, pol V has been implicated in the high proportion of 
lesion-targeted, base substitution mutations arising after UV treatment of E. coli 
(Lawrence et al., 1990; LeClerc et al., 1991; Tang et al., 1999; 2000). Pol IV, on the other 
hand, possesses limited TLS ability (Napolitano et al., 2000; Tang et al., 2000; Kim et al., 
2001; Shen et al., 2002; Wagner et al., 2002). Furthermore, unlike pol V (Rangarajan et 
al., 1999), deletion of pol IV does not result in damage hypersensitivity (Kim et al., 1997). 
Similarly, although overexpression of pol IV dramatically increases spontaneous mutation 
rates (Kim et al., 1997, 2001; Wagner & Nohmi, 2000; Kobayashi et al., 2002), decreasing 
intracellular pol IV levels has a less profound effect (Strauss et al., 2000; Kim et al., 2001; 
McKenzie et al., 2001; Kuban et al., 2004; Wolff et al., 2004). Instead, pol IV has been 
proposed to re-initiate stalled replication forks by extending transiently misaligned primer-
template strands (Wagner et al., 1999; Kim et al., 2001; Kobayashi et al., 2002; Goodman, 
2002). Consistent with this role, E. coli pol IV generates small, non-targeted frameshift 
mutations in vivo (Brotcorne-Lannoye et al., 1986; Kim et al., 1997). 
 
3.2.5 Stress-induced mutagenesis and stationary-phase adaptation 
A common misconception is that spontaneous mutations arise as a consequence of errors 
made exclusively during DNA replication in actively growing cells. However, it is well 
established that mutations arise in apparently static (or non-dividing) bacterial populations 
subjected to non-lethal selective conditions (Ryan, 1955; Cairns et al., 1988; Taddei et al., 
1995; Hughes & Andersson, 1997; Karunakaran & Davies, 2000). Furthermore, the 
increased periods spent in stationary phase by most cellular populations ensures that 
even very low mutation rates can lead to the accumulation of high mutation frequencies 
per cell (Bridges, 1998). Prolonged exposure of bacterial populations to non-lethal 
selective pressure elevates mutation rates by a process known as adaptive or stationary-
phase mutagenesis (Foster, 2000; McKenzie & Rosenberg, 2001). Among the mutation 
mechanisms reported are transposition events (Modi et al., 1992; Naas et al., 1994), 
substitution and frameshift mutations (Zambrano et al., 1993; Zinser & Kolter, 1999; 
Bhamre et al., 2001; Bull et al., 2001; Sung et al., 2003; Tegova et al., 2004), and gene 
amplifications (Sonti & Roth, 1989; Andersson et al., 1998; Hastings et al., 2000; 
Hendrickson et al., 2002). In general, stress is likely to arise as a consequence of the 
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specific ecological niche inhabited and is compounded by host immune effectors. 
However, the presence of antibiotic concentration gradients in vivo might result in lethal 
antibiotics causing non-lethal stress (Baquero & Negri, 1997; Baquero et al., 1998). 
Moreover, the importance of stress-related mutagenesis in the emergence of resistant 
bacteria has been repeatedly demonstrated, and is particularly relevant to the application 
of bacteriostatic selective pressure (Phillips et al., 1987; Ysern et al., 1990; Riesenfeld et 
al., 1997; Ren et al., 1999; Alonso et al., 1999; Oliver et al., 2000; Björkholm et al., 2001; 
Denamur et al., 2002; Visser, 2002; Boshoff et al., 2003).  
 
Several lines of evidence implicate SOS-induced mutagenesis in adaptive mutation 
pathways. SOS genes are upregulated in stationary bacterial populations (Dri & Moreau, 
1994; Taddei et al., 1995) and endogenous DNA damage has been implicated in 
mutagenesis in apparently static cells (Benov & Fridovich, 1996; Hall, 1998). Both SOS 
induction, as well as SOS-regulated pol IV, are required for the generation of stationary-
phase but not growth-dependent point mutations in E. coli (Cairns & Foster, 1991; Foster, 
2000; McKenzie et al., 2000, 2001, 2003). Furthermore, strains defective in the repair of 
DNA lesions exhibit increased rates of adaptive mutation (Rebeck & Samson, 1991; 
Bridges, 1995; Bridges et al., 1996; Pedraza-Reyes & Yasbin, 2004). In addition, E. coli 
pol IV is induced by the general stress-response s factor, RpoS, during long-term 
starvation (Layton & Foster, 2003). Significantly, the involvement of EP repair 
polymerases in stationary-phase mutation is consistent with the emergence in restrictive 
environments of mutants of increased fitness (Zambrano et al., 1993; Zambrano & Kolter, 
1993, 1996; Foster, 1999; Smeulders et al., 1999; Zinser & Kolter, 1999; Yeiser et al., 
2002). Furthermore, the detection of resistant phenotypes after prolonged exposure to a 
specific antibiotic is reminiscent of adaptive mutagenesis, and hints at the possible 
involvement of inducible mutator polymerases in such cases (McKenzie & Rosenberg, 
2001; Rosenberg, 2001). 
 
3.2.6 The stationary phase in mycobacteria 
The physiological state adopted by M. tuberculosis during latent clinical infection is poorly 
understood despite being crucial to propagation and sustained cycles of infection (Parrish 
et al., 1998; Stewart et al., 2003; Gomez & McKinney, 2004). Although often referred to as 
dormant, in its strictest sense this term should be reserved for a “reversible state of low 
metabolic activity in which cells can persist for extended periods without cell division” (Kell 
et al., 1995). In particular, emergence from dormancy requires specific molecular signals – 
such as resuscitation promoting factors (Rpfs) (Mukamolova et al., 1998) - in contrast to 
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stationary-phase exit, which is induced by a favourable change in environmental 
conditions. Although possibly containing a proportion of dormant cells, clinically latent M. 
tuberculosis infections are thought to comprise heterogeneous populations of mostly 
metabolically-active bacilli maintained in a state of non-growth or prolonged stationary 
phase (Canetti, 1955; Rees & Hart, 1961; Hu et al., 2000; Bouley et al., 2001; Grosset, 
2003; Muñoz-Elías et al., 2005) by a combination of nutrient limitation (McKinney et al., 
2000; Dahl et al., 2003; Timm et al., 2003) and environmental stress (Loebel et al., 1933; 
Nyka, 1967, 1974; Nathan & Shiloh, 2000; Fenhalls et al., 2002b; Shi et al., 2003). In such 
populations, a state of slow-replicating or nonreplicating persistence ensures limited cell 
turnover and a constant net viable count (Rees & Hart, 1961; Parrish et al., 1998; Muñoz-
Elías et al., 2005). 
 
3.2.7 Inducible mutagenesis in mycobacteria 
M. tuberculosis possesses the components of a functional LexA/RecA-regulated SOS 
response (Durbach et al., 1997; Movahedzadeh et al., 1997a, 1997b; 
Papavinasasundaram et al., 1997; Mizrahi & Andersen, 1998; Davis et al., 2002a). In 
addition, there is evidence of hypermutability (Karunakaran & Davies, 2000) and adaptive 
mutation (Smeulders et al., 1999) during stationary-phase growth in M. smegmatis. The 
identification of genes encoding putative Y-family homologues (Cole et al., 1998; Mizrahi 
& Andersen, 1998) was, therefore, strongly suggestive of the presence in mycobacteria of 
mutagenic processes under cellular control. However, since the inception of this study, 
several other groups have failed to observe the M. tuberculosis pol IV homologues in 
screens of DNA damage-response genes (Brooks et al., 2001; Boshoff et al., 2003; Rand 
et al., 2003). Instead, the dnaE2-encoded alternative catalytic (α) subunit of DNA 
polymerase III represents the only polymerase that is induced in the mycobacterial SOS 
regulon (Boshoff et al., 2003). Furthermore, DnaE2 has been shown to be the central 
player in damage-induced base substitution mutagenesis in M. tuberculosis (Boshoff et 
al., 2003), identifying the mycobacterial polymerase as the founder member of a novel 
family of dnaE-type family C polymerases from Gram-positive bacteria that catalyse TLS 
synthesis (Tippin et al., 2004b). An M. tuberculosis dnaE2 deletion mutant exhibits 
damage hypersensitivity in vitro, and is attenuated in vivo in a murine infection model 
(Boshoff et al., 2003). Moreover, abrogation of DnaE2 activity in vivo is associated with 
reduced emergence of drug resistance mutations. Coupled with the induction of dnaE2 
during stationary infection, these observations implicate DnaE2-mediated DNA repair in 
virulence and in the adaptive evolution of drug resistance during persistent infection 
(Boshoff et al., 2003). Furthermore, the phenotypes associated with loss of DnaE2 activity 
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suggest that this family C polymerase is functionally analogous to E. coli SOS-inducible 
pols IV and V in many respects and might, therefore, have usurped the predicted 
physiological roles of the identified mycobacterial pol IV homologues (Mizrahi et al., 2005).
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3.2.8 Aims and objectives of this study 
At the inception of this work, the components of a functional mycobacterial LexA/RecA-
dependent damage response had been identified and characterised (Mizrahi & Andersen, 
1998; Durbach et al., 1997; Movahedzadeh et al., 1997a, 1997b; Papavinasasundaram et 
al., 1997). In particular, it was known that the dinP- and dinX-encoded mycobacterial DinB 
(pol IV) homologues were not included in the inducible polymerase complement of the 
SOS regulon (Davis et al., 2002a). However, evidence implicating Y-polymerases (then 
referred to as the UmuC/DinB/Rev1/Rad30 polymerase superfamily; Gerlach et al., 1999) 
in damage tolerance and adaptive evolution in other bacteria suggested a link between 
pol IV gene function, stress-induced mutagenesis, and the emergence of drug resistance 
in mycobacteria, which was explored in both M. tuberculosis and the non-pathogenic M. 
smegmatis. The specific objectives extended primarily to the genetic characterisation of 
the mycobacterial pol IV homologues, and were:  
1.  To investigate the mutagenic capacity of the pol IV homologues by 
determining whether overexpression of M. tuberculosis dinP or dinX 
resulted in increased rates of spontaneous mutagenesis. 
2.  To establish whether the mycobacterial pol IV homologues were implicated 
in adaptive, or stress-induced, mutagenesis. 
During the course of this study, three significant findings were reported which impacted on 
the original stated aims: firstly, the characterisation of an alternative LexA/RecA-
independent damage-response pathway (Rand et al., 2003) which, like the SOS 
response, did not include the dinP- and dinX-encoded pol IV homologues; secondly, and 
most importantly, the identifiction of the dnaE2-encoded C-family polymerase as the 
primary mediator of inducible mutagenesis in mycobacteria (Boshoff et al., 2003); and, 
finally, evidence that the dinP-encoded pol IV homologue might be implicated in 
replication restart (Boshoff et al., 2004). As a result of these data, the aims were modified 
to include the following: 
3. Given the dominant role of dnaE2, to investigate whether the mycobacterial 
pol IV homologues contributed at all to damage tolerance, and whether the 
homologues were individually redundant. 
4. An attempt to identify conditions under which the pol IV homologues were 
induced, if any. 
5. An analysis of the role of the additional, Rv3394c-encoded SOS-inducible 
Y-family polymerase in damage tolerance. 
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3.3 MATERIALS AND METHODS 
3.3.1 Mycobacterial strains, plasmids, and probes 
The strains used in this study are detailed in Table 3.1, plasmids are listed in Table 3.2, 
probes in Table 3.3, and primers in Table 3.4. 
 
Table 3.1 Strains used in this study 
Strain Description Reference/Source 
M. smegmatis   
dinP+/- Single dinP knockout mutant of mc2155; HygR This study 
dinP-/- dinP null mutant of mc2155; HygR This study 
DDR Deletion mutant in duplicated region of mc2155; derivative of dinP+/-; HygR This study 
dinPKin Deletion mutant in duplicated region of mc
2155 with reconstituted wild-type 
dinP allele; derivative of ΔDR; unmarked This study 
ΔdinP3 dinP3 (MSMEG6405) deletion mutant of mc2155; unmarked S. Dawes 
ΔdinX dinX deletion mutant of mc2155; HygR This study 
dinP-/-/dinP3 Double dinP and dinP3 deletion mutant of mc2155; derivative of dinP-/-; HygR This study 
dinP-/-/dinX Double dinP and dinX deletion mutant of mc2155; derivative of dinP-/-; HygR This study 
ΔY Triple dinP, dinP3 and dinX deletion mutant of mc
2155;  
derivative of dinP-/-/dinP3; HygR This study 
ΔC Quadruple dinP, dinP3, dinX and dnaE2 deletion mutant of mc
2155;  
derivative of ΔY; HygR KmR This study 
M. tuberculosis   
ΔRv3394c Rv3394c deletion mutant of M. tuberculosis H37Rv; HygR This study 
ΔRv3394c/ 
ΔRv3395c 
Double ΔRv3394c/ ΔRv3395c deletion mutant of M. tuberculosis H37Rv; 
HygR This study 
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Table 3.2 Plasmids used in this study 
Plasmid 
Promoter analysis 
pAIdinP pAINT containing 631 bp upstream plus 29 bp internal M. tuberculosis dinP sequence H. Boshoff 
pAIdinX pAINT containing 1009 bp upstream plus 32 bp internal M. tuberculosis dinX sequence H. Boshoff 
pAI3055 pAINT containing 1009 bp upstream plus 36 bp internal M. tuberculosis Rv30055 sequence H. Boshoff 
pEM28w RBSlacZ (promoterless) from pATB12 in pHINT; HygR AmpR E. Machowski 
pEMdinP pEM28w containing 1815 bp Asp718-EcoRV fragment from pAIdinP This study 
pEMdinX pEM28w containing 2214 bp EcoRV fragment from pAIdinX This study 
pEM3055 pEM28w containing 2213 bp EcoRV fragment from pAI3055 This study 
Overexpression vectors 
pOLYGaa Multicopy E.coli–Mycobacterium shuttle vector with inducible acetamidase promoter; HygR  This study 
pOLYGaa::dinP Multicopy E.coli–Mycobacterium shuttle vector overexpressing M. tuberculosis dinP off the inducible acetamidase promoter; HygR This study 
pOLYGaa::dinX Multicopy E.coli–Mycobacterium shuttle vector overexpressing M. tuberculosis dinX off the inducible acetamidase promoter; HygR This study 
M. smegmatis knockout constructs 
p2ΔdinP p2NIL carrying ΔdinP allele; KmR This study 
p2ΔdinP::hyg p2ΔdinP with hyg cassette from pIJ963 cloned in BamHI site; KmRHygR This study 
p2ΔdinP17 hyg-marked dinP knockout vector -  p2ΔdinP::hyg containing PacI cassette from pGOAL17; KmRHygRSucS This study 
p2ΔdinP19 Unmarked dinP knockout vector - p2ΔdinP containing PacI cassette from pGOAL19; KmRHygRSucS This study 
p2dinP p2NIL carrying 2749 bp TdinPF1R2 PCR fragment containing mc
2155 dinP 
plus 1660 bp flanking sequence; KmR This study 
p2dinPKin Unmarked dinP “knock-in” vector – p2dinP containing PacI cassette from pGOAL17; KmRSucS This study 
p2ΔdinX p2NIL carrying ΔdinX allele; KmR This study 
p2ΔdinX::hyg p2ΔdinX with hyg cassette from pIJ963 cloned in BglII site; KmRHygR This study 
p2ΔdinX17 hyg-marked dinX knockout vector -  p2DdinX::hyg containing PacI cassette from pGOAL17; KmRHygRSucS This study 
p2ΔdinX19 Unmarked dinX knockout vector - p2ΔdinX containing PacI cassette from pGOAL19; KmRHygRSucS This study 
dinP3ZHB Knockout vector carrying unmarked deletion allele of mc
2155 dinP3 
(MSMEG6405) and PacI cassette from pGOAL19; KmRHygRSucS S. Dawes 
pGmsmE2KO Knockout vector carrying aph-marked deletion allele of mc
2155 dnaE2 and 
PacI cassette from pGOAL17; AmpRKmRHygRSucS H. Boshoff 
M. tuberculosis knockout constructs 
p2ΔRv3394c p2NIL carrying ΔRv3394c allele; KmR This study 
p2ΔRv3394c::hyg p2ΔRv3394c with hyg cassette from pIJ963 cloned in BglII site; KmRHygR This study 
p2ΔRv3394c17 hyg-marked Rv3394c knockout vector -  p2ΔRv3394c::hyg containing PacI cassette from pGOAL17; KmRHygRSucS This study 
p2ΔRv3394/5c p2NIL carrying ΔRv3394/5c allele; KmR This study 
p2ΔRv3394/5c::hyg p2ΔRv3394/5c with hyg cassette from pIJ963 cloned in BamHI site; KmRHygR This study 
p2ΔRv3394/5c17 hyg-marked Rv3394/5c knockout vector -  p2ΔRv3394/5c::hyg containing PacI cassette from pGOAL17; KmRHygRSucS This study 
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3.3.2 Construction of overexpression vectors 
The pAGAN11 vector, carrying the 4.1 Kb inducible acetamidase gene of M.smegmatis as 
a BamHI insert (Parish et al., 1997), was obtained from Tanya Parish. The insert was 
excised as a BamHI fragment and cloned into pOLYG in the opposite direction to the hyg 
cassette in order to minimise possible read through effects, yielding a vector termed 
pOLYGaa (Table 3.2). The M. tuberculosis dinP and dinX regions were amplified from 
genomic DNA using oligonucleotide primers (Table 3.4) containing artificial EcoRV 
restriction sites, and cloned into the TOPO 2.1 PCR cloning vector. The 1091 bp 
DINPFR1 PCR product contained the entire M. tuberculosis H37Rv dinP gene plus 30 bp 
upstream sequence, while the the 1472 bp DINXFR1 fragment contained the entire M. 
tuberculosis H37Rv dinX and 65 bp upstream sequence. Sequenced PCR products were 
digested with EcoRV and cloned into the blunted ClaI site of the pOLYGaa vector, to 
generate inducible expression vectors overexpressing M. tuberculosis dinP 
(pOLYGaa::dinP) and dinX (pOLYGaa::dinX), respectively. Initial experiments were 
performed in liquid media supplemented with 2g/l acetamide (Sigma) to induce expression 
of the vector, or succcinate as a control (Sigma), as described (Parish et al., 1997). 
However, semi-quantitative RT-PCR determined that the vector was leaky and that the 
relative expression  in mc2155 strains containing either pOLYGaa::dinP or pOLYGaa::dinX 
versus the vector control (pOLYGaa) was sufficient to invalidate the need for acetamide 
induction. 
 
 
3.3.3 Construction of reporter probes and measurement of β-galactosidase 
activities 
Construction of reporter probes 
Transcriptional reporters were constructed by cloning the promoter regions of M. 
tuberculosis dinP (pEMdinP) and dinX (pEMdinX) into a reporter construct (pEM28w; E. 
Table 3.3 Probes used in this study 
Probe 
TdinPFR1 948 bp PCR product containing 45 bp 5’ dinP coding sequence This study 
TdinPFR2 880 bp PCR product containing 44 bp 3’ dinP coding sequence This study 
P3p 798 bp EcoRv-XbaI fragment from dinP3ZHB S. Dawes 
MsXFR2 1744 bp PCR product containing 87 bp 3’ dinX coding sequence This study 
MsmE2 780 bp Asp718 fragment from pGmsmE2KO H. Boshoff 
3395FR1 1763 bp PCR product containing 213 bp 3’ M. tuberculosis dinP coding sequence This study 
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Machowski, unpublished) containing a promoterless lacZ gene. The pEMdinP construct  
contained 631 bp sequence upstream of dinP plus 29 bp internal dinP sequence and was 
generated by cloning the 1815 bp Asp718-EcoRV fragment from pAIdinP (H. Boshoff, 
unpublished) into pEM28w. Both pEM3055 and pEMdinX were similarly created by 
cloning the 2214 bp EcoRV fragment from pAIdinX (H. Boshoff, unpublished) and the 
2213 bp EcoRV fragment from pAI3055 (H. Boshoff, unpublished) into pEM28w to yield 
reporter constructs comprising 1009 bp upstream plus 37 bp internal dinX sequence 
(pEMdinX) and 1009 bp sequence upstream of Rv3055 plus 36 bp internal Rv3055 
sequence (pEM3055), respectively. 
Measurement of β-galactosidase activities 
β-galactosidase assays were performed using modifications of a previously described 
method (Ghanekar et al., 1999). Absorbance readings (OD600) of individual M. smegmatis 
cultures were determined at each timepoint, and 2ml aliquots harvested in duplicate by 
centrifugation at 4oC (5000 rpm for 5 min). Cell pellets were washed in 1ml pre-chilled Z-
buffer (60mM Na2HPO4; 40 mM NaH2PO4; 10 mM KCl; 1 mM MgSO4; 50 mM β-
mercaptoethanol), resuspended in 900μl Z-buffer before transferring to a Lysing Matrix A 
tube (Qbiogene), and lysed in a ribolyser (Savant Fastprep FP120) for 2 cycles (15 
seconds at speed 4) with cooling on ice for 2 minutes between pulses. The samples were 
then tansferred to clean microcentrifuge tubes, the cell debris pelleted by centrifugation, 
and the lysate aspirated and transferred to another clean microcentrifuge tube and stored 
on ice. To assess β-galactosidase activity in each sample, 100 μl of the above lysate was 
made up to 900 μl with Z-buffer, and 200 μl ONPG (2-nitrophenyl β-D-galactopyranoside, 
8 mg/ml stock; Sigma) added. The mixture was incubated at 37°C for 80 min, before 
reading the absorbance of each sample at 420 nm (OD420), using Z buffer as the blank. β-
gal activity (Miller units) was calculated acording to the following equation:  
β-gal activity (Miller units) = (OD420 x 1000)/(OD600 x T x V) 
  where, T = time (min);  V = volume (ml) of lysate 
To determine specific activity, 200ul of the lysate was made up to a volume of 800ul with 
Z-buffer, and 200μl Bradford’s reagent added and mixed gently by inversion. The mixtures 
were incubated at room temperature for approximately 10 minutes, and the absorbances 
read at 595 nm (OD595). Protein concentrations were determined with reference to a 
standard curve which was established simulataneously by performing the same assay on 
an appropriate range of known concentrations of BSA (Roche). Specific activity (Miller 
units per mg of protein) was then determined by dividing calculated β-galactosidase 
activities by the relative protein concentrations. 
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3.3.4 Construction of the marked and unmarked suicide delivery vectors 
M. smegmatis ΔdinP. The sequences of the putative M. smegmatis dinP and dinX genes 
were obtained by BLAST homology search (Altschul et al., 1990) of the preliminary M. 
smegmatis genome sequence database at The Institute for Genomic Research (TIGR; 
http://www.tigr.org) using the respective M. tuberculosis gene sequences (TubercuList; 
http://www.pasteur.fr/Bio/TubercuList) as probes. Two primer sets, TdinPF1/TdinPR1 and 
TdinPF2/TdinPR2 (Table 3.4) were designed to amplify sequence upstream and 
downstream of the putative M. smegmatis dinP gene from wild-type mc2155 genomic 
DNA. Ligation of the PCR products TdinPFR1 (948 bp) and TdinPFR2 (880 bp) eliminated 
982 bp dinP coding sequence. Sequenced PCR products were cloned into p2NIL (Parish 
and Stoker, 2000) to yield p2ΔdinP. To mark the deletion allele, the BamHI/BglII hyg 
cassette (1738 bp) from pIJ963 (Blondelet-Rouault et al., 1997) was inserted into the 
deletion junction between upstream and downstream PCR fragments to generate 
p2ΔdinP::hyg. Finally, the 6359-bp PacI fragment from pGOAL17 (lacZ-sacB; Parish and 
Stoker, 2000), or the 7939-bp PacI fragment from pGOAL19 (hyg-lacZ-sacB; Parish & 
Stoker, 2000) was cloned into the corresponding site of the vector carrying the marked 
(deletion-insertion; p2ΔdinP::hyg) or unmarked (deletion; p2ΔdinP) allele, generating 
p2ΔdinP17 and p2ΔdinP19, respectively. 
M. smegmatis dinPKin. PCR amplification of M. smegmatis mc2155 genomic DNA using 
the TdinPF1 and TdinPR2 primers generated a 2749 bp fragment containing the entire 
mc2155 dinP gene plus 877 bp upstream and 783 bp downstream sequence. The 
sequenced fragment was cloned into p2NIL (Parish and Stoker, 2000) to generate p2dinP, 
and the p2dinPKin vector created by the addition of the 6359-bp PacI fragment from 
pGOAL17 (lacZ-sacB; Parish and Stoker, 2000). 
M. smegmatis ΔdinX. The M. smegmatis ΔdinX deletion allele was constructed in the 
same manner as the ΔdinP deletion allele. Briefly, two primer sets, MsXF1/MsXR1 and 
MsXF2/MsXR2 (Table 3.4) were used to amplify sequence upstream and downstream of 
the putative M. smegmatis dinX gene from wild-type mc2155 genomic DNA. Ligation of the 
PCR products MsXFR1 (2107 bp) and MsXFR2 (1727 bp) eliminated 1185 bp dinX coding 
sequence. Sequenced PCR products were cloned into p2NIL (Parish and Stoker, 2000) to 
generate p2ΔdinX. To mark the deletion allele, the BamHI/BglII hyg cassette (1738 bp) 
from pIJ963 (Blondelet-Rouault et al., 1997) was inserted into the deletion junction 
between upstream and downstream PCR fragments, thereby creating p2ΔdinX::hyg. 
Finally, the 6359-bp PacI fragment from pGOAL17 (Parish and Stoker, 2000), or the 7939-
bp PacI fragment from pGOAL19 (Parish & Stoker, 2000) was cloned into the relevant 
marked or unmarked deletion allele to generate p2ΔdinX17 and p2ΔdinX19, respectively. 
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Table 3.4 Oligonucleotide primers used in this study 
Name Sequence (5’-3’) Comments† 
TaqMan analysis of M. tuberculosis dinP and dinX 
DINP-F AAGCAGCGCGCCAAGA forward primer 
DINP-R CGGTGAGCTGATAGATGCCA reverse primer 
DINP-PR CGCTACCGGGTTGGCGAAACC probe 
DINX-F TGACCACCATGGAGCAATTG forward primer 
DINX-R CGTTGGTGCGCGTGC reverse primer 
DINX-PR ACGAGGCGATCGACTCCATCGCT probe 
sigAF GACGAGGAGATCGCTGAACC forward primer  
sigAR TCGTCTTCATCCCAGACGAAA reverse primer  
sigA-PR CCGAAAAGGACAAGGCCTCCGG probe  
M. tuberculosis polIV overexpression constructs 
DINPF1 GGGGGGATATCGAAAACTGTGCGGACGATGAT EcoRv  
DINPR1 CCCCCCTATAGATCCGGTCAAGATTGGCGTGA EcoRv  
DINXF1 GGGGGGATATCGCCATAGCGAAAACTAGCTCG EcoRv  
DINXR1 CCCCCCTATAGTGGCCAGCGGCTGCAGTAG EcoRv  
M. smegmatis mc2155 dinP knockout allele 
TdinPF1 GCGGCGAAGCTTCGTTGTAGAACGGCACCT HindIII 
TdinPR1 CGGCCGGGATCCACCGAAGCCAGGAACTG BamHI 
TdinPF2 CGGCGGGGATCCGGTCCGGTTGCTCGGGGT BamHI 
TdinPR2 CGGCGGGGTACCCTGGCGCCGTCGAACGCG Asp718 
M. smegmatis mc2155 dinX knockout allele 
MSXF1 CGGCCCCATGGGCGCGTA Asp718 
MSXR1 GGGGGCTCTAGAGGGTGG BglII 
MSXF2 GGGCTCTAGACGGCGCGGCT BglII 
MSXR2 GGCGCTCTTCGAACCAGTGGT HindIII 
M. smegmatis rpoB sequencing 
MsmrpoBF1 GCAGACCCTGATCAACATCC forward primer 
MsmrpoBR1 ACGTCGCGGACCTCGAGG reverse primer 
Semi-quantitative RT-PCR of M. smegmatis pol IV homologues 
dinPF GGGATCAGTGACAACAAGCA forward primer 
dinPR CCATCACCGTCATCCAGTTC reverse primer 
dinXF GACGTCGAGGCGTTCTGT forward primer 
dinXR TCTTGGCGATCTGTTTACCC reverse primer 
dinP3F CGAGGCGTTCCTCGACGTAT Courtesy R. Brackin 
dinP3R CACCAAGTTCCTGGCCAAGG Courtesy R. Brackin 
M. tuberculosis Rv3394c and Rv3395c knockout alleles 
3395F1 GCCCCGTTCGAAAGCCTA HindIII 
3395R1 CCCCCTTCTAGAGGCGCCT BglII 
3395F2 GCCGGCTCTAGACGAGCCT BglII 
3395R2 GGCGCCCCATGGGCTCCA Asp718 
3395F3 GGGGCCGGATCCACCCTGGT BamHI 
3395R3 GCGCGGGGTACCGGTTCTT Asp718 
†Restriction sites utilised for subsequent cloning of PCR fragments are underlined where appropriate, and the relevant 
enzyme detailed under Comments. 
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M. tuberculosis ΔRv3394c and ΔRv3394c/ΔRv3395c. The M. tuberculosis ΔRv3394c 
and ΔRv3394c/ΔRv3395c deletion alleles were constructed using the same methods as 
those described above for M. smegmatis. Briefly, three primer sets - 3395F1/3395R1, 
3395F2/3395R2, and 3395F3/3395R3 (Table 3.4) - were designed to amplify sequence 
upstream and downstream of wild-type M. tuberculosis H37Rv Rv3394c and Rv3395c. 
Ligation of the PCR products 3395FR1 (1745 bp) and 3395FR2 (1900 bp) eliminated 
1014 bp Rv3394c coding sequence to create the ΔRv3394c allele; ligation of 3395FR1 
(1745 bp) and 3395FR3 (1899 bp) eliminated the entire Rv3395c gene as well as 1371 bp 
Rv3394c coding sequence to create the ΔRv3394/5c allele. Sequenced PCR products 
were cloned into the relevant sites of suicide vector p2NIL (Parish and Stoker, 2000) to 
generate p2ΔRv3394c and p2ΔRv3394/5c, respectively. To mark the deletion allele, the 
BamHI/BglII hyg cassette (1738 bp) from pIJ963 (Blondelet-Rouault et al., 1997) was 
inserted into the deletion junction between upstream and downstream PCR fragments, 
thereby creating p2ΔRv3394c::hyg and p2ΔRv3394/5c::hyg. Finally, the 6359-bp PacI 
fragment from pGOAL17 (lacZ-sacB; Parish and Stoker, 2000), was cloned into the 
marked deletion alleles to generate p2ΔRv3394c17 and p2ΔRv3394/5c17, respectively. 
 
3.3.5 Mutation rate (μ) assessment by fluctuation assay 
RifR mutations 
Rates of forward mutations to RifR in M. smegmatis strains overexpressing M. tuberculosis 
dinP or dinX were determined by Luria-Delbrück fluctuation assay, and analysed 
according to Rosch & Foster (2000). Briefly, a single colony of each M. smegmatis strain 
was picked from a fresh electroporation plate, and used to inoculate a pre-culture (7H9M-
ADC plus 50 μg/ml Hyg) which was grown to log phase (OD600 ~.1.0). Cells were 
harvested by centrifugation (13000 rpm for 1 min), diluted in 0.5 % Tween80, and used to 
inoculate a starting culture (7H9M-ADC plus 50 μg/ml Hyg) at a concentration of 
approximately 100 CFU/ml. Aliquots were plated in duplicate on plain 7H10M-OADC for 
initial CFU counts (N0), and on 7H10M-OADC containing 200 μg/ml Rif for assessment of 
possible revertants in the starting culture. The starting culture was aliquoted into parallel 
15 ml culture tubes to yield individual 2.5 ml cultures of approximately 100 CFU/ml. The 
number of tubes used was dependent on the m value (Rosche & Foster, 2000), and was 
determined over the course of the study to be satisfied by experiments comprising at least 
7 parallel tubes. The tubes were incubated in a New Brunswick series 25 Orbital incubator 
(New Brunswick, Inc, USA) at 300-400 rpm at 37oC until log phase (OD600 ~ 1.0) was 
reached. Before harvesting, Tween80 was added to each culture tube to a final 
concentration of 0.5%; and mixed by gently vortexing. Cultures were diluted serially in 
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0.5% Tween80, and plated on plain 7H10M-OADC or on 7H10M-OADC plus 200 ug/ml 
Rif to determine number of RifR mutants and final CFU (Nt) values, respectively. 
Adapted protocol for assessment of frameshift reversion rates to histidine 
prototrophy 
Freezer stocks of the M. smegmatis histidine auxotroph strains were streaked on 7H10 
plates supplemented with 100 μg/ml histidine as well as 7H10 plates without histidine to 
confirm histidine auxotrophy before onset of the fluctuation assay. A single colony was 
inoculated into 10 mL Middlebrook 7H9 liquid medium containing 100 μg/ml histidine and 
grown to log phase (OD600 ~ 1.0). A 1 ml aliquot was harvested (13000 rpm for 1 min) and 
washed twice in 1ml 0.5% Tween80 (13000 rpm, 1 min) to remove any residual 
supplement. After the final wash, cells were re-suspended in 1ml 0.5% Tween80. A 
dilution series was established in 0.5% Tween80, and used to inoculate a starting culture 
(Middlebrook 7H9 without histidine supplement) at a concentration of approximately 100 
CFU/ml, as per above. Aliquots were plated in duplicate on 7H10M-OADC without 
supplement for assessment of possible revertants in the starting culture, and on 7H10M-
OADC containing 100 μg/ml histidine for initial CFU counts (N0). The starting culture was 
aliquoted into parallel 15 ml culture tubes to yield 2.5 ml cultures, and incubated as per 
above. Before harvesting, Tween80 was added to each culture tube to a final 
concentration of 0.5%; and mixed by gently vortexing. The entire volume of each culture 
tube was aspirated into 2 ml microcentrifuge tubes, and cells harvested by centrifugation 
(13000rpm, 1min). Cells were then re-suspend in 500ml 0.5% Tween80, combined into 
single microcentrifuge tubes, and washed twice in 1ml 0.5% Tween80 to remove any 
residual supplement. After the final wash, cells were re-suspended in 1ml 0.5% Tween80, 
diluted serially, and plated on solid 7H10 agar with or without histidine supplement to 
determine Nt values or number of revertants, respectively. 
Determination of mutation rates 
Rates of frameshift reversion to histidine prototrophy or mutations to RifR were determined 
from at least three independent fluctuation assay experiments as per algorithms described 
in Rosche & Foster (2001). Briefly, the Lea-Coulsen Method of the Median (Rosche & 
Foster, 2000) was used to generate m values which were refined by iteration on a set of 
Microsoft Office Excel spreadsheets generated by E. Machowski, L.Machowski & S. 
Barichievy (unpublished). According to the MSS algorithm, the probability (pr) of observing 
all the experimental values of the number of mutants (r) for a given m is calculated until an 
m is identified that maximises the likelihood function for r = 0 to150 (Ma et al., 1992; 
Rosche & Foster, 2000). The mutation rate is then calculated by dividing m (the mean 
number of mutations per culture) by the total number of cells in the culture, Nt. 
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3.3.6 Damaging treatments of mycobacteria 
Mycobacterium tuberculosis 
For Taqman analyses of M. tuberculosis dinP and dinX expression in response to 
damage, duplicate 10 ml cultures were grown to an OD650 of 0.3–0.4 and were treated 
with 2mM S-nitrosoglutathione (GSNO; Sigma) or 4 mM H2O2 (Sigma) and incubated for 
12 hours at 37oC. For DNA damage by UV, cells were split into parallel 5 ml aliquots in 78 
cm2 dishes and open dishes irradiated with 20 mJ/cm2 (UV Stratalinker 1800, Stratagene) 
before being recombined in 10 ml volumes and incubated at 37oC for 24 hr. 
Mycobacterium smegmatis 
UV survival of M. smegmatis mc2155 strains was determined according to Boshoff et 
al.(2003). Briefly, duplicate serial dilutions of log phase cultures of each strain were plated 
in triplicate on solid 7H10M-ADC without any antibiotic. Open plates were irradiated at the 
specific UV fluence (UV Stratalinker 1800, Stratagene) and then incubated at 30 oC for 3-4 
days until visible CFUs were enumerated. For analysis of induced mutagenesis in 
response to UV damage, log phase cultures were harvested and resuspended in 6 ml 
aliquots in 78 cm2 dishes and irradiated with 20 mJ/cm2 (UV Stratalinker 1800, 
Stratagene). After irradiation of open dishes, cells were resuspended in fresh media and 
allowed to grow for specific intervals before aliquots were plated on solid 7H10M-ADC 
without antibiotic (for viable CFU assessment) or containing 200 μg/ml Rif (for 
determination of RifR frequencies). To monitor the mutation frequencies of M. smegmatis 
strains in response to novobiocin (NVB) treatment, log phase cells were exposed to 
specific NVB concentrations for defined time intervals before plating as above. 
 
3.3.7 RNA isolation and first-strand cDNA synthesis 
RNA was isolated according to the method of Betts et al. (2002). Briefly, 50 ml cultures 
were harvested by centrifugation (1100 x g for 10 minutes) and pellets resuspended in 1 
ml TRIzol (Gibco-BRL) on ice. The cell suspensions were immediately transferred to tubes 
containing Lysing Matrix B (Qbiogene) and lysed in a ribolyser (Savant Fastprep FP120) 
for three cycles (20 seconds at speed 6) with cooling on ice for 1 min between pulses. 
Samples were then centrifuged (13000 rpm for 45 seconds), and the solution above the 
beads and cellular debris removed to a tube containing 200 ml of chloroform and Phase 
Lock gel (heavy; Sigma). Samples were inverted rapidly for 15 s and then periodically for 
2 min before centrifugation in an Eppendorf 5415D microcentrifuge (13000 rpm for 5 
minutes). The top aqueous layer was transferred to a fresh tube and an equal volume of 
isopropanol added and mixed well. Precipitated nucleic acids were collected by 
centrifugation (12000 x g for 20 min at 4oC), and pellets washed with 70% ethanol and air 
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dried. Crude RNA samples were treated with DNase I (Ambion) by incubation at 37oC for 
20 min and purified further using an RNeasy kit (Qiagen) according to the manufacturer’s 
instructions. Samples were then subjected to a final DNase I treatment using the Ambion 
DNA-freeä kit, according to manufacturer’s instructions. The quality of purified total RNA 
was assessed by gel electrophoresis (2% agarose; 0.1% SDS). 
Reverse Transcription 
All RT reactions were performed in an Eppendorf MasterCycler Gradient using the method 
modified from Manganelli et al. (1999). Briefly, 20 μl reactions were set up in DEPC-
treated H2O comprising 20 ng/μl of total RNA and 0.25 μM of each antisense primer. RNA 
was denatured at 94oC for 90 seconds, and then annealing of the RNA and antisense 
primers alowed to occur at 65oC for 3 minutes followed by 3 minutes at 57oC. RNA was 
reverse transcribed in 20 μl reactions comprising 10 μL of the annealing mixture, 1x Avian 
Myeloblastoma Virus (AMV) RT Buffer (Sigma), 200 μM each dNTP (Sigma), 4 mM MgCl2 
(Sigma), 0.6 μl Dimethyl Sulphoxide (DMSO; Sigma) and 2 U Enhanced AMV RT (Sigma), 
which were incubated for 30 min at 60oC, heated at 95oC for 5 min and chilled to 4oC. 
Control reactions containing no AMV RT were established in parallel to assess levels of 
contaminating DNA. Samples were then diluted with 70ml H2O and stored at -70oC. 
 
3.3.8 Real-Time, Quantitative RT-PCR Assay (Taqman) 
First-strand cDNA synthesis was performed as described above (3.3.7) and real-time 
quantitative PCR performed on the ABI Prism 7700 sequence detection system using the 
PE Applied Biosystems Taqman PCR core reagent kit. Taqman primer and probe sets 
were designed on the ABI Prism 7700 sequence detection system using Primer Express 
software and are described in Table 3.4. RNA levels were normalised to sigA gene 
expression (Manganelli et al., 1999; Boshoff et al., 2003). Gene expression was 
determined using two independent induction experiments using a control untreated cell 
sample for each time point. Each RNA sample was independently reverse transcribed 
twice and tested in triplicate for each probe-primer set. 
 
3.3.9 Semi-quantitative RT-PCR of the mc2155 response to gyrase inhibitors 
Primers used for semi-quantitative RT-PCR were designed using the Primer3 design 
programme (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and are detailed in 
Table 3.4. All primers were designed to amplify DNA fragments internal to the coding 
sequence of the relevant genes with the same annealing temperatures. 
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PCR amplifications 
The standard 50 μl PCR reactions consisted of 1x FastStart PCR buffer without MgCl2 
(Roche), 4 mM MgCl2 (Roche), 250 μM each dNTP (Roche), 5 μl DMSO (Sigma), 0.5 
mg/ml BSA (Roche), 0.5 μM of each primer, 2.5 U FastStart Taq DNA Polymerase 
(Roche) and 2 μl cDNA from the RT reaction or genomic DNA. Cycling parameters were 
as follows: an initial heat activation step of 95oC for 10 minutes and 15 cycles stringent 
amplification (95oC denaturation for 30 seconds, 65oC anealing for 30 seconds, and 72oC 
polymerisation for 30 seconds) was followed by a second round of amplification (95oC 
denaturation for 30 seconds, 57oC anealing for 30 seconds, and 72oC polymerisation for 
30 seconds). The amount of contaminating chromosomal DNA was tested in parallel using 
the control samples. Samples were separated on 4% agrose gel (2.4.1). 
 
3.3.10 Long-term competitive survival assays 
Competitve survival of M. smegmatis mc2155 strains was determined essentially 
according to Smeulders et al. (1999). Briefly, aerobic cultures comprising equal 
concentrations of hyg-marked deletion mutants and wild-type mc2155 were set up in 50 ml  
liquid 7H9M-ADC without antibiotic in 500 ml Ehrlenmeyer flasks. Pure cultures of each 
strain were also set up in parallel in order to control for possible long-term survival 
defects. Cultures were incubated at 30oC with slow rotation (100 rpm), and media were 
not refreshed at any stage during the course of the experiment. At each timepoint, aliquots 
were harvested in duplicated, and serial dilutions plated in triplicate on solid 7H10-
MOADC containing no antibiotic (for assessment of total viable CFU) and 50 μg/ml Hyg 
(for assessment of mutant CFU). To avoid problems associated with clumping at later 
timepoints, aliquots were harvested and resuspended in 0.5% Tween80 before diluting in 
0.5 % Tween80. Aliquots from the pure cultures were also plated on solid 7H10M-OADC 
containing 200 μg/ml Rif to allow determination of mutation frequencies.  
 
3.3.11 Sequencing of the rpoB locus of RifR M. smegmatis mutants 
Extraction of DNA for sequencing. DNA was extracted from RifR colonies using a small-
scale extraction method. Briefly, RifR colonies were picked from Middlebrook 7H10 plates 
containing 200 μg/ml Rif and chromosomal DNA extracted by boiling each colony for 20 
minutes in a solution of 40 μL chloroform and 20 μL of distilled water at 100oC. 
Centrifugation followed for 5 minutes at 10000 x g. The supernatant was used 
immediately as PCR template or stored at -20oC. 
Amplification and sequencing. The rpoB region was amplified with the 
MsmrpoBF1/MsmrpoBR1 primer set and using the Expand High Fidelity PCR System 
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(Roche Molecular Biochemicals). For the PCR reaction, 2 μl of the boiled mixture was 
included in a 20 μl reaction comprising 1 x supplied reaction buffer, 1.0 μM of each of the 
forward and reverse primers, 10 μM of each dNTP, 1.5 mM MgCl2, and 10% GC-RICH 
solution. Cycling parameters were as follows: denaturation at 95oC for 5 minutes, 30 
cycles of denaturation (95oC for 60 seconds), annealing at 60oC for 45 seconds, and 
extension at 72oC for 45 seconds, followed by a final extension at 72oC for 5 minutes. An 
aliquot (2μl) was removed for gel electrophoreses on a 4% agarose gel to confirm 
successful amplification as well as the approximate fragment size (183 bp in wild-type 
mc2155). The remaining volume was dispatched for sequencing. 
.
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3.4  RESULTS 
3.4.1 The mycobacterial Y-family homologues 
The crystal structures of various bacterial and eukaryotic Y-family homologues have 
revealed similar palm, finger and thumb domains characteristic of the catalytic cores of the 
high-fidelity replicative enzymes (Ling et al., 2001; Silvian et al., 2001; Trincao et al., 
2001; Zhou et al., 2001). However, polymerases of the Y superfamily also contain a 
unique C-terminal “little-finger” (LF) domain (Ling et al., 2001; Silvian et al., 2001; Trincao 
et al., 2001) that is structurally conserved among Y-family members and has been shown 
to be essential for TLS in vivo, perhaps through an ability to bind regulatory co-factors 
(Haracska et al., 2001b; Kannouche et al., 2001). The interaction of E. coli pol IV with the 
b processivity factor, for example, is dependent on five residues at the extreme C-
terminus of this domain (Figure 3.1) (Lenne-Samuel et al., 2002) and is essential for pol 
IV-mediated bypass and mutagenesis (Becherel et al., 2002; Lenne-Samuel et al., 2002). 
Significantly, conserved consensus pentapeptide motifs mediating β clamp binding have 
been identified in most eubacterial genomes (Dalrymple et al., 2001; 2003) and have been 
implicated in the interaction of a number of protein families with β (Yang, 2000; López de 
Saro & O’Donnell, 2001; Dalrymple et al., 2001, 2003; Ohmori et al., 2001; Noirot-Gros et 
al., 2002; Sung et al., 2003; Kurz et al., 2004). 
 
The M. tuberculosis H37Rv genome contains two putative Y-family polymerases of the 
DinB sub-class (Figure 3.1, Figure 3.2) (Ohmori et al., 2001), namely dinP (Rv3056) and 
dinX (Rv1537) (Cole et al., 1998). Consistent with the significant sequence homology 
DinP and DinX share with E. coli pol IV (Figure 3.1), these proteins are designated Pol IV 
2 and Pol IV 1, respectively, on the TubercuList database 
(http://genolist.pasteur.fr/TubercuList/). In addition, based on predicted binding affinities 
for the β sliding clamp, dinP and dinX have been identified as DinB1.5 and DinB1.4 Y-
family sub-class polymerases, respectively (Dalrymple et al., 2003). Interestingly, 
members of the DinB1.5 sub-class, including M. tuberculosis DinP (Figure 3.1), contain no 
identifiable β clamp binding region, suggesting that polymerases of this sub-class either 
do not bind the β clamp or bind through an alternative β-binding motif (Dalrymple et al., 
2003). In addition to the pol IV homologues, the presence of a putative consensus β-
binding motif recently identified M. tuberculosis Rv3394c as a novel DinB3-type Y-family 
polymerase (Dalrymple et al., 2003). However, although containing putative DinB and IMS 
domains that are suggestive of a role in damage protection, Rv3394c lacks conserved 
acidic residues shown to be essential for polymerase activity (Figure 3.1). Therefore,
 54 
 
75 
 
M - - - - - - - R K I I H V - D M D C F F A A V E M R D N P A L R D I P I A I G G - - - S R E R R G V I S T A N Y P A R K F G V R S A M P T  1 ecDinB.PRO
M I V - - - - - - - - L F V - D F D Y F Y A Q V E E V L N P S L K G K P V V V C V F S G R F E D S G A V A T A N Y E A R K F G V K A G I P I  1 ssDpo4.PRO
M - - P T A A P R W I L H V - D L D Q F L A S V E L L R H P E L A G L P V I V G G N G D P T E P R K V V T C A S Y E A R A Y G V R A G M P L  1 mtdinP.PRO
- - - - - - - - - - V L H L - D M D A F F A S V E Q L T R P T L R G R P V L V G G L G G - - - - R G V V A G A S Y E A R A Y G A R S A M P M  1 mtdinX.PRO
M F V S A A E S A S I L H A - D L D S F Y A S V E Q R D D P A L R G R P V I V G G - - - - - - - - G V V L A A S Y E A K A Y G V R T A M S G  1 msdinP3.PRO
V M A S A - - - - R V L A I W C M D - - W P A V A A A A A A G L S A T A P V A V T L A N R - - - - - - V I A C S A T A R A A G V R R G L R R  1 mtRv3394c.PRO
M F A - - - - - - - - - L C - D V N A F Y A S C E T V F R P D L W G K P V V V L S - - - - - N N D G C V I A R N A E A K A L G V K M G D P W  1 ecUmuC.PRO
G M A L K L C P - H L T L - L P G R F D A Y K E A S N H I R E I F S R Y T S R I E P L S L D E A Y L D V T D S V H - C H G S A T L I A Q E I  60 ecDinB.PRO
V E A K K I L P - N A V Y - L P M R K E V Y Q Q V S S R I M N L L R E Y S E K I E I A S I D E A Y L D I S D K V R D Y R E A - Y N L G L E I  62 ssDpo4.PRO
R T A A R R C P - E A T F - L P S N P A A Y N A A S E E V V A L L R D L G Y P V E V W G W D E A Y L A - - - V A P G T P D D P I E V A E E I  68 mtdinP.PRO
H Q A R R L I G V T A V V - L P P R G V V Y G I A S R R V F D T V R G L V P V V E Q L S F D E A F A E P P Q L A G A V A E D V E T F C E R L  56 mtdinX.PRO
G Q A R A L C P - Q A I V - V P P R M A A Y T Q A S R D V F A V F H D T T P L V E P L S V D E A F L D V S G L A R - V S G T P V E I A A R L  62 msdinP3.PRO
R E A A A R C P - - Q L F I A T A D A D R D A R L F E G V I A A V D D L V P R A E L L R P G L L V L P V R G P A R F F G S E - - Q M A A E R  59 mtRv3394c.PRO
F K Q K D L F R R C G V V C F S S N Y E L Y A D M S N R V M S T L E E L S P R V E I Y S I D E A F C D L T G - V R N C R D - L T D F G R E I  56 ecUmuC.PRO
R Q T I F N E L Q L T A S A G V A P V K F L A K I A S D M N K - - - - - P N G Q F V I T P - A E V P A F L Q T L P L A K I P G V G K V S A A  127 ecDinB.PRO
K N K I L E K E K I T V T V G I S K N K V F A K I A A D M A K - - - - - P N G I K V I D D - E E V K R L I R E L D I A D V P G I G N I T A E  129 ssDpo4.PRO
R K V I L S Q T G L S C S I G I S D N K Q R A K I A T G L A K - - - - - P A G I Y Q L T D - A N W M A I M G D R T V E A L W G V G P K T T K  133 mtdinP.PRO
R R R V R D E T G L I A S V G A G S G K Q I A K I A S G L A K - - - - - P D G I R V V R H - A E E Q A L L S G L P V R R L W G I G P V A E E  125 mtdinX.PRO
R A R V R E Q V G L P I T V G I A R T K F L A K V A S Q E G K - - - - - P D G L L L V P P - D R E L A F L H P L P V R R L W G V G A K T A E  129 msdinP3.PRO
L I D A V A A A G A E C Q V G I A D R L S T A V F A A R A G R - - I V E P G G D A R F L S L L S I R Q L A T E - - - P S L S G P G R D D L T  125 mtRv3394c.PRO
R A T V L Q R T H L T V G V G I A Q T K T L A K L A N H A A K K W Q R Q T G G V V D L S N L E R Q R K L M S A L P V D D V W G I G R R I S K  124 ecUmuC.PRO
K L E - A M G L R T C G D V Q K C D L V M L L K R F G - K F G R I L W E R S Q G I D E R D V N S E R L R - K S V G V E R T M A E D I H H W S  191 ecDinB.PRO
K L K - K L G I N K L V D T L S I E F D K L K G M I G E A K A K Y L I S L A R D E Y N E P I R T R V R - - K S I G R I V T M K R N S R - - -  193 ssDpo4.PRO
R L A - K L G I N T V Y Q L A H T D S G L L M S T F G P R T A L W L L - L A K G G G D T E V S A Q A W V P R S R S H A V T F P R D L T C R S  197 mtdinP.PRO
K L H - R L G I E T I G Q L A A L S D A E A A N I L G A T I G P A L H R L A R G I D D R P V V E R A - E A K Q I S A E S T F A V D L T T M E  189 mtdinX.PRO
K L R - A H G I E T V A D V A E L S E A T L G S M V G G A M G R Q L F T L S R N I D R R R V T T G V R R - S S V G A Q R A L G R R G N S M S  193 msdinP3.PRO
D L L W R M G I R T I G Q F A A L S R T D V A S R F G A D - A V A A H R F A R G E P E R A P C G R E P P P D - L A A E L A C D P P I D R V D  190 mtRv3394c.PRO
K L D - A M G I K T V L D L A D T D I R F I R K H F N V V L E R T V R E L - R G E P C L Q L E E F A P T K Q E I I C S R S F G E R I T - - -  194 ecUmuC.PRO
- - E C E A I I E R L Y P E L E R R L - - - - - - - A K V K P D L L I A R - Q G V - K L K F D D F - - - - - - - Q Q T T Q E H V - - W P R L  258 ecDinB.PRO
- - N L E E I K P Y L F R A I E E S Y - - - - - - - Y K L - - D K R I P K - A I H V V A V T E D L - - - - - - - D I V S R G R T F P H G I S  257 ssDpo4.PRO
- - E M E S A V T E L A - - - Q R T L - - - - - - - N E V V A S S R T V T - R V A V T V R T A T F - - - - - - - Y T R T K I R K L Q A P S T  265 mtdinP.PRO
- - Q L H E A I D S I A - - - E H A H - - - - - - - Q R L L R D G R G A R - T I T V K L K K S D M - - - - - - - S T L T R S A T M P Y P T T  257 mtdinX.PRO
A A E V D A V V V N L V D R I T R R M - - - - - - - - - - R A A G R T G R - T V V L R L R F D D F - - - - - - - G R A T R S H T M P W A T A  261 msdinP3.PRO
A A A F A G - - R S L A A E L H R A L M A A G V G C T R L A I H A V T A N G E E R S R V W R C A E P L T E D A T A D R V R W Q L D G W L N N  258 mtRv3394c.PRO
- - D Y P S M R Q A I C S Y A A R A A - - - - - - - E K L R S E H Q Y C R - F I S T F I K T S P F A L N E P Y Y G N S A S V K L L T P T Q D  259 ecUmuC.PRO
N K A D L I A T A R K - - - T W D E R R G G R G V R L V G L H V - T L L D P Q M E - - R Q L V L G - - - - - - - - - - - - - - - - - - - - -  308 ecDinB.PRO
K E T A Y - - - - - - - - - - - - - - - - S E S V K L L - - - - - - - - - - - - - - - - Q K I L E E D E R K I R R - - - - - - - - - - - - -  308 ssDpo4.PRO
D P D V I T A A A R H V L - - - D L F E L D R P V R L L G V R L - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  315 mtdinP.PRO
D A G A L F T V A R R L L P - - D P L Q I G - P I R L L G V G F - S G L S D I R Q - - E S L - - - F A D S D L T Q E T A A A H Y V E T P G A  307 mtdinX.PRO
S T D V I L C A A R E L V A A A A P L I A E R G L T L I G F A V - S N I D R G G T - - Q Q L E L P F A D N R I R S R S I R P S I R C G S G S  313 msdinP3.PRO
R N A R D R P T A A V T L L R L Q A V E T V S A S E G L Q L P L W G G L G E Q D R L R A R R A L V R V Q G L L G P E A V R V P V L S G G H G  326 mtRv3394c.PRO
S R D I I N A A T R S L D A I W Q - - - A G H R Y Q K A G V M L - G D F F S Q G V - - A Q L N L - F D D N A - - P R P G S E Q L M T V M D T  319 ecUmuC.PRO
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  351 ecDinB.PRO
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - I G V R F S K F I E - - - - - - - - - A I G L D K F F - - - - - - - -  333 ssDpo4.PRO
- - - - - - - - - - - - - - - - - - - - - E L A                                                344 mtdinP.PRO
V V P A A H D A T M - W R V G D D V A H P E L G H G W V Q G A G H G V V T V R F E T R G S - - - - - - - - - G P G S A R T F P V D T G D I S  368 mtdinX.PRO
A T P C S P A V C - - W S A A - - - - - - - - T R A W R C P C - - - - - - - - - - C R T R - - - - - - - - - R T G L Q R - - - - - - - - - -  380 msdinP3.PRO
P A E R I T L T V L G L V A P E P V P Q A D P G Q P W P G R L P D P S P A V L F D D P V D L L D A Q G N P I R V T S R G M F S A D P A R L R  396 mtRv3394c.PRO
L N A K E G R G T L - Y F A G Q G I Q Q Q - - - - - W Q M K - - R A M L S P R Y T T R S S - - - - - - - - - D L - - - - - - - - - - - - - -  380 ecUmuC.PRO
- - - - L                                                                   351 ecDinB.PRO
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - D T                            351 ssDpo4.PRO
                                                                       346 mtdinP.PRO
N A S P L D S L D W - - - - - P D - - - Y I G Q L S V E G S A G A S A P T V D D V G D R                            428 mtdinX.PRO
- - N P .                                                                   411 msdinP3.PRO
V R G R D D R L R W W A G P W P D D E R W W D P D R A S G R T A R A Q V L L D G D P G T A L L L C Y R Q R R W Y L E G S Y E          466 mtRv3394c.PRO
- - - - - - - - - - - - - - - - - - - - - - - - L R V - - - - - - - - - - - - - - - - K                            419 ecUmuC.PRO
Decoration 'Decoration #1': Shade (with bright yellow at 90% fill) residues that match ecDinB.PRO exactly.
  
 
    
  
 
  
 
 
 
  
 
  
  
 
 
 
 76 
Figure 3.1 Sequence alignment of the mycobacterial Y-family polymerases. M. tuberculosis 
H37Rv DinP (mtdinP. PRO), DinX (mtdinX.PRO) and Rv3394c (mtRv3394c.PRO), and M. 
smegmatis mc2155 DinP3 (msdinP3.PRO), are aligned with E.  coli  pol IV (ecDinB.PRO) and the 
UmuC subunit of E. coli  pol V (ecUmuC.PRO). Based on structural data from Sulfolobus 
solfataricus P2 Dpo4 (ssDpo4.PRO), conserved residues known to be important for polymerase 
activity are boxed in red, and for structural integrity in green (Ling et al., 2001). In addition, the little-
finger domain secondary  structures observed in S. solfataricus Dpo4 are represented by dark-blue 
arrows –  representing β strands, and light-blue arrows – representing α-helices (Ling et al., 2001). 
The consensus β-clamp-binding motifs (Dalrymple et al., 2003) for M. tuberculosis DinX and 
Rv3394c, M. smegmatis DinP3, and E. coli  pol IV (DinB) and UmuC, are contained within black 
boxes. M. tuberculosis DinP does not possess a β-binding motif (Dalrymple et al., 2003). The 
absence in M. tuberculosis Rv3394c of conserved acidic residues required for polymerase activity 
should also be noted. 
 
 
 
 
Rv3394c was excluded from the mycobacterial Y-polymerase complement for the 
purposes of this study. 
 
The corresponding gene complement of M. smegmatis mc2155 is more complex 
(http://www.tigr.org): there are two copies of dinP (MSMEG1002, and an unannotated 
ORF located between MSMEG2295 and MSMEG2296) as a result of a chromosomal 
duplication (see 3.4.4), as well as a single dinX homologue (MSMEG3178). In addition, 
the mc2155 genome encodes another pol IV homologue (MSMEG6405) that is not present 
in M. tuberculosis H37Rv, but is found in M. avium subsp. paratuberculosis 
(http://www.tigr.org). For ease of reference, the additional mc2155 pol IV homologue was 
provisionally designated dinP3 (for third dinP-like gene; S. Dawes & R. Brackin, 
unpublished). M. smegmatis DinP3 belongs to the DinB1.2 Y-family sub-class containing 
a carboxy-terminal β-binding domain (Dalrymple et al., 2003; Figure 3.1). Significantly, 
bioinformatic analysis revealed the presence of a Cheo-type SOS box (Cheo et al., 1991) 
upstream of M. smegmatis dinP3 (R. Brackin, unpublished). In addition, the LexA/RecA-
mediated regulation of dinP3 expression in response to DNA damage was recently 
confirmed (R. Brackin, unpublished). Critically, although sequence identities are strongly 
suggestive of DNA polymerase function (Figure 3.1), thus far of the mycobacterial Y-
family homologues only M. tuberculosis DinX has been shown biochemically to possess 
polymerase activity (B. Kana, unpublished). 
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Figure 3.2 Genomic organisation of the mycobacterial pol IV homologues. M. tuberculosis 
H37Rv contains two pol IV homologues encoded by dinP and dinX. An additional, pol IV 
homologue, dinP3 (MSMEG6405), is contained in the M. smegmatis mc2155 genome. The 
absence of dinP3 in M. tuberculosis distinguishes the two mycobacterial SOS responses (see 
Table 3.12). Rv3055-encoded TetR-family transcriptional regulators precede dinP in both 
genomes. An ethR-encoded TetR-family transcriptional regulator is situated directly upstream of 
dinP3 in M. smegmatis mc2155. 
 
 
3.4.2 Regulation of M. tuberculosis dinP and dinX 
The M. tuberculosis  pol IV homologues are not DNA damage inducible 
Previous studies have established that, despite the din or “damage inducible” designation, 
neither pol IV homologue (dinP or dinX) is upregulated following treatment of M. 
tuberculosis H37Rv with a variety of DNA damaging agents (Brooks et al., 2001; Boshoff 
et al., 2003). Although consistent with the dominant role of DnaE2 in SOS mutagenesis in 
mycobacteria (Boshoff et al., 2003), the failure of DNA damage to cause upregulation of 
these genes contrasts with the SOS-inducibility of the Y-polymerases in other bacteria 
(Kenyon & Walker, 1980; Bagg et al., 1981; Friedberg et al., 1995; Walker et al., 2000; 
Courcelle et al., 2001; Sung et al., 2003). Furthermore, the presence of multiple Y-family 
members in addition to dnaE2, coupled with evidence that recombinant DinX displays 
template-directed DNA polymerase activity in vitro (B. Kana, unpublished), raises several 
questions as to the function and regulation of these enzymes. In particular, evidence 
indicating a potential role for M. tuberculosis dinP following inhibition of DNA replication 
(Boshoff et al., 2004) is reminiscent of a previous suggestion that regulation of 
mycobacterial damage response pathways might be lesion-specific (Boshoff et al., 2003).  
ethA   ethR  
M. smegmatis mc2155  
M. tuberculosis H37Rv 
ileS ansA Rv3055  dinX dinP ethA   ethR        Rv3856c 
ileS ansA dinX 
MSMEG1003/ 
MSMEG2296  dinP 
MSMEG6405 
(dinP3) MSMEG6408 
TetR-family transcriptional regulator 
DNA-dependent DNA polymerase X family 
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Table 3.5 Induction of M. tuberculosis pol IV homologues† 
Treatment dinP dinX 
GSNO (2 mM) 2.13 ± 2.36 0.50 ± 0.09 
H2O2 (5 mM) 1.92 ± 0.99 0.35 ± 0.02 
UV (20 mJ/cm2) 2.04 ± 1.76 0.70 ± 0.09 
†Fold induction relative to log phase expression and normalised to sigA gene 
 
To confirm that neither Y-family homologue is induced in response to alternative DNA 
damaging agents, H37Rv was exposed to 2 mM S-nitrosoglutathione (GSNO) - an RNI 
source (St. John et al., 2001), and 5 mM hydrogen peroxide (H2O2) – an ROI source 
(Firmani & Riley, 2002), as well as to UV irradiation, and expression of dinP and dinX 
determined by real-time, quantitative RT-PCR (Table 3.5). None of the DNA damaging 
treatments resulted in statistically significant alterations in dinP or dinX mRNA transcript 
levels relative to log phase, in accordance with previous reports (Brooks et al., 2001; 
Boshoff et al., 2003). 
 
M. tuberculosis Rv3055 and dinX promoter regions are active in M. smegmatis 
during stationary phase in vitro 
Genes encoding the SOS-inducible polymerases pol IV (dinB), pol II (polB) and pol V 
(umuDC) are transcribed during prolonged stationary phase in E. coli in the absence of 
exogenous DNA damaging agents (Yeiser et al., 2002). In addition, expression of E. coli 
dinB is further induced late in stationary-phase, potentially implicating pol IV in a global 
response to long-term starvation and stress (Layton & Foster, 2003, 2005). To investigate 
the expression profiles of the mycobacterial Y-family polymerases, transcriptional 
reporters were constructed in which the promoter regions of M. tuberculosis dinP 
(pEMdinP) and dinX (pEMdinX) were fused to a promoterless lacZ gene, and β-
galactosidase activities monitored during in vitro growth of M. smegmatis mc2155. The 
pEMdinP construct contained 631 bp sequence upstream of dinP plus 29 bp internal dinP 
sequence, while pEMdinX comprised 1009 bp upstream plus 37 bp internal dinX 
sequence. A putative TetR-like transcriptional regulator, encoded by Rv3055, is located 
immediately upstream of dinP in the H37Rv genome (Figure 3.2; Cole et al., 1998). 
Therefore, another construct (pEM3055) was designed to examine expression of the 
putative regulator and contained 1009 bp sequence upstream of Rv3055 plus 36 bp 
internal Rv3055 sequence. Alignments of the M. tuberculosis promoter regions with the
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MtdinP:    46 CGCGAGG-CAA-GAGCCCGTACC--AG-AGCGGGGCGACGCGGCACGCAATCGTGCACTC 100 
              | ||||| ||  || | ||  ||  || |||| |||||||| || || || || || | |  
MsdinP:    28 CTCGAGGTCACCGACCGCGCGCCGCAGGAGCGCGGCGACGCCGCCCGGAACCGGGC -CGC 86 
 
MtdinP:   101 C-TGTTGGAGGCGGCGCGCCGCCTGATCGCCCGAA-GCGGTGCGGACGCAATCACCATGG 158 
                |  | || ||||||||||| || |||||| ||  ||||  | |||||  | | ||  | 
MsdinP:    87 GATCCTCGACGCGGCGCGCCGGCTCATCGCC-GAGCGCGGACCCGACGCCGTGAGCACCG 145 
 
MtdinP:   159 ACGACGTTGCCGCGGCCGCTGGCGTCGGCAAAGGCACCTTGTTTCGCCGCTTCGGCAGCC 218  
              ||||| | ||||  |  || ||||||||||| |||||| |||| |||| ||||||||| || 
MsdinP:   146 ACGACATCGCCGTCGAGGCCGGCGTCGGCAAGGGCACCCTGTTCCGCCGCTTCGGCACCC 205  
 
MtdinP:   219 GTGCCGGCCTGATGATGGTGTTGCTCGATGAAGACGAGCGAGCCAGTCAGCAGGCCTTCC 278  
              | ||||| |||||||||||| ||||||| || ||||||   |||   ||| | || |||  
MsdinP:   206 GCGCCGGGCTGATGATGGTGCTGCTCGACGAGGACGAGAAGGCCCACCAGGACGCGTTCA 265  
 
MtdinP:   279 TGTTCGGCCCGCCACCGCTGGG-CCCGGATGCTCCGCCGCTGGACCGCCTGATCGCATTC 337 
              | ||||| ||||| ||||| || |||||  || || || || ||||| ||| |||| | |  
MsdinP:   266 TCTTCGGGCCGCCGCCGCTCGGTCCCGGG-GCCCCTCCCCTCGACCGTCTGCTCGCCTAC 324 
 
MtdinP:   338 GGTCGGGAGCGAATGCGCTTCGTCCATGCCCATCAC-CAGCTGCTGTCGGAAGCCAACCG 396 
              || || || || |||   |||||||  |  || ||| || ||||| || || |||   ||  
MsdinP:   325 GGCCGCGAACGGATGAAGTTCGTCCGCGAGCACCACGCA -CTGCTCTCCGACGCCGCGCG 383 
 
MtdinP:   397 GGATCCACAAACCCGCCACAGCGCGGCGCTATCGGTACTGCGCACCCATTTGCGGGTACT 456  
               ||||| ||  | |||  | ||| | ||    || | |  ||  ||||  | ||| | ||  
MsdinP:   384 CGATCCGCAGGCACGCTTCGGCGGGCCGGACACGCTGCACCGGTCCCACGTCCGGATGCT 443 
 
MtdinP:   457 GCTGGCCTCGGCGCCGACCACCGGCGACCTGGATGCCCAGACCGATGCCCTGCTAGCGCT 516  
              ||||    | |||  |||||| |||||||| || || ||| |||| || ||  | |||||  
MsdinP:   444 GCTGCAGGCCGCGGGGACCACGGGCGACCTCGACGCACAGGCCGACGCGCTCGTCGCGCT 503  
 
MtdinP:   517 GCTCGACGTCGACTATGTCGAGCACCAACTC-AACGCCGGCGGCCATACCCTGCAAAC-C 574 
              |||||||| |||||| ||||   |||||||  ||||| | ||  ||  |  ||| |   |  
MsdinP:   504 GCTCGACGCCGACTACGTCGCCTACCAACTGGAACGCGGACG --CAG-C--TGCGAGGTC 558 
 
MtdinP:   575 CTGGGCGACGCATGGGA-GAGCCTGGCGCGAAAACTGTGCGGAC 617 
              | || || ||| ||||  ||  | | | || ||  |||| || |  
MsdinP:   559 CAGGCCGCCGCCTGGGCCGACACCG-CACGTAAGTTGTGTGGCC 601 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Mt3055:   139 CAAGTCCGACATCAAAATCTTGGCCTTAGTGGGAAGCCTGCGCGCGGCGTCGTTCAACCG 198  
              || | |||| |||||  | ||||   | || || ||||| || ||||||||  |||||||  
Ms3055:    15 CATGGCCGAAATCAAGGTGTTGGTACTCGTCGGCAGCCTCCGGGCGGCGTCCATCAACCG 74  
 
Mt3055:   199 CCAGATCGCCGAGCTGGCTGCCAAGGTCGCTCCGGACGGCGTC -ACCGTCACCATGTTCG 257 
              |||  ||||||| ||||| | | ||  ||| || ||||| ||  |||  ||   |||||| 
Ms3055:    75 CCAACTCGCCGAACTGGCAGTCGAGACCGCGCCCGACGGTGTGGACCTGCAGG -TGTTCG 133 
 
Mt3055:   258 AGGGGCTGGGGGACCTGCCGTTCTACAACGAAGACATCGACACAGCGACGGAGGTGCCGG 317  
              |  ||||||  ||  |||||||||||||||||||||||||| ||  || | || ||||| | 
Ms3055:   134 ACCGGCTGGCCGAGGTGCCGTTCTACAACGAAGACATCGACAC --CG-CTGATGTGCCCG 190 
 
Mt3055:   318 CGCCGGTGAGCG-CGTTGCGGGAGGCCGCG-TCTGACGCGCACGCTGCCTTGGTGGTCAC 375 
               |||||   ||| || |||| |  || ||| || || ||| |||| ||| || | |||||  
Ms3055:   191 AGCCGGCC-GCGGCGCTGCGTGCCGCGGCGGTC-GAGGCGGACGCAGCCCTGCTCGTCAC 248 
 
Mt3055:   376 GCCGGAATACAACGGCAGCATTCCGGCCGTGATCAAGAACGCGATCGACTGGCTGTCCAG 435  
               || || ||||||| || ||| || |||||  |||||||||| ||||||||||||||  |  
Ms3055:   249 CCCCGAGTACAACGCCACCATCCCCGCCGTCCTCAAGAACGCCATCGACTGGCTGTCGCG 308  
 
Mt3055:   436 GCCATTCGGCGATGGCGCGTTGAAGGACAAGCCGTTGGCCGTGATCGGCGGCTC -CATGG 494 
              ||| | ||||  ||||||| || | | |||||||   ||||||||||||| | | || ||  
Ms3055:   309 GCCGTACGGCAGTGGCGCGCTGCACGGCAAGCCGGCCGCCGTGATCGGCGCCGCGCACGG 368 
 
Mt3055:   495 GCCGCTACGGCGGGGTATGGGCGCACGACGAGACTCGCAAGTCGTTCAGCATCGCTGGCA 554  
              || |||||||||| || ||||||||||||||||| ||||||||| |  || |||| |||  
Ms3055:   369 GC-GCTACGGCGGTGTGTGGGCGCACGACGAGACCCGCAAGTCGCTGGGCGTCGCAGGCC 427 
 
Mt3055:   555 CGCGGGTGGTCGATG-CGATCAAACTGTCGGT-GCCGTTCCAAACTCTGG--G-CAAGTC 609 
              |||| |||||||| | || |||| |||||| | || |   | | | ||||  | |||| |  
Ms3055:   428 CGCGCGTGGTCGAGGACG-TCAAGCTGTCGATCGCAGCGTCGA-CGCTGGACGACAAG-C 484 
 
Mt3055:   610 GGTCGCG-GACGACGCCGGGCTGGCGGCGAATGTGCGCGACGCCGTCGGCAA-CTTG-GC 666 
                 |||| ||  |||||| | || | | || ||| || || ||||||| ||| |||| |  
Ms3055:   485 ACCCGCGCGAGAACGCCGAGGTGACCGTGAGTGTCCGGGAAGCCGTCGCCAAGCTTGTGG 544  
 
Mt3055:   667 CG-CTGAGGTCG-GCTGATC-CCTGGGCCG 693 
              || | |  | || | ||  | || ||| || 
Ms3055:   545 CGGCCGTCGCCGAGGTGCCCGCCGGGGTCG 574 
 
 
 
     
 
 
 
 
A B 
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 MtdinX:     8 CCACCGAGATAATCTGGCGTGGTCTGACACGCGAGCGATCGGTGCACCTGACGGACTGGC 67  
               |||||||| | |||||||| ||||||||  | ||||| ||||||||||| || ||||||| 
 MsdinX:  2333 CCACCGAGGTGATCTGGCGGGGTCTGACGGGGGAGCGCTCGGTGCACCTCACCGACTGGC 2392  
 
 MtdinX:    68 CAGCGCCCGACCTGCTGCCGTCGGATGCCGACCTGGTCGCCGCGATGGACCAGGTCCGCG 127  
               | |   ||||  |||||||   |||| | |||||||| |||||||||||||||||  |||| 
 MsdinX:  2393 CGGAAGCCGATGTGCTGCCCAAGGATCCGGACCTGGTGGCCGCGATGGACCAGGTGCGCG 2452  
 
 MtdinX:   128 ACGTGTGCTCGG-CGGCATCCTCGCTGCGCAAGGCCAAGAAGCTACGGGTGCGCCTGCCG 186 
               | |||||||||| |||| || ||||||||||||||||||||||| |||||||||||||||  
 MsdinX:  2453 AGGTGTGCTCGGTCGGC-TCGTCGCTGCGCAAGGCCAAGAAGCTGCGGGTGCGCCTGCCG 2511 
 
 MtdinX:   187 CTACCGAAACTCATTGTGGCAGTTGAGAATCCGCAACTTCTGAGGCCGTTCGTCGACCTC 246  
               || |||||||| |  ||||| ||  || ||||| |   |||| ||||||||| ||||||  
 MsdinX:  2512 CTGCCGAAACTGACCGTGGCCGTGCAGGATCCGGACAGTCTGCGGCCGTTCGCCGACCTG 2571 
 
 MtdinX:   247 ATTGGCGACGAGCTTAACGTGAAGCAGGTCGAACTGACCGATGCCATCGACACCTATGGC 306  
               || | ||||||||| ||||| |||   ||||| || | ||| | | |   | |||| ||  
 MsdinX:  2572 ATCGCCGACGAGCTCAACGTCAAGGCCGTCGAGCTCAGCGACGACGTGCCCGCCTACGGG 2631 
 
 MtdinX:   307 CGATTCGAGCTCACGGTCAACGCCCGGGTAGCCGGACCACGGCTGGGCAAAGATGTGCAG 366  
               || ||||||||| |||||||||||||||| ||||| || ||  | ||||| || ||||||  
 MsdinX:  2632 CGCTTCGAGCTCGCGGTCAACGCCCGGGTCGCCGGGCCGCGCATCGGCAAG GACGTGCAG 2691 
 
 MtdinX:   367 GCCGCCATCAAGGCGGTCAAGGCCGGCGACGGCGTCATAAACCCGGACGGCACCTTGTTG 426  
               ||||| |||||||| |||||||| || || |||||  | ||||| ||||||||  |     
 MsdinX:  2692 GCCGCGATCAAGGCCGTCAAGGCGGGGGAGGGCGTGGTCAACCCCGACGGCACGCTCACC 2751  
 
 MtdinX:   427 GCGGGCCCCGCGGTGCTGACGCCCGACGAGTACAACTCCCGGCTGGTGGCCGCCGACCCG 486  
               |||||||| | |||||||   ||||| ||||||| ||||  |||||| || |||||||||  
 MsdinX:  2752 GCGGGCCCTGTGGTGCTGCAACCCGAGGAGTACACCTCCAAGCTGGTTGCGGCCGACCCG 2811  
 
 MtdinX:   487 GAGTCCACCGCGGCGTTGCCCGACGGCGCCGGGCTGGTCGTTCTGGATGGCACCGTCACT 546  
               || |  ||||||||| |||||||||| || || ||||| || || || ||||| || ||  
 MsdinX:  2812 GAATGGACCGCGGCGCTGCCCGACGGTGCGGGTCTGGTGGTCCTCGACGGCACGGTGACC 2871  
 
 MtdinX:   547 GCCGAACTCGAAGCCGAGGGCTGGGCCAAAGATCGCATCCGCGAACTGCAAGAGCTGCGT 606 
               |  || ||||| ||||||||||||||||| || |||||||| |||||||| || |||||  
 MsdinX:  2872 GAGGAGCTCGAGGCCGAGGGCTGGGCCAAGGACCGCATCCGTGAACTGCAGGAACTGCGG 2931  
 
 MtdinX:   607 AAGTCGACCGGGCTGGACGTTTCCGACCGCATCCGGGTGGT GATGTCGGTGCCTGCGGAA 666 
               ||||||||||| ||||| || || |||||||||  |||    || |||||||| || |||  
 MsdinX:  2932 AAGTCGACCGGCCTGGAGGTGTCGGACCGCATCTCGGTACGCATCTCGGTGCCCGCCGAA 2991  
 
 MtdinX:   667 CGCGAAGACTGGGCGCGCACCCATCGCGACCTCATTGCCGGAGAAATCTTGGCTACCGA C 726 
               | |||  | ||||| ||||| || ||||| ||||| || || || ||| | || |||    
 MsdinX:  2992 CACGAGCAGTGGGCACGCACGCACCGCGATCTCATCGCAGGCGAGATCCTCGCGACCAGT 3051  
 
 MtdinX:   727 TTCGAATTCGCCGACCTCGCCGATGGTGTGGCCATCGGCGACGGCGTGCGGGTA -AGCAT 785 
               ||||||||||||||  |  |||| |||| ||  ||||||||||||||||||||  || ||  
 MsdinX:  3052 TTCGAATTCGCCGAGGTGACCGACGGTGCGGAGATCGGCGACGGCGTGCGGGTCGAG -AT 3110 
 
 MtdinX:   786 CGAAAAGACCTGA 798 
                |  |||  |||| 
 MsdinX:  3111 TGCGAAGGTCTGA 3123 
 
       
 
Figure 3.3 Nucleotide sequence alignments of promoter regions. BLAST alignment 
(Altschul et al., 1990) of the putative M. tuberculosis promoter regions with the corresponding M. 
smegmatis mc2155 upstream regions. A. M. tuberculosis dinP (MtdinP) aligned with mc2155 dinP 
(MSMEG1002; MsdinP); B. M. tuberculosis Rv3055 (Mt3055) aligned with mc2155 MSMEG1003 
(Ms3055); and C. M. tuberculosis dinX (MtdinX) aligned with mc2155 dinX (MSMEG3178; MsdinX). 
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corresponding M. smegmatis regions confirmed significant sequence homology (Figure 
3.3): the M. tuberculosis dinP promoter region (pEMdinP) shares 69% sequence identity 
in 584 bp overlap with M. smegmatis mc2155, the Rv3055 promoter region (pEM3055) 
73% identity in 570 bp overlap, and the dinX promoter region (pEMdinX) 78% in 793 bp 
overlap. The reporter plasmids as well as the promoterless control (pEM28w) were 
delivered into wild-type mc2155 and integration at the attP locus confirmed by PCR. 
During exponential growth in liquid media, both Rv3055 and dinX were highly expressed 
in comparison to dinP or the control, as determined by specific β-galactosidase activities 
(Figure 3.4). The activity of the dinP promoter construct did not differ significantly from the 
vector control throughout the assay. After two weeks in stationary phase, expression 
ofboth Rv3055 and dinX was well above the dinP construct and the vector control, and 
had increased above the corresponding levels achieved during exponential growth (Figure 
3.4). The failure to observe any activity associated with the dinP promoter construct 
indicated that dinP might be operonic with the Rv3055-encoded transcriptional regulator. 
Furthermore, the activity of the M. tuberculosis dinX and Rv3055 promoter constructs in 
M. smegmatis mc2155 suggested the potential stationary-phase induction of these genes. 
However, neither pol IV homologue was identified in global transcriptional profiles of M. 
tuberculosis H37Rv maintained in prolonged stationary-phase (Hampshire et al., 2004), 
raising the possibility that the regulation of these genes differs in stationary-phase M. 
smegmatis mc2155. Therefore, although the degree of homology between M. tuberculosis 
and M. smegmatis promoter sequences (Figure 3.3) was suggestive of the utility of M. 
smegmatis as a surrogate for expression analysis of M. tuberculosis genes, the relevance 
of these data requires confirmation by transcriptional analysis. 
 
3.4.3 Overexpression of M. tuberculosis dinP and dinX has no effect on rates 
of spontaneous point or frameshift mutagenesis 
Spontaneous mutagenesis is significantly increased in E. coli strains overexpressing dinB 
and is characterised primarily by elevated frequencies of frameshift mutations, particularly 
–1 frameshifts, but also by increased levels of base substitutions (Kim et al., 1997, 2001; 
Wagner & Nohmi, 2000; Kobayashi et al., 2002). To determine whether overexpression of 
the mycobacterial Y-family homologues results in increased untargeted mutagenesis, M. 
tuberculosis dinP (pGaa::dinP) and dinX (pGaa::dinX) were placed under the control of an 
inducible M. smegmatis acetamidase promoter (Mahenthiralingam et al., 1993; Parish et 
al., 1997; Narayanan et al., 2000) in a pOLYG-based replicating plasmid (Figure 3.5). The 
constructs, as well as a vector control (pOLYGaa), were delivered into M. smegmatis 
mc2155 by electroporation, and successful transformants confirmed by electroduction.
 
Figure 3.4 Stationary-phase upregulation of M. tuberculosis pol IV homologues. β-galactosidase activities of M. smegmatis mc2155 strains carrying 
lacZ transcriptional fusions of the promoter regions of M. tuberculosis dinP (pEMdinP), dinX (pEMdinX), and Rv3055 (pEM 3055), as well as the vector 
control (pEM28w), were monitored during long-term growth in vitro. The schematic diagram on the left shows the locations of the relevant promoter 
regions which were cloned upstream of a promoterless lacZ gene (blue rectangular box). A. Miller Units indicated both Rv3055 and dinX were highly 
expressed during exponential growth and remained elevated throughout the 380 hr incubation. In contrast, expression of dinP did not differ significantly 
from the vector control at any time during the assay. B. Normalisation of Miller Unit values for protein concentration confirmed the differential activities of 
the Rv3055 and dinX promoter constructs versus dinP and the vector control in logarithmic phase (red bars) and after two weeks stationary phase 
incubation (green bars). Data are representative of at least two independent experiments. Each timepoint shows the mean of duplicate samples, and error 
bars indicate standard deviations 
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Transcriptional upregulation of dinP and dinX in the presence or absence of acetamide 
was assessed by semi-quantitative RT-PCR using M. tuberculosis-specific oligonucleotide 
primers (Figure 3.5). Expression of both dinP and dinX was significantly induced after 
addition of acetamide. However, elevated mRNA levels were also evident in the absence 
of acetamide treatment, and likely resulted from the leaky acetamide promoter 
compounded by the presence in each bacillus of multiple copies of the pOLYG-based 
shuttle vector (O’Gaora et al., 1997).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Inducible expression of the M. tuberculosis pol IV homologues. Upregulation of 
M. tuberculosis dinP (pGaa::dinP) and dinX (pGaa::dinX) under the control of an inducible M. 
smegmatis acetamidase promoter (Mahenthiralingam et al., 1993; Parish et al., 1997; Narayanan 
et al., 2000) was assessed by semi-quantitave RT-PCR in the presence or absence of acetamide. 
Expression levels are compared with the vector control (pOLYGaa) and potential DNA 
contamination excluded by performing the reaction with or without reverse transcriptase (RTase). 
Although expression of both dinP and dinX was induced after addition of acetamide, significant 
mRNA levels were also evident in the absence of acetamide treatment, perhaps indicating a leaky 
acetamide promoter or the presence of elevated transcript levels in cells harbouring multiple copies 
of the expression vector (see text). 
 
Spontaneous mutagenesis in the mc2155 strains harbouring the overexpression vectors 
was assessed by determining rates of forward mutations to rifampicin resistance (RifR) in 
a Luria-Delbrϋck fluctuation assay (Luria & Delbrϋck, 1943). Mutations in an 80 bp region 
of the rpoB gene encoding the RNA polymerase β subunit account almost exclusively for 
RifR isolates of M. tuberculosis (Telenti et al., 1993, 1997; Musser, 1995; Ramaswamy & 
Musser, 1998; Morlock et al., 2000), of which almost 70% result from point mutations in 
the codons for Ser531 and His526, with a Ser531Leu substitution (TCG to TTG) the most 
common mutation encountered clinically and in vitro (Telenti et al., 1993, 1997; Billington 
et al., 1999; Morlock et al., 2000; Boshoff et al., 2003; Mariam et al., 2004), probably 
because that mutation is associated with the lowest fitness cost in vitro (Billington et al., 
1999; Morlock et al., 2000; Mariam et al., 2004). Using the MSS algorithm (Ma et al., 
1992; Rosche & Foster, 2000), the mutation rate in wild-type mc2155 was calculated at 
approximately 5x10-8 mutations per cell per generation (Table 3.6), consistent with 
previous reports (Boshoff et al., 2003). Significantly, rates of mutations to RifR in strains 
RTase + - + -
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+ - -+ + - -+
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hyg 
oriM 
dinP 
acetamidase 
pOLYGaa::dinP 
 84 
carrying either the empty vector (pOLYGaa) or the M. tuberculosis dinP (pOLYGaa::dinP) 
or dinX (pOLYGaa::dinX) overexpression vectors were indistinguishable from wild-type 
mc2155, irrespective of acetamide induction (2-9 x 10-8 mutations per cell per generation; 
Table 3.6). To eliminate the possibility that heterologous overexpression of the M. 
tuberculosis homologues in mc2155 is inherently flawed despite increased transcript 
levels, the overexpression vectors were recently applied in M. tuberculosis H37Rv. 
Preliminary data of RifR mutation frequencies from these studies have confirmed the 
inability of dinP and dinX overexpression to elevate spontaneous mutagenesis (data not 
shown). 
 
Table 3.6 Mutation rates for M. smegmatis strains overexpressing M. tuberculosis dinP and dinXa. 
Strain Rif mutation rate (x 10-8) hisD5T frameshift mutation rate (x 10-8) 
mc2155 4.90 ± 1.4 NA 
pGaa 3.22 ± 1.2 4.79 ± 2.0 
pGaa::dinP 8.43 ± 1.5 8.74 ± 1.7 
pGaa::dinX 2.55 ± 1.0 6.25 ± 2.5 
a The table indicates the mutation rate calculated by the MSS algorithm. 
 
The essentiality of RpoB for mycobacterial survival (Sassetti et al., 2003) demands that 
only mutations that do not abrogate gene function are detected, and raises the possibility 
that an assay based on the emergence of RifR mutations will be too proscriptive in terms 
of the mutational event tolerated, and so will result in an underestimation of mutagenesis. 
Previous studies have identified frameshift mutations as the characteristic pol IV-mediated 
mutational event (Kim et al., 1997, 2001; Wagner & Nohmi, 2000; Kobayashi et al., 2002) 
with fourfold increases in dinB expression having no effect on base substitution rates 
(Wolff et al., 2004). Therefore, in order to ascertain whether overexpression of the M. 
tuberculosis pol IV homologues mediates increased frameshift mutations, the 
overexpression vectors (as well as the vector control) were introduced into an M. 
smegmatis reporter strain carrying a frameshift mutation in the hisD gene (hisD5T; E. 
Machowski, unpublished). Reversion to histidine prototrophy is restored by a -1 frameshift 
at the position of an artificial 5T run, ctttttg®cttttg (LeuPhe205**®LeuLeu205), allowing 
frameshift mutations to be scored by plating on unsupplemented media. Again, the 
number of His+ revertants arising during a Luria-Delbrϋck fluctuation assay was analysed 
using the MSS method (Rosche & Foster, 2000). Based on this assay, the rate of 
spontaneous -1 frameshift mutations in wild-type mc2155 containing the vector control 
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(pGaa) was estimated as approximately 4.8 x 10-8 mutations per cell per generation 
(Table 3.6). As observed for mutations to RifR (Table 3.6), no significant difference in 
frameshift mutation rate was associated with overexpression of either of the M. 
tuberculosis pol IV homologues with or without acetamide induction. The failure of dinP or 
dinX overexpression to increase spontaneous mutagenesis is similar to results observed 
with M. tuberculosis dnaE2 (Boshoff et al., 2003) and adds further impetus to the 
suggestion that additional factors might be required to facilitate access of the non-
replicative polymerases to undamaged DNA (Boshoff et al., 2003; Tippin et al., 2004b).  
 
3.4.4 A chromosomal duplication in M. smegmatis mc2155 
To investigate the potential physiological roles of the mycobacterial pol IV homologues in 
DNA repair, genetic diversification, and long-term survival, a dinP deletion mutant of M. 
smegmatis mc2155 was generated by allelic exchange. M. smegmatis has been widely 
used to investigate mycobacterial physiology and genetics and, despite significant 
limitations to its applicability (Reyrat & Kahn, 2001; Barry III, 2001), is often employed in 
preliminary experiments to determine the value of pursuing a particular line of research in 
the more intransigent pathogenic mycobacteria. The two-step homologous recombination 
method employed to generate the dinP knockout mutant (Boshoff & Mizrahi, 1998; Parish 
& Stoker, 2000) was standard to the creation of all gene deletion mutants of M. 
tuberculosis and M. smegmatis discussed in this thesis, and so will be described in some 
detail here. Flanking genomic sequence upstream and downstream of M. smegmatis dinP 
was amplified by PCR using oligonucleotide primers with engineered restriction sites in 
the respective 5’ termini to facilitate subsequent cloning and, in the case of marked 
insertion-deletion alleles, the insertion of an antibiotic resistant cassette. All PCR 
amplifications were performed using the EXPANDTM high-fidelity PCR system and the 
products sequenced to confirm sequence integrity. Ligation and cloning of the dinP 
upstream (TdinPFR1) and downsteam (TdinPFR2) fragments into p2NIL resulted in a 
deletion allele that effectively eliminated 943 bp internal dinP sequence (p2ΔdinP). The 
PacI cassette from pGOAL19 - containing a hygromycin resistance gene (hyg), as well as 
the lacZ and sacB genes to enable blue/white and sucrose counterselection, respectively - 
was then cloned into p2ΔdinP to yield an unmarked dinP knockout construct (p2ΔdinP19; 
Figure 3.6A). In order to create a marked dinP deletion allele, the hyg cassette was 
inserted into p2ΔdinP at the site of the deletion (p2ΔdinP::hyg). Cloning of the PacI 
cassette from pGOAL17 - containing the lacZ and sacB genes but lacking hyg - into 
p2ΔdinP::hyg yielded a knockout construct containing a hyg-marked dinP deletion-
insertion allele (p2ΔdinP17; Figure 3.6A).  
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Figure 3.6  Construction of a dinP deletion mutant strain of M. smegmatis mc2155.  
A. Schematic representation of the p2DdinP17 and p2DdinP19 delivery vectors in which 982 bp M. 
smegmatis mc2155 dinP coding sequence is eliminated. The deletion junction into which the 
hygromycin resistance gene (hyg) was inserted to generate the marked deletion-insertion allele, is 
indicated. (aph, kanamycin resistance gene; PAg85a-lacZ, b-galactosidase driven by the 
mycobacterial antigen 85A promoter; Phsp60-sacB, sucrose sensitivity gene driven by the 
mycobacterial Hsp60 promoter). B. Site-specific integration of either the marked (p2DdinP17) or 
unmarked (p2DdinP19) knockout delivery vector to give an upstream (SCOup) or downstream 
(SCOdn) SCO should result in only two bands (H, HindIII restriction sites; open arrows indicate the 
lacZ, sacB, aph and hyg genes carried on the relevant deletion vectors; TdinPFR1 probe 
represented by a purple box; hyg represented by q). C. Southern blot analysis of wild-type M. 
smegmatis mc2155 (mc2155) and putative dinP single cross-over recombinants (SCOs). Three of 
the putative dinP SCOs (indicated by a Ý) appeared to give the expected banding pattern: 1827 bp 
and 4344 bp for a marked downstream cross-over (lane 4) and 1827 bp and 2604 bp for an 
unmarked downstream cross-over (lanes 5 and 9). However, the deeper intensity of the wild-type 
band (WT dinP) in these lanes and mc2155 was suggestive of an extra dinP copy. 
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Wild-type mc2155 was separately electroporated with p2ΔdinP17 and p2ΔdinP19 and 
plated on solid medium containing Km, Hyg, and X-gal. Putative single cross-over (SCO) 
recombinants that were KmR, HygR and blue in colour were analysed by Southern 
hybridisation (Figure 3.6C). Briefly, genomic DNA from each of the putative SCOs was 
subjected to HindIII restriction digest and probed with the radio-labelled upstream PCR 
fragment (TdinPFR1). Site-specific integration of the deletion construct should result in 
only two bands - the intact wild-type gene and the disrupted allele carried on the vector. 
Only three of the putative SCOs recovered from the two electroporation experiments gave 
bands of the expected sizes and, in all three cases, the knockout vector had integrated 
downstream of the chromosomal dinP (Figure 3.6C; lanes 4, 5, and 9). However, the 
intensity of the 1827-bp wild-type band (WT dinP) in the downstream SCOs was noticably 
deeper (lanes 4, 5, and 9). In addition, the remaining clones (excluding lane 1) showed 
composites of the banding patterns expected of a single wild type gene (1827 bp) and an 
upstream SCO (1456 bp and 4020 bp for the marked construct and 1456 bp and 2282 bp 
for the unmarked construct; lanes 2, 3, 6 and 7). During the course of this work, Galamba 
et al. (2001) reported the identification of a duplication region in mc2155 carrying the adhC 
gene. This finding, together with the unexpected complexity in the SCO banding patterns, 
immediately suggested the possible existence of an extra copy of dinP in mc2155 and, 
further, that dinP might be contained within the duplicated region. Consistent with this 
proposal, the banding pattern in lane 1 could be resolved into two separate SCO events at 
duplicate dinP loci. 
 
As per the established two-step protocol, the downstream SCOs were cultured in liquid 
media containing no antibiotic (for the unmarked deletion allele) or Hyg only (for the 
marked deletion-insertion allele) to allow the second cross-over event to occur. Serial 
dilutions of each culture were then plated on solid media containing X-gal and 2% sucrose 
to enable phenotypic counterselection of putative double-cross over (DCO) recombinant 
mutants. White, sucrose-resistant colonies were selected for analysis by Southern blot. 
SalI digested genomic DNA from each putative DCO mutant was probed with the 
downstream PCR fragment (TdinPFR2; Figure 3.7). Ten strains (eight from p2ΔdinP17 
and two from p2ΔdinP19) were identified with the genotype expected of the relevant DCO 
mutation in addition to an intact wild-type copy. The presence of the both the wild-type 
dinP and a deletion allele in a single strain confirmed that mc2155 is merodiploid for dinP. 
A representative mutant (dinP+/-) carrying both wild-type and DdinP::hyg deletion-insertion 
alleles is shown in Figure 3.7. 
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Figure 3.7 Construction of the M. smegmatis dinPKin mutant. Hybridisation of the TdinPFR2 
probe to SalI-digested DNA from wild-type M. smegmatis mc2155 (mc2155), the single dinP 
knockout mutant (dinP+/-), the dinP null mutant (dinP-/-), and the region-deleted mutant (ΔDR), as 
well as dinPKin SCO and DCO recombinant strains. The genotypes of the relevant dinP deletion 
mutants and wild-type mc2155 are illustrated in the schematic diagram (S, SalI restriction sites; 
probe represented by a brown box). Elimination of 982 bp dinP sequence results in the loss of the 
internal SalI site; however, an additional SalI site is present in the hyg cassette. The single dinP 
knockout mutant (dinP+/-) produced two bands (WT dinP and ΔdinP::hyg, 2796 bp and 3263 bp) 
indicating that mc2155 is merodiploid for dinP. Both copies of dinP have been disrupted in the null 
mutant (dinP-/-) by replacement with marked (ΔdinP::hyg, 2796 bp) and unmarked (ΔdinP, 3986 bp) 
deletion alleles. Absence of the unmarked deletion allele (ΔdinP, 3986 bp) in the DDR mutant 
(ΔDR) indicated the probable loss of the duplicated region in this strain. Finally, replacement of the 
DdinP::hyg allele in the DDR mutant with a wild-type dinP allele resulted in the creation of a novel 
M. smegmatis strain (dinPKin) that is isogenic with mc2155 but lacks the duplicated region. 
 
 
M. smegmatis mc2155 dinP is dispensable for growth in vitro 
To eliminate the second copy of dinP, the dinP+/- strain was transformed with p2ΔdinP19. 
It was reasoned that maintaining the dinP+/- strain under Hyg selection throughout the two-
step method might serve to minimise the risk of homologous recombination at the same 
locus, which would result in the futile replacement of the marked deletion allele 
(ΔdinP::hyg) with its unmarked counterpart (ΔdinP). Following this approach, a dinP null 
mutant of mc2155 was constructed in which both copies of the gene had been replaced – 
one by a marked deletion-insertion (ΔdinP::hyg) and the other by an unmarked dinP 
deletion allele (ΔdinP). This strain was designated dinP-/- (Figure 3.7). As expected, loss 
of DinP activity was not associated with a growth phenotype under standard in vitro 
conditions (data not shown). 
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Isolation of a dinP deletion mutant lacking the duplicated region 
During the process of generating dinP-/- from dinP+/-, an unusual mutant was identified 
which seemed, on genotypic analysis, to have lost entirely the second copy of dinP and its 
flanking sequence (ΔDR; Figure 3.7). Growth of the ΔDR deletion mutant was 
indistinguishable from wild-type mc2155 under standard in vitro conditions (data not 
shown). Furthermore, the fact that ΔDR was isolated from the same precursor strain (a 
SCO mutant obtained after transforming dinP+/- with p2DdinP19), and in the same 
counterselection step of the two-step procedure as gave rise to dinP-/-, strongly suggested 
that the second dinP copy might have been lost as a result of a homologous 
recombination event that eliminated the entire duplicated region. That possibility was 
recently confirmed by the release of the M. smegmatis mc2155 genome sequence 
(http://www.tigr.org) which established that the duplicated regions are approximately 52 kb 
in size and are situated 1.2 Mb apart on the mc2155 chromosome (Figure 3.8). 
Significantly, each region is flanked by two IS1096 elements (http://www.tigr.org) that 
likely acted as substrates for the homologous recombination event that gave rise to the 
original duplication. Consistent with this proposal, subsequent work has confirmed the 
loss of the chromosomal duplication, as well as the retention of only a single IS1096 
element, in the ΔDR mutant (Figure 3.8; Galamba et al., unpublished). 
 
Transformation efficiency of the ΔDR strain 
M. smegmatis mc2155 was originally isolated as an efficient plasmid transformation (ept) 
mutant derived from the M. smegmatis reference strain ATCC 607 (mc26; Snapper et al., 
1990). Given recent evidence that the chromosomal duplication is absent from mc26 and 
must have occurred during the evolution of M. smegmatis mc2155 from the parental strain 
(Galamba et al., unpublished), the potential role of the duplication (or at least a region or 
gene contained therein) in the differential transformability of the mc2155 and mc26 stains 
was considered worth investigating. Therefore, both wild-type mc2155 and the ΔDR 
mutant were electroporated with decreasing concentrations of an integrating plasmid 
(pAINT) and transformants scored by plating on selective media. If the duplicated region 
were somehow associated with increased transformation efficiency, loss of the duplication 
in the ΔDR mutant should result in the reduction of transformability to levels associated 
with mc26. However, no significant difference in transformation frequencies was observed 
(data not shown), eliminating the duplication as a candidate for the ept phenotype. 
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Figure 3.8 The M. smegmatis mc2155 duplicated region. A. Homologous recombination 
between flanking IS1096 repeat elements during the evolution of M. smegmatis mc2155 (WT) from 
the parental mc26 strain resulted in the duplication of a 52 kb chromosomal region  (Galamba et al., 
unpublished; www.tigr.org). In addition to dinP, approximately 49 predicted ORFs are located in the 
duplicated region, including nrdE and adhA (originally called adhC; Galamba et al., 2001). B. 
During construction of a mc2155 dinP-/- null mutant, the duplication was fortuitously lost via another 
IS1096-mediated homologous recombination event that left behind a single IS1096 copy at the site 
of the duplication. Loss of the duplication resulted in the creation of the ΔDR mutant strain 
containing a hyg-marked (p) dinP deletion allele. C. Site-specific replacement of the dinP::hyg 
allele in ΔDR with a wild-type mc2155 dinP gene yielded the dinPKin mutant. 
 
 
 
Restoration of a wild-type dinP allele in ΔDR 
The M. smegmatis mc2155 genome sequence revealed the presence of 50 predicted 
ORFs in the duplicated region (http://www.tigr.org), prompting speculation that the higher 
gene dose in mc2155 versus mc26 might manifest in altered physiology. Coupled with the 
fact that multiple sequential gene knockout steps are required to create null mutants of 
any one of the fifty duplicated genes in mc2155, it was proposed that the ΔDR mutant 
might prove useful as an alternative to mc2155 in studies aiming to disrupt genes with 
corresponding copies located in the duplicated region. However, the presence of a hyg-
containing dinP deletion allele in the ΔDR mutant would necessarily limit the biological 
relevance of this strain and derivatives. In order to create a mutant containing the full 
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genetic complement of wild-type mc2155, but lacking the duplicated region (Figure 3.8), a 
functional dinP allele (dinPKin) was re-introduced into the ΔDR mutant by the same two-
step method (Boshoff & Mizrahi, 1998; Parish & Stoker, 2000). In this case, however, the 
presence of a hyg marker at the site of the dinP deletion in ΔDR raised the possibility that 
recombination might occur at the hyg locus rather than between homologous 
chromosomal and vector-delivered dinP ORFs. A “knock-in” construct was therefore 
created comprising the intact mc2155 dinP flanked by 877 bp upstream and 783 bp 
downstream sequence, and the PacI cassette from pGOAL17 lacking the hyg cassette 
(p2dinPKin). Southern analysis of the putative SCO mutants confirmed site-specific 
integration of p2dinPKin at the dinP locus (dinPKin_SCO; Figure 3.7). After further 
phenotypic selection, a DCO mutant was isolated in which the ΔdinP::hyg allele had been 
replaced by an intact copy of the wild-type mc2155 dinP gene (dinPKin; Figure 3.7). The 
re-introduced allele and flanking regions were sequenced to confirm sequence integrity of 
the dinPKin strain (data not shown). No growth phenotype was associated with loss of the 
duplicated region under standard in vitro conditions (data not shown) and, although still to 
be tested, it is unlikely that the re-introduction of a functional dinP allele will affect the wild-
type transformability of the ΔDR mutant. Furthermore,  it was recently shown that cell-wall 
physiology in the mutant is indistinguishable from wild-type mc2155 (Gilles Etienne, 
personal communication), providing further support for the potential utility of dinPKin. 
 
3.4.5 M. smegmatis mc2155 EP polymerases are not required for long-term 
survival in vitro 
M. smegmatis Y-family polymerases are dispensable for growth in vitro  
To determine the effects of the putative Y-family polymerases on mycobacterial fitness 
and mutagenesis, strains of mc2155 were generated that contained individual deletions in 
the M. smegmatis dinP, dinX, and dinP3 genes (Figure 3.9). Again, all knockout mutants 
were generated by two-step allelic mutagenesis (Boshoff & Mizrahi, 1998; Parish & 
Stoker, 2000). A hyg-marked insertion-deletion allele eliminated 1185 bp of 1354 bp dinX 
sequence (ΔdinX::hyg; Figure 3.10C). Similarly, an mc2155 dinP3 mutant was created in 
which 1106 bp of 1239 bp dinP3 sequence was deleted (S. Dawes, unpublished; Figure 
3.10B). The presence in M. smegmatis of multiple pol IV homologues raised the possibility 
that the remaining, alternative polymerases might complement, and therefore mask, lost 
activity in the dinP-/-, dinX, and dinP3 single gene deletion mutants. Therefore, a 
programme of sequential gene deletion was adopted to create combined deletion mutants 
in the dinP-/- background. The hyg-marked dinP deletion-insertion in dinP-/- excluded the  
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Figure 3.9 M. smegmatis mc2155 pol IV and EP polymerase knockout strains. The flow 
diagram illustrates the sequential generation of pol IV and EP polymerase deletion mutants of M. 
smegmatis mc2155. The single ΔdinP3 and ΔdnaE2 mutants were provided courtesy of Dr. S. 
Dawes and Dr. H. Boshoff, respectively. Construction of the additional single and multiple deletion 
mutants is described in the text. Genotypes are illustrated in Figure 3.9. 
 
 
 
use of hyg-marked knockout constructs owing to the risk of unwanted cross-over events at 
that locus. Therefore, an unmarked dinX deletion allele was constructed that was identical 
to ΔdinX::hyg except for the absence of the inserted hyg marker (Figure 3.10). The 
unmarked dinP3 and dinX knockout constructs were then applied to disrupt the 
corresponding genes in the dinP-/- background, thereby generating double mutants 
characterised by dinP-/-/dinP3 and dinP-/-/dinX genotypes, respectively (Figure 3.10). 
Deletion of dinX in the double dinP-/-/dinP3 mutant yielded a strain of mc2155 in which all 
putative Y-family activity was disrupted, designated ΔY (dinP-/-/dinP3/dinX). Elimination of 
each of the Y-family genes in ΔY was confirmed by Southern blot using the appropriate 
gene-specific probe (Figure 3.10). None of the single (dinP-/-, dinX, dinP3), double (dinP-/-
/dinP3, dinP-/-/dinX) or ΔY deletion mutants displayed any growth defect under standard in 
vitro conditions, indicating the individual and collective dispensability of these genes for 
normal growth (data not shown). 
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Figure 3.10 Construction of multiple sequential pol IV deletion mutants of mc2155. 
DNA from wild-type M. smegmatis mc2155 (mc2155), the single dinP (dinP-/-) and dinX (ΔdinX::hyg) 
mutants, the double dinP-/-/dinP3 (dinP-/-/ΔdinP3) and dinP-/-/dinX (dinP-/-/ΔdinX) mutants, and the 
ΔY deletion mutant was digested by the relevant restriction enzyme and probed with each of the 
three pol IV-specific probes. Restriction maps of the various strains are schematically illustrated in 
the line drawings adjacent to each Southern blot (not drawn to scale). A. SalI-digested DNA 
hybridised to the TdinPFR2 probe. Construction of the DdinP allele eliminates 982 bp of dinP 
coding sequence, and results in the loss of the internal SalI restriction site. However, an additional 
SalI restriction site is introduced by the hyg cassette in the DdinP::hyg allele (S, SalI restriction 
sites; WT, wild-type; probe represented by a hatched box). B. MluI-digested DNA hybridised to the 
P3p probe. The DdinP3 allele eliminates 1371 bp of dinP3 coding sequence (M, MluI restriction 
sites; WT, wild-type; probe represented by a chequered box). C. SmaI-digested DNA hybridised to 
the MsXFR2 probe. The DdinX allele eliminates 1186 bp dinX coding sequence. An additional SmaI 
restriction site is introduced by the hyg cassette in the DdinX::hyg allele (Sm, SmaI restriction sites; 
WT, wild-type; probe represented by a spotted box). 
 
 
 
Loss of pol IV activity does not impair long-term competitve fitness of mc2155 
Maintenance of a population in a constant environment with limiting amounts of essential 
nutrients tends to select for fitter mutants (Novick & Szilard, 1950; Atwood et al., 1951; 
Dykhuizen, 1990; Zambrano et al., 1993; Zambrano & Kolter, 1996; Finkel & Kolter, 1999; 
Yeiser et al., 2002) which are thought to arise as a result of a random mutation that 
confers a competitive advantage on the cell (Dykhuizen, 1990). The enhanced fitness of 
the mutant enables near complete population takeover by cells of the specific genotype in 
a process referred to as “periodic selection” (Novick & Szilard, 1950; Atwood et al., 1951; 
Dykhuizen, 1990). Specifically, incomplete takeover results in the coexistence of multiple 
adaptive mutants, and is considered especially relevant to the evolution of diversity in 
natural populations (Finkel & Kolter, 1999). E. coli possesses three damage-induced 
polymerases, each of which is dispensable for in vitro growth in pure culture (Yeiser et al., 
2002). However, inactivation of one or more of the Y-family polymerases impairs E. coli 
for long-term stationary-phase survival in vitro (Yeiser et al., 2002). 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Long-term competitve growth of the mc2155 Y-family and EP polymerase deletion mutants.  
A. Composite growth and survival patterns of the dinP-/- null (dinP’’) and dinX::hyg (dinX) single deletion mutants, the dinP-/-/dinP3 (dinP’’P3) and dinP-/-
/dinX (dinP’’X) double deletion mutatns, as well as ΔY (dinP’’P3X) grown in competitive co-culture with wild-type mc2155 (wt). 
B. Wild-type M. smegmatis mc2155 (wt) and the ΔC mutant (dinP’’P3XE2) were grown in pure culure and in competition [P’’P3XE2 (comp) and wt (comp)]. 
 
 
 
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
1.00E+10
0 3 18 56 188
Days post inoculation
C
FU
/m
l wt
dinP''P3XE2
wt (comp)
P''P3XE2 (comp)
1.00E+06
1.00E+07
1.00E+08
1.00E+09
1.00E+10
0 13 30 63 128 262
Days post inoculation
C
FU
/m
l
wt
dinP''
dinX
dinP''P3
dinP''X
dinP''P3X
A B 
 96 
Furthermore, the reduced fitness of the mutant is evident only in competition with wild-
type, suggesting the involvement of damage-inducible polymerases in the growth 
advantage in stationary phase (GASP) phenotype (Zambrano et al., 1993; Zambrano & 
Kolter, 1993, 1996; Zinser & Kolter, 1999). To determine the role of the Y-family 
polymerases in long-term fitness of M. smegmatis, a survival assay (LTG1) was 
established (Smeulders et al., 1999) in which selected hyg-marked single (dinP-/-, 
dinX::hyg) and double (dinP-/-/dinP3, dinP-/-/dinX) gene deletion mutants, as well as ΔY 
(dinP-/-/dinP3/dinX), were grown in co-culture with wild-type mc2155 (Figure 3.11A). Pure 
cultures of each of the strains were also assessed as a control. Loss of one or any 
combination of mycobacterial Y-family polymerases had no effect on long-term survival of 
any of the mutant strains in pure culture (data not shown). In addition, none of mutant 
strains, including ΔY, was compromised in its ability to compete with wild-type mc2155 
over the 262 day duration of the experiment (Figure 3.11A). 
 
M. smegmatis dnaE2 does not confer a fitness advantage during stationary-phase 
The failure to observe a competitive disadvantage associated with loss of the putative 
mycobacterial Y-family members contrasted with the severe impairment observed in E. 
coli SOS polymerase mutants (Yeiser et al., 2002) and was particularly surprising in the 
case of the ΔY mutant, which had been stripped of all putative pol IV activity. However, 
given the dominant role of DnaE2 in mediating damage-induced mutagenesis in 
mycobacteria (Boshoff et al., 2003), it was conceivable that the intact M. smegmatis 
dnaE2 gene might complement abrogated Y-family function in ΔY. Therefore, an 
additional gene deletion mutant was constructed in which dnaE2 was eliminated in the DY 
background. The fact that the ΔY mutant carried a ΔdinP::hyg allele again required a 
knockout construct lacking the hyg cassette in order to minimise the potential for spurious 
recombination. To this end, a marked dnaE2 deletion-insertion allele (Boshoff et al., 2003) 
carrying a kanamycin (Km) resistance cassette (aph) was delivered into ΔY by 
electroporation. Putative white DCO mutants were selected in a single step by plating on 
media containing Km, 2% sucrose, and X-gal. Disruption of dnaE2 in ΔY resulted in a 
mutant mc2155 strain denuded of all predicted EP activity. This strain was designated ΔC 
(for “complete deletion”) and was characterised by a dinP-/-/dinP3/dinX/dnaE2 genotype 
(Figure 3.12). Growth of the ΔC mutant was indistinguishable from wild-type mc2155 
under standard in vitro conditions (data not shown). To assess the effects of complete EP 
loss on long-term survival of mc2155, a competitive assay (LTG2) was established in 
which the ΔC strain was maintained alone, or in co-culture with wild-type mc2155, for 188 
days (Figure 3.11B). Remarkably, complete abrogation of predicted EP function conferred
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Figure 3.12 An EP polymerase-free strain (DC) of M. smegmatis mc2155. Disruption of dnaE2 
in the ΔY (dinP-/-/dinP3/dinX) background (see Figure 3.7) results in a multiple dinP-/-
/dinP3/dinX/dnaE2 deletion mutant (ΔC). The Southern blot shows SmaI-digested DNA from wild-
type (mc2155) and the ΔC mutant probed with MsmE2 (purple box). Restriction maps of the 
relevant genotypes for wild-type and mutant strains are schematically illustrated in the line 
drawings adjacent to the blot (not drawn to scale; Sm, SmaI; WT, wild-type). 
 
 
 no significant growth or survival phenotype on the ΔC mutant, either in pure culture or in 
competition with wild-type mc2155. 
 
M. smegmatis does not exhibit stationary-phase mutagenesis in vitro 
Evidence implicating induced mutagenesis in long-term in vitro survival of E. coli under 
starvation conditions (Yeiser et al., 2002) raised the posssibility that the Y-family 
homologues might mediate the hypermutable state previously reported in stationary-
phase mycobacterial populations (Karunakaran & Davies, 2000). To assess the 
contribution of the Y-family members, as well as DnaE2, to stationary-phase mutagenesis 
in M. smegmatis, the emergence of rifampicin resistant (RifR) mutants of each of the 
strains in pure culture was scored for the first 128 days during both long-term survival 
assays. That is, RifR mutants of wild-type mc2155, dinP-/-, dinX, dinP-/-/dinP3, dinP-/-/dinX, 
and ΔY were isolated during LTG1, and of wild-type mc2155 and ΔC during LTG2. 
Mutation frequencies in each of the single (dinP-/- and dinX), and double (dinP-/-/dinP3, 
dinP-/-/dinX) gene deletion mutants, as well as the ΔY and ΔC multiple deletion mutants, 
did not differ significantly from wild-type mc2155 in both LTG1 and LTG2 (Figure 3.13). 
Furthermore, no increase in mutation frequency was observed in wild-type mc2155 or 
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Figure 3.13 Rifampicin resistance fequencies of M. smegmatis strains during long-term 
growth in vitro. The emergence of rifampicin resistant (RifR) mutants of each of the M. smegmatis 
pol IV and EP polymerase mutant strains was scored for the first 128 days during the LTG1 and 
LTG2 long-term survival assays. 
 
 
mutant strains at any timepoint during either assay (Figure 3.13). Although contradicting 
previous evidence of stationary-phase hypermutability in M. smegmatis mc26 
(Karunakaran & Davies, 2000), the mutation frequencies observed under the conditions 
tested are supported by parallel point and frameshift mutation rate assessments by 
fluctuation assay (S. Barichievy & R. Brackin, unpublished).  
 
The identification of novel rpoB mutations in M. smegmatis mc2155 in stationary 
phase 
Base substitutions and small frameshift deletions constitute the most abundant TLS 
polymerase-mediated mutations (Friedberg et al., 2001, 2002; Goodman, 2002; Tippin et 
al., 2004b). However, patterns or “fingerprints” (Wolff et al., 2004) of nucleotide 
incorporation or deletion have been identified that are specific to the nature of the DNA 
template (or lesion if damaged) and the polymerase involved (Kim et al., 1997, 2001; 
Reuven et al., 1999; Tang et al., 1999, 2000; Wagner & Nohmi, 2000; Kobayashi et al., 
2002; Shen et al., 2002; Goodman, 2002; Wagner et al., 2002; Tippin et al., 2004a). 
Despite the apparent dispensability of the mycobacterial EP polymerases for stationary-
phase mutagenesis, it was postulated that loss of one or more TLS polymerases might 
alter the mutational profile during long-term persistence. To investigate this possibility, the 
rpoB resistance determining regions (Musser, 1995) of RifR mutants arising during LTG1  
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and LTG2 were amplified by PCR and sequenced. Sequence analysis of the RifR 
genotypes isolated at specific timepoints during LTG1 (Table 3.7) and LTG2 (Table 3.8) 
revealed no obvious mutation fingerprint that might be assigned to an individual 
mycobacterial Y-family polymerase. In addition, the prevalence of Ser531 and His526 
mutations in mediating RifR in mycobacteria was confirmed. However, in contrast to the 
rpoB mutational profiles described in M. tuberculosis (Telenti et al., 1993, 1997; Musser, 
1995; Ramaswamy & Musser, 1998; Billington et al., 1999; Morlock et al., 2000; Boshoff 
et al., 2003; Mariam et al., 2004), point mutations in the His526 codon constituted the 
dominant mc2155 RifR genotype. Mutations at His526 accounted for all RifR mutants 
isolated from the Y-family gene deletion mutants after 128 days in  LTG1 (Table 3.7), as 
well as the majority of RifR mutants of wild-type mc2155 and ΔC after 56 days in LTG2. 
Furthermore, it was possible to discern a progressive trend in both LTG1 (Table 3.7) and 
LTG2 (Table 3.8) from diverse RifR genotypes at the earlier timepoints to almost exclusive 
His526 and Ser531 substitutions later on. The prevalence of these mutations suggests 
that His526 substitutions might incur the least fitness cost in M. smegmatis.  
Table 3.7 rpoB mutations in Rif-resistant mutants derived from M. smegmatisa in LTG1. 
  
dinP-/- dinX dinP-/-P3 dinP-/-X DC 
  
63 128 63 128 63 128 63 128 63 128 
Mutation Substitution (12) (12) (9) (6) (14) (13) (14) (11) (11) (11) 
cac→cgc His526→Arg 66.7 58.3 44.4 50 42.8 54 43 36 64 36 
cac→ccc His526→Pro       14 9 9 18 
cac→tac His526→Tyr 16.7 33.3 33.3 16.7 21.4 31 36 55 18 46 
cac→gac His526→Asp  8.3         
tcg→ttg Ser531→Leu 8.3          
tcg→ttc Ser531→Phe      15     
tcg→tgg Ser531→Trp         9  
cag→aag Gln513→Lys 8.3  11.1 16.7 21.4      
cag→cgg Gln513→Arg     7.1      
cag→ctg  Gln513→Leu    16.7       
30 bp deln. Gln513→Ser522   11.1  7.1  7    
a The table indicates the percentage frequency of each mutation recovered from a particular strain 
after 63 or 128 days growth in LTG1. The total number of mutants at each timepoint is shown in 
brackets.  
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Base substitutions in the codon for Gln513 served as another source of RifR mutants, 
consistent with similar observations in M. tuberculosis (Musser, 1995). However, 
Arg529Leu mutants were identified (Table 3.8) which have not been described previously 
for M. tuberculosis (Musser, 1995). Finally, although the contribution of individual 
polymerases to the mutational spectrum was not detectable in this analysis, two novel 
rpoB deletions conferring rifampicin resistance were identified. The largest of these 
comprised a 30 bp deletion spanning the residues Gln513 to Ser522 (Figure 3.14) and 
was found in RifR mutants isolated during both LTG1 – in dinX, dinP-/-/dinP3, and dinP-/-
/dinX strains (Table 3.7); and LTG2, in the ΔC mutant (Table 3.8). In addition, RifR ΔC 
mutants were isolated containing a smaller 12 bp deletion that eliminated Gln513 to 
Asp516 (Table 3.8). While they could not be attributed to the loss of a specific individual 
polymerase, it was notable that deletions arising in both LTG1and LTG2 were restricted to 
mutant strains deficient in one or more Y-family members. Moreover, the identification of 
Table 3.8 rpoB mutations in Rif-resistant mutants derived from M. smegmatisa in LTG2. 
  WT ΔC 
  0 3 18 56 0 3 18 56 
Mutation Substitution (0) (8) (20) (19) (1) (16) (5) (18) 
cac→cgc His526→Arg  12.5 10 16  6  28 
cac→ccc His526→Pro   5 11  19  33 
cac→tac His526→Tyr  50 10 26 100 38 20 28 
cac→gac His526→Asp   5      
tcg→ttg Ser531→Leu  12.5 35 31  13 20 5.5 
tcg→tgg Ser531→Trp      6 20  
cag→aag Gln513→Lys        5.5 
cag→cgg Gln513→Arg      6   
cag→ctg  Gln513→Leu   15 16     
cgt→ctt Arg529→Leu  25 5      
12 bp deln. Gln513→Asp516      6   
30 bp deln. Gln513→Ser522      6 40  
Unknownb    15      
a The table indicates the percentage frequency of each mutation recovered from a 
particular strain after 0, 3, 18, or 56 days growth in LTG2. The total number of mutants 
isolated at each timepoint is shown in brackets. 
b RifR mutants which did not map to the sequenced rpoB amplicon. 
  
 
 
 
 
 
 
 
 
Mtb AGC CAG CTG AGC CAA TTC ATG GAC CAG AAC AAC CCG CTG TCG GGG TTG ACC CAC AAG CGC  
  
 509 ¾ Ser Gln Leu Ser Gln Phe Met Asp Gln Asn Asn Pro Leu Ser Gly Leu Thr His Lys Arg ¾ 528 
 
Msm AGC CAG CTG TCG CAG TTC ATG GAC CAG AAC AAC CCG CTG TCG GGT CTG ACC CAC AAG CGT 
 
 
 
 
Figure 3.14 Deletions in the rpoB gene of M. smegmatis mc2155 conferring RifR. The novel 30 bp in-frame deletion eliminates 10 aa from Gln513 to 
Ser522 (marked by ä). The 9 bp direct repeat sequences that might stabilise a hairpin structure or recombination intermediate (see Discussion) and so 
result in the deletion of the intervening DNA sequence are highlighted in red and underlined (®). Although sharing 100% amino acid identity (Hetherington 
et al, 1995), the M. tuberculosis (Mtb) and mc2155 (Msm) coding sequences differ at Ser512 (highlighted in blue), thought likely to prevent the emergence 
of similar RifR deletion mutants in M. tuberculosis isolates. The location of the 12 bp deletion in the M. smegmatis ΔC RifR isolate is also shown (boxed 
region), and might depend on identical flanking Gln513 and Gln 517 codons (highlighted in green and underlined, ®). A smaller 9 bp deletion found in the 
same locus in M. tuberculosis clinical isolates (Musser, 1995) is underlined in black. The codon numbering system is as previously described (Telenti et 
al., 1993; Musser, 1995). The inset shows a 3% agarose gel comparing the rpoB PCR amplicons from RifS wild-type mc2155 (mc2155 RifS) with a RifR SNP 
mutant (SNP RifR), as well as the 12bp and 30bp RifR deletion mutants. 
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the 30 bp deletion in ΔC (lacking all Y-family homologues as well as dnaE2) as well as 
individual Y-family gene deletion mutants indicated that the polymorphism arose 
independently of DnaE2.  
 
3.4.6 The Y-family polymerases in TLS 
 
The M. smegmatis pol IV homologues are not required for UV tolerance 
Loss of Y-family activity in other bacteria is associated with damage hypersensitivity 
(Rangarajan et al., 1999; Sung et al., 2003) and is consistent with the demonstrated TLS 
ability of these polymerases (Reuven et al., 1999; Tang et al., 1999, 2000; Wagner et al., 
1999, 2002; Napolitano et al., 2000; Wagner & Nohmi, 2000; Kim et al., 2001; Kobayashi 
et al., 2002; Shen et al., 2002; Maor-Shoshani et al., 2003a). To assess the collective 
contribution of the mycobacterial Y-family homologues to damage tolerance, a UV survival 
assay was performed (Figure 3.15). Mycobacteria are highly sensitive to direct UV 
exposure, and that sensitivity is profoundly increased in M. smegmatis and M. 
tuberculosis dnaE2 deletion mutants (Boshoff et al., 2003). Because of the dominant role 
of DnaE2, it was expected that any contribution of the Y-family members to UV tolerance 
would be small at best, and perhaps undetectable. However, the fact that UV survival data 
had been established for wild-type mc2155 and the dnaE2 deletion mutant (Boshoff et al., 
2003) meant that the same strains could be used as benchmarks to confirm UV killing 
efficiencies, as well as to elucidate the potentially minor role of the Y-family members in 
damage tolerance. To this end, UV survival of the ΔC strain (lacking all predicted EP 
activity) was compared with the ΔdnaE2 mutant (possessing the full mycobacterial Y-
family complement; Boshoff et al., 2003) and wild-type mc2155. Irradiation with a range of 
UV fluences (0-45 mJ/cm2) confirmed the previously reported (Boshoff et al., 2003) 
differential susceptibilities of wild-type mc2155 and the dnaE2 mutant to UV exposure 
(Figure 3.15). In addition, although percentage survival values appeared to be 
approximately one log fold higher in our hands for both strains, the overall trend in UV-
mediated killing was faithfully replicated. The discrepancy was therefore not considered 
sufficient to invalidate the assay, and likely resulted from differences between effective UV 
doses. Survival of the ΔC strain appeared to be slightly reduced in comparison to the 
ΔdnaE2 mutant over the range of UV fluences tested but was not statistically significant 
relative to the standard error (Figure 3.15). To confirm that the mycobacterial DinP and 
DinX homologues do not participate in UV-induced damage tolerance, post-UV survival of 
mc2155 strains containing the inducible M. tuberculosis dinP and dinX overexpression 
vectors (see Figure 3.5) was assayed. Heterologous overexpression of the M. 
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Figure 3.15 Effect of UV irradiation on survival of M. smegmatis. Serial dilutions of wild-type 
M. smegmatis mc2155 (-¢-), the ΔdnaE2 mutant (-p-) and ΔC (-¢-) were plated in triplicate and 
irradiated at different energy fluences. No significant difference in survival frequencies was 
observed between the ΔdnaE2 and ΔC mutant strains. Results represent the mean values of at 
least three independent experiments with standard errors. 
 
 
tuberculosis Y-family homologues in this system did not result in enhanced UV tolerance 
in comparison with wild-type mc2155, with or without acetamide induction (data not 
shown). 
 
rpoB fingerprinting of RifR mutants from UV-irradiated cultures 
The failure to identify a contribution of the mycobacterial Y-family homologues to UV 
survival suggested that damaged-induced mutation frequencies in the ΔC strain, lacking 
all EP activity, should be indistinguishable from the dnaE2 mutant, containing the full 
putative mycobaterial Y-family complement. The measurement of UV-induced mutation 
frequencies was, however, complicated by the profound UV sensitivity associated with 
loss of dnaE2 in the ΔdnaE2 and ΔC mutants (Boshoff et al., 2003; Figure 3.15). 
Therefore, as expected, no significant difference could be detected by scoring RifR 
mutants arising after UV irradiation of the ΔdnaE2 and ΔC strains (data not shown). To 
confirm that the mycobacterial pol IV homologues do not participate in error-prone TLS 
(and so are not mutagenic), an indirect strategy was applied in which the rpoB mutational 
profiles arising in RifR ΔdnaE2 and ΔC mutants post-UV irradiation were compared. Both 
ΔdnaE2 and ΔC strains were exposed to a single, UV dose and allowed to recover in 
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liquid culture for specific time intervals before plating on Rif-containing media. Recovery 
was necessary to allow potentially mutagenic TLS repair of UV damage, and an 
intermediate fluence of 25 mJ/cm2 was applied to ensure a sufficient population of 
surviving bacilli for selection. Genotypic analysis of the rpoB locus of all RifR mutants 
arising in both ΔdnaE2 and ΔC at each recovery timepoint revealed no mutational bias 
between the two strains (Table 3.9). However, RifR mutants of ΔC were again isolated that 
contained the 30 bp deletion (Gln513®Ser522) in rpoB, thereby confirming the relevance 
of this polymorphism to the emergence of RifR in strains lacking one or more of the Y-
polymerases.  
 
 
 
 
Significantly, the same deletion was not observed at any timepoint in the dnaE2 deletion 
mutant (Table 3.9), consistent with previous evidence suggesting that the appearance of 
rpoB deletion mutants was dnaE2-independent. In addition, it was notable that the 
Table 3.9 rpoB mutations in Rif-resistant mutants derived from UV irradiated M. smegmatisa. 
  ΔdnaE2  ΔC  
  2.5 hr 5 hr 24 hr 2.5 hr 5 hr 24 hr 
Mutation Substitution (n=9) (n=6) (n=20) (n=6) (n=6) (n=19) 
cac→cgc His526→Arg   5  33.3 10.5 
cac→ccc His526→Pro   30   10.5 
cac→tac His526→Tyr 33.3 16.7 25 33.3 33.3 42 
ccac→ttac ThrHis526→ThrTyr 11.1  10    
tcg→ttg Ser531→Leu 33.3 50 20  16.7 32 
tcg→ttc Ser531→Phe   10    
gac→gag Asp516→Glu 11.1      
gac→ggc Asp516→Gly  16.7     
ggac→aaac MetAsp516→IleAsn  16.7     
tcg→ttg Ser522→Leu    16.7   
30 bp deln. Gln513→Ser522      5 
Unknownb  11.1   50 16.7  
a The table indicates the percentage frequency of each mutation recovered from a particular 
strain after 2.5, 5, or 24 hours recovery following UV irradiation. The total number of mutants 
isolated at each timepoint is shown in brackets. 
b RifR mutants which did not map to the sequenced rpoB amplicon. 
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mutation conferring RifR in half of all RifR ΔC mutants (3/6) isolated after 2.5 hrs recovery 
could not be mapped to the 81 bp resistance determining region, or to flanking sequence 
in the approximately 150 bp portion of the 183 bp PCR amplicon that gave readable 
sequence. One RifR dnaE2 mutant was isolated at the initial timepoint that similarly could 
not be mapped to the analysed rpoB region. A small percentage of RifR mutations in 
clinical M. tuberculosis isolates do not contain mutations in the 81 bp rpoB core region 
and, in some cases, resistance cannot be mapped to mutations in rpoB at all (Musser, 
1995). The origin of resistance in these strains remains unknown; however, it would 
appear that the undefined mutation might incur a significant fitness cost since this 
“genotype” was gradually cleared from the ΔC population over the course of recovery and 
was not evident after 24 hrs in either strain. 
 
A cac®tac transition, resulting in a His®Tyr substition at His526, constitutes the most 
frequent UV-induced mutation in M. tuberculosis (Boshoff et al., 2003), and was similarly 
dominant in both M. smegmatis ΔdnaE2 and ΔC RifR mutants (Table 3.9). The 
characteristic mutation associated with UV-induced mutagenesis in wild-type M. 
tuberculosis is, however, a double ccac®ttac (ThrHis526®ThrTyr) transition that is very 
rarely present in non-irradiated H37Rv (Boshoff et al., 2003). This double transition was 
completely absent in an M. tuberculosis ΔdnaE2 deletion mutant, implying probable 
DnaE2-dependent mutagenic TLS across a cyclobutane pyrimidine dimer or a pyrimidine 
pyrimidone (6-4) photoproduct (Boshoff et al., 2003). In contrast to M. tuberculosis, the 
ccac®ttac resistance mutation was evident in the M. smegmatis ΔdnaE2 mutant strain, 
albeit at low frequencies (Table 3.9). However, the same mutation was not present in any 
of the ΔC RifR isolates, again suggesting the possible involvement of one or more of the 
pol IV homologues in mutagenic repair synthesis. Of the possible candidate polymerases, 
it is significant that dinP3 is found in M. smegmatis but not M. tuberculosis and, further, 
that dinP3 is inducible as part of the SOS response in mc2155 (Figure 3.16). It is likely, 
therefore, that the functional DinP3 in the M. smegmatis dnaE2 strain might partially 
compensate for loss of DnaE2-mediated TLS activity. However, the profound lethality 
associated with loss of dnaE2 indicates that DinP3 activity barely complements  DnaE2-
mediated TLS.  
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3.4.7 Gyrase inhibition and induced mutagenesis 
 
Mycobacterial Y-family polymerases are differentially induced in response to 
gyrase inhibitors 
Considerable attention has been focused on the potential supplementation of TB 
chemotherapy with broad-spectrum antimicrobial agents, particularly the fluoroquinolones 
(FQs) (Tsukamura, 1985; Grosset, 1992; Cambau et al., 1994; Crofton et al., 1997; Ji et 
al., 1998; Blumberg et al., 2003; Fattorini et al., 2003; Gosling et al., 2003; O’Brien, 2003; 
Veziris et al., 2003; Aubry et al., 2004; Nuermberger et al., 2004; Pletz et al., 2004). 
However, there have been reports of the rapid emergence of FQ-resistant M. tuberculosis 
clinical isolates (Perlman et al., 1997; Ginsburg et al., 2003). FQs block bacterial 
replication and transcription by targeting the type II topoisomerases, DNA gyrase and 
topoisomerase IV. Binding of topoisomerase IV and the GyrA subunit of DNA gyrase in 
complex with DNA results in the formation of stable ternary structures that cause 
potentially lethal DSBs (Drlica & Zhao, 1997) and potently induce the SOS response 
(Gudas & Pardee, 1976; Phillips et al., 1987; Piddock & Wise, 1987; Walters et al., 1989; 
Piddock et al., 1990; Ysern et al., 1990; Gmuender et al., 2001). Mycobacterial SOS and 
damage repair genes including dnaE2 are upregulated following exposure of H37Rv to 
FQs in vitro (Boshoff et al., 2004). Of particular interest, however, was the observation 
that M. tuberculosis dinP is induced in response to treatment with a related replication and 
transcription inhibitor of the coumarin class of antibiotics, novobiocin (NVB) (Boshoff et al., 
2004). NVB is bacteriostatic, and binds the DNA gyrase GyrB subunit without causing 
DSBs (Maxwell, 1993; Gmuender et al., 2001; Boshoff et al., 2004). Although exposure to 
NVB fails to cause DSBs – and, therefore, does not result in mycobacterial SOS induction 
- dnaE2 expresion is also upregulated in M. tuberculosis following NVB treatment (Boshoff 
et al., 2004). The SOS-independent induction of dnaE2 contradicts previous evidence that 
dnaE2 is solely LexA/RecA regulated (Boshoff et al., 2003; Rand et al., 2003) and is 
suggestive of an alternative damage-independent regulatory mechanism that might 
operate during replication stalling. To confirm the differential transcription of the M. 
smegmatis Y-family polymerases in response to alternative classes of gyrase inhibitor, 
wild-type mc2155 was exposed to NVB and the fluoroquinolone, ofloxacin (OFX). 
Expression analysis by semi-quantitative RT-PCR revealed that neither dinP or dinX was 
upregulated after treatment with OFX for one or four hours (data not shown), confirming 
similar observations in M. tuberculosis (Boshoff et al., 2004). 
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Figure 3.16 Transcriptional response of M. smegmatis dinP3 to stalled replication. RT-PCR 
analysis of dinP3 expression in M. smegmatis mc2155 after exposure to alternative classes of 
gyrase inhibitor. Cells were treated with novobiocin (NVB) or ofloxacin (OFX) for one or four hours, 
and expression compared with untreated or solvent (DMSO) controls. 
 
 
In contrast, transcription of dinP3 was highly induced after only one hour OFX exposure 
(Figure 3.16), consistent with a postulated role for the additional M. smegmatis Y-family 
homologue in the LexA/RecA-mediated mycobacterial SOS regulon. Furthermore, 
treatment of M. smegmatis with NVB did not result in elevated dinP3 expression (Figure 
3.16). 
 
The role of Y-family polymerases in survival and mutagenesis after gyrase 
inhibition 
The unique upregulation of dinP in mycobacteria in response to transcriptional inhibition 
by NVB but not OFX (Boshoff et al., 2004) was suggestive of a potential role of this Y-
family homologue in mediating replication re-start following NVB-mediated replication fork 
arrest. In E. coli , for example, SOS-inducible Pol II (polB) is required for error-free rescue 
of stalled replication forks on damaged DNA (Rangarajan et al., 1999, 2002), perhaps 
followed by pol V-mediated lesion bypass (Friedberg et al., 1995; Rangarajan et al., 1999; 
Goodman & Woodgate, 2000; Pham et al., 2001). To determine whether loss of dinP was 
associated with increased susceptibility to gyrase inhibitors, wild-type mc2155, as well as 
dinP-/-, ΔdinP3 and ΔC strains, were treated with OFX and NVB and cell densities and 
plating efficiencies determined at a series of timepoints extending over 24 hours. The ΔC 
and the dinP-/- mutants were utilised because it was felt that comparative susceptibilities of 
these two strains to different gyrase inhibitors might reveal the possible roles of the other 
mycobacterial pol IV (DinX and DinP3) and C-family EP (DnaE2) polymerases. Similarly, 
the dinP3 mutant was included because of the demonstrated SOS-mediated upregulation 
of dinP3 expression in response to OFX treatment (Figure 3.16). In addition, to elucidate 
any subtle effects of loss of the Y-family and EP polymerases, a range of NVB and OFX 
concentrations was employed spanning the known MICs of those compounds (Aubry et 
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al., 2004; Boshoff et al., 2004). However, the susceptibilities of both the Y-family (dinP-/- 
and dinP3) and EP (ΔC) mutants to either drug were indistinguishable from wild-type 
mc2155 throughout the 24 hour treatment (data not shown).  
 
The demonstration that FQ treatment results in an SOS-mediated elevation in the 
mutation rate in other organisms (Gudas & Pardee, 1976; Phillips et al., 1987; Piddock & 
Wise, 1987; Walters et al., 1989; Piddock et al., 1990; Gmuender et al., 2001) suggested 
that an evaluation of susceptibility might not detect subtle differences manifest in re-
growth post antibiotic treatment. In particular, in the absence of published data on the 
mutagenicity of NVB, it was postulated that interference in DNA replication might result in 
an increased mycobacterial mutation rate despite a failure to induce the SOS response, 
potentially as a pleiotropic effect of DinP-mediated replication re-start. The presence of 
numerous Y-family homologues in mc2155, however, posed the problem of redundant 
function. To eliminate the possible confounding effects of the other mycobacterial Y-family 
polymerases, NVB-induced mutation frequencies of wild-type mc2155 and ΔY were 
compared by scoring the appearance of RifR mutants of each strain at specific timepoints 
following treatment. In addition, to determine the potential contribution of DnaE2, the ΔC 
mutant was included in the assay (Table 3.10). Susceptibilities of the ΔY and ΔC mutants 
to NVB (25 μg/ml) did not differ significantly from wild-type mc2155, irrespective of 
treatment duration (data not shown). Exposure of mc2155 to NVB resulted in an 
approximately 10-fold increase in frequency of RifR mutants throughout the 24 hr 
treatment period and, surprisingly, was indistinguishable in both ΔY and ΔC strains. 
 
 
 
 
 
 
 
 
 
 
 However, it was noted that the RifR mutants arising in the ΔC and ΔY strains seemed 
overall to exhibit altered colony morphotypes - specifically smaller size  – and were 
delayed in their appearance (data not shown). To confirm the increased RifR mutation 
frequencies, streptomycin resistant (StrR) mutants of mc2155, ΔY and ΔC were isolated in 
Table 3.10 Mutation frequencies following NVB treatment. 
 Rif mutation frequency (x 10-8) 
Strain untreated + NVB 
mc2155 6.04 ± 2.7 70.9 ± 15.2 
ΔY 6.15 ± 2.0 54.5 ± 24.6 
ΔC 9.67 ± 3.7 54.2 ± 20.5 
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parallel at the timepoints described above. The frequency of StrR mutations in untreated 
wild-type mc2155 as well as the ΔY and ΔC mutants was estimated at 7.0 ± 4.0 x 10-9, in 
line with previously reported values (Boshoff et al., 2003). In contrast to the Rif analysis, 
however, treatment with NVB did not result in an increased StrR mutation frequency in any 
of the strains throughout the 24 hr period (data not shown).  
 
Novobiocin-induced mutagenesis 
The elevated RifR frequency was indicative of induced mutagenesis, consistent with the 
observed upregulation of dinP expression after NVB treatment (Boshoff et al., 2003). 
However, analysis of StrR frequencies did not corroborate the hypermutability inferred 
from the emergence of RifR mutants. Furthermore, the failure to detect differential RifR 
mutation fequencies in wild-type mc2155 versus either the ΔY or ΔC strains suggested 
that the phenomenon was independent of either the Y-family polymerases or DnaE2. To 
further investigate the contribution of mycobacterial Y-family homologues, as well as 
DnaE2, to NVB-induced mutagenesis, RifR mutants isolated after 3 hr NVB exposure were 
analysed genotypically (Table 3.11). Sequencing of a region of rpoB (Figure 3.14) from 
each of twenty RifR mutants of mc2155, ΔY and ΔC revealed starkly contrasting mutational 
profiles (Table 3.11). Eighty-five percent (17/20) of RifR mutants arising in wild-type 
mc2155 after 3hr NVB treatment contained substitutions at the common His526 or Ser531 
loci, the majority of which resulted from a cac→cgc (His526→Arg) transition mutation. Of 
the remaining fifteen percent (3/20), one RifR mutant did not map to the sequenced rpoB 
region, and another possessed a ctg→cgg (Leu533→Pro) transversion previously 
identified in RifR M. tuberculosis isolates (Musser, 1995). The final mc2155 RifR mutant 
was characterised by separate mutations in two sequential codons (accc→gcca), resulting 
in a double 519AsnPro520→519SerGln520 substitution, a mutation that has not been 
described in M. tuberculosis (Musser, 1995). Novel RifR mutations were also identified in 
the ΔY and ΔC strains, including two substitutions at Arg529 in ΔY and at His542 in ΔC. 
Most revealing, however, was the finding that 55% of RifR ΔC and 70% of RifR ΔY mutants 
could not be mapped to the sequenced rpoB region. In addition, 30 bp rpoB deletion 
mutants of ΔC and ΔY were again isolated. No deletions were observed in wild-type 
mc2155, consistent with previous data suggesting that the deletion might be unique to 
strains partially or completely deficient in Y-family homologues.  
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3.4.8 The role of Rv3394c in damage protection 
Transcriptional profiling of the M. tuberculosis response to various DNA damaging agents 
in vitro revealed the upregulation of two additional putative DNA polymerases, encoded by 
Rv3856c and Rv3394c (Boshoff et al., 2003). Induction of Rv3856c is apparently 
LexA/RecA-independent (Davis et al., 2002a), suggesting alternative damage-response 
regulation (Rand et al., 2003; Gamulin et al., 2004). Furthermore, although Rv3856c 
contains both phosphodiesterase and X-family polymerase domains 
(http://genolist.pasteur.fr/TubercuList/), the X-family polymerases consitute a large family 
of nucleotidyl transferases, many of which are not DNA polymerases (Aravind & Koonin, 
1999). Similarly, although identified as the founder member of the novel DinB3 subfamily 
of putative eubacterial Y-family polymerases (Dalrymple et al., 2003), the predicted amino 
acid sequence of Rv3394c indicates loss of catalytic residues required for polymerase 
Table 3.11 rpoB mutations in Rif-resistant mutants after treatment of M. smegmatisa with NVB. 
  WT DY DC 
Mutation Substitution (n=20) (n=20) (n=20) 
cac→cgc His526→Arg 60 5 5 
cac→ccc His526→Pro 5 5  
cac→tac His526→Tyr 5 5  
tcg→ttg Ser531→Leu 10   
tcg→tgg Ser531→Trp 5  5 
cag→ccg Gln513→Pro   5 
gac→ggc Asp516→Gly   5 
ctg→atg Leu521→Met   5 
cgt→tgt Arg529→Cys  5  
cgt→cat Arg529→His  5  
ctg→cgg Leu533→Pro 5  10 
cac→ctc His542→Leu   5 
aac→agc/ 
ccg→cag 
Asn519→Ser/ 
Pro520→Gln 5   
30 bp deln. Gln513→Ser522  5 5 
Unknownb  5 70 55 
a The table indicates the percentage frequency of each mutation identified in selected 
RifR isolates arising after 3 hr NVB exposure. Twenty mutants were isolated at each 
timepoint (ishown in brackets). 
b RifR mutants which did not map to the sequenced rpoB amplicon. 
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activity (Figure 3.1). However, the involvement of DinB3 and DnaE2 family members in 
the same replication or repair pathway is implied by their frequent co-localisation in 
sequenced eubacterial genomes (Dalrymple et al., 2003); in M. tuberculosis, for example, 
dnaE2 (Rv3370c) and Rv3394c are separated by 24.7 kb. Furthermore, and consistent 
with damage induction (Boshoff et al., 2003), a Cheo-type SOS box (Cheo et al., 1991) 
has been identified upstream of the coding region of a predicted ORF, Rv3395c, that 
appears to be operonic with Rv3394c (Davis et al., 2002a).  
 
Figure 3.17 Construction of Rv3394c and Rv3395c deletion mutants of M. tuberculosis 
H37Rv. EcoRI-digested DNA from H37Rv, the DRv3394c deletion mutant, and the 
DRv3394c/DRv3395c deletion mutant probed with 3394FR1 (shaded box). Construction of the 
DRv3394c allele eliminates 1014 bp of Rv3394c coding sequence; the DRv3394c/DRv3395c allele 
eliminates 1371 bp of Rv3394c coding sequence and Rv3395c entirely. However, an additional 
EcoRI site is introduced by the hyg cassette (E, EcoRI; WT, wild-type). 
 
 
To investigate the potential role of Rv3394c in mediating damage tolerance induced 
mutagenesis in M. tuberculosis, two hyg-marked deletion-insertion mutants of H37Rv 
were generated by the two-step method. The first of these, ΔRv3394c, eliminated 1014 bp 
(of 1584 bp) Rv3394c sequence (Figure 3.17), while in the other (ΔRv3394c/ΔRv3395c) a 
segment comprising the entire Rv3395c gene plus 1371 bp Rv3394c sequence was 
4930 bp ¾ 
3409 bp ¾ 
H
37
R
v 
D
R
v3
39
4c
::h
yg
 
D
R
v3
39
4c
/ 
D
R
v3
39
5c
 
é 
E 
4930 bp 
Rv3395c 
é 
E 
WT 
Rv3394c 
DRv3394c é 
E 
3409 bp 
hyg 
E 
ê 
 
DRv3394c::hyg Rv3395c 
DRv3394c/ 
DRv3395c 
 3409 bp 
hyg 
é 
E 
DRv3394c é 
E 
 112 
deleted (Figure 3.17). Neither strain was impaired in vitro under normal growth conditions 
(data not shown). Rv3394c contains a conserved IMS (impB/mucB/samB) domain that, in 
other bacteria, has been implicated in UV protection and induced mutagenesis (Lodwick 
et al., 1990; Gruz et al., 1996, 1998; Runyen-Janecky et al., 1999). The induction of 
Rv3394c in response to UV and H2O2 exposure was, therefore, strongly suggestive of a 
role in SOS-regulated damage repair (Boshoff et al., 2003). To determine whether loss of 
Rv3394c resulted in increased susceptibility to DNA damaging agents, survival of wild-
type H37Rv and the ΔRv3394c mutant were compared after 6 hours treatment with 5 mM 
H2O2. No difference in plating efficiencies was observed between strains at either H2O2 
concentration (data not shown). Similarly, exposure of both wild-type H37Rv and 
ΔRv3394c to a range of UV fluences from 0-45 mJ/cm2 did not reveal increased damage 
susceptibility in the Rv3394c mutant (Figure 3.18). 
 
 
Figure 3.18 Damage survival of M. tuberculosis strains. Serial dilutions of wild-type M. 
tuberculosis (-¢-) and the ΔRv3394c mutant (-p-) were plated in triplicate and irradiated at 
different energy fluences. No significant difference  in survival frequencies was observed between 
the two strains. Results represent the mean values of two independent experiments with standard 
errors. 
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3.5  DISCUSSION 
Prokaryotic Y-family polymerases share several characteristic genetic features, including 
their induction in most bacterial SOS responses (Kenyon & Walker, 1980; Bagg et al., 
1981; Friedberg et al.,1995; Becherel & Fuchs, 1999; Walker et al., 2000; Courcelle et al., 
2001; Duigou et al., 2004), as well as the demonstration that their overexpression results 
in elevated rates of untargeted (Kim et al., 1997; Duigou et al., 2004) and UV-targeted 
mutagenesis (Duigou et al., 2004). Members of the Y-family have been implicated in two 
broad, but intricately linked, cellular processes – damage tolerance through the rescue of 
stalled replication forks by specialised lesion bypass, and the generation of targeted and 
untargeted mutations that contribute to adaptive evolution. Preliminary experiments with 
recombinant enzyme have established that M. tuberculosis DinX exhibits template-
directed DNA polymerase activity (B. Kana, unpublished). In contrast, previous reports 
have shown that neither M. tuberculosis pol IV homologue – encoded by dinP and dinX – 
is upregulated in response to DNA damage (Brooks et al., 2001; Boshoff et al., 2003). The 
absence of pol IV homologues from the mycobacterial SOS regulon (as well as the 
LexA/RecA-independent damage response; Rand et al., 2003; Gamulin et al., 2004) 
represents the first departure from classic Y-family behaviour. That observation was 
extended in the work presented here to a demonstration that the mycobacterial 
homologues fail, with limited exceptions, to fulfil additional genetic requirements of 
prototypical Y-polymerase activity. Specifically, heterologous overexpression of M. 
tuberculosis dinP and dinX does not increase M. smegmatis mc2155 mutation rates 
irrespective of DNA damage (Table 3.6). Moreover, loss of the M. smegmatis pol IV 
complement has no effect on UV susceptibility (Figure 3.15), and overproduction of the M. 
tuberculosis dinP- and dinX-encoded pol IV homologues does not restore damage 
tolerance even partially. Conversely, abrogation of all identifiable pol IV (ΔY) or EP 
polymerase activity (ΔC) fails to impair the long-term survival of mc2155 (Figure 3.11), 
suggesting that none of these polymerases – including the SOS-inducible pol IV encoded 
by dinP3 – confers a competitive fitness advantage during stationary phase adaptation. 
 
EP polymerases in Gram-positive versus Gram-negative bacteria 
The recent identification of DnaE2 as the dominant player in damage tolerance and 
induced mutagenesis in M. tuberculosis  (Boshoff et al., 2003) was particularly surprising 
given the mycobacterial Y-family complement (Table 3.12). In E. coli, the dnaE-encoded C 
family polymerase provides the main, high-fidelity replicative polymerase activity 
(McHenry & Kornberg, 1977; McHenry, 1988; Kornberg & Baker, 1992), while pol II and 
the EP pols IV and V are strongly upregulated during SOS (Kenyon & Walker, 1980; Bagg 
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et al., 1981; Iwasaki et al., 1990; Woodgate & Ennis, 1991; Friedberg et al., 1995; Bonner 
et al., 1988; Kim et al., 1997, 2001; Qiu & Goodman, 1997; Walker et al., 2000; Courcelle 
et al., 2001). In contrast, two distinct subclasses of C-family polymerases have been 
identified in Gram-positive bacteria (Bruck & O’Donnell, 2000): class I (dnaE-type) which 
lack intrinsic proofreading ability; and class II (polC-type), which contain both polymerase 
and 3’®5’ proofreading exonuclease activities on one polypeptide chain. Significantly, 
recent evidence has shown that the complement and function of the C-family polymerases 
varies among these organisms (Dervyn et al., 2001; Inoue et al., 2001; Boshoff et al., 
2003; Bruck et al., 2003). In B. subtilis and S. aureus, for example, both polC and dnaE 
polymerase subclasses are essential, separately catalysing leading and lagging strand 
synthesis, respectively (Dervyn et al., 2001; Inoue et al., 2001). Furthermore, B. subtilis 
dnaE has been implicated in SOS-induced mutagenesis (Le Chatelier et al., 2004), 
suggesting a role in both replication and EP TLS depending on differential protein 
interactions (Tippin et al., 2004b). Streptococcus pyogenes, on the other hand, encodes 
essential class I and class II polymerases, with PolC providing sole replicative function 
and DnaE EP polymerase activity (Bruck & O’Donnell, 2000; Bruck et al., 2003). M. 
tuberculosis does not contain a polC-type C-family polymerase but, instead, two dnaE-
type polymerases separately fulfil essential replicative (dnaE1) and non-essential EP 
(dnaE2) polymerase roles (Boshoff et al., 2003). Although unusual, the presence of two 
dnaE-type C-polymerases is not unique, and several other Gram-positive bacterial 
species have been shown to contain multiple dnaE genes (Boshoff et al., 2003; Tippin et 
al., 2004b). Of course, the presence of one or more Y-family homologues in addition to 
the expanded dnaE complement raises compelling questions regarding the function of the 
Y-polymerases in mediating damage tolerance and induced mutagenesis in those 
organisms (Tippin et al., 2004b). In particular, the unusual induction of the specific 
polymerase types in M. tuberculosis and some other Gram-positive organisms (Y-family 
polymerases are not SOS-regulated, C-family polymerases are) has prompted speculation 
that distinct LexA/RecA-dependent damage responses might have evolved in Gram-
negative versus Gram-positive organisms involving discrete polymerase families (Tippin et 
al., 2004b). 
 
The mycobacterial SOS and damage-inducible polymerase complement 
M. tuberculosis does not possess homologues of either E. coli  SOS-inducible pols II or V 
(Cole et al., 1998; Mizrahi & Andersen, 1998). Instead, in addition to DnaE2, the M. 
tuberculosis SOS regulon includes another putative DNA polymerase, Rv3394c (Davis et 
al., 2002a; Boshoff et al., 2003). Despite lacking conserved acidic residues required for 
 Table 3.12 Y-family and EP polymerase complements and properties. 
Expression Polymerase SOS NVB Stat. phase 
UV 
tolerance 
UV 
mutagenesis β clamp‡ Reference 
E. coli        
pol II ü ? ü ü û ü Kenyon & Walker, 1980; Bagg et al., 1981; 
pol IV ü ? ü û û ü Walker et al., 2000; Courcelle et al., 2001; 
pol V ü ? ü ü ü ü Yeiser et al., 2002; Layton & Foster, 2003 
B. subtilisÝ        
DnaE ü ? ? û ü ü Le Chatelier et al., 2004 
pol IV (YqjH)† û ? ? û û ü Duigou et al., 2004 
pol V (YqjW) ü ? ? û ü ü Duigou et al., 2004 
M. smegmatis        
DnaE2 ü ü ? ü ü û Boshoff et al., 2003; This work 
pol IV        
DinP û ü ? û û û  
DinX û û ? û û ü This work 
Rv3394c ü ü ? û û ü R. Brackin & E. Machowski, unpublished 
DinP3 ü û ? û û ü  
M. tuberculosis        
DnaE2 ü ü ? ü ü û Brooks et al., 2001; Boshofff et al., 2003 
pol IV        
DinP û ü ? û û û Brooks et al., 2001; Davis et al., 2002a; 
DinX û û ? û û ü Boshoff et al., 2003; 
Rv3394c ü û ? û û ü Rand et al., 2003 
‡ The presence of a consensus β-clamp binding motif is as per Dalrymple et al. (2001, 2003). 
Ý In addition to yqjH and yqjW, the B. subtilis genome contains putative yozK-yobH and uvrX-encoded Y-family DNA polymerases which are part of integrated 
prophages (Kunst et al., 1997). The study cited, by Duigou et al. (2004), employed a B. subtilis strain cured of its prophages. 
† B.subtilis YqjH and YqjW are loosely designated homologues of E. coli pols IV and V, respectively, based on the genetic analysis of Duigou et al. (2004). 
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polymerase activity (Figure 3.1), Rv3394c contains putative DinB and IMS domains 
(http://genolist.pasteur.fr/TubercuList/) that are suggestive of a role in damage tolerance. 
In addition, a putative β clamp binding motif classifies Rv3394c as a novel DinB3-type Y-
family polymerase (Dalrymple et al., 2003). Expression of Rv3394c is regulated by an 
SOS-box located immediately upstream of Rv3395c (Davis et al., 2002a), and is strongly 
upregulated following DNA damage (Davis et al., 2002a; Boshoff et al., 2003) and OFX-
mediated gyrase inhibition. However, in this study it was demonstrated that Rv3394c 
activity is not required for survival of oxidative (H2O2) or UV-induced DNA damage (Figure 
3.18). The dispensability of Rv3394c for damage tolerance in M. tuberculosis is consistent 
with the dominant role of DnaE2 (Boshoff et al., 2003). However, it is possible that loss of 
Rv3394c does not affect survival but instead translates into altered damage-induced 
mutation profiles. The contribution of Rv3394c to induced mutagenesis might, therefore, 
be better elucidated by comparing ΔdnaE2 and ΔdnaE2/ΔRv3394c double mutants. It is 
notable, for example, that the cac®tac (His526®Tyr) transition that constitutes the most 
frequent mutation in UV-irradiated wild-type M. tuberculosis H37Rv (Boshoff et al., 2003) 
was also the dominant RifR mutation in both M. smegmatis ΔdnaE2 and ΔC RifR strains 
after UV irradiation (Table 3.9), suggesting that some other TLS activity might be present 
in strains deficient in DnaE2 and pol IV-mediated EP polymerase activity.  
 
The M. smegmatis mc2155 damage-inducible regulon is distinct from M. tuberculosis 
(Table 3.12) in that it includes a LexA/RecA-dependent pol IV homologue encoded by 
dinP3 (MSMEG6405). Treatment of mc2155 with the known mycobacterial SOS inducer, 
OFX (Boshofff et al., 2004), confirmed the potent upregulation of dinP3 in response to 
DNA damage (Figure 3.16) and pointed to a possible role in damage tolerance, although 
this was not supported by the indistinguishable UV susceptibilities of the ΔdnaE2 and ΔC 
mutant strains (Figure 3.15). However, some evidence of a possible role for DinP3 was 
provided by the RifR profiles of UV-irradiated mc2155 strains. In particular, genotypic 
analysis of the core rpoB resistance-determining region in RifR mutants of UV-treated 
mc2155 ΔdnaE2 identified the ccac®ttac (ThrHis526®ThrTyr) double transition mutation 
that is the hallmark of UV-irradiated M. tuberculosis cells (Table 3.9). Although detected at 
low frequencies, the presence of the double transition genotype in the M. smegmatis 
ΔdnaE2 mutant contrasted with previous evidence of the elimination of that mode of lesion 
bypass in M. tuberculosis ΔdnaE2 (Boshoff et al., 2003). Furthermore, the same mutation 
was not present in any of the UV-induced RifR isolates of M. smegmatis ΔC, again 
implicating one or more of the mc2155 Y-family homologues (dinP3, dinP or dinX) in 
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mutagenic repair synthesis. Of these, the SOS-inducible dinP3 uniquely distinguishes M. 
tuberculosis and M. smegmatis and is, therefore, the most compelling candidate. Of 
course, the profound damage susceptibility associated with loss of dnaE2 indicates that 
DinP3 cannot complement the absent DnaE2, but may play a minor role in UV-induced 
TLS. 
 
The failure of M. tuberculosis dinP or dinX overexpression to enhance UV tolerance in 
mc2155 is also consistent with the dispensability of the mycobacterial pol IV homologues 
in repair of UV-induced damage. However, it is possible that access of the overexpressed 
M. tuberculosis pol IV homologues to the template DNA might be restricted by the full 
replicative and EP polymerase complement in wild-type mc2155 (explored below). In E. 
coli, for example, pol IV interacts with RecA, and the UmuD2 homodimer, to form a 
complex that stabilises stalled replication forks (Godoy et al., 2004). Interestingly, if UmuD 
is supplied, rates of adaptive mutagenesis in strains overexpressing pol IV are reduced 
(Godoy et al., 2004), which suggests that previous reports of hypermutation as a result of 
pol IV overproduction likely reflected artificial “flooding” of regulatory interactions. 
Similarly, although genotypic analysis hinted at a role for the pol IV homologues in TLS, it 
is possible that the effect is not biologically relevant, but instead reflects artificially 
increased access to the damaged DNA template in the absence of DnaE2. Therefore, it 
might be interesting to investigate the potential competition among the mycobacterial 
polymerases for the replication fork. To this end, spontaneous hisD frameshift mutation 
and point mutation rates, as well as post-UV survival, will be assessed in M. smegmatis 
ΔC mutants overexpressing M. tuberculosis dinP and dinX. The HygR genotype of ΔC 
precludes the use of the acetamidase-inducible expression vectors (which are also hyg-
marked); therefore, alternative, KmR vectors have been constructed in which M. 
tuberculosis dinP and dinX are constitutiveley expressed off the mycobacterial Hsp60 
promoter (data not shown). In addition, an investigation of potential mycobacterial pol IV 
interactions - using a yeast two-hybrid system, for example – should also reveal auto- or 
cross-modulatory binding. 
 
Mycobacterial EP polymerases do not contribute to long-term fitness 
Mutants of increased fitness emerge in bacterial populations subject to prolonged 
stationary phase or starvation (Novick & Szilard, 1950; Helling et al., 1987; Cairns & 
Foster, 1991; Zambrano et al., 1993; Zambrano & Kolter, 1993, 1996; Lenski & Travisano, 
1994; Zinser & Kolter, 1999; Sung & Yasbin, 2002; Elena & Lenski, 2003; Pedraza-Reyes 
& Yasbin, 2004; Tegova et al., 2004). Similarly, long-term maintenance of M. smegmatis 
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in vitro results in the generation of strains that are better adapted to the limiting conditions, 
out-competing exponential phase-adapted bacilli in stationary-phase culture (Smeulders 
et al., 1999). Mutants are thought to arise during an induced state of stationary-phase 
hypermutability in mc2155 (Karunakaran & Davies, 2000), reminiscent of adaptive 
mutations in other model systems (Foster, 2000; Rosenberg, 2001; Sung & Yasbin, 2002; 
Hastings et al., 2004). Together with the requirement for DnaE2 for persistence of M. 
tuberculosis in vivo and, particularly, emergence of antibiotic resistance isolates, these 
observations were strongly suggestive of the relevance of adaptive mutagenesis to 
mycobacterial pathogenesis. Significantly, pol IV homologues have been implicated more 
than any other SOS polymerase in stationary-phase mutagenesis in several bacterial 
systems (Sung et al., 2003; Tegova et al., 2004; Hastings et al., 2004), although the 
precise contribution remains unresolved (Strauss et al., 2000; McKenzie et al., 2000, 
2001, 2003; Kim et al., 2001; Hastings et al., 2004; Kuban et al., 2004; Wolff et al., 2004).  
 
Deletion of all pol IV function (other than the possible contribution of the Rv3394c 
homologue) in ΔY (dinP-/-/dinP3/dinX) failed to impair competitive fitness of M. smegmatis 
mc2155 during extended stationary-phase adaptation in vitro (Figure 3.11A). This result 
was consistent with the failure of individual (dinP-/-, dinX) and double (dinP-/-/dinP3, dinP-/-
/dinX) pol IV deletion mutants to impact survival (Figure 3.11A) but was surprising given 
the activity (Figure 3.4) of the M. tuberculosis Rv3055 (directly upstream of dinP; Figure 
3.2) and dinX promoter regions in mc2155 during stationary-phase. In E. coli, for example, 
although all three SOS polymerases are required for competitive fitness and are 
constitutively transcribed throughout long-term survival (Yeiser et al., 2002), pol IV alone 
is induced late in stationary-phase subject to RpoS and GroE regulation (Layton & Foster, 
2003, 2005), perhaps in combination with RpoS-mediated MMR downregulation (Tsui et 
al., 1997; Bjedov et al., 2003). Furthermore, although overexpression of dinP and dinX 
failed to influence mutagenesis in mc2155 (Table 3.6), it was felt that the conditions (or 
factors) required for enhanced access of any or all of the pol IV homologues to the DNA 
template might prevail during stationary phase - the dnaN-encoded β-processivity factor 
(discuused below), for example, is induced during early adaptation of M. tuberculosis to 
starvation in vitro (Betts et al., 2002). DnaE2 similarly fails to elevate rates of spontaneous 
mutagenesis when overexpressed in vitro (Boshoff et al., 2003) but is implicated in 
adaptive evolution of drug resistance. However, deletion of dnaE2 as well as the three pol 
IV homologues did not impair the ability of ΔC to survive in co-culture with wild-type 
(Figure 3.11B). Although this observation correlated with the failure to observe stationary-
phase hypermutability in any mc2155 strain including wild-type during either LTG1 or 
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LTG2, the dispensability of dnaE2, in particuar, was difficult to reconcile with the 
demonstrated in vivo role of M. tuberculosis dnaE2 (Boshoff et al., 2003). It is possible, 
however, that M. smegmatis does not incur sufficient damage during stationary-phase 
survival under the conditions tested and that the mycobacterial SOS damage response 
pathway (Brooks et al., 2001; Boshoff et al., 2003) is not induced. Alternatively, Rv3394c 
might be able to complement the loss of the pol IV homologues during long-term 
persistence, a possibility which requires further investigation. 
 
Restricted access of mycobacterial EP polymerases to the replication fork? 
The demand for high speed and high fidelity of DNA replication requires that the TLS 
polymerases be maintained in close proximity to the replicative complex but with their 
mutagenic activity under control, and prompts an unresolved question regarding the ability 
of cells to co-ordinate the activities of multiple different polymerases at a single replication 
fork (Friedberg et al., 2002; Yang, 2003; Kunkel, 2004). In particular, the observation that 
the replicative flexibility provided by the TLS polymerase is counter-balanced by poor 
processivity and reduced fidelity on undamaged DNA or non-cognate lesions suggests 
that the expression of these enzymes, and their interaction with the DNA template, must 
be closely regulated (Friedberg et al., 2002; Dalrymple et al., 2003; Yang, 2003; Rattray & 
Strathern, 2003; Tippin et al., 2004b). Overexpression of  E. coli  pol IV on multi-copy 
plasmids profoundly increases rates of spontaneous mutagenesis, resulting particularly in 
–1 frameshifts, but also base substitutions (Kim et al., 1997, 2001; Wagner & Nohmi, 
2000; Kobayashi et al., 2002). In contrast, overexpression of M. tuberculosis dinP and 
dinX in M. smegmatis mc2155 did not increase rates of spontaneous point (RifR) or 
frameshift (hisD5T) mutations above wild-type mc2155 (Table 3.6), despite the 
confirmation of increased transcript levels (Figure 3.5). This result was analagous to the 
failure of M. tuberculosis dnaE2 overproduction to elevate mutation frequencies in the 
absence of DNA damage (Boshoff et al., 2003 
  
As has been repeatedly emphasised, the M. tuberculosis genome encodes two pol IV 
homologues (dinP and dinX) plus Rv3394c (Cole et al., 1998); M. smegmatis mc2155, on 
the other hand, contains a dinP3-encoded Y-family member and an extra copy of dinP 
(Figure 3.7), in addition to homologues of all three M. tuberculosis Y-polymerases. 
Combined with the essential, high-fidelity C-family replicative polymerase encoded by 
dnaE1 and the novel TLS C family polymerase encoded by dnaE2 (Boshoff et al., 2003), 
as well as the mycobacterial pol I (polA; Mizrahi & Huberts, 1996), M. tuberculosis H37Rv 
therefore contains at least six defined or putative polymerases (Cole et al., 1998; Mizrahi 
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et al., 2000), and M. smegmatis eight (http://www.tigr.org). Together with the prospect that 
these numbers might be expanded by further polymerase homologues (Makarova et al., 
2002), it seems likely that additional factors might be required to facilitate access of the 
non-replicative polymerases to undamaged DNA in mycobacteria (Boshoff et al., 2003; 
Tippin et al., 2004b). 
 
The β clamp and mycobacterial polymerase switching 
The current TLS model proposes that a stalled replicative polymerase is temporarily 
replaced by one or more TLS polymerases to prevent replication fork collapse and to 
ensure efficient lesion bypass and strand elongation (Friedberg et al., 2002; Goodman, 
2002; Yang, 2003; Kunkel, 2004). On completion of TLS, the specialised polymerases 
dissociate from the DNA, allowing the main replicative enzyme to resume high-fidelity 
processive replication. Recent evidence implicates the dnaN-encoded eubacterial β2 
processivity factor in modulating the recruitment and operation of many proteins involved 
in various steps of DNA replication, recombination, and repair (Naktinis et al., 1996; 
Warbrick, 2000; Yang et al., 2000; Dalrymple et al., 2001, 2003; López de Saro & 
O’Donnell, 2001; Ohmori et al., 2001; Lenne-Samuel et al., 2002; Noirot-Gros et al., 2002; 
Bunting et al., 2003; López de Saro et al., 2003a, 2003b; Sung et al., 2003; Burnouf et al., 
2004; Kurz et al., 2004; Sutton, 2004; Wijffels et al., 2004). According to the model, 
polymerase “switching” is facilitated by the action of processivity factors which function as 
molecular “tool-belts” to interchangeably attach replicative and TLS polymerases to the 
primer-template junction, perhaps without disruption of the Pol III core assembly (Pagès 
and Fuchs, 2002, 2003). Significantly, all five characterised E. coli DNA polymerases 
interact with the β clamp (Hughes et al., 1991; Naktinis et al., 1995; Kim & McHenry, 
1996; Wagner et al., 2000; López de Saro & O’Donnell, 2001; Sutton et al., 2001a, 2002; 
Lenne-Samuel et al., 2002), and β binding increases the processivity and efficiency of 
pols II, IV and V (Hughes et al., 1991; Bonner et al., 1992; Rangarajan et al., 1999; Sutton 
et al., 1999; Wagner et al., 1999; Tang et al., 2000). Furthermore, biochemical and 
structural suggest that the β clamp might fulfil the dual role of maintaining pol IV near the 
primer-template junction as well as ensuring that the polymerase remains bound to DNA 
sufficiently long to allow replication through intractable template sequences, but not long 
enough to generate a lethal mutational load (Bunting et al., 2003; Bertram et al., 2004). 
 
Homology to the b-binding consensus motif is the sole determinant of binding strength 
and defines permissable (and competitive) protein interactions. On this basis, DnaE1 – 
containing a sequence that closely matches the consensus (Dalrymple et al., 2001) – is 
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likely to  assume primary position among the polymerases in the mycobacterial β-binding 
hierarchy. A consensus β-binding sequence is absent from DnaE2, a feature which 
appears to be common in organisms possessing multiple dnaE copies (Boshoff et al., 
2003). Of the mycobacterial pol IV homologues, DinX is classified as a DinB1.4-type 
polymerase containing a carboxy-terminal β-binding motif, whereas DinP lacks the 
consensus (Dalrymple et al., 2003). M. smegmatis DinP3, on the other hand, is included 
in the DinB1.2 sub-family (Dalrymple et al., 2003), representatives of which have been 
shown to bind β (Tang et al., 2000; Wagner et al., 2000; Lenne-Samuel et al., 2002; 
Noirot-Gros et al., 2002). Although β-binding affinities of each of the mycobacterial pol IV 
homologues require biochemical confirmation, it is submitted that dnaE1 might prove 
difficult to displace under normal replicative conditions (discussed below), and that 
polymerase exchange might be restricted exclusively to replication stalling as a result of 
damage or other inhibitors (Wijffels et al., 2004). A mutation in E. coli dnaE, for example, 
results in higher-fidelity synthesis (Fijalkowska et al., 1993) and has been shown to 
reduce adaptive mutagenesis (Foster et al., 1995; Harris et al., 1997), perhaps by 
inhibiting access of pols IV and V to DNA termini (McKenzie et al., 2001; Foster, 2004). 
Similarly, evidence suggests that, in E. coli, pol II competes with pol IV to limit 
mutagenesis (Foster et al., 1995): rates of adaptive mutagenesis are elevated in E. coli 
polB mutants (Escarceller et al., 1994) - apparently as a result of increased pol IV 
expression (Foster, 2000; Layton & Foster, 2003) - and in mutants in which pol II 
proofreading but not polymerase ability has been eliminated (Foster et al., 1995; Foster, 
2000).  
 
Of course, a limitation inherent in the defined b-binding hierarchies is that the consensus 
motif is the sole determinant of binding strength and priority. Since a small percentage of 
all proteins in a eubacterial cell would inevitably contain pentapeptide sequences 
matching the observed or permissible variants of the consensus motif, it is likely that 
interactions in the replisome governing DNA access involve many other protein-protein 
and protein-DNA interactions intricately regulated by a series of switches. However, 
evidence that some b-binding partners interact with b2 outside the common peptide-
binding site (López de Saro et al., 2003a, 2003b) is consistent with the proposal that the 
cell effectively imposes a hierarchy of competitive interactions by forcing β-binding 
proteins (including replicative and TLS polymerases) to use a combination of unique and 
common contacts with the clamp, thereby ensuring that certain partners only are able to 
compete effectively with a particular β-partner-DNA complex for access to the restriction 
fork during various DNA transactions (Sutton, 2004). Finally, it has recently been 
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proposed that, in E. coli, the UmuD2C (pol V) complex might function as a prokaryotic 
DNA damage checkpoint control by binding and sequestering the β-clamp (Opperman et 
al., 1999; Murli et al., 2000; Sutton et al., 2001a; Sutton & Walker, 2001). Similarly, the B. 
subtilis pol IV homologue (YqjH), has tentatively been implicated in the transient growth 
inhibition of stationary-phase cells, possibly subject to stress (Duigou et al., 2004). It is 
conceivable that either of the M. tuberculosis pol IV homologues functions in an 
analogous manner; however, the absence of an identified β-binding motif in DinP seems 
to favour DinX as a potential checkpoint protein. Therefore, it would be interesting to 
compare the growth re-start kinetics of dinP and dinX null mutants with wild-type, either 
exiting from stationary-phase, or after treatment with a replication inhibitor such as NVB. 
 
Induced mutagenesis and gyrase inhibition 
The observation that M. tuberculosis dinP is upregulated, together with dnaE2, in 
response to NVB-mediated gyrase inhibition (Boshoff et al., 2004), was significant since it 
constituted the first reported evidence of induced dinP expression and, further, suggested 
that an alternative SOS- and damage-independent regulatory mechanism might operate 
to rescue stalled replication. In E. coli, pols II and V are proposed to act sequentially after 
DNA damage - pol II providing the initial catalyst for replication restart, to be followed later 
by pol V-mediated lesion bypass at persisting damage sites (Friedberg et al., 1995; 
Rangarajan et al., 1999; Goodman & Woodgate, 2000; Pham et al., 2001; Goodman, 
2002). The superficial (functional) similarities of M. tuberculosis DnaE2 to E. coli pol V 
were noted previously (Boshoff et al., 2003). Therefore, the co-induction of dinP and 
dnaE2 after NVB treatment hinted at a loosely analogous role for the mycobacterial 
polymerases in replication restart, with DinP and DnaE2 fulfilling the roles of pols II and V, 
respectively. Furthermore, the differential transcriptional responses to OFX- and NVB-
mediated stalling (Boshoff et al., 2004) - in particular, the induced polymerase 
complement - seemed to be indicative of tight regulation. That observation was confirmed, 
and extended, in this study with the demonstration that M. smegmatis dinP3 is included in 
the OFX-induced SOS response but is not induced by NVB. In addition, evidence was 
presented showing that NVB exposure is mutagenic (Table 3.10). Previous studies have 
established that, in other bacteria, treatment with OFX results in SOS induction and 
elevated mutation rates (Gudas & Pardee, 1976; Phillips et al., 1987; Piddock & Wise, 
1987; Walters et al., 1989; Piddock et al., 1990; Gmuender et al., 2001). While FQ-
induced SOS upregulation in M. tuberculosis (Boshoff et al., 2003) suggests a link 
between induced mutagenesis and the rapid emergence of FQ resistance (Perlman et al., 
1997; Ginsburg et al., 2003), the data presented here indicate that replication inhibition 
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might be mutagenic per se, though mediated by different mechanisms. Of course, the in 
vitro analysis of the mutagenicity of compounds with antibacterial activity raises several 
technical issues, in particular the fact that concentrations approaching the MIC eliminate 
the majority of the bacteria, including mutants. In addition, compounds mediating killing 
effects by targeting DNA might inevitably cause damage at lower concentrations that will 
elevate mutagenicity. However, the suggested link between prolonged, low-dose antibiotic 
exposure and mutations to resistance in M. tuberculosis demands investigation. 
Significantly, although NVB does not induce a classic SOS response (Boshoff et al., 
2003), gyrase inhibition-induced mutagenesis is consistent with evidence that disruptions 
in genes involved in DNA metabolism result in constitutive SOS upregulation (O’Reilly & 
Kreuzer, 2004). Furthermore, the relevance of SOS-independent pol IV induction in 
response to antibiotic treatment was recently given additional impetus by the 
demonstration that β-lactam-mediated inhibition of cell wall synthesis in E. coli results in 
LexA/RecA-independent dinB expression and elevated rates of frameshift mutagenesis 
(Pérez-Capilla et al., 2005). 
 
The indistinguishable frequencies of RifR mutations in NVB-treated mc2155 versus ΔY and 
ΔC strains appeared to indicate DnaE2- and pol IV-independent mutagenesis (Table 
3.10), and were consistent with the inability to detect altered NVB susceptibilities 
associated with loss of either TLS polymerase class. In contrast, NVB-induced rpoB 
mutational profiles (Table 3.11) implicated one or more pol IV homologue in error-free 
replication restart (explored below). Although still to be validated, the potential 
morphological differences between RifR isolates arising in wild-type and mutant strains 
suggest that the mechanism of resistance might differ in strains lacking the full pol IV 
complement, a possibility further strengthened by the high proportion of unmapped RifR 
mutations in ΔY and ΔC. While StrR frequencies failed to corroborate NVB-induced 
mutagenesis, it is possible that the assay does not tolerate the mutational events that 
result from NVB treatment. Whatever the source of the resistance, the distinct “genotypes” 
seem to implicate the mycobacterial pol IV homologues in differential NVB-induced 
mechanisms. It has recently been shown that certain E. coli umuC mutants are resistant 
to hydroxyurea (HU), a replication inhibitor which functions by limiting the supply of dNTPs 
(Godoy et al., 2004). Intriguingly, HU treatment in those strains results in pol IV-dependent 
induced mutagenesis, suggesting that the low Km of the TLS polymerase for dNTPs 
(Bertram et al., 2004) might enable pol IV-mediated EP synthesis in limiting dNTP levels. 
Whether elevated mutation rates are associated with HU treatment of M. tuberculosis is 
unknown; however, it would be interesting to investigate the capacity of HU-mediated 
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replication stalling to induce dinP expression (analogous to NVB induction) and elevate 
mutagenesis. 
 
The role of the Y-family homologues in the novel rpoB deletion  
Genotypic analyses of RifR isolates of wild-type mc2155 and the various pol IV deletion 
mutants arising under numerous applied stresses failed to assign a distinct mutagenic 
profile to any of the individual M. smegmatis pol IV homologues. However, novel 12 bp 
and 30 bp rpoB deletions were identified that were restricted to strains carrying deletions 
in one or more pol IV or EP polymerase homologues. Although the apparent absence of 
the deletion polymorphism from wild-type mc2155 might be reflective of selection bias, the 
prevalence of this genotype in low fequency mutant populations (such as ΔC post-UV), as 
well as the repeated identifiction of deletion polymorphisms under various imposed 
stresses, likely eliminate that possibility. The restriction of the deletion polymorphisms to 
strains lacking one or more pol IV homologues seemed to indicate the non-redundancy of 
the individual genes. However, the precise mechanism for the generation of the deletions 
in rpoB remains unclear. It is possible that, in the case of the 30 bp deletion, the codons 
for the flanking LeuSer motifs (CTG TCG) act as substrates for inappropriate 
recombination or slipped-strand mispairing events that result in the looping out of the 
intervening sequence (Figure 3.14). The direct homology between nine of the ten 
nucleotides extending from the 3’ base of Ser509 to the 3’ base of Ser513, and the 
corresponding sequence from the 3’ base of Asn519 to the 3’ base of Ser522, might be 
predicted to stabilise a recombination or hairpin-like intermediate. The flanking Gln513 
and Gln517 codons could function in an analogous manner in the smaller 12 bp deletion 
(Figure 3.14). M. smegmatis and M. tuberculosis share perfect amino acid sequence 
identity over the core 81 bp resistance determining region of rpoB (Hetherington et al., 
1995). However, codon usage differs between the two mycobacterial species (Figure 
3.14). It is possible that the non-homologous Ser512 codon in M. tuberculosis rpoB 
provides a natural block to any looping out that might occur in the corresponding M. 
smegmatis rpoB region. Consistent with this hypothesis, neither polymorphism – 12 bp 
deletion or 30 bp deletion - has been reported in M. tuberculosis clinical or laboratory 
isolates. Several smaller insertion and deletion events are, however, localised to the 
region between Gln513 and Asn519 (Telenti et al., 1993, 1997; Musser, 1995; 
Ramaswamy & Musser, 1998; Morlock et al., 2000) that, together with the observed 
deletions in M. smegmatis rpoB, are likely indicative of the relative mutational flexibility 
this region provides in mediating RifR while maintaining RNA polymerase function.
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It was recently shown that E. coli pols IV and V are able to replicate across foreign, non-
DNA segments lacking all fundamental features and inherent chemical properties of DNA, 
the profile of the bypass products depending on the nature of the insert and the 
polymerase involved (Maor-Shoshani et al., 2003b). Significantly, bypass of hydrocarbon 
chains of 12 methylene residues resulted in the elimination of the insert, and, in the case 
of pol IV, an adjacent nucleotide. The authors proposed that the deletions occured via a 
looping out mechanism that required TLS polymerases to “hop” across potentially 
replication-blocking adducts (Maor-Shoshani et al., 2003b), consistent with previous 
evidence of synthesis across DNA hairpins (Viswanathan et al., 1999) and template 
switching (Pääbo et al., 1990). Furthermore, it has been shown that RNA polymerases co-
operate during transcription elongation to read-through intrinsic and extrinsic obstacles in 
the DNA template (Ephstein et al., 2003; Ephstein & Nudler, 2003), and to extend across 
gaps (Liu & Doetsch, 1996). In effect, multiple RNA polymerases initiating from the same 
promoter reactivate and “push” backtracked elongation complexes at arrest sites, perhaps 
in combination with trailing ribosomes. Intriguingly, such co-operative behaviour has 
recently been implicated in transcriptional mutagenesis (Brooks & Marietta, 2004), 
including deletions of 5 to 22 nt downstream of a lesion. Furthermore, 12 nt deletions in 
this system are predominantly associated with synthetic thymine dimers characteristic of 
UV-induced damage. Although such a mechanism has not been demonstrated for any of 
the DNA polymerase families, it is tempting to speculate that, in the absence of the full 
cellular Y-polymerase complement, the replicative polymerase subunits might mediate 
similar lesion avoidance. Otherwise, alternative repair mechanisms might operate to 
overcome the stalling of the replication fork at sites of unrepaired DNA damage or as a 
result of NVB-mediated gyrase inactivation. The identification among RifR Y polymerase 
mutants of deletions in rpoB between loci of microhomology (Tables 3.7, 3.8, 3.9, 3.11; 
Figure 3.14), is suggestive of the activity of recombinational DNA repair (Lusetti & Cox, 
2002). Alternatively, the recently identified mycobacterial NHEJ system might mediate 
damage tolerance under certain circumstances (Weller et al., 2002; Della et al., 2004). 
NHEJ constitutes the major pathway for the repair of DSBs in mammalian cells (Krejci et 
al., 2003), and has been proposed to operate in tandem with nucleases and/or 
polymerases to anneal directly repeated sequences flanking DSBs with a resultant loss of 
intervening sequence (Rattray & Strathern, 2003). Of course, not all repair mechanisms 
require sequence homology and it is possible that the mutational events identified 
represent the only sizeable polymorphisms that retain essential RpoB activity. Smaller 
deletions that introduce frameshifts or nonsense mutations might also occur that are not 
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commensurate with cell viability. That is, the frequency of the 30 bp deletions might reflect 
a selection bias rather than a mechanistic preference. 
 
Why so many mycobacterial pol IV homologues? 
Fundamental questions pertain to the presence in mycobacteria of so many polymerase 
classes and sub-classes in addition to the replicative polymerase. It is possibe that each 
has evolved for the specialised bypass of a particular lesion(s), or for the rescue of 
replication forks at specific slipped-base mispairs (Goodman, 2002). The prevalence of 
RifR deletion polymorphisms in mc2155 mutants carrying single and multiple pol IV 
deletion alleles, in particular, suggests that the individual pol IV homologues are not 
redundant, and is supported by recent evidence indicating that loss of dinP3 in M. 
smegmatis mc2155 results in elevated rates of spontaneous -1 frameshift mutations (R. 
Brackin & E. Machowski, unpublished). The failure of this study to identify a definite 
phenotype associated with loss of a particular pol IV homologue might, therefore, reflect 
the inherent inability of artificial, exogenous damaging agents to mimic in vitro the lesions 
which constitute the cognate template of each polymerase in vivo. For example, although 
UV irradiation has been utilised profitably to demonstrate EP TLS by E. coli pol V (Reuven 
et al., 1999; Tang et al., 1999) the observation that pol V homologues are more often 
associated with enteric bacteria (Tegova et al., 2004) raises questions as to the dominant 
lesions in that environment. Similarly, the read-out – rpoB resistance or hisD frameshift 
mutations - limits the locus and mechanism of allowable mutagenic events and so 
underestimates both rates and functional requirements. In addition, the binary nature of in 
vitro assays (resistant versus susceptible; auxotroph versus prototroph) is likely to 
overlook subtleties in phenotype. The heterogeneity of environments colonised during an 
infection, for example, suggests that varying degrees of antibiotic resistance might 
emerge. The broad range of antibiotic susceptibility profiles in P. aeruginosa strains 
isolated from the sputa of cystic fibrosis patients (Mereghetti et al., 1998) provides some 
support for the notion that a wider variety of antibiotic resistant mutants are selected 
during infection than can be estimated from in vitro assays. However, the absence of any 
evidence implicating DinP or DinX in mutagenic TLS, coupled with the failure to associate 
any of the mycobacterial pol IV homologues with a competive survival advantage in vitro, 
suggests that a predicted role for these polymerases in adaptive mutagenesis is invalid. 
 
A model for polymerase activity 
The variation in strength, frequency and nature of inducible mutagenesis mechanisms is 
thought to be reflective of the dynamic response of different pathogens to specific local 
 127 
environments (Tenaillon et al., 2004). Stable, acquisitive evolution results from minimal 
disturbances to established bacterial pathways and host-pathogen interactions (Wright, 
2004) - a concept reinforced by recent evidence of the adaptation of separate M. 
tuberculosis lineages to particular host populations (Hirsh et al., 2004). These 
observations suggest that the long-term selection or counter-selection of small-effect 
mutators is likely to exert greater influence on bacterial evolution (Taddei et al., 1997). As 
stated earlier, two distinct but interrelated biological functions characterise the Y-family 
polymerases - damage tolerance and adaptive mutagenesis. Although the potential for 
mutagenesis classifies Y-family members as error-prone or “sloppy” (Goodman, 2002), it 
has been argued that the specialised TLS ability of these polymerases demands their re-
designation as “high-fidelity” on lesions or classes of lesions that constitute their preferred, 
or cognate, templates (Friedberg et al., 2002). Extending this argument - and without 
invalidating the contention that evolution has not tended to higher fidelity systems since 
the relative biological cost (mutation versus survival) is small (Tenaillon et al., 2004) - it is 
submitted that mechanisms might have evolved in mycobacteria to restrict the Y-family 
(pol IV) homologues to specialised high-fidelity polymerase function, thereby eliminating a 
role in mutagenesis.  
 
The model proposed (Figure 3.19) is based on the idea that the dual biological functions 
of Y-family polymerases (TLS and adaptive mutagenesis) might be thought of as being 
regulated on two distinct levels – gene expression, and access to the replicative complex. 
The second of these, access, is explored first. Recent evidence has emphasised the role 
of the β-clamp in mediating competitive polymerase switching (and other DNA interacting 
proteins) at the replication fork. As discussed above, a restricted number of mycobacterial 
polymerases contain consensus β-binding motifs. Based on homology to the consensus, it 
appears that high-affinity binding by the dnaE1-encoded, high-fidelity replicative 
polymerase might occlude access of the other polymerases to the replication complex 
under normal growth conditions. Furthermore, although expression analysis has failed to 
detect increased dnaE1 transcript levels following damage (Boshoff et al., 2003), the 
identification upstream of dnaE1 of a putative consensus motif (RecA-NDp; Gamulin et al., 
2004) regulating the mycobacterial LexA/RecA-independent damage response raises the 
possibility that the high-fidelity subunit might continue to modulate access of the 
alternative polymerase classes to the template after damage. A combination of increased 
(damage-induced) expression, and enhanced affinity for the holoenzyme complex 
(perhaps in the presence of additional damage-induced factors or subunits) would, 
therefore, be required for DnaE2 to access the replication fork at a replication-blocking 
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Figure 3.19 A model for polymerase dynamics in fast- versus slow-growing organisms. 
During normal replication in E. coli, pol II (polB) and pol IV (dinB) are constitutively expressed to 
ensure rapid replication restart following routine, spontaneous inactivation of the replication fork. If 
the replication fork is not immediately re-activated, or if stalled by a replication-blocking lesion (X), 
a RecA nucleoprotein filament can assemble on the unwound, single-stranded DNA, thereby 
inducing the SOS response. SOS upregulates expression of pol II (polB), pol IV (dinB), and pol V 
(umuDC) – all of which contain consensus β-clamp binding motifs (represented by p) and so are 
able to displace the replicative polymerase (pol III). Elevated expression of the three polymerases 
ensures greater damage tolerance but might also be subject to second-order selection as a result 
of the potential for mutagenesis. Pol V, in particular, is highly regulated both transcriptionally and 
post-translationally and is induced late in SOS. In M. tuberculosis, the high-affinity binding of the 
dnaE1-encoded high-fidelity replicative polymerase likely limits access of other polymerases to the 
replication complex under normal growth conditions. Furthermore, slow polymerisation by the 
replicative polymerase might reduce the need for rapid, pol IV-mediated replication restart. 
Significantly, in addition to DnaE1, only DinX and Rv3394c contain putative β-binding motifs. In 
response to damage, or as a result of replication fork collapse, expression of dnaE2 is highly 
elevated. Of the M. tuberculosis pol IV homologues, only Rv3394c is upregulated following 
damage, but its function is unknown. The faster growing M. smegmatis possesses an additional pol 
IV homologue (DinP3) which is SOS-inducible. Treatment of M. tuberculosis with NVB, a gyrase B 
inhibitor, causes replication arrest (X) and upregulates expression of dnaE2 and dinP, which might 
combine in error-free replication restart. The response of E. coli to NVB is unknown. 
 
 
lesion (Boshoff et al., 2003). The B. subtilis pol V homologue (YqjW), for example, despite 
containing a consensus β-binding motif, mediates UV-induced mutagenesis independently 
of the β-clamp, suggesting alternative protein interactions when replicating undamaged 
and UV-damaged templates (Duigou et al., 2004). Finally, it has been suggested that, in 
E. coli, mismatch repair proteins might be required to mediate access of Pol IV to the 3’ 
OH end of the DNA strand in the presence of a functional replicative polymerase (Strauss 
et al., 2000) – a mechanism the naturally MMR deficient mycobacteria have eliminated 
(Mizrahi et al., 2000). The second regulatory activity pertains to expression. A genetic 
characteristic of the Y-family polymerases relates to their induction in the canonical 
bacterial SOS response. However, as discussed above, the mycobacterial pol IV 
homologues are excluded from both SOS- and LexA/RecA-independent damage 
response regulons. In contrast, the importance of dnaE2 for TLS is suggested by its 
upregulation in at least two different damage responses – SOS (Davis et al., 2002a; 
Boshoff et al., 2003) and NVB-mediated replication stalling (Boshoff et al., 2004). 
 
During high speed replication in fast-growing organisms, extension by the replicative 
polymerase competes with exonucleolytic proofreading mechanisms as well as 
polymerase dissociation from the 3’ terminus (Fijalkowska & Schaaper, 1995). In 
particular, the efficiency of proofreading is thought to be limited by the decreased 
residence time of mismatched termini in the active site of the proofreading subunit. 
Therefore, multiple post-replicative repair pathways are required to maintain genomic 
 130 
integrity (Eisen & Hanawalt, 1999). During aerobic growth of E. coli, replication forks 
undergo routine, spontaneous inactivation as often as once per round of replication (Cox 
et al., 2000). If the replication fork is not immediately re-activated, or if stalled by a 
replication-blocking lesion, the continued unwinding of DNA ahead of the stalled 
replication complex creates a stretch of single-stranded DNA that can support assembly of 
a RecA nucleoprotein filament and results in SOS induction (Figure 3.19; Sassanfar & 
Roberts, 1990). Significantly, E. coli dinB (pol IV) is expressed at high constitutive levels – 
approximately 250 molecules of pol IV per cell (Kim et al., 1997), compared with about 50 
molecules of pol II, 30 molecules of pol III, and fewer of the pol III holoenzyme (McHenry 
& Kornberg, 1977; Bonner et al., 1988; Qiu & Goodman, 1997). The relatively high basal 
expression of E. coli pol IV, in particular, is thought to be required for rapid replication 
restart under normal replicative conditions (Goodman, 2002). The proposed housekeeping 
role is further supported by evidence of the wide distribution of pol IV homologues among 
most organisms (Ohmori et al., 2001; Goodman, 2002). In contrast, the other E. coli TLS 
polymerase, pol V, is limited to prokaryotic genomes (Ohmori et al., 2001; Goodman, 
2002). Furthermore, in E. coli, pol V is tightly controlled being essentially undetectable in 
uninduced cells, but increasing to ~ 200 copies per cell post-SOS induction (Woodgate & 
Ennis, 1991). Consistent with the inherent error-prone nature of the enzyme, pol V activity 
is highly regulated both transcriptionally - as part of the LexA/RecA regulon (Bagg et al., 
1981), and post-translationally - through Lon and ClpXP protease-mediated processing 
(Frank et al., 1996; Gonzalez et al., 1998; Goodman & Woodgate, 2000; Sutton et al., 
2001b; Neher et al., 2003), and access of pol V to DNA might further be limited by late 
SOS induction (Sommer et al., 1998; Tippin et al., 2004b). In addition, it has been 
proposed that subunit exchange between UmuD and UmuD’ in the UmuD’2C complex 
inactivates pol V following TLS, reducing the potential for mutations on undamaged DNA 
during SOS (Shen et al., 2003). Both pols II and IV are also induced in response to 
damage – pol II about seven-fold (Bonner et al., 1988; Qiu & Goodman, 1997) and pol IV 
about ten-fold (Kim et al., 2001). Interestingly, despite SOS induction, no obvious repair 
defects have been associated with loss of pol IV in E. coli (Rattray & Strathern, 2003); 
however, E. coli dinB mutants are defective in untargeted mutagenesis (Brotcorne-
Lannoye et al., 1986). Therefore, beyond the repair requirement, the mechanism of pol IV 
induction (as part of the SOS response) has likely also been subject to second-order 
selection since it is intricately linked to genetic adaptation and diversification. 
 
In contrast, it has been proposed (Mizrahi et al., 2000) that the decreased extension rate 
of M. tuberculosis pol III might improve proofreading efficiency by increasing access of 3’-
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exonucleases to mismatched primer termini, thereby ensuring fidelity in the absence of 
several post-replicative DNA repair pathways (Mizrahi & Andersen, 1998). In addition, 
slower replication will inevitably limit the need for rapid, pol IV-mediated replication fork 
rescue (Figure 3.19). Although one or more pol IV homologues could be constitutively 
expressed under normal growth conditions (a possibility requiring further investigation), 
access to the replication complex might be restricted by apparently non-existent (dinP) or 
limited (dinX or Rv3394c) β-clamp binding affinity. Instead, it is proposed that the damage 
lesion itself might select for, and enable access of, the specialised polymerase(s) to the 
template. That is, the preference for damaged DNA templates or stalled replication 
complexes, together with the relative processivity of the main mycobacterial replicative 
polymerase, will inevitably limit the opportunities for the pol IV homologues to access the 
replisome. Following damage, expression is not upregulated because the pol IV 
homologues have been selectively eliminated from the mycobacterial SOS (Davis et al., 
2002a; Boshoff et al., 2003) or alternative (Rand et al., 2003; Gamulin et al., 2004) 
damage response regulons. M. smegmatis, on the other hand, which has a faster growth 
rate, possesses a damage-inducible pol IV homologue (dinP3) with a β-binding motif 
(Dalrymple et al., 2003). Although difficult to reconcile with the presence of a dinP3 
homologue in M. avium subsp. paratuberculosis, it is tempting to speculate that SOS-
inducibility of pol IV homologues might be linked to growth rate.  
 
Of course, the proposed evolutionary balance between mutagenesis and replication rate 
will also dictate the damage-inducible polymerase complement in an organism. As stated 
above, B. subtilis - like mycobacteria - encodes an SOS-inducible EP DnaE (Table 3.12; 
Le Chatelier et al., 2004); however, unlike the mycobacterial DnaE2, B. subtilis DnaE is 
essential - catalysing lagging strand synthesis during normal replication (Dervyn et al., 
2001) – and, moreover, contains a consensus β-binding motif (Dalrymple et al., 2001). In 
a further departure from the mycobacteria, genetic analyses have shown that B. subtilis 
possesses a damage-inducible Y-polymerase complement that is loosely analogous to the 
SOS polymerases in E. coli (Table 3.12). Specifically, B. subtilis contains yqjH- and yqjW-
encoded pol IV and pol V homologues, respectively (Duigou et al., 2004), both of which 
contain consensus β-binding motifs (Dalrymple et al., 2001). During normal growth, YqjH 
(pol IV) is constituvely expressed, whereas YqjW (pol V) is almost undetectable, 
increasing significantly in response to UV damage (Duigou et al., 2004). In contrast to E. 
coli, however, loss of YqjW (pol V) function in B. subtilis does not confer damage 
hypersensitivity (Duigou et al., 2004). Together with evidence that decreasing dnaE 
transcript levels similarly does not increase damage susceptibility in B. subtilis (Table 
 132 
3.12; Le Chatelier et al., 2004), the apparent dispensability of YqjW (pol V) for damage 
tolerance seems to indicate the potential for DnaE and pol V to provide complementing 
post-UV TLS activity. Furthermore, expression of YqjH (pol IV) is not damage inducible 
(Duigou et al., 2004), suggesting that increased access of DnaE and pol V to the 
damaged template might negate the role of pol IV-mediated mutagenesis in that 
organism. Significantly, the failure to detect upregated pol IV expression in both M. 
tuberculosis and B. subtilis in response to damage implies the dispensability of inducible 
pol IV function in organisms possessing EP C-family polymerase subunits. 
 
The evolution of drug resistance in M. tuberculosis 
The exclusion of the mycobacterial pol IV homologues from induced mutagenesis appears 
to nominate the dnaE2-encoded pol III subunit as the sole player in the evolution of drug 
resistance in M. tuberculosis, as suggested (Boshoff et al., 2003). However, given the 
stated disparity between in vitro mutation rates and the rapid emergence of drug-resistant 
clinical isolates, a fundamental question remains unanswered: is EP replication the only 
mechansism by which chromosomally-encoded drug resistance mutations arise? Recent 
evidence suggests that the evolution of metabolic pathways (Wright, 2000, 2003, 2004), 
as well as somatic hypermutation (Wright et al., 2004), might be driven by the 
transcriptional response of an organism to an applied stress. Stress-directed mutagenesis 
- as the process is termed (Wright, 2004) - is distinct from adaptive or inducible mutation 
mechanisms in its strict insistence that the stress causing the mutation also constitutes 
the selective pressure. Essentially, transcription of genes derepressed in response to 
starvation or other stresses is thought to create localised supercoiling and DNA secondary 
structures, such as stem loops, that can stabilise conformations containing an unpaired 
base in a loop or at the base of the stem (Wright, 2003, 2004; Wright et al., 2004). 
Inherent thermodynamic instability as well as an increased likelihood of being modified by 
other intracellular enzymes renders unpaired bases vulnerable to mutation (Lindahl, 
1993). Subsequent replication, especially in (mismatch) repair-deficient organisms, can fix 
chromosomal mutations, and therefore targets mutations to the very genes required to 
mutate to alleviate the stress (Wright, 2000, 2003, 2004). 
 
It is tempting, therefore, to speculate that two alternative (but overlapping) mutagenic 
mechanisms might operate in combination in M. tuberculosis depending on the stimulus 
(Figure 3.20). The first of these is the classic, damage-induced or SOS-type which, in M. 
tuberculosis, is mediated by DnaE2 and is, perhaps, amplified by stationary-phase 
physiology. A range of host immune effectors and other environmental damaging agents, 
  
Figure 3.20 The in vivo evolution of drug resistance in M. tuberculosis. Two mechanisms are proposed to mediate inducible mutagenesis in M. 
tuberculosis during host infection. A. A damage lesion (X) might be caused by a range of host immune effectors and other environmental damaging 
agents, as well as endogenous oxidative and nitrosative metabolic stresses, or antibiotics. Stalled replication at the lesion induces dnaE2 expression. In 
some cases, EP repair synthesis by DnaE2 fixes a mutation at the site of the damage. Where the mutation confers antibiotic resistance (R), it is selected. 
B. Alternatively, antibiotic concentration gradients in vivo might expose bacilli to non-lethal antibiotic selection, and so result in upregulated transcription of 
the target gene(s). Localised supercoiling and DNA secondary structures in the wake of the RNA polymerase (RNAP) stabilise conformations with an 
unpaired base (N) in a loop or at the base of a stem (Wright, 2004). Unpaired bases are thermodynamically unstable and vulnerable to enzymatic 
modification (Lindahl, 1993). Mutated bases are fixed during DNA replication, especially in (mismatch) repair-deficient organisms, and those conferring 
antibiotic resistance are selected. Stress-directed mutagenesis (Wright, 2004) therefore targets mutations to the gene(s) required to mutate to alleviate the 
stress (Wright, 2000, 2004). 
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as well as endogenous oxidative and nitrosative metabolic stresses, or antibiotics, might 
induce damage lesions. Stalled replication at a lesion induces dnaE2 expression either as 
part of the mycobacterial SOS response, or by unknown regulatory mechanisms 
analogous to NVB-mediated dnaE2 induction. EP repair synthesis by DnaE2 might fix 
mutations in chromosomal DNA at the site of the damage, in some cases conferring 
antibiotic resistance which is then selected. Secondly, it is proposed that stress-directed 
mutagenesis might operate in sequestered environments in vivo (Mitchison, 1985).  
Specifically, the effective antibiotic concentration (subject to a chemical gradient) is 
thought likely to expose bacilli to non-lethal antibiotic selection (Baquero & Negri, 1997; 
Baquero et al., 1998) which might result in upregulated transcription of the particular 
antibiotic target or compensatory pathway gene(s), increasing the possibility of mutations 
– and, therefore, resistance mutations. Significantly, the mutation rate for a given antibiotic 
has been shown to change depending on the effective concentration during selection and, 
further, that different mutation rates and resistant mutants might be obtained at 
discontinuous intervals along the spectrum of applied concentrations (Kohler et al., 1997). 
An obvious flaw in this proposal is that, apart from translational inhibitors, exposure of M. 
tuberculosis to most classes of antibiotic does not necessarily induce expression of 
specific target or drug-resistance genes (Boshoff et al., 2004). However, most studies are 
conducted using antibiotic concentrations that – even if not at the specific MIC – are likely 
at levels far in excess of those that might impose non-lethal selective pressure in vivo. 
Furthermore, evidence of cross-induction – that is, treatment with one antibiotic 
upregulates expression of genes implicated in resistance to another, unrelated antibiotic 
(Boshoff et al., 2004) – is consistent with the recent demonstration that well-implemented 
TB control programmes may actually exacerbate the emergence of MDR-TB isolates 
(Blower & Chou, 2004; Cohen & Murray, 2004).  
 
Finally, the evolution of low-level drug resistant variants in other infecting bacterial 
populations (such as the extended-spectrum TEM β-lactamases) implies that the locally 
available concentration of an antibiotic within particular host environments selects for the 
different variants (Baquero et al., 1998). In addition, the specific antibiotic concentrations 
inhibiting the variant and wild type strains have been shown to be extremely close in many 
cases, resulting in a narrow selective concentration range (Baquero et al., 1998). The 
narrowness of the selective range often results in some low-level resistant mutants being 
considered clinically irrelevant. However, the ability of a given antibiotic concentration 
(even if very low) to select for a particular resistance mutation (even if almost neutral) has 
profound implications for the generation of diverse microbial populations (Baquero & 
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Negri, 1997). The evolution of high-level resistant mutants may be enhanced in vivo in 
populations in which low-level resistant mutants have been selected and maintained in 
various compartments; in fact, the role of low-level resistant variants may be analogous to 
that of multidrug efflux pump systems in the emergence of antibiotic resistant mutants. 
Expression of the efflux system genes is usually down-regulated, and even when 
constitutively expressed produces only minor variations in the MIC values of antibiotics. 
However, the idea that mutations in efflux pump systems, in combination with mutations in 
other antibiotic targets, are the basis of clinically relevant antibiotic resistant phenotypes 
has recently gained credence, as demonstrated in the acquisition of quinolone resistance 
(Martinez et al., 1998). 
 
Future studies 
In order to validate many of the claims of the polymerase model proposed, it is critical that 
the relative and absolute expression levels of all mycobacterial polymerases be 
determined during log- and stationary-phase growth. Furthermore, biochemical analyses 
of the catalytic activity of the individual polymerases are required to elucidate possible 
redundant (or non-redundant) function with particular emphasis on the lesions bypassed 
and relative polymerase processivities. Studies are already underway to measure 
indirectly the possible competition between pol IV and EP polymerases for the replication 
fork by overexpressing the M. tuberculosis pol IV homologues in the M. smegmatis ΔC 
mutant. However, as suggested, a parallel investigation into potential mycobacterial pol IV 
interactions to elucidate auto- or cross-modulatory binding - using a yeast two-hybrid 
system, for example – is required. Furthermore, the potential interaction(s) of the various 
polymerases with regulatory factors such as the mycobacterial β-clamp also demand 
investigation. Heterologous promoter assays hinted at the operonic expression (and 
induction) of Rv3055 and dinP during stationary phase; therefore, the potential regulatory 
role of Rv3055 in modulating dinP activity is considered worth pursuing. Finally, the 
contribution of additional putative polymerases and polymerase classes to damage 
tolerance needs to be examined, particularly the roles of the SOS-inducible mycobacterial 
Rv3394c and dinP3 gene products. 
 
Chapter 4 
 
Ribonucleotide reduction in Mycobacterium tuberculosis 
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4.1 ABSTRACT 
M. tuberculosis encodes both oxygen-dependent (class I) and –independent (class II) 
ribonucleotide reductase (RNR) subunits, suggesting that the organism might modulate 
deoxyribonucleotide triphosphate (dNTP) biosynthesis in response to oxygen availability. 
In particular, evidence of the induction of the nrdZ-encoded class II RNR under 
microaerophilic conditions potentially implicated NrdZ in the survival of M. tuberculosis in 
the hypoxic environment thought to prevail in vivo. To investigate the contribution of NrdZ 
to the growth and persistence of M. tuberculosis, a ΔnrdZ null mutant was constructed by 
allelic exchange mutagenesis. Treatment of the ΔnrdZ mutant with hydroxyurea, a class I-
specific inhibitor, confirmed the inability of NrdZ to substitute for the nrdEF2-encoded 
class I RNR under aerobic conditions. In addition, survival of the ΔnrdZ mutant strain was 
not impaired under hypoxic conditions in vitro. Moreover, bacterial loads in the lungs of 
B6D2/F1 mice infected with the ΔnrdZ mutant were comparable to those of lungs infected 
with the parental wild-type strain, suggesting that nrdZ might not be required for the 
virulence of M. tuberculosis in the mouse model. 
 
4.2  INTRODUCTION 
4.2.1 Ribonucleotide reductases (RNRs) 
DNA synthesis and repair are dependent on the adequate supply of deoxyribonucleotides 
(dNTPs) to replicative and repair DNA polymerases. Ribonucleotide reductases (RNRs) 
catalyse the de novo synthesis of all four dNTPs from their ribonucleotide precursors, 
thereby performing an essential  role in nucleotide cycling and dNTP pool modulation 
(Reichard, 1993, 1997; Chimploy et al., 2000). Significantly, RNR expression and activity 
are induced following DNA damage in both eukaryotes and prokaryotes (Gaudet & Tsang, 
1999; Courcelle et al., 2001; Chabes et al., 2003), and disruptions in several genes 
involved in nucleotide pool maintenance are associated with constitutive SOS gene 
upregulation (O’Reilly & Kreuzer, 2004). Since the activity of RNRs constitutes the first 
committed step in DNA synthesis, these enzymes are potentially rate-limiting and so have 
been recognised as attractive targets for novel antiviral, antiparasitic and antiproliferative 
chemotherapeutics (Moss et al., 1993; Rubin et al., 1993; Nocentini, 1996; Szekeres et 
al., 1997; Ingram et al., 1999) as well as potential subunit vaccines (Fagan et al., 2001). 
 
RNRs are classified into three major classes according to both sequence homology and 
mechanisms for free radical generation (Reichard, 1993, 1997). Although the members of 
each class appear unrelated - their amino acid sequences differ, they utilise different 
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means to generate the protein radicals required for substrate activation, and usage of the 
essential metal co-factors has not been evolutionarily conserved - all RNRs employ a 
cysteine thiyl free-radical mechanism to catalyse essentially the same chemistry at the 
ribonucleotide level (Stubbe & van der Donk, 1995; Reichard, 1997; Sjöberg, 1997; 
Eklund et al., 2001; Stubbe et al., 2003). In addition, RNRs of all classes regulate their 
substrate specificity by allosteric mechanisms to ensure balanced production of each of 
the four dNTPs, and have retained critical residues in their protein sequences, an 
indication that despite large differences in primary structure, some similarity in tertiary 
structure has been preserved which is suggestive of divergent RNR evolution (Jordan & 
Reichard, 1998; Eklund et al., 2001; Reichard, 2002). For this reason, it has been 
proposed that ribonucleotide reduction constituted a crucial step in the ancient transition 
from RNA to DNA genomes (Reichard, 1993, 2002; Riera et al., 1997). 
 
4.2.2 RNRs and adaptation to oxygen availability 
An essential difference between the classes of RNR is the relation of the free radical to 
dioxygen. Whereas class I enzymes are limited to aerobic conditions (oxygen forms part 
of the system that generates the tyrosyl radical; Fontecave et al., 1992), class III RNRs 
are strictly anaerobic and undergo rapid destruction of the glycyl radical in the presence of 
oxygen (Gedde-Dahl, 1952); the process of radical formation by class II enzymes, 
however, is neither oxygen dependent nor oxygen sensitive, affording enzymes in this 
class the flexibility to operate in both aerobic and anaerobic organisms (Jordan & 
Reichard, 1998). The presence of more than one class of RNR in many organisms 
(Jordan et al., 1994, 1996, 1999), coupled with evidence of the altered expression of RNR 
genes in response to changes in oxygen tension (Garriga et al., 1996; Vollack et al., 1999; 
Masalha et al., 2001), suggests that RNRs function principally to allow adaptation to 
varying oxygen levels in the environment (Poole et al., 2002; Reichard, 2002) and 
probably evolved to facilitate survival during different stages of the life cycle (Jordan & 
Reichard, 1998; Jordan et al., 1999; Torrents et al., 2000, 2002). However, different RNR 
classes have been shown to be simultaneously active in some organisms during aerobic 
growth (Jordan et al., 1999; Borovok et al., 2002, 2004), and a number of bacterial 
genomes contain more than one enzyme of the same class or subclass (Jordan et al., 
1994; Kunst et al., 1997; Monje-Casas et al., 2001). In addition, there is increasing 
evidence that functional redundancy should not be inferred from the presence of multiple 
alternative RNR subunits (Huang & Elledge, 1997; Dawes et al., 2003). 
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4.2.3 The mycobacterial RNR complement 
A loose correlation has been observed between growth rate and pathogenicity in 
mycobacteria (Young, 1990). Coupled with the demonstration that chromosomal 
replication is the primary determinant of the mycobacterial growth rate (Jacobs et al., 
1993; Wheeler & Ratledge, 1994; Hiriyanna et al., 1996), the position of RNRs at the 
potentially rate-limiting step of DNA synthesis has prompted several investigations into the 
activity of the M. tuberculosis RNR homologues (Yang et al., 1994, 1997; Dawes et al., 
2003). M. tuberculosis contains genes for subunits of both class I (nrdE/F1/F2) and class 
II (nrdZ) RNRs (Yang et al., 1994, 1997; Cole et al., 1998), but does not possess a strictly 
anaerobic class III RNR. Class I RNRs are cell cycle-regulated, tetrameric enzymes, 
comprising homodimers of two large subunits containing substrate and allosteric 
regulatory sites, and two small subunits which enclose an iron(III)/tyrosyl radical redox 
centre (Reichard, 1997; Jordan & Reichard, 1998).  Enzymes of the class I form have 
traditionally been divided into two subclasses, Ia and Ib, based on allosteric regulation and 
utilisation of different electron donors (Jordan et al., 1996), the active enzyme in M. 
tuberculosis falling into class Ib (Yang et al., 1997). In most organisms, the large and 
small subunits of enzymes in this class are encoded by the well-characterised nrdEF 
system. However, in M. tuberculosis, nrdF2 encodes the active small subunit (Yang et al., 
1994, 1997) and, despite containing key catalytic residues, NrdF1 is unable to associate 
with NrdE to form a functional RNR (Yang et al., 1997), as confirmed by the 
demonstration that nrdF2 is essential for growth in vitro (Dawes et al., 2003; Sassetti et 
al., 2003). The M. tuberculosis class I RNR complement was recently expanded with the 
identification of an alternative class Ic subfamily in which the tyrosyl radical site is absent 
and replaced by an iron-coupled radical (Högbom et al., 2004). Significantly, comparative 
genomics suggests that class Ic enzymes are restricted to intracellular pathogens, 
including M. tuberculosis and M. bovis, and archaeons and/or thermophiles, prompting 
speculation that the independence of the stable tyrosyl radical in the class Ic subunit 
confers increased resistance to the antimicrobial effects of iNOS-generated NO (Högbom 
et al., 2004). 
 
 
4.2.4 The nrdZ-encoded class II RNR 
The oxygen-independent class II RNRs require 5’-deoxyadenosylcobalamin (coenzyme 
B12) for radical generation, and are composed of a single subunit homologous to the large 
subunit of the class I enzymes (Reichard, 1993, 1997; Jordan & Reichard, 1998). The 
inclusion of nrdZ and a putative transcriptional regulator (Rv0569 - located 29 bp 
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upstream of nrdZ) in the DosR dormancy regulon that is highly induced in response to NO 
and hypoxia (Sherman et al., 2001; Park et al., 2003; Voskuil et al., 2003; Muttucumaru et 
al., 2004) prompted speculation that the M. tuberculosis class II RNR might enable dNTP 
biosynthesis under conditions of low oxygen availability (Voskuil et al., 2003). In particular, 
the presence in the M. tuberculosis genome of a putative nrdZ-encoded class II RNR in 
addition to the oxygen-dependent class Ib RNR fuelled speculation that NrdZ might 
function in the supply of dNTPs for replication or repair during long-term persistence in 
vivo, and so might be implicated in the growth or survival of the bacillus in the 
microaerophilic environment thought to prevail in a clinically dormant lesion (Mizrahi et al., 
2000; Voskuil et al., 2003). 
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4.2.5 Aims and objectives of this study 
When this study was initiated, the potential contibution of the nrdZ-encoded class II RNR to 
mycobacterial pathogenesis and hypoxic persistence was unknown. A parallel study 
established the essentiality of NrdF2 (Dawes et al., 2003), implying the essentiality of the 
oxygen-dependent class Ib RNR for normal aerobic growth. However, the contribution, if any, 
of NrdZ to normal aerobic growth and under conditions of limitiing oxygen availability 
remained to be determined. Therefore, the specific objectives extended to the phenotypic 
characterisation of an nrdZ deletion mutant, and were: 
 1. To create a null mutant of nrdZ in M. tuberculosis H37Rv. 
2.  To determine whether NrdZ contributed to RNR activity under aerobic 
conditions. 
3. To investigate the role of NrdZ during hypoxic adaptation and persistence in 
vitro. 
4.  To determine whether nrdZ was required for virulence of M. tuberculosis in 
vivo
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4.3 MATERIALS AND METHODS 
4.3.1 Bacterial strains and plasmids 
The strains, plasmids, primers and probes used in this study are detailed in Table 4.1.  
 
 
4.3.2 Site-specific knockout of M. tuberculosis nrdZ 
Construction of the ΔnrdZ deletion allele 
A PCR-generated nrdZ amplicon was used to probe a gridded plasmid library of the M. 
tuberculosis genome (kindly provided by M. Everett, GlaxoSmithKline, Stevenage, United 
Kingdom). The pDWZ04 clone was found to contain the entire 2076-bp nrdZ gene plus 3286-
bp sequence downstream of the stop codon and 1260 bp upstream of the start codon. A 
1568-bp PstI-SalI fragment and a 2205-bp SalI-KpnI fragment were excised from pDWZ04 
and cloned into the corresponding sites of p2NIL to obtain a vector (p2ΔnrdZ; S. Andersen) 
containing a ΔnrdZ allele lacking the internal 814-bp SalI fragment that encodes three of the 
five cysteine residues shown to be essential for RNR activity in Lactobacillus leichmannii 
Table 4.1 List of strains, plasmids, primers and probes 
Strain Description Reference/source 
ΔnrdZ nrdZ knockout mutant of H37Rv This study 
Plasmid 
pDWZ04 
Subclone from gridded library of M. tuberculosis cloned in 
pBluescript carrying M. tuberculosis nrdZ gene and 
flanking sequences; AmpR 
S. Andersen 
p2ΔnrdZ p2NIL carrying  ΔnrdZ allele; KmR S. Andersen 
p2ΔnrdZ19 Unmarked nrdZ knockout vector - p2ΔnrdZ containing PacI cassette from pGOAL19; KmR HygR SucS This study 
pMV306K E. coli-Mycobacterium integrating shuttle vector, KmR H. Boshoff 
pMVnrdZ pMV306K containing M. tuberculosis nrdZ plus 800 bp upstream sequence This study 
Primers   
attBS1 ACGTGGCGGTCCCTACCG S. Barichievy 
attBS2 ACAGGATTTGAACCTGCGGC S. Barichievy 
attL2 CTTGGATCCTCCCGCTGCGC  S. Barichievy 
attL4 AATTCTTGCAGACCCCTGGA S. Barichievy 
Probe 
nrdZp 2011 bp SalI-PvuII fragment from pDWZ04 containing 865 bp 3’ nrdZ sequence This study 
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(Booker et al., 1994). The hyg-lacZ-sacB cassette from pGOAL19 (Parish & Stoker, 2000) 
was cloned into the PacI site to generate p2ΔnrdZ19. 
Genotypic characterisation of ΔnrdZ deletion mutants 
The p2ΔnrdZ19 knockout construct was electroporated into M. tuberculosis H37Rv and 
deletion mutants isolated as described (2.2.3). Both SCO and DCO recombinants were 
confimed genotypically by Southern blot (2.4.4). Briefly, chromosomal DNA digested with MluI 
was probed with the 2011 bp SalI-PvuII fragment from pDWZ04 (nrdZp; Table 4.1). 
Integration of pMVnrdZ into M. smegmatis mc2155  
pMVnrdZ was delivered into wild-type M. smegmatis mc2155 by electroporation as described 
(2.2.3). To ensure correct integration of pMVnrdZ into M. smegmatis mc2155 host strains, 
PCR primers were designed to flank the attL and attR sites. A forward (attBS2) and reverse 
(attL4) PCR primer set was used to amplify a 320 bp sized fragment spanning the attL region 
while a forward (attL2) and reverse (attBS1) PCR primer set was used to amplify a 282 bp 
sized fragment spanning the attR region. PCR products were analysed by agarose gel 
electrophoresis. 
 
4.3.3 Hydroxyurea assay 
MICs of hydroxyurea (HU) for parental and ΔnrdZ strains were determined by using BACTEC 
460-TB methodology (Rastogi et al., 1995) and BACTEC 12B vials (Becton-Dickinson, 
Towson, Md.) containing cyanocobalamin (CNCbl; Sigma-Aldrich, St. Louis, Mo.) at a 
concentration of 1 μg/ml and concentrations of HU (Sigma-Aldrich) ranging from 1 to 50 mM. 
 
4.3.4 Wayne model conditions 
Stirred Wayne model conditions were reproduced in round-bottom Pyrex tubes (capacity 15 
ml) filled with 10 ml Dubos albumin broth (Difco) containing 0.05% Tween 80, as described 
(Wayne & Sohaskey, 2001), generating a headspace-to-volume ratio of 0.5. The Wayne 
model for adaptation of M. tuberculosis to hypoxia induces a sequential shiftdown of the 
organism through two stages of nonreplicating persistence (NRPI and NRPII) in response to 
a self-generated, temporal O2 gradient (Wayne & Hayes, 1996). In this model, the sealed 
culture replicates in a logarithmic fashion, but as O2 becomes limiting (concentration, <1%), 
replication ceases and, although the optical density continues to increase, the CFU counts do 
not (NRPI). The culture enters NRPII at O2 concentrations less than 0.06%, when no further 
increase in optical density is observed. All tubes used were inoculated with a 1/100 dilution of 
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a log-phase culture in fresh Dubos medium and sealed with Parafilm internally and externally. 
Duplicate indicator tubes containing 0.5 μg of methylene blue per ml were established for 
each experiment, as described (Wayne & Lin, 1982; Wayne & Hayes, 1996). All cultures were 
stirred slowly with 5 mm magnetic stir bars (Fisher Scientific, Pittsburgh, Pa.). For the settled 
Wayne model, parallel cultures were established as above but without agitation (Wayne & 
Lin, 1982). Individual cultures were removed at various timepoints for CFU assessments and 
discarded. Where appropriate, metronidazole (MTZ; Sigma) was added to cultures prior to 
sealing with Parafilm. 
 
4.3.5 Infection of mice, determination of bacterial load, and survival 
Ten-week-old female B6D2/F1 mice (Charles River Laboratories, Wilmington, Mass.) were 
infected via the respiratory route, as previously described (Moreira et al., 1997). Mice were 
inoculated by exposure to an aerosolized suspension of the parental or ΔnrdZ strains of M. 
tuberculosis using a nose-only exposure system (In-Tox Products, Albuquerque, N.M.) 
(Tsenova et al., 1997). This procedure resulted in implantation of approximately 100 
organisms into the lungs of each mouse, which was confirmed by plating lung homogenates 
on Middlebrook 7H11 plates 3 h post infection. At specific timepoints four mice from each 
group were sacrificed, and organs harvested. Lungs, livers, and spleens were homogenized 
and plated to determine bacterial loads. A portion of the upper right lung was used for 
histological analysis. Five mice from each group were monitored for survival 
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4.4 RESULTS 
4.4.1 The contribution of NrdZ to aerobic RNR activity 
The nrdZ-encoded class II RNR is dispensable for growth in vitro  
The demonstration that the nrdF2-encoded alternative small subunit is essential for M. 
tuberculosis viability in vitro (Dawes et al., 2003; Sassetti et al., 2003) implied that the class II 
RNR, NrdZ, does not provide sufficient RNR activity during normal aerobic growth to 
complement even partially the loss of the functional class I enzyme. However, the possible 
function of NrdZ under aerobic growth conditions, as well as the predicted requirement for 
nrdZ in microaerophilic growth or adaptation to anoxia (Mizrahi et al., 2000), remained 
unexplored. To this end, a ΔnrdZ allele was constructed in which the 814 bp internal SalI 
fragment containing three of the five highly-conserved cysteine residues (Figure 4.1) shown 
to be essential for coenzyme B12-dependent class II RNR activity in other organisms (Booker 
et al., 1994; Tauer & Benner, 1997) was eliminated. The unmarked deletion allele 
(p2ΔnrdZ19) was delivered into wild-type H37Rv by electroporation. Using two-step selection 
(Parish & Stoker, 2000), marked and unmarked ΔnrdZ DCO mutants were obtained, and the 
unmarked deletion mutant selected for further manipulation. The genotypic confirmation by 
Southern blot of the unmarked deletion is shown in Figure 4.2. The successful generation of 
allelic exchange mutants indicated that nrdZ is dispensable for viability of M. tuberculosis in 
vitro. In addition, the nrdZ deletion mutant was indistinguishable from wild-type H37Rv under 
normal in vitro growth conditions (data not shown). 
 
NrdZ does not contribute to tolerance of hydroxyurea in M. tuberculosis  
The potent class I RNR inhibitor, hydroxyurea (HU), inhibits DNA synthesis by specifically 
destroying the essential class I RNR free radical (Sinha & Snustad, 1972; Jordan et al., 
1994). HU was previously shown to abrogate M. tuberculosis NrdEF2 function in vitro (Yang 
et al., 1997), although the seclusion of the tyrosyl free radical in the interior of the protein (Liu 
et al., 1998) ensures the relative resistance of M. tuberculosis to radical scavengers 
(Elleingand et al., 1998). To ascertain the potential for NrdZ to catalyse RNR activity under 
aerobic conditions, as well as detect any possible contribution of the class II RNR to aerobic 
growth, class I RNR activity was inhibited by treating the ΔnrdZ mutant and the isogenic 
parental strain with HU, and radiometrically determining comparitive growth kinetics using the 
BACTEC method. The results reported represent data from this study and a collaboration 
with Dr. S. Dawes. HU inhibited the growth of M. tuberculosis at an MIC of 5 mM which was 
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Figure 4.1 Alignment of M. tuberculosis NrdZ with other class II RNRs. The nrdZ-encoded class II RNR from M. tuberculosis H37Rv 
(RNR_Mtb nrdZ.pro) aligned with class II RNRs from selected actinomycetes, including Symbiobacterium thermophilum (RNR_SymbTherm.pro; 
YP076589.1), Propionibacterium acnes (RNR_Propionibact.pro; YP055736), and Streptomyces coelicolor A3(2) (RNR_Streptomyces.pro; NP629929). 
Accession numbers are included in brackets. Amino acid identity is highlighted in yellow. The five conserved cysteine residues are boxed in red and 
marked with an asterisk (Þ). Arrows () mark the position of the 814-bp deletion in nrdZ which eliminated three of the active cysteine residues. 
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Figure 4.2 Construction of an nrdZ deletion mutant of M. tuberculosis H37Rv. MluI-digested DNA 
from H37Rv and the DnrdZ mutants probed with nrdZp. Restriction maps of the various clones are 
schematically illustrated in the line drawings adjacent to the Southern blot (not drawn to scale). 
Construction of the ΔnrdZ allele by elimination of 814 bp of nrdZ coding sequence results in the loss of 
the internal MluI site (M, MluI; WT, wild-type; probe is represented by a hatched box). 
 
 
consistent with the previously reported susceptibility of recombinant NrdEF2 to HU inhibition 
(Yang et al., 1997). However, no increased susceptibility in the ΔnrdZ strain to HU was 
observed over the range tested (data not shown). Class II RNRs require coenzyme B12 
(adenosylcobalamin; AdoCbl) for radical generation (Reichard, 1993, 1997; Jordan & 
Reichard, 1998). Although the ability of mycobacteria to synthesise AdoCbl is established 
(Peterson & Pope, 1951; Aithal & Sirsi, 1963, 1964; Karasseva et al., 1977), the regulation of 
AdoCbl biosynthesis in M. tuberculosis is not well defined. To eliminate the possibility that a 
vitamin B12 deficiency might impair NrdZ function in wild-typ H37Rv and result in the failure to 
detect differential HU susceptibilities, the above assay was repeated, this time providing both 
wild-type and ΔnrdZ strains with exogenous vitamin B12. Again, however, no differential 
susceptibility was observed in the nrdZ mutant versus wild-type (Figure 4.3). 
 
4.4.2 NrdZ is not reqired for adaptation to hypoxia 
The DnrdZ deletion mutant is not impaired for survival under microaerophilia  
Basal expression of nrdZ in aerated in vitro cultures was shown by a colleague (Dr. S. 
Dawes) to be at levels at least ten-fold lower than the other nrd genes. In contrast, under  
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Figure 4.3 Inhibition of M. tuberculosis strains by HU. Wild-type M. tuberculosis H37Rv and 
the ΔnrdZ mutant were inoculated into Middlebrook 7H12 test medium supplemented with 
cyanocobalamin (vitamin B12) and growth monitored radiometrically by the BACTEC method for ten 
days after exposure to different concentrations of HU (courtesy Dr. S. Dawes). 
 
 
Wayne model conditions (Wayne & Hayes, 1996; Wayne & Sohaskey, 2001), nrdZ was 
significantly upregulated (approximately eight-fold) during adaptation to limiting oxygen levels 
through the NRPI and NRPII phases of nonreplicating persistence (NRP) and, unlike the 
other nrd genes, exhibited a net increase in transcription in comparison with unstressed 
growth. The responsiveness of nrdZ to reduced oxygen availability prompted an investigation 
of the role of nrdZ in survival of M. tuberculosis under microaerophilic conditions. Parallel 
cultures of wild-type H37Rv and the DnrdZ mutant were subjected to gradual oxygen 
depletion under both the settled and stirred models of adaptation to NRP, and anaerobiosis 
confirmed by observing decolourisation in a monitor tube containing M. tuberculosis and 
methylene blue (Wayne & Lin, 1982; Wayne & Hayes, 1996). Plating efficiencies at 1 week 
post-NRPII in the stirred Wayne model or 6 months post-NRPII in the settled model revealed 
that the nrdZ mutant was not impaired for survival in comparison with the isogenic parental 
strain (Figure 4.4). Furthermore, no difference in colony size or morphology was observed 
which might otherwise have indicated an impaired ability to re-initiate growth on exit from 
dormancy in vitro. 
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Figure 4.4 Hypoxic survival of M. tuberculosis strains. Wild-type M. tuberculosis H37Rv 
(green bars) and the ΔnrdZ mutant (red bars) subjected to gradual oxygen depletion under the settled 
model of adaptation to NRP (Wayne & Lin, 1982) were plated at specific timepoints following entry into 
NRPII. Data represent mean values from duplicate platings at each timepoint and error bars standard 
deviations. 
 
 
Loss of nrdZ does not attenuate M. tuberculosis for survival in vivo  
To determine if nrdZ is required for in vivo survival of M. tuberculosis, a collaboration was set 
up in which immunocompetent mice were infected with wild-type H37Rv and the ΔnrdZ 
mutant. The results discussed comprise mouse work done by Dr. L. Tsenova & Dr. S. Dawes. 
The predicted role of NrdZ in providing dNTPs for replication or repair during microaerophilic 
growth recommended the use of the relatively M. tuberculosis-resistant B6D2/F1 mouse strain 
(Medina & North, 1998). Mice were infected by the aerosol route, and bacillary load assessed 
in lung, spleen and liver up to 14 months post infection. From an initial lung bacillary count of 
approximately 100 CFU, the mycobacterial load increased progressively before attaining a 
maximal level of 106 CFU at around 90 days post infection (Figure 4.5). Thereafter, high 
numbers of viable bacilli persisted for the remainder of the 14 month infection period. 
Significantly, loss of nrdZ did not impair the ability of M. tuberculosis to establish infection, or 
to survive for the 14 month infection period, as determined by lung CFU counts (Figure 4.5). 
Both spleen and liver counts were similarly unaffected by loss of nrdZ (data not shown). In 
addition, histological analysis revealed no significant difference in disease pathology between 
the nrdZ mutant and wild-type H37Rv at 90 days and nine months post infection (data not 
shown). 
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Figure 4.5 Growth of M. tuberculosis strains in B6D2/F1 mice. Mice were infected with wild-
type M. tuberculosis H37Rv and the ΔnrdZ mutant by aerosol, and bacillary loads in the lungs 
determined over a 14-month infection period. Each timepoint represents the mean bacillary count from 
four mice, and error bars indicate standard deviations (courtesy Dr. L. Tsenova and Dr. S. Dawes).  
 
4.4.3 NrdZ and damage tolerance under microaerophilia 
Despite the demonstrated upregulation of nrdZ on transition between NRPI and NRPII 
(Dawes et al., 2003), the ΔnrdZ mutant displayed no survival phenotype in vivo in the mouse 
model and in vitro under oxygen limitation. These results were suggestive of a possibile 
inability of plating efficiencies to detect subtle effects on DNA replication. Synthesis of DNA 
ceases as the oxygen tension falls below 1% under Wayne model conditions (Wayne & 
Hayes, 1996). However, evidence implicating dnaE2-mediated error-prone DNA synthesis in 
the emergence of drug resistant mutants (Boshoff et al., 2003) is highly suggestive of on-
going repair activity during long-term persistence, and is consistent with the predicted role of 
NrdZ in the provision of dNTPs for repair of DNA damage in vivo under microaerophilic 
conditions (Mizrahi et al., 2000). It has been shown that metronidazole (MTZ), a DNA-
damaging nitroimidazole that specifically kills anaerobes (Edwards, 1979), preferentially 
targets that subpopulation of M. tuberculosis which has adapted to nonreplicating persistence 
via sequential metabolic shiftdown in vitro in the Wayne model (Wayne & Sramek, 1994). 
Although the precise mechanism of action of MTZ in mycobacteria is unknown (Brooks et al., 
1999; Lim & Dick, 2001), studies in other bacterial systems indicate that the active metabolite 
causes DNA strand breaks which prevent replication (Edwards, 1979). To investigate the 
potential requirement for a functional NrdZ in survival of MTZ-mediated DNA damage under 
Wayne model conditions, wild-type and DnrdZ strains were treated with 64 mg.ml-1 MTZ and 
plated 14 days after onset of anaerobiosis. The complete inactivity of MTZ against aerobically 
grown bacilli, even at concentrations well in excess of the MIC (Wayne & Sramek, 1994), 
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enabled the addition of MTZ at inception of the experiment, and so eliminated the need to 
manipulate the cultures during incubation, avoiding any unintended alteration to the oxygen 
tension. Preliminary data indicated that the mean survival of the nrdZ mutant appeared to be 
slightly depressed in comparison with wild-type H37Rv under these conditions, although the 
increased susceptibility was not statistically significant. Furthermore, addition of exogenous 
vitamin B12 to the cultures had no discernible effect (data not shown). 
 
Analysis of the complete and unfinished genomes of other mycobacteria revealed the 
presence of an identical nrdZ gene in M. bovis (Garnier et al., 2003), but no homologues 
within the genomes of M. leprae (Cole et al., 2001), M. avium, or M. smegmatis 
(http://www.sanger.ac.uk; http://www.tigr.org). Despite the absence of a class II RNR, 
however, M. smegmatis displays similar susceptibility to MTZ activity in vitro in models of 
dormancy (Dick et al., 1998; Lim & Dick, 2001). Therefore, as an alternative approach to 
abrogation of nrdZ gene function in M. tuberculosis, it was felt that the effect of conferring 
NrdZ activity on M. smegmatis should be investigated. Specifically, it was reasoned that the 
presence of the functional M. tuberculosis class II enzyme might improve the ability of M. 
smegmatis to survive MTZ-induced damage under Wayne conditions. A pMV206-based 
integrating plasmid (Mdluli et al., 1996) - containing the M. tuberculosis nrdZ gene plus 800 
bp upstream (specifically including the putative Rv0569-encoded transcriptional regulator) 
and 400 bp downstream sequence - was delivered into M. smegmatis mc2155 by 
electroporation and integration at the attP locus confirmed by PCR. MTZ treatment of wild-
type mc2155 and the nrdZ-containing strain again yielded no differential susceptibility, with or 
without exogenous vitamin B12 (data not shown). 
.
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4.5  DISCUSSION 
This study formed part of a broader genetic analysis of the essentiality and differential 
expression of the putative M. tuberculosis RNRs (Dawes et al., 2003), and extended to an 
attempt to identify a potential physiological function for the nrdZ-encoded class II RNR. 
Underpinning all manipulations was the knowledge that the functionality of NrdZ had not been 
biochemically demonstrated, but was inferrred from the conservation in M. tuberculosis of the 
residues shown to be essential for catalytic activity in well-characterised archaeal and 
eubacterial class II RNRs (Figure 4.1; Booker & Stubbe, 1993; Booker et al., 1994). Similarly, 
little was known regarding the regulation or activity of the vitamin B12 biosynthetic pathway in 
M. tuberculosis - essential for class II RNR radical generation (Reichard, 1993, 1997; Jordan 
& Reichard, 1998)  - or of the organism’s ability to transport exogenous vitamin B12 or convert 
the supplement to the necessary coenzyme B12 form. The deficiency in published data on 
mycobacterial cobalamin metabolism prompted a parallel investigation that is presented in 
Chapter 5. 
 
The class Ib RNR is essential and provides dominant aerobic RNR activity 
The succesful disruption of nrdZ implied the non-essentiality of the M. tuberculosis class II 
RNR for viability in vitro. M. tuberculosis contains multiple RNR genes encoding subunits of 
class Ib (nrdE/F1/F2) and class II (nrdZ) enzymes (Yang et al., 1994, 1997; Cole et al., 1998), 
as well as a recently identified class Ic homologue (Högbom et al., 2004). In the related 
actinomycete S. coelicolor, the class Ia (NrdAB) and class II (NrdJ) RNRs are individually 
dispensable, and the simultaneous inactivation of both enzymes is required for lethality 
(Borovok et al., 2004). This observation is suggestive of the ability of the two enzyme classes 
to substitute functionally during in vitro aerobic growth of that organism (Borovok et al., 2004). 
The oxygen-independent class II RNR has further been shown to provide dominant RNR 
activity during vegetative growth in some organisms containing both class II and class Ib 
enzymes (Jordan et al.,1997; Borovok et al., 2002). The failure to isolate ΔnrdF2 deletion 
mutants of M. tuberculosis without supplying an intact copy of the nrdF2 allele in trans 
(Dawes et al., 2003) was, therefore, surprising since it implied the inability of NrdZ to 
complement - even partially - class Ib RNR function during normal in vitro growth. The 
subsequent demonstration of nrdE and nrdF2 essentiality by high-density mutagenesis 
confirmed this observation (Sassetti et al., 2003). 
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Abrogation of the dominant RNR acitivity, either through genetic disruption or chemical 
inhibition, has been shown in some organisms to result in increased transcription of 
alternative RNR classes in order to maintain the nucleotide pool balance (Masalha et al., 
2001; Borovok et al., 2004). For example, deletion of the class II RNR in S. coelicolor results 
in the constitutive elevation of class Ib expression, and is indicative either of cross-regulation 
of the class Ia and class II RNRs (Borovok et al., 2004) or of possible allosteric regulatory 
mechanisms (Thelander & Reichard, 1979; Hofer et al., 1998). Little is known of the 
regulation of the different RNR genes in M. tuberculosis, however. The two class Ib subunits 
appear to be co-ordinately regulated (Dawes et al., 2003), and RNR gene expression is 
induced after exposure to chemical inhibitors of transcription or translation (Boshoff et al., 
2004). Evidence that transcription of nrdZ under aerobic conditions is approximately ten-fold 
lower than that of the nrdF2-encoded alternative subunit (Dawes et al., 2003) suggested that, 
in the absence of direct or allosteric upregulation, reduced NrdZ expression might account for 
the inability to complement loss of the class Ib RNR. Therefore, to identify any contribution 
whatever of NrdZ to RNR activity under aerobic conditions, class Ib RNR function in the nrdZ 
mutant and the isogenic parental strain was chemically abrogated by treatment with HU 
(Figure 4.3). It was expected that exposure to a range of concentrations spanning the dose 
shown previously to inhibit recombinant NrdEF2 (Yang et al., 1997) might enable detection of 
subtle differences in HU sensitivities in the ΔnrdZ mutant versus wild-type. However, the 
susceptibilities of H37Rv and ΔnrdZ to HU were indistinguishable, indicating that NrdZ does 
not contribute to aerobic growth of M. tuberculosis, and that the activity of the class II RNR is 
not stimulated following repression of the functional class Ib enzyme. Moreover, the 
demonstrated inhibition of the chlamydial class Ic RNR by HU (Roshick et al., 2000) 
eliminates the possibility that the recently identified mycobacterial class Ic homologue 
(Högbom et al., 2004) might provide residual activity during HU treatment. It was recently 
demonstrated that, during oxidative stress, the E. coli cobalamin-independent methionine 
synthase (MetE) is inactivated by glutathionylation of a key active-site cysteine residue 
(Hondorp & Matthews, 2004). The dependence of class II RNRs on five highly-conserved 
cysteines for catalytic activity (Booker et al., 1994; Tauer & Benner, 1997), raises the 
possibility that enzymes of this class might be similarly inactivated. While oxidative 
inactivation might conceivably be applied to explain the apparent failure of NrdZ to contribute 
RNR activity during aerobic gowth, it is difficult to reconcile this contention either with the fact 
that inactivation of E. coli MetE required treatment with exogenous oxidative agents or, more 
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importantly, with evidence that class II RNRs provide dominant RNR activity during aerobic 
growth of some other organisms (Jordan et al.,1997; Borovok et al., 2002). 
 
Regulation of mycobacterial RNR activity 
The apparent cross-regulation of RNR activity in S. coelicolor is thought to be at least partially 
mediated by the nrdR-encoded transcriptional regulator (Borovok et al., 2004). Unlike in 
Streptomyces spp., however, the M. tuberculosis NrdR homologue (Rv2718c) and the nrdZ-
encoded class II RNR are unlinked. Furthermore, an unrelated transcriptional regulator 
(Rv0569), lacking the ATP-cone domain characteristic of class I and class III RNR allosteric 
activity sites (Aravind et al., 2000), is situated directly upstream of nrdZ. The proximal location 
of Rv0569 to nrdZ, as well as the presence of two putative DosR binding motifs upstream of 
Rv0569 (Park et al., 2003) suggests that the two genes are operonic. Both Rv0569 and nrdZ 
have been included in the DosR regulon (Sherman et al., 2001; Park et al., 2003; Voskuil et 
al., 2003), although some studies have detected increased Rv0569 transcription in response 
to low-oxygen in the absence of nrdZ induction (Bacon et al., 2004). Interestingly, there is 
evidence that Rv0569 might be down-regulated by HspR during the heat-shock response in 
M. tuberculosis (Stewart et al., 2002). Together with evidence that the recently identified class 
Ic RNRs are well-represented in thermophilic organisms as well as intracellular pathogens 
(Högbom et al., 2004), the possible HspR-mediated repression of M. tuberculosis Rv0569 
raises the possibility that expression of the various RNR classes might be regulated in 
response to environmental stimuli other than oxygen tension. The potential role of Rv0569 in 
the regulation of RNR expression is considered worth investigating, and an Rv0569 deletion 
mutant of H37Rv has been constructed to this end (data not shown). 
 
Is NrdZ dispensable for hypoxic adaptation? 
The inclusion of nrdZ in the DosR dormancy regulon (Park et al., 2003; Voskuil et al., 2003) 
suggested that the class II RNR might be required to modulate dNTP biosynthesis under 
conditions of low oxygen availability (Voskuil et al., 2003). However, disruption of nrdZ had no 
effect on the survival of M. tuberculosis in either the settled or stirred Wayne models of 
adaptation to in vitro hypoxic dormancy. The absence of a survival phenotype in the ΔnrdZ 
strain contrasted with the profoundly impaired survival of a M. bovis BCG dosR mutant under 
the same conditions (Boon & Dick, 2002). However, DosR regulates a concerted shift in 
metabolic activity to enable bacillary adaptation to long-term hypoxic persistence (Park et al., 
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2003; Voskuil et al., 2003) and it is considered unlikely that loss of a single component would 
impair survival as dramatically. In addition, although nrdZ is included in the DosR regulon, the 
observation that DNA synthesis terminates as the oxygen tension falls below 1% in NRPI 
(Wayne & Hayes, 1996) possibly implies that the class II enzyme is more likely to function in 
the low-level maintenance of dNTP pools for repair, or in preparation for exit from the 
dormant state. Consistent with this hypothesis, an S. coelicolor mutant strain lacking a 
functional class II RNR was recently shown to be impaired in its ability to recover from 
prolonged anaerobic incubation (Borovok et al., 2004). Of particular interest, however, was 
the observation that loss of the class II enzyme was not lethal: despite exhibiting a significant 
delay before resuming growth following re-exposure to oxygen, the mutant strain ultimately 
attained wild-type viable counts (Borovok et al., 2004). Although no alterations in colony 
morphology were observed in the DnrdZ mutant after exit from the Wayne model, it is 
possible that the three to four week incubation period necessary for unaided detection of 
visible colonies on plates might have afforded the mutant strain sufficient time to reduce any 
lag. The prolonged generation time of M. tuberculosis could have rendered a recovery 
phenotype undetectable by colony size alone, and might demand the application of a 
microscope to analyse colony forming ability during the outgrowth period (Wayne & Hayes, 
1996).  
 
RNRs constitute the only known de novo pathway for the biosynthesis of dNTPs (Jordan & 
Reichard, 1998) and have traditionally been considered essential components of a minimal 
bacterial genome. However, complete loss of RNR activity might not be lethal where 
deoxyribonucleosides are externally available, however, and exogenous supplementation 
with deoxyribonucleosides has been shown to restore anaerobic growth  in vitro (Shearer et 
al., 1999; Folmsbee et al., 2004). It is theoretically possible, therefore, that limited cell 
turnover might release sufficient DNA and dNTP precursors into the medium to enable 
complementation of the nrdZ deletion during in vitro persistence. Although no evidence exists 
for the natural competence of M. tuberculosis (Derbyshire & Bardarov, 2000), uptake of DNA 
as a carbon and energy source has been reported in starving populations of other bacteria 
not otherwise competent (Finkel & Kolter, 2001). An additional possibility holds that either the 
M. tuberculosis class Ib or recently identified class Ic enzymes might operate under severe 
oxygen limitation (Jordan et al., 1996; Masalha et al., 2001), and remains to be explored. 
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Mycobacteria in hypoxia-induced dormancy under the Wayne model are diploid, and 
resumption of growth on re-exposure to oxygen is characterised by the synchronous initiation 
of RNA synthesis, followed by cell division and then finally DNA replication (Wayne, 1977; 
Wayne & Hayes, 1996; Wayne & Sohaskey, 2001; Lim et al., 1999). Although unlikely to be 
significantly involved in the chromosomal duplication that occurs in NRPI (the class Ib RNR 
should operate at this oxygen tension; Dawes et al., 2003), the observed maximal expression 
of nrdZ late in NRPII as the bacilli enter anaerobiosis (Dawes et al., 2003) was suggestive of 
a role for NrdZ in the completion of the final round of chromosomal replication, thereby 
enabling synchronous exit. Of course, the caveat remains that M. smegmatis too displays 
synchronised replication on exit from Wayne model conditions (Dick et al., 1998) despite 
lacking a class II homologue. Unfortunately, the phenomenon of synchronous growth has 
proven a challenging model to reproduce, frustrating any comparison between wild-type and 
DnrdZ mutant strains. 
 
DNA damage under limiting oxygen 
It is likely that anerobioisis on its own does not cause extensive DNA damage, and might 
explain the failure to identify an impaired ability of the nrdZ mutant to survive or adapt to in 
hypoxia in vitro. In eukaryotes, survival of DNA damage has been shown to depend on 
elevated RNR activity and a resultant expansion in dNTP pools, and is intimately linked with 
cell cycle regulation (Elledge & Davis, 1990; Tanaka et al., 2000; Chabes et al., 2003). 
Similarly, class I RNR genes are strongly upregulated in E. coli following UV exposure 
(Courcelle et al., 2001) and, in some organisms, class I RNR induction is specific to 
novobiocin (NVB)-mediated gyrase inhibition (Gmuender et al., 2001). In M. tuberculosis, the 
class Ib RNR genes as well as nrdF1 are induced in response to transcriptional inhibition by 
fluoroquinolones (FQs) and coumarins (Boshoff et al., 2004), as well as by the DNA 
damaging agent mitomycin C (Rand et al., 2003). Treatment of M. tuberculosis with FQs and 
mitomycin C induces the SOS regulon (Davis et al., 2002; Boshoff et al., 2003, 2004) 
whereas NVB does not (Boshoff et al., 2004). The upregulation of the class I RNR genes in 
response to NVB treatment is, therefore, suggestive of an SOS-independent regulatory 
mechanism, analogous to the strong, LexA-independent induction of nrdAB in E. coli 
(Courcelle et al., 2001). Significantly, the promoter region of nrdF2 contains motifs for LexA 
binding as well as the dominant LexA/RecA-independent mycobacterial damage response 
pathway (Gamulin et al., 2004). To elucidate the potential role for the class II RNR in 
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provision of dNTPs for DNA repair synthesis under hypoxia in vivo, a relatively resistant 
mouse strain was infected with wild-type and mutant nrdZ M. tuberculosis strains and 
proliferation and survival under immune surveillance determined by CFU assessment over a 
14 month infection period. No phenotype was associated with loss of NrdZ activity during 
both acute and chronic stages of infection, suggesting that nrdZ does not contribute 
significantly to in vivo infection in the murine model. However, in contrast to the attenutaion 
observed in the guinea pig (Malhotra et al., 2004), loss of dosR is associated with 
hypervirulence in the mouse model (Parish et al., 2003a), suggesting that oxygen availability 
and dominant immune effectors within murine granulomas might differ significantly from 
human TB. 
 
The lack of a phenotype in the mouse model prompted an investigation into the effects of 
DNA damage on survival of M. tuberculosis in the Wayne model. Preliminary data suggesting 
that the ΔnrdZ mutant is not more susceptible than wild-type H37Rv to MTZ-mediated DNA 
damage are unexpected; however, the activity of DSB or other energy-intensive repair 
mechanisms during effective metabolic shutdown is uncertain, and NrdZ might simply provide 
dNTPs for repair on resumption of growth. Therefore, as with the recovery phenotype, lack of 
the class II enzyme might translate into delayed repair and therefore outgrowth, and could 
demand microscopic analysis of colony forming ability. Alternatively, the critical role played by 
RNRs in modulating dNTP levels (Elledge et al., 1992) suggests that loss of NrdZ under 
these conditions might result in unbalanced dNTP pool compositions (Chimploy et al., 2000). 
Excessive dNTP concentrations are associated with elevated mutagenesis (Chabes et al., 
2003) and mutations in genes involved in maintaining balanced nucleotide pools result in 
constitutive upregulation of the SOS response (O’Reilly & Kreuzer, 2004). It is, therefore, 
postulated that comparing mutagenesis in the mutant and isogenic wild-type strains after 
hypoxia-induced dormancy might prove a more revealing assay. 
 
MTZ was selected for its known anaerobic killing effects, and also because its demonstrated 
inactivity against M. tuberculosis under aerobic conditions (Wayne & Sramek, 1994) ensures 
minimal manipulation of the experimental setup. However, the technical difficulties 
notwithstanding, it is possible that another damaging agent that does not result in DSBs might 
be more effectively employed. Of course, an assessment of damage survival assumes on-
going (or at least sporadic) DNA synthetic activity under hypoxia. It is thought that the 
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damage likely incurred during long-term survival in the human host necessitates some degree 
of DNA repair during latent infection. The demonstration that loss of the dnaE2-encoded 
error-prone repair polymerase impairs M. tuberculosis for long-term survival in vivo (Boshof et 
al., 2003) provides additional evidence of DNA repair during prolonged infection, a process 
likely to demand dNTP pool replenishment. However, the minimal effect of MTZ on bacillary 
survival in the Cornell model (Brooks et al., 1999) suggests that anaerobiosis may not 
characterise murine infection, and might explain the observation that the DnrdZ mutant is not 
impaired for survival in vivo (Dawes et al., 2003). It was recently reported that M. tuberculosis 
adapts sufficiently to long-term, starvation-induced non-replication in vitro to re-initiate cellular 
division (Hampshire et al., 2004). Of particular interest was the observation that DNA repair 
genes are upregulated prior to re-activation of growth, and that no alteration in environmental 
conditions is required to stimulate this process (Hampshire et al., 2004). Significantly, these 
data suggest that M. tuberculosis might actively repair chromosomal DNA during long-term 
persistence provided the bacilli are adequately adapted. 
 
NrdZ and transmission 
Finally, an analysis of large sequence polymorphisms in a cohort of clinical M. tuberculosis 
isolates recently identified a deleted region (RD 121) comprising nrdZ and two downstream 
ORFs,  implying the non-essentiality of these genes in causing disease (Tsolaki et al., 2004).  
Significantly, RD121 clusters with another deletion (RD 174) containing additional members 
of the DosR regulon. Loss of regulatory mechanisms in M. tuberculosis is associated with 
dramatic phenotypes in vivo (Kaushal et al., 2002; Steyn et al., 2002; Parish et al., 2003a), 
prompting speculation that the absence of genes implicated in metabolic shutdown in the face 
of the immune response (Schnappinger et al., 2003; Shi et al., 2003; Voskuil et al., 2003; 
Karakousis et al., 2004) might inevitably result in altered disease progression, perhaps 
favouring active disease and transmission (Tsolaki et al., 2004). 
 
Chapter 5 
 
Biosynthesis of adenosylcobalamin in  
Mycobacterium tuberculosis 
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5.1 ABSTRACT 
The biosynthesis of adenosylcobalamin (AdoCbl), the precursor of several cobalamin co-
factors including methylcobalamin (MeCbl) and vitamin B12 (cyanocobalamin; CNCbl), is 
energetically demanding and relies on a complex network of enzyme-catalysed reactions. 
Previous studies have established the ability of mycobacteria to synthesise AdoCbl, 
consistent with the presence of at least three putative AdoCbl or MeCbl-dependent 
isozymes in the M. tuberculosis H37Rv genome. To investigate the effects of abrogated 
AdoCbl biosynthetic function on M. tuberculosis, mutants were constructed containing 
deletions in genes required during early (cobK) or late (cobU) stages of the biosynthetic 
pathway. Loss of CobU and CobK activity had no effect on the growth of M. tuberculosis 
H37Rv in liquid minimal media. However, differential growth phenotypes in parental and 
ΔcobU mutant strains following sudden CNCbl withdrawal suggested that disruptions to 
the biosynthetic pathway might affect cobalamin homeostasis. The relevance of AdoCbl 
biosynthesis or B12-dependent isozymes to mycobacterial pathogenesis was further 
suggested by the apparent attenuation of the ΔcobU deletion mutant in vivo in a mouse 
model, despite exhibiting no survival phenotype in human or murine macrophage models 
of infection. A M. tuberculosis H37Rv mutant containing a deletion in the B12-independent 
methionine synthase (metE) was impaired for growth in vitro and could not be rescued by 
L-methionine supplementation. Significantly, exogenous CNCbl complemented growth of 
the ΔmetE mutant, simultaneously demonstrating the ability of M. tuberculosis to transport 
CNCbl despite encoding no identifiable B12-specific transport system. The demonstration 
that methionine auxotrophy in the ΔmetE mutant could be rescued by supplementation 
with CNCbl but not L-methionine was suggestive of separate but interlinked regulatory 
functions governing mycobacterial methionine metabolism and cobalamin homeostasis. 
Finally, M. tuberculosis double deletion mutants in which CobU or CobK function was 
abrogated in addition to MetE were not attenuated for growth in liquid minimal media, 
possibly indicating the presence in M. tuberculosis of an alternative mechanism for 
methionine synthesis. 
 
5.2 INTRODUCTION 
The adenosylcobalamin (AdoCbl) requirement of the nrdZ-encoded class II RNR (Chapter 
4) prompted an investigation into the biosynthesis of, and requirement for, AdoCbl by M. 
tuberculosis. Furthermore, the proposed role of NrdZ in maintaining nucleotide pools for 
repair of DNA damage suggested that the synthesis (or transport) of AdoCbl by M. 
tuberculosis during chronic persistence might be relevant to the long-term maintenance of 
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Figure 5.1 Structures of cobalamin co-factors and derivatives. Cobalamin co-factors are 
organometallic corrinoid derivatives comprising a central cobalt atom ligated equatorially by four 
nitrogen atoms contained within a tetrapyrrolic corrin ring. An intramolecular nucleotide, 
dimethylbenzimidazole (DMB), occupies the lower axial position. The upper axial position (R) 
constitutes the site of cofactor reactivity in cobalamin-dependent enzymes, and is occupied by a 
methyl or a deoxyadenosyl group in methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), 
respectively. Vitamin B12 (or cyanocobalamin, CNCbl) was the first cobalamin to be isolated 
(Rickes et al., 1948; Smith, 1948), the cyano group being an artifact of the extraction process. 
(Adapted from Banerjee & Ragsdale, 2003) 
 
 
genomic integrity, and to the function of the various mycobacterial DNA polymerases 
during stationary-phase adaptation and survival. In particular, it was expected that loss of 
the class II RNR, either in vitro or in vivo, would impair adaptation of M. tuberculosis to 
hypoxia and, further, that the phenotype might be replicated by creating a mutant strain 
defective in the ability to synthesise the necessary cobalamin-derived co-factor. However, 
while attempting to determine the capacity of NrdZ to function during aerobic growth and, 
therefore, complement (even partially) the loss of the dominant class Ib RNR, it became 
clear that little was known regarding either the ability of M. tuberculosis to synthesise 
sufficient AdoCbl for class II RNR activity, or to transport exogenous cobalamin. 
Specifically, although several investigators have previously established by biological 
assay that mycobacteria synthesise AdoCbl (Peterson & Pope, 1952; Aithal & Sirsi, 1963, 
1964; Karasseva et al., 1977), none has determined the regulation of AdoCbl biosynthesis 
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in M. tuberculosis, the enzymes in that organism dependent on cobalamin-derived co-
factors for activity, or the consequences of the loss of AdoCbl biosynthetic ability on 
viability or virulence. In addition, the failure to identify putative mycobacterial B12-specific 
transporters (Rodionov et al., 2003) raised the possibility that M. tuberculosis might rely 
exclusively on de novo AdoCbl synthesis. 
 
5.2.1 Cobalamin co-factors 
Cobalamin is a general term describing a group of organometallic corrinoid derivatives  
that includes two versatile, biologically-active co-factors - AdoCbl and methylcobalamin 
(MeCbl), according to the methyl or deoxyadenosyl group occupying the site of co-factor 
reactivity (Figure 5.1; Banerjee & Ragsdale, 2003). Cyanocobalamin (CNCbl; vitamin B12) 
is produced exclusively by prokaryotes (Warren et al., 2002), although the cyano- ligand is 
artificial and results from the extraction procedure (Rickes et al., 1948; Smith, 1948). 
However, to avoid confusion, throughout the course of this chapter the term ‘B12-
dependent’ will be applied to denote a process or enzyme utilising a cobalamin co-factor. 
Although required in a range of metabolic processes, the actual number of B12-dependent 
enzymes is limited, and probably explains the minute quantities of AdoCbl necessary for 
survival (Raux et al., 2000). The largest subset of B12-dependent enzymes requires an 
AdoCbl cofactor, and includes methylmalonyl-CoA mutase and the class II RNR 
(Banerjee, 1997; Martens et al., 2002). AdoCbl-associated enzymes generally catalyse 
isomerase reactions, although the specific pathway of radical propagation differs in each 
case (Licht et al., 1996; Padmakumar et al., 1997). MeCbl, on the other hand, mediates 
B12-dependent methyl transfer reactions, for example in methionine and methane 
biosynthesis (Banerjee, 1997; Ludwig & Matthews, 1997). As well as NrdZ, the M. 
tuberculosis proteome contains two enzymes predicted to require cobalamin-derived co-
factors (Rodionov et al., 2003): the B12-dependent methionine synthase (5-
methyltetrahydrofolate-homocysteine methyltransferase, MetH), and methylmalonyl CoA 
mutase (MutAB) which is required for the conversion of succinyl CoA to methylmalonyl 
CoA, a crucial substrate in polyketide synthesis (Rainwater & Kalattukudy, 1985). Both 
NrdZ and MetH have corresponding B12-independent isozymes catalysing similar 
functions, namely the class Ib and newly-identified (Högbom et al., 2004) class Ic RNR 
enzymes, and the B12-independent methionine synthase (5-
methyltetrahydropteroyltriglutamate-homocysteine methyltransferase, encoded by metE), 
respectively. In addition, M. tuberculosis contains several genes encoding putative 
propionyl CoA carboxylase α and β subunits that might function to produce methylmalonyl 
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Figure 5.2 The putative M. tuberculosis adenosylcobalamin biosynthetic pathway. 
Shown is a construction of the pathway as predicted to occur in M. tuberculosis H37Rv based on 
sequence homology with known cobalamin biosynthetic genes. The aerobic pathway is 
characterised by late cobalt insertion. The genes relevant to this study are highlighted in red. Gene 
names are from Tuberculist (http://genolist.pasteur.fr/TubercuList/). (Adapted from Roth et al., 1993; 
Rodionov et al., 2003; S. Dawes, unpublished) 
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CoA independently of AdoCbl via carboxylation of propionyl CoA (Rodriguez & Gramajo, 
1999; Rainwater & Kalattukudy, 1985), two of which are essential for optimal in vitro 
growth (Sassetti et al., 2003). In E. coli, the B12-independent methionine synthase (MetE) 
is approximately 100-fold less active than the B12-dependent enzyme (MetH) but the 
reduced activity is compensated for by significantly increased levels of metE transcription 
(Whitfield et al., 1970; Gonzalez et al., 1992; Greene, 1996; Bandarian & Matthews, 
2001). However, with the partial exception of class Ib and class II RNRs (Dawes et al., 
2003; Boshoff et al., 2004) little is known of the regulation or activities of the various 
mycobacterial B12-dependent and B12-independent isozymes. 
 
5.2.2 The AdoCbl biosynthetic pathway 
AdoCbl has the most complex structure of any biological co-factor (Figure 5.1; Battersby, 
1994). Its intricate and energetically expensive synthesis from uroporphyrinogen III (UroIII, 
the common precursor of various tetrapyrrolic co-factors; Warren & Scott, 1990; Warren et 
al., 2002) requires over 25 enzyme-catalysed reactions (Figure 5.2), and is unique among 
vitamins in being confined to certain microorganisms (Marsh, 1999; Raux et al., 2000; 
Warren et al., 2002; Rodionov et al., 2003). The prototypical aerobic and anaerobic 
AdoCbl biosynthetic pathways are defined by those occurring in Pseudomonas 
denitrificans (Stamford, 1994) and S. typhimurium (Roth et al., 1993), respectively, and 
have traditionally been divided into three main steps (Roth et al., 1993; Lawrence & Roth, 
1995) - part I (referred to as cobI) entailing the conversion of UroIII to the complex 
intermediate adenosylcobinamide (AdoCbi); part II (cobII) comprising α-ribazole synthesis 
from dimethylbenzimidazole (DMB) and a phosphoribosyl group donated by nicotinate 
mononucleotide (NaMN) (Warren et al., 2002); and, finally, part III (cobIII) in which AdoCbi 
and α-ribazole are covalently linked to produce AdoCbl. The classification of distinct 
aerobic and anaerobic biosynthetic pathways, however, has recently favoured the division 
of AdoCbl biosynthesis into two major stages (O’Toole et al., 1994; Rodionov et al., 2003); 
the first of these, corrin ring synthesis, differs for aerobic and anaerobic pathways, 
critically in the timing of cobalt insertion (“early” in anaerobic biosynthesis, “late” in 
aerobic) whereas the second, comprising adenosylation, aminopropanol attachment, and 
nucleotide loop assembly, is common to both (Warren et al., 2002). Consistent with the 
classification according to oxygen dependency, several genes have been identified that 
are considered sentinels of the presence in a particular organism of the either aerobic or 
anaerobic pathways (Debussche et al., 1992, 1993; Raux et al., 1997, 2002; Rodionov et 
al., 2003). However, this distinction is not rigid and there is growing evidence that some 
 165 
bacteria are able to synthesise AdoCbl under both conditions (Shearer et al., 1999; Raux 
et al., 2000). 
 
5.2.3 The mycobacterial AdoCbl biosynthetic gene complement 
A complete pathway for de novo AdoCbl biosynthesis, including putative non-orthologous 
substitutes, has been constructed for M. tuberculosis based on bioinformatic analysis 
(Figure 5.2; Rodionov et al., 2003; S. Dawes, unpublished) and is suggestive of the 
aerobic type: the mycobacterial cobaltochelatase - predicted to comprise cobN- and 
Rv2850c-encoded subunits (Rodionov et al., 2003) - is characteristic of ‘late’ (aerobic) 
cobalt insertion; the cobG-encoded mono-oxygenase is oxygen-dependent and specific to 
aerobic synthesis (Debussche et al., 1993); and the CobK and CobJ orthologues contain 
residues typical of aerobic organisms (Shearer et al., 1999). Homologues of nearly all of 
the M. tuberculosis genes are found in the complete and uncompleted genomes of M. 
smegmatis, M. bovis, and M. avium with some notable differences (S. Dawes, 
unpublished); for example, cobF is present in M. smegmatis and M. avium but a non-
orthologous enzyme is predicted to function in M. tuberculosis and M. bovis (Rodionov et 
al., 2003). In addition, although M. bovis has retained the ability to synthesise AdoCbl in 
vitro (Karasseva et al., 1977), the effect of the RD9 deletion - eliminating the 5’-terminal 
region of cobL and the two upstream genes in other members of the M. tuberculosis 
complex (Brosch et al., 2001; Garcia-Pelayo et al., 2004) - on the expression and activity 
of the cobLKM operon is unknown. Both cobK and cobL were recently identified in a 
limited set of genes whose expression is unique to replication in immunocompetent mice 
(Talaat et al., 2004) and disruption of cobL has been shown to impair M. tuberculosis for 
in vivo survival in the murine model (Sassetti & Rubin, 2003). Similarly, high density 
mutagenesis has identified two additional putative AdoCbl biosynthetic genes, cobC – 
required for both in vitro and in vivo survival (Sassetti et al., 2003; Sassetti & Rubin, 
2003), and cobQ2, which is necessary for optimal growth in vitro (Sassetti et al., 2003). 
Interestingly, M. tuberculosis possesses paralogous pairs of genes associated with 
AdoCbl biosynthesis, comprising cobQ (encoding the corrin amidase) and cobQ2, as well 
as cysG (encoding a multifunctional uroporphyrin III methyltransferase) and hemD (Cole 
et al., 1998), the roles of which remain to be elucidated. Although the essentiality of 
cobQ2 is suggestive of non-redundant activity, it is likely that, as with cobC - encoding an 
aminotransferase involved in aminopropanol synthesis -  these genes function in 
additional cellular processes beyond AdoCbl synthesis. Finally, the biological relevance of 
AdoCbl to pathogenesis of M. tuberculosis might be inferred, albeit loosely, from the 
significant representation of genes associated with AdoCbl biosynthesis or encoding B12-
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dependent enzymes among the ranks of genes predicted to be under strong negative 
evolutionary selection for amino acid substitutions (Plotkin et al., 2004). 
 
5.2.4 Regulation of AdoCbl metabolism and transport 
AdoCbl post-transcriptionally regulates expression of a number of AdoCbl biosynthetic 
and transport genes (Lundrigan et al., 1991; Richter-Dahlfors and Andersson, 1992). 
Regulation is dependent on the formation of alternative RNA structures (Richter-Dahlfors 
et al., 1994; Franklund & Kadner, 1997; Ravnum & Andersson, 1997, 2001; Nou & 
Kadner, 1998; Nahvi et al., 2002), and is thought to be mediated by a so-called B12-
element, a motif highly conserved on both sequence and structural levels (Vitreschak et 
al., 2003). Although widely distributed among 5’-untranslated regions of cobalamin-related 
genes (Rodionov et al., 2003; Vitreschak et al., 2003), regulation of gene expression by 
the B12-element is postulated to occur by different mechanisms depending on the 
bacterial taxon. For example, it is proposed that inhibition of translation initiation regulates 
AdoCbl biosynthesis and transport in actinomycetes, whereas transcriptional attenuation 
predominates in some other groups (Vitreschak et al., 2003). Comparative genomics 
recently identified several additional genes potentially regulated by the B12-element, 
including cobalt transporters and chelatases, and corrin ring methyltransferases 
(Rodionov et al., 2003). In addition, B12-independent methionine synthases and RNRs are 
usually associated with B12 elements in genomes containing corresponding B12-
dependent isozymes (Rodionov et al., 2003). However, while M. tuberculosis contains two 
putative B12-element-binding motifs located upstream of a predicted cbtG-type cobalt 
transporter as well as the B12-independent methionine synthase (metE),  a B12-regulatory 
motif is not associated with nrdZ (Rodionov et al., 2003). 
 
5.2.5 Cobalamin and cobalt transporters 
Most bacteria that utilise AdoCbl, but do not synthesise their own, possess a combination 
of B12-element-regulated B12-specific and ferric siderophore transporters to actively 
transport cobalamins, cobinamide or other corrinoid precursors (Rodionov et al., 2003). 
The most well-characterised B12-specific transport system is found in enteric bacteria and 
consists of a TonB-dependent outer membrane receptor, BtuB, that operates in complex 
with a btuFCD-encoded ABC transporter (Cadieux et al., 2002). Transport of cobalt and 
other heavy metal ions is generally mediated by the unspecific CorA transport system 
(Smith et al., 1993), although high-affinity, AdoCbl synthesis-specific cobalt transporters 
have been identified (Roth et al., 1993) that are usually preceded by regulatory B12 
elements (Rodionov et al., 2003). As stated above, mycobacteria possess a putative B12-
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regulated, cbtG-type cobalt transporter (Rodionov et al., 2003); furthermore, cobalt 
supplementation has been shown to increase AdoCbl biosynthesis in vitro (Karasseva et 
al., 1977). There is, however, a complete or partial lack of btu-type B12-specific 
transporters in sequenced mycobacterial genomes (Rodionov et al., 2003), although the 
expression and activities of two FecB homologues (ABC-type cobalamin/Fe3+ siderophore 
transporters) remain to be determined (S. Dawes, unpublished). 
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5.2.6 Aims and objectives of this study 
This study was initially instigated by the need to generate a M. tuberculosis mutant strain 
impaired in its ability to synthesise the AdoCbl co-factor required for NrdZ activity, in the 
hope of mimicking any observed nrdZ phenotype. To this end, the aims comprised: 
 1. the construction of a M. tuberculosis ΔcobU deletion mutant 
2. analysis of the ability of the ΔcobU mutant to adapt to hypoxia in vitro 
During the course of this work, however, the enigmatic phenotypes associated with 
disruptions to cobalamin homeostasis, coupled with the demonstrated inability of NrdZ to 
complement class Ib RNR activity and the apparent dispensability of NrdZ for adaptation 
to hypoxia in vitro, prompted the following revised aims: 
 1. the demonstration of vitamin B12 auxotrophy in a M. tuberculosis mutant  
  strain restricted to the utilisation of alternative, B12-dependent metabolic  
  pathways 
 2. an assessment of the role of AdoCbl biosynthesis and B12-dependent  
  metabolism in survival and virulence of M. tuberculosis in vivo. 
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5.3 MATERIALS AND METHODS 
5.3.1 Bacterial strains and plasmids 
The mycobacterial strains, plasmids and probes used in this study are detailed in Table 
5.1. All cob and met deletion mutants of M. tuberculosis were maintained in the presence 
of 1 μg/ml CNCbl (Sigma) unless otherwise indicated. 
 
5.3.2 Construction of the marked and unmarked suicide delivery vectors 
M. tuberculosis ΔcobU. Two primer sets, cobUF1/cobUR1 and cobUF2/cobUR2 (Table 
5.2), were designed to amplify sequence upstream and downstream of cobU from wild-
type M. tuberculosis H37Rv genomic DNA. Ligation of the PCR products cobUFR1 (2058 
bp) and cobUFR2 (1732 bp) eliminated 280 bp cobU coding sequence to create the 
ΔcobU allele. Sequenced PCR products were cloned into the relevant sites of suicide 
vector p2NIL (Parish and Stoker, 2000) to generate p2ΔcobU. Finally, the 7939-bp PacI 
fragment from pGOAL19 (hyg-lacZ-sacB; Parish & Stoker, 2000) was cloned into the 
corresponding site of p2ΔcobU to generate p2ΔcobU19. 
Table 5.1 List of strains, plasmids, and probes used in this study 
Strain Description Reference/source 
ΔcobU cobU deletion mutant of H37Rv This study 
ΔmetE metE deletion mutant of H37Rv This study 
ΔcobK cobK deletion mutant of H37Rv K. Downing/This study 
ΔcobU/ΔmetE Double cobU/metE deletion mutant of H37Rv This study 
ΔcobK/ΔmetE Double cobK/metE deletion mutant of H37Rv This study 
Plasmid 
p2ΔcobU p2NIL carrying ΔcobU allele; KmR This study 
p2ΔcobU19 Unmarked cobU knockout vector - p2ΔcobU containing PacI cassette from pGOAL19; KmRHygRSucS This study 
p2ΔmetE p2NIL carrying ΔmetE allele; KmR This study 
p2ΔmetE::hyg p2ΔmetE with hyg cassette from pIJ963 cloned in BamHI site; KmRHygR This study 
p2ΔmetE17 hyg-marked metE knockout vector - p2ΔmetE::hyg containing PacI cassette from pGOAL17; KmRHygRSucS This study 
p2ΔmetE19 Unmarked metE knockout vector - p2ΔmetE containing PacI cassette from pGOAL19; KmRHygRSucS This study 
p2ΔcobK19 Unmarked cobK knockout vector containing PacI cassette from pGOAL19; KmRHygRSucS K. Downing 
Probe 
cobUFR2 1750 bp PCR product containing 113 bp 3’ cobU coding sequence This study 
metEFR2 1740 bp PCR product containing 562 bp 5’ metE coding sequence This study 
cobKp 1162 bp XhoI/SalI fragment from p2ΔcobK19 This study 
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M. tuberculosis ΔmetE. The M. tuberculosis ΔmetE deletion allele was constructed using 
essentially the same method as that described above for ΔcobU. Briefly, two primer sets, 
metEF1/metER1 and metEF2/metER2 (Table 5.2), were designed to amplify sequence 
upstream and downstream of metE from wild-type M. tuberculosis H37Rv genomic DNA. 
Ligation of the PCR products metEFR1 (1720 bp) and metEFR2 (1969 bp) eliminated 
1367 bp metE coding sequence to create the ΔmetE allele. Sequenced PCR products 
were cloned into the relevant sites of suicide vector p2NIL (Parish and Stoker, 2000) to 
generate p2ΔmetE. To mark the deletion allele, the BamHI/BglII hyg cassette (1738 bp) 
from pIJ963 (Blondelet-Rouault et al., 1997) was inserted into the deletion junction 
between upstream and downstream PCR fragments, thereby creating p2ΔmetE::hyg. 
Finally, the 6359-bp PacI fragment from pGOAL17 (lacZ-sacB; Parish and Stoker, 2000), 
or the 7939-bp PacI fragment from pGOAL19 (hyg-lacZ-sacB; Parish & Stoker, 2000) was 
cloned into the relevant marked or unmarked deletion allele to generate p2ΔmetE17 and 
p2ΔmetE19, respectively. 
 
5.3.3 Macrophage infections 
THP-1 infections 
THP-1 (ATCC TIB-202) cells were grown in RPMI 1640 medium (Gibco-BRL) 
supplemented with 10% fetal calf serum, 0.45% glucose, 0.15% sodium pyruvate, and 4 
mM L-glutamine. Cultures were maintained at concentrations of approximately 5 x105 
cells/ml, and the cells were induced to the macrophage-like state by 24 h pre-treatment 
with 40 nM 12-O-tetradecanoylphorbol-13-acetate (PMA) (Tsuchiya et al., 1982). Cells 
were infected with M. tuberculosis strains at multiplicity of infection (MOI) of 1 bacillus to 5 
Table 5.2 Primers used in this study 
Name Sequence (5’-3’) Comments† 
cobUF1 GGCGGCAAAGCTTCGGGTACCTGGT HindIII 
cobUR1 GCCGGGGGATCCCAATCGGGATCGCT BamHI 
cobUF2 GGGGCGGGATCCCATTCTTCGGGCGT BamHI 
cobUR2 GGCGGCGGTACCAAGGGCGAGCTGAAGT Asp718 
metEF1 GGGGTTCGGTACCATCCGGCTGCCG Asp718 
metER1 GGCGCCCGGATCCACACGCATCTGT BamHI 
metEF2 GGGGGCCGGATCCAACTCTTCGAG BamHI 
metER2 GCGCGGGAAGCTTCAACTTCGGGCA HindIII 
†Restriction sites utilised for subsequent cloning of PCR fragments are underlined, and the relevant enzyme 
detailed under Comments. 
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macrophages; infections were allowed to occur for approximately 2 hours before washing 
with phosphate-buffered saline and replacement of the medium with fresh medium. 
Intracellular bacteria were isolated at each timepoint after lysis of the macrophages with 
0.05% SDS, and plated on solid 7H10 M-OADC supplemented with 1 μg/ml CNCbl. 
J774 infections 
The murine macrophage-like cell line J774 was cultured as per established methods 
(Mueller-Ortiz et al., 2001). Adherent monolayers at a concentration of 106 cells/ml were 
established in 24-well plates 1 day prior to infection with M. tuberculosis strains. 
Suspensions of M. tuberculosis H37Rv and the ΔcobU mutant were added to Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% fetal calf serum and 4 mM L-glutamine. 
Mycobacteria were incubated at 37oC for 1 hour before being added to the J774 cells, 
which had been washed twice with warm PBS, in duplicate wells at a MOI of 1 to 5. After 
1 hour, the monolayers were washed three times for 5 min at 37°C with gentle shaking 
with warm PBS to remove nonadherent bacteria. At each timepoint, the J774 cells were 
lysed with 0.10% SDS, and serial dilutions of the lysates plated on 7H10-OADC agar 
plates containing 1 μg/ml CNCbl for CFU assessment. 
 
5.3.4 Infection of mice, determination of bacterial load, and survival 
Six-to-eight-week old female C57BL/6 mice (Taconic) were infected with approximately 50 
CFU of MTb via the aerosol route and infection monitored by plating of lung and spleen 
homogenates from 3–5 mice at different times post-infection (Manca et al., 2001; Boshoff 
et al., 2003). Time-to-death analysis was performed on the remaining mice. Mice were 
euthanized when they became moribund. 
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5.4 RESULTS 
5.4.1 Disruption of AdoCbl biosynthesis in M. tuberculosis 
Generation of a ΔcobU deletion mutant of H37Rv 
The final stage of AdoCbl biosynthesis is characterised by nucleotide loop assembly, and 
comprises the activation and joining of cobinamide and DMB (Warren et al., 2002). In S. 
enterica, a cobU-encoded cobinamide kinase/cobinamide phosphate guanylyltransferase 
converts AdoCbi to AdoCbi-GDP, which then combines with α-ribazole to produce AdoCbl 
(Figure 5.2; Roth et al., 1993).  
 
Figure 5.3 Reactions catalysed by the CobU enzyme. CobU autoguanylylation induces the 
catalytically active conformation that phosphorylates the hydroxyl group of the aminopropanol 
moiety of adenosylcobinamide (AdoCbi). Either ATP or GTP (shown as NTP) can function as g-
phosphate donor (O’Toole & Escalante-Semerena, 1995). Transfer of the GMP moiety attached to 
CobU onto AdoCbi-P generates AdoCbi-GDP, which is combined with α-ribazole to produce 
adenosylcobalamin (AdoCbl) in a reaction catalysed by CobS (not shown). (Adapted from Warren et 
al., 2002.) 
 
 
Despite its small size (180 amino acids in Salmonella, 174 amino acids in M. tuberculosis; 
Cole et al., 1998), CobU is a multifunctional enzyme that catalyses sequential reactions 
comprising its own auto-guanylylation and the phosphorylation of AdoCbi to AdoCbi-P 
and, finally, transfer of the guanylyl group to AdoCbi-P to yield AdoCbi-GDP (Figure 5.3; 
O’Toole & Escalante-Semerena, 1995; Thomas et al., 2000). The crucial role of CobU late 
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in AdoCbl biosynthesis, together with the identification of orthologues in several other 
bacterial species (O’Toole & Escalante-Semerena, 1995; Raux et al., 2000; Rodionov et 
al., 2003), recommended cobU as an initial target for disruption in order to abrogate 
AdoCbl biosynthesis in M. tuberculosis. To this end, an unmarked ΔcobU deletion allele 
was constructed in which 280 bp (of 522 bp) internal cobU sequence was eliminated 
(Figure 5.4A), and delivered into H37Rv by electroporation. The possibility that loss of 
AdoCbl biosynthetic ability in M. tuberculosis might result in CNCbl auxotrophy demanded 
that media be supplemented with 1 μg/ml CNCbl throughout the process of generating the 
ΔcobU mutant. Putative DCO mutants were obtained by the two-step method (Parish & 
Stoker, 2000) and confirmed genotypically by Southern blot (Figure 5.4A).  
 
Possible B12 dysregulation in the ΔcobU mutant  
The successful isolation of an unmarked ΔcobU deletion mutant on media supplemented 
with CNCbl suggested that either AdoCbl was not required for normal in vitro growth, or 
that M. tuberculosis is able to transport CNCbl. To examine whether loss of cobU 
impacted on unsupplemented growth of M. tuberculosis in vitro, parallel cultures of wild-
type H37Rv and the ΔcobU mutant were established in Middlebrook 7H9 liquid media with 
(7H9+B12) and without (7H9-B12) exogenous CNCbl and aliquots plated after 168 hours 
incubation. In order to establish the CNCbl requirements of both strains throughout the 
assay, as well as to avoid possible growth artefacts arising from different media or 
residual CNCbl supplement, bacilli were harvested and washed twice in 10% glycerol 
before plating onto solid 7H10 agar both with (7H10+B12) and without (7H10) CNCbl 
supplement (Figure 5.5). The growth kinetics of wild-type H37Rv and the ΔcobU mutant, 
as determined by optical density, were indistinguishable in liquid culture irrespective of the 
presence of exogenous CNCbl (data not shown). In addition, plating efficiencies of wild-
type H37Rv on supplemented (7H10+B12) and unsupplemented (7H10) solid agar 
suggested that AdoCbl availability does not affect normal in vitro growth of wild-type 
H37Rv (data not shown). In contrast (Figure 5.5), growth of the ΔcobU mutant on 
unsupplemented solid agar (7H10) was impaired if bacilli had been harvested from liquid 
media containing CNCbl (+B12). However, no effect on plating efficiency was observed if 
the ΔcobU mutant had been cultured in liquid media lacking CNCbl supplement (-B12). 
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Figure 5.4 Construction of M. tuberculosis mutants disrupted in cobalamin and 
methionine biosynthetic pathways. DNA from wild-type M. tuberculosis H37Rv, the single 
ΔcobU, ΔcobK, and ΔmetE mutants, and the double ΔcobU/ΔmetE and ΔcobK/ΔmetE deletion 
mutants was digested with BamHI and probed with each of the three probes specific to cobU, cobK 
and metE. Restriction maps of the various gene deletions are schematically illustrated in the line 
drawings adjacent to each Southern blot (B, BamHI; WT, wild-type; not drawn to scale). A. BamHI-
digested DNA hybridised to the cobUp probe. Construction of the DcobU allele eliminates 280 bp of 
cobU coding sequence. An additional BamHI restriction site is introduced in the DcobU deletion 
allele (probe represented by a striped box). B. BamHI-digested DNA hybridised to the metEFR2 
probe. The ΔmetE::hyg deletion-insertion allele eliminates 1367 bp of metE coding sequence. An 
additional BamHI site is introduced by the hyg cassette in the ΔmetE::hyg allele (probe represented 
by a chequered box). C. BamHI-digested DNA hybridised to the cobKp probe. The DcobK allele 
eliminates 214 bp cobK coding sequence, including an internal BamHI site (probe represented by a 
hatched box). 
 
 
Figure 5.5 The vitamin B12 “shock” phenotype in M. tuberculosis ΔcobU. Plating 
efficiencies of the M. tuberculosis ΔcobU deletion mutant were determined by scoring CFUs on 
CNCbl-supplemented (7H10+B12) and unsupplemented (7H10) 7H10 agar after 168 hours growth 
in 7H9 liquid media with (+B12) and without (-B12) exogenous CNCbl. Data represent mean CFU 
values from duplicate platings in at least three idependent experiments and error bars indicate 
standard deviations. An asterisk (Ý) denotes the significant difference between mean CFU values 
(p<0.0001). 
 
M. tuberculosis cobU is not required for survival in vitro in macrophage models  
The upregulation of putative AdoCbl biosynthetic genes in wild-type H37Rv in response to 
CNCbl withdrawal seemed to imply the operation of at least one B12-dependent metabolic 
pathway. To determine whether functional AdoCbl biosynthetic activity was required for 
pathogenesis of M. tuberculosis, intracellular survival of the ΔcobU mutant was compared 
with wild-type H37Rv in the macrophage model of infection. Both murine (J774) and PMA-
stimulated human (THP-1) macrophage cell lines were infected in parallel with ΔcobU and 
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wild-type H37Rv, and intracellular survival of the bacilli determined by CFU assessments 
at 24 hour timepoints extending over 8 days. Plating efficiencies of the ΔcobU mutant did 
not differ significantly from wild-type H37Rv in the human macrophage model (data not 
shown). Similarly, deletion of cobU did not impair survival of M. tuberculosis H37Rv in 
murine macrophages (Figure 5.6). 
Figure 5.6 Survival of M. tuberculosis strains in murine macrophages. A J774 murine bone-
marrow macrophage cell line was infected with wild-type H37Rv (-¢-) and the ΔcobU deletion 
mutant (-p-), and intracellular survival of the bacilli determined by CFU assessment on 7H10 agar 
supplemented with 1 μg/ml CNCbl. Each timepoint represents the mean bacillary count from at 
least two dilutions plated in triplicate, and error bars indicate standard deviations. 
 
5.4.2 The B12-independent methionine synthase (MetE) 
Disruption of metE impairs normal growth of M. tuberculosis in vitro 
The inability to detect a definite in vitro phenotype associated with loss of CobU activity 
prompted the genetic manipulation of M. tuberculosis to force the utilisation of putative 
B12-dependent isozymes. The specific AdoCbl biosynthetic abilities of enteric bacteria – S. 
typhimurium synthesises AdoCbl de novo under anaerobic conditions only (Jeter et al., 
1984) while E. coli requires a cobinamide precursor (Ford et al., 1955) – ensure that 
mutant strains containing disruptions in the B12-independent methionine synthase (metE) 
are methionine auxotrophs under aerobic conditions in vitro.  As an alternative to 
methionine supplementation, ΔmetE mutants of S. typhimurium and E. coli can be 
rescued with exogenous CNCbl, which stimulates activity of the B12-dependent methionine 
synthase (metH) and so restores growth rates to normal levels (Davis & Mingioli, 1950; 
Smith, 1961). The enforced reliance of ΔmetE mutants on the MetH apoprotein for 
methionine synthase activity has, therefore, become an established method to elucidate 
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AdoCbl biosynthetic pathways in these organisms, using methionine auxotrophy as an 
indirect readout (Jeter et al., 1984).  It was felt, therefore, that a ΔmetE mutant of H37Rv 
might provide a useful background to elucidate the AdoCbl biosynthetic requirements of 
M. tuberculosis. To this end, hyg-marked and unmarked deletion alleles of M. tuberculosis 
metE were delivered into H37Rv by electroporation and putative DCO mutants selected 
by the two-step homologous recombination method (Boshoff & Mizrahi, 1998; Parish & 
Stoker, 2000). The deletion allele eliminated 1367 bp (of 2280 bp) metE coding sequence. 
Surprisingly, no unmarked DCO mutants could be isolated – all white colonies obtained 
after sucrose selection were wild-type revertants; in addition, the marked construct yielded 
only minute colonies after a considerable period of outgrowth (in excess of four weeks) on 
unsupplemented media. Based on the knowledge that M. tuberculosis synthesises 
AdoCbl, it had not been predicted that disruption of the metE-encoded B12-independent 
methionine synthase on its own would impair normal in vitro growth. The sucrose 
selection step was, therefore, considered flawed and so was repeated. To eliminate the 
possibility that M. tuberculosis might not produce AdoCbl in sufficient quantity to enable 
MetH to complement fully the absent MetE function under normal aerobic conditions, 
CNCbl was added to all media. Again, only wild-type revertants were obtained with the 
unmarked metE deletion allele; however, the putative HygR DCO mutants exhibited 
normal, wild-type colony size and morphology on the CNCbl-supplemented selective 
media. Genotypic analysis of these clones revealed the successful replacement of wild-
type metE with the marked deletion allele (Figure 5.4B). The requirement for exogenous 
CNCbl supplementation was confirmed by patching the ΔmetE mutant on 
unsupplemented media and media containing CNCbl (Figure 5.7A). Significantly, the 
ability of exogenous CNCbl supplement to complement the ΔmetE mutant simultaneously 
demonstrated the ability of M. tuberculosis to transport vitamin B12. 
 
Generation of a ΔcobU/ΔmetE double knockout mutant 
The partial CNCbl auxotrophy exhibited by the ΔmetE mutant - despite retaining full 
AdoCbl biosynthetic ability - suggested that MetH-mediated methionine synthesis was 
insufficient to complement loss of metE or, alternatively, that de novo AdoCbl synthesis 
was unable to meet the co-factor requirements of the B12-dependent isozyme. Whatever 
the cause, it was predicted that abrogation of AdoCbl biosynthetic ability in the ΔmetE 
mutant would cripple MetH function, and so result in complete CNCbl (or methionine) 
auxotrophy. Because the ΔmetE mutant carried a hyg-marked metE deletion allele, a 
strategy was adopted in which the marked ΔmetE::hyg knockout constuct was delivered  
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Figure 5.7 Substrate utilisation by M. tuberculosis mutants disrupted in cobalamin and 
methionine biosynthetic pathways. A 50 μl aliquot of a log-phase culture of each of the mutant 
strains was streaked onto solid 7H10 agar supplemented with the appropriate substrate and growth 
scored after 21 days incubation. A. The M. tuberculosis ΔmetE mutant exhibited wild-type growth 
on 7H10 agar supplemented with 1 μg/ml CNCbl (ΔmetE + B12), but was unable to grow on 
unsupplemented 7H10 agar (ΔmetE) or on 7H10 agar containing 1 mg/ml L-methionine (ΔmetE + 
L-METHIONINE). B. Growth of the M. tuberculosis ΔcobK and ΔcobU mutant strains was compared 
with the ΔmetE mutant on 7H10 agar containing 1 mg/ml L-methionine. 
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into the unmarked ΔcobU mutant. After electroporation, DCOs were obtained by two-step 
selection (Parish & Stoker, 2000) on media containing CNCbl supplement. Southern blot 
analysis confirmed the ΔcobU/ΔmetE double deletion genotype (Figure 5.4A,B). 
Surprisingly, growth of the ΔcobU/ΔmetE double mutant in liquid 7H9 media was 
indistinguishable from wild-type whether provided with exogenous CNCbl supplement or 
not (data not shown). However, on solid 7H10 agar, the ΔcobU/ΔmetE double mutant 
exhibited the same partial CNCbl auxotrophy that characterised the single ΔmetE mutant 
(data not shown). 
 
5.4.3 Functionality of M. tuberculosis CDC1551 MetH  
The cobalamin moiety in B12-dependent methyltransferases is estimated to undergo 
oxidative inactivation once every 2000 turnovers (Drummond et al, 1993), necessitating its 
reductive reactivation for re-entry into the catalytic cycle. In E. coli, MetH is a monomer 
comprising four distinct domains consistent with the partial reactions catalysed - an N-
terminal homocysteine-binding domain, an N5-methyl-tetrahydrofolate-binding domain, a 
cobalamin-binding domain, and a C-terminal S-adenosylmethionine-binding domain 
required for reactivation (Drummond et al., 1993; Goulding et al., 1997). Sequence 
analysis revealed that the M. tuberculosis H37Rv MetH shares significant homology with 
the E. coli enzyme and possesses key residues associated with each of the four domains 
(S. Dawes, unpublished). In M. tuberculosis CDC1551, the C-terminal region of metH 
containing the reactivation domain - in particular, the essential S-adenosyl-L-methionine 
(SAM) binding motif (Dixon et al., 1996) - is truncated (Fleischmann et al., 2002), 
suggesting that the B12-dependent methionine synthase is disabled. To ascertain whether 
the absence of this domain necessarily abrogates MetH activity, the hyg-marked deletion 
allele used to disrupt H37Rv metE was delivered into CDC1551 by electroporation. It was 
predicted that loss of MetE should not be lethal in the presence of a functional metH. 
Despite readily generating SCO recombinants, post-sucrose selection has yielded only 
HygR mutants among almost fifty putative DCO mutants, even when supplemented with 
exogenous CNCbl (data not shown). Although a conclusive complementation analysis has 
not yet been performed, the data suggest that metE is essential in CDC1551 and 
therefore, that the truncated MetH is defective. M. tuberculosis CDC1551 is a highly 
infectious clinical isolate that has been implicated in a number of tuberculosis outbreaks 
(van Embden et al., 1993; Valway et al., 1998). The deletion of two of the three putative 
B12-dependent enzymes (NrdZ and MetH) in individual M. tuberculosis clinical isolates 
(Fleischmann et al., 2002; Tsolaki et al., 2004) is, therefore, potentially significant and 
suggests that loss of B12-dependent isozymes might favour transmission and active 
 180 
disease - analogous to the deletion of DosR components in other clinical isolates (Tsolaki 
et al., 2004). 
 
5.4.4 Targeting an earlier step in AdoCbl biosynthesis 
Generation of ΔcobK and ΔcobK/ΔmetE double deletion mutants 
The failure to associate CNCbl auxotrophy with the ΔcobU mutant in vitro raised the 
possibility that another enzyme(s) was substituting for absent CobU activity. A non-
orthologous protein has recently been shown to fulfil cobinamide kinase activity in 
archaea, for example (Thomas & Escalante-Semerena, 2000). Therefore, it was decided 
that targeting an earlier step in AdoCbl biosynthesis might prove more instructive. The 
cobK-encoded mycobacterial precorrin-6x reductase homologue functions in part I (CobI) 
of the predicted AdoCbl biosynthetic pathway, dedicated to AdoCbi synthesis (Figure 5.2; 
Blanche et al., 1992). Significantly, loss of cobK in Paracoccus denitrificans eliminates the 
activity of the B12-dependent RNR and so is lethal under anaerobic conditions (Shearer et 
al., 1999). An unmarked ΔcobK deletion mutant of M. tuberculosis H37Rv was generated 
in collaboration with Dr. K. Downing (Figure 5.4C). The ΔcobK allele eliminated 214 bp (of 
735 bp) cobK sequence. Growth kinetics of the ΔcobK mutant were indistinguishable from 
wild-type H37Rv under standard conditions (data not shown), corroborating the in vitro 
dispensability of AdoCbl biosynthesis previously inferred from the ΔcobU mutant. To 
confirm the inability of combined ΔcobU/ΔmetE deletions to confer CNCbl auxotrophy on 
M. tuberculosis, a double ΔcobK/ΔmetE deletion mutant was also generated (Figure 
5.4B,C). As with the single ΔmetE and double ΔcobU/ΔmetE deletion mutants, the 
ΔcobK/ΔmetE strain exhibited partial CNCbl auxotrophy on solid 7H10 agar, but was not 
impaired in liquid 7H9 (data not shown). 
 
The M. tuberculosis AdoCbl and methionine biosynthetic pathway mutants are not 
strict CNCbl auxotrophs 
The failure to demonstrate complete CNCbl auxotrophy in any of the M. tuberculosis 
mutants raised the possibility that trace amounts of CNCbl might be present in solid 7H10 
and liquid 7H9 media. To eliminate the potential effects of contaminating CNCbl, parallel 
cultures of each of the single (ΔcobU, ΔcobK, ΔmetE) and double (ΔcobU/ΔmetE, 
ΔcobK/ΔmetE) deletion mutants were established in unsupplemented Sauton’s minimal 
media and growth compared with wild-type H37Rv (Figure 5.8). Initial bacillary counts 
were determined by plating on solid 7H10 agar supplemented with 1 μg/ml CNCbl, and 
growth assessed by measuring absorbances at 600 nm (OD600) at specific timepoints 
extending over 216 hours. In addition, final OD600 readings were confirmed by plating  
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Figure 5.8 Growth kinetics of M. tuberculosis strains in vitro in minimal media. Growth 
of wild-type M. tuberculosis H37Rv (-®-) in unsupplemented Sauton’s liquid minimal media was 
determined by absorbance (OD600) and compared with the single ΔcobU (-¢-), ΔcobK (-p-), and 
ΔmetE (-¢-) deletion mutants, as well as the double ΔcobU/ΔmetE (-®-) and ΔcobK/ΔmetE (-Î-) 
mutant strains. Absorbance measurements were confirmed by plating aliquots of the individual 
cultures on 7H10 agar supplemented with 1 μg/ml CNCbl at 0 hours, 48 hours and 216 hours, and 
scoring CFUs. 
 
 
CFUs at the 216 hour timepoint. Based on both absorbance readings and CFU analysis, 
growth of each of the deletion mutants from an intial OD600 ~ 0.100 to a final OD600 > 1.5 
was indistinguishable from wild-type H37Rv. 
 
Methionine supplementation does not rescue growth of M. tuberculosis ΔmetE  
Although S. typhimurium and E. coli ΔmetE strains have largely been used to define steps 
in AdoCbl biosynthesis, methionine auxotrophy in those mutants can be complemented by 
supplementing growth media with exogenous methionine (Davis & Mingioli, 1950; Smith, 
1961; Jeter et al., 1984). To assess the ability of methionine supplementation to 
complement loss of MetE activity in M. tuberculosis , aliquots of all mutant strains as well 
as wild-type H37Rv were harvested from unsupplemented minimal media, washed, and 
plated on solid 7H10 agar containing no supplement, 1 μg/ml CNCbl, and 1 mg/ml L-
methionine (Figure 5.7B). Growth of wild-type H37Rv was identical on all media (data not 
shown). Furthermore, all mutants exhibited wild-type growth on 7H10 containing CNCbl.  
However, growth of mutants containing deletions in metE (ΔmetE, ΔmetE/ΔcobU, and 
ΔmetE/ΔcobK) was impaired on unsupplemented 7H10 and, surprisingly, was not rescued 
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by plating on 7H10 supplemented with L-methionine. In addition, the ΔcobU mutant – 
which achieved wild-type growth levels in the presence of CNCbl supplement – did not 
grow on L-methionine-supplemented plates (Figure 5.7B).  In contrast, the ΔcobK mutant 
grew equally well on CNCbl- and L-methionine-supplemented media. 
 
5.4.5 M. tuberculosis ΔcobU and ΔmetE mutants are attenuated in vivo 
The varied responses of wild-type H37Rv and the ΔcobU and ΔmetE deletion mutants to 
perturbations in cobalamin homeostasis - manifest in the altered growth phenotypes 
(ΔcobU and ΔmetE) and transcriptional profiles (H37Rv and ΔcobU) resulting from 
manipulations of exogenous CNCbl availability as well as intrinsic AdoCbl biosynthetic 
and B12-related metabolic activity – suggested that AdoCbl biosynthesis might play a role 
in vivo during host infection. To assess the requirement for functional AdoCbl metabolic 
activity in vivo, immunocompetent C57BL/6 mice were infected with wild-type H37Rv and 
the ΔcobU and ΔmetE deletion mutants (Figure 5.9). All mouse infections and early CFU 
analyses were performed in the laboratory of Dr. Clif Barry III with the assistance of Dr. H. 
Boshoff; subsequent CFU and time-to-death assessments are courtesy Dr. H. Boshoff. 
Mice were infected by the aerosol route, and bacillary loads assessed in lung and spleen 
up to 210 days post infection. For the ΔcobU and ΔmetE strains, bacillary load 
assessments were extended throughout the course of the time-to-death analysis. The 
median survival time of mice infected with H37Rv was 290 days, consistent with previous 
assessments (Boshoff et al., 2003). However, the prolonged median survival times 
observed in mice infected with either the ΔcobU (460 days) or ΔmetE (534 days) mutant 
strain, indicated that disruptions to AdoCbl biosynthetic (ΔcobU) or B12-independent 
methionine synthase (ΔmetE) activity impair the virulence of M. tuberculosis (Figure 5.9B). 
Two weeks after infection, lung counts for the ΔcobU mutant (7.36 ± 7.20 x 104) were not 
significantly different from corresponding wild-type levels (3.68 ± 2.41 x 104; P>0.3). 
However, after four weeks, lung counts for the ΔcobU mutant differed significantly from 
wild-type by approximately one log (8.76 ± 1.86 x 106 for H37Rv versus 6.84 ± 6.36 x 105 
for ΔcobU; P<0.001) and, after thirty weeks, remained at depressed levels (9.22 ± 3.48 x 
105 for ΔcobU versus 7.71 ± 4.93 x 106 for H37Rv; P<0.1). Lung CFU counts for the 
ΔmetE mutant after two weeks (9.00 ± 7.43 x 102) were two log-fold lower than either 
ΔcobU or wild-type H37Rv, and reached a maximum of 1.92 ± 1.02 x 104 bacilli after thirty 
weeks. 
 
  
Figure 5.9 Virulence of M. tuberculosis strains in C57BL/6 mice. A. Lung CFU counts determined at different times post-infection for wild-type 
H37Rv, and the ΔcobU and ΔmetE deletion mutants. Each timepoint represents the mean bacillary count from three to four mice, and error bars indicate 
standard deviations. Asterisks (Ý) indicate significant differences between mean bacillary counts from mice infected with  wild-type H37Rv versus the 
ΔcobU deletion mutant. B. Time-to-death analysis in mice infected by aerosol with wild-type H37Rv, and the ΔcobU and ΔmetE mutants. Fifteen mice 
were used for time-to-death studies of each strain. 
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5.5 DISCUSSION 
Precedent for the relevance of vitamin metabolism to mycobacterial pathogenesis was 
recently provided by evidence of the essentiality of genes encoding pantothenate (vitamin 
B5) biosynthetic subunits (Sambandamurthy et al., 2002; Sassetti et al., 2003). A 
functional pantothenate biosynthetic pathway is required for persistence of M. tuberculosis 
in vivo in the murine model (Sambandamurthy et al., 2002), and M. tuberculosis 
pantothenate auxotrophs have been succesfully applied as live attenuated vaccine 
candidates either alone or in combination with additional attenuating mutations 
(Sambandamurthy et al., 2002, 2005; Sampson et al., 2004). The work presented here 
represents an attempt to investigate the role of AdoCbl in mycobacterial pathogenesis, 
and has shown that disruptions to AdoCbl biosynthesis are associated with altered 
metabolism and disease progression (Table 5.3). Specifically, deletions in putative early 
(cobK) or late (cobU) stages of the mycobacterial AdoCbl biosynthetic pathway are not 
lethal and do not affect growth in vitro in unsupplemented liquid minimal media. However, 
despite having no effect on survival in either murine or human macrophage models of 
infection, loss of cobU impaired the ability of M. tuberculosis H37Rv to achieve wild-type 
bacillary loads in vivo in immunocompetent mice, as well as attenuating virulence. 
Disruption of the B12-independent methionine synthase, MetE, was similarly associated 
with attenuation of survival and virulence in vivo; in contrast to the AdoCbl biosynthetic 
mutants, however, loss of MetE function on its own resulted in partial CNCbl auxotrophy in 
vitro on solid media. Significantly, the growth defect was not exacerbated by disruptions to 
AdoCbl biosynthetic function in the ΔcobU/ΔmetE and ΔcobK/ΔmetE double deletion 
mutants and, moreover, could not be replicated in any of these strains in liquid minimal 
media, therefore suggesting the complex interaction of AdoCbl, methionine and, 
potentially, sulphur metabolic pathways in mycobacterial pathogenesis (discussed below). 
  
AdoCbl biosynthesis in mycobacteria 
The presence in M. tuberculosis of homologues of the majority of enzymes required for 
AdoCbl biosynthesis (Rodionov et al., 2003; S. Dawes, unpublished) is highly suggestive 
of the conservation in mycobacteria of at least one essential B12-dependent metabolic 
pathway. Additional support for the proposed relevance of AdoCbl to mycobacterial 
pathogenesis might also be obtained from evidence of the dramatic survival and virulence 
phenotypes associated with the loss of putative AdoCbl biosynthetic genes in vitro 
(Sassetti et al., 2003) and in vivo (Sassetti & Rubin, 2003), as well as the inferred 
significance of related AdoCbl biosynthetic pathway genes in infection of 
immunocompetent mice (Talaat et al., 2004). Significantly, the M. leprae genome 
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sequence (Cole et al., 2001) revealed homologues of both B12-dependent (MetH) and -
independent (MetE) methionine synthases, as well as putative adenosyltransferase and 
B12-dependent methylmalonyl-CoA homologues (Rodionov et al., 2003). The conservation 
of B12-dependent pathways in M. leprae, in particular - despite the wholesale loss of 
AdoCbl biosynthetic pathway components (Cole et al., 2001) - strongly suggests that a 
selective advantage is associated with the retention of B12-dependent isozymes and, 
further, that the organism (and perhaps other pathogenic mycobacteria) might be able to 
obtain cobalamin from the host. Moreover, although only tenuously pertaining to 
mycobacterial AdoCbl synthesis, clinical data describing a high incidence of tuberculosis 
among strictly vegetarian Indians - thought likely to result from chronic vitamin B12 
deficiency (Chanarin & Stephenson, 1988) – provide an alternative perspective on the 
multiple roles cobalamin co-factors might fulfil in disease progression. In particular, 
although multiple host immune and physiological pathways are likely impacted by a 
chronic lack of vitamin B12, an intriguing hypothesis holds that vitamin B12 deficiency 
results in a  failure to convert methylmalonic acid to succinic acid -  a methylmalonyl CoA 
mutase-catalysed reaction requiring AdoCbl - and so results in methylmalonic acid build-
up, thereby providing a favourable environment for mycobacterial replication (Chanarin & 
Stephenson, 1988). 
 
The mycobacterial cob genes and cobalamin homeostasis 
The failure to induce obvious CNCbl auxotrophy in either ΔcobU or ΔcobK deletion mutant 
was consistent with the presence in the M. tuberculosis genome of alternative, B12-
independent isozymes. Furthermore, the recent demonstration that a non-orthologous 
protein provides cobinamide kinase activity in archaea (Thomas & Escalante-Semerena, 
2000) raises the possibility that an unidentified protein(s) might complement deficient 
CobU activity in the M. tuberculosis ΔcobU mutant. Of course, cobK-encoded precorrin-6x 
reductase function might similarly be complemented in the ΔcobK strain, and therefore 
demands that AdoCbl production in the ΔcobU and ΔcobK mutants be directly analysed in 
order to confirm abrogated biosynthetic ability. Significantly, the differential growth 
phenotypes of wild-type H37Rv and the ΔcobU mutant in response to CNCbl 
supplementation semed to indicate that, although not necessary for normal growth, 
AdoCbl might regulate an aspect of metabolism. In particular, the apparent CNCbl “shock” 
phenotype of the ΔcobU mutant (Figure 5.5) implies that loss of the full AdoCbl 
biosynthetic complement might result in the dysregulation of B12-dependent pathways, or 
an impaired ability to adapt to CNCbl availability.  
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Table 5.3 Growth characteristics of M. tuberculosis mutants containing disruptions in AdoCbl and methionine biosynthetic pathway genes† 
 In vitro  In vivo 
STRAIN 7H10 7H10 + CNCbl 
7H10 + 
L-Methionine 
Liquid minimal 
media J774 THP-1  Growth Virulence 
H37Rv ü ü ü ü ü ü  ü ü 
ΔcobU ü (“shock”) ü û ü ü ü  û û 
ΔcobK ü ü ü ü NA NA  NA NA 
ΔmetE û (impaired) ü û ü NA NA  û û 
ΔcobU/ΔmetE û (impaired) ü û ü NA NA  NA NA 
ΔcobK/ΔmetE û (impaired) ü û ü NA NA  NA NA 
† A tick (ü) indicates wild-type growth or virulence, a cross (û) impaired growth or attenuation. 
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The regulation of AdoCbl metabolism in M. tuberculosis 
M. tuberculosis possesses putative B12-element-binding motifs that are thought to 
regulate cobalt transport as well as the activity of the B12-independent methionine 
synthase (Rodionov et al., 2003). The inferred inability of the ΔcobU mutant to respond to 
CNCbl availability (Figure 5.5) has recently prompted an investigation into the capacity of 
M. tuberculosis to adapt to CNCbl levels and, perhaps, regulate B12-dependent 
metabolism. Preliminary microarray analyses of the transcriptional responses of both wild-
type H37Rv and the ΔcobU mutant to sudden CNCbl withdrawal, in particular, have failed 
to detect distinct B12-associated regulons in either wild-type H37Rv or the ΔcobU mutant 
(data not shown). However, the transcriptional profiles of wild-type M. tuberculosis H37Rv 
grown under various conditions of CNCbl availability have revealed the differential 
regulation of several genes associated with AdoCbl biosynthesis, providing tentative 
support for hypothesis that wild-type M. tuberculosis regulates AdoCbl production. 
Specifically, with the exception of cobI - encoding the mycobacterial SAM:precorrin-2 
methyltransferase required for the generation of precorrin-3A (Figure 5.2), expression of 
each of the enzymes catalysing the initial steps from δ-aminolaevulinic acid (ALA) 
condensation to precorrin-3B production is consistently upregulated in wild-type H37Rv 
within 6 hours of CNCbl withdrawal. In contrast, whole-genome expression profiles of the 
ΔcobU mutant under the same condtions have failed to identify an obvious B12-dependent 
response, again suggesting dysregulation of cobalamin homeostasis in strains containing 
disruptions in the biosynthetic pathway. 
 
Methionine biosynthesis in M. tuberculosis 
The successful disruption of metE was significant since it demonstrated that loss of B12-
independent methionine synthase activity in M. tuberculosis H37Rv is not lethal. Although 
not essential, the growth phenotype associated with loss of metE confirms the inclusion of 
metE among genes required for optimal growth of M. tuberculosis in vitro (Sassetti et al., 
2003), the nature of the TraSH technique necessarily excluding any mutant too defective 
to satisfy even the moderate “intermediate growth rate” criteria (Sassetti et al., 2003). 
Furthermore, the profound growth impairment and partial CNCbl auxotrophy of the ΔmetE 
deletion mutant provide support for the proposal that a complex regulatory network likely 
governs the interaction of AdoCbl, methionine and, potentially, sulphur metabolic 
pathways in mycobacteria, consistent with the surprising inability of L-methionine to 
complement growth of ΔmetE. Considerable attention has recently been focused on the 
construction of amino acid auxotrophs of mycobacteria, particularly for their possible 
application as live-attenuated vaccines (Hinshelwood & Stoker, 1992; McAdam et al., 
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Figure 5.10  L-Methionine biosynthesis in M. tuberculosis. Alternative B12-dependent (MetH) 
and B12–independent (MetE) methionine synthase isozymes (highlighted in red) catalyse S-
methyltransfer from 5-methyltetrahydrofolate (N5-methyl-THF) and 5-methyltetrahydropteroyltri-L-
glutamate (N5-methyl-THG) to L-homocysteine to generate L-methionine. M. tuberculosis H37Rv 
does not encode a 5,10-methylenetetrahydrofolate reductase (MetF) homologue and the 
enzyme(s) catalysing regeneration of 5-methyltetrahydrofolate (N5-methyl-THF) and 5-
methyltetrahydropteroyltri-L-glutamate (N5-methyl-THG) in the folate pathway are unknown. Blue 
arrows indicate the transsulphuration and green arrows the direct sulfhydrylation pathways of 
sulphur incorporation. Broken arrows represent conversions with multiple intermediate steps. The 
dotted lines indicate the putative mmuM-mediated pathway of L-methionine synthesis from L-
homocysteine and S-methylmethionine; the alternative pathway, also requiring mmuM activity, 
utilises SAM directly as methyl donor in the methylation of homocysteine (not shown). M. 
tuberculosis metB (Rv1079) encodes bifunctional cystathionine g-synthase and cystathionine g-
lyase activities, and therefore functions in both transsulphuration and reverse transsulphuration 
pathways (Wheeler et al., 2004). The mycobacterial branched-chain amino acid aminotransferase 
(BCAT) is encoded by ilvE (Rv2210c) and preferentially utilises isoleucine (Ile), leucine (Leu), and 
valine (Val) as amino donors (Venos et al., 2004). KIC, ketoisocaproate; KIV, ketoisovalerate; 
KMV, ketomethylvalerate. 
 
1995; Chambers et al., 2000; Hondalus et al., 2000; Gordhan et al., 2002; Pavelka et al., 
2003; Sampson et al., 2004). The impaired growth of ΔmetE mutants on unsupplemented 
media is, however, surprising given the presence in M. tuberculosis of a B12-dependent 
methionine synthase (MetH), and suggests a dominant role for the B12-independent 
isozyme in meeting bacillary methionine requirements. The inability of the B12-dependent 
methionine synthase (MetH) to completely restore growth in the metE mutant on 
unsupplemented media might be ascribed to insufficient AdoCbl production to satisfy the 
co-factor requirements of the B12-dependent enzyme, or to the rapid oxidative inactivation 
of AdoCbl under aerobic conditions (Drummond et al., 1993). The potential insufficiency of 
AdoCbl production in M. tuberculosis is, however, difficult to reconcile with evidence of 
significant AdoCbl biosynthesis during growth in vitro (Peterson & Pope, 1952; Aithal & 
Sirsi, 1963, 1964). Microbiological assays of AdoCbl biosynthesis by M. tuberculosis have 
traditionally relied on liquid culturing of bacilli and, importantly, have shown that the bulk of 
AdoCbl activity is associated with the culture filtrate. It is possible, though, that M. 
tuberculosis might not produce similar quantities of AdoCbl on solid media, consistent with 
recent evidence of the inability to isolate AdoCbl from bacilli grown on solid 7H10 agar (S. 
Dawes, personal communication). 
 
An alternative methionine biosynthetic pathway in M. tuberculosis? 
The M. tuberculosis B12-dependent (MetH) and B12-independent (MetE) methionine 
synthase isozymes are predicted to catalyse the final, S-methyltransfer reaction in 
methionine biosynthesis (Figure 5.10). The demonstration that loss of AdoCbl biosynthetic 
ability (cobU or cobK) in the ΔmetE mutant was not lethal in unsupplemented liquid 
minimal media was significant because it suggested that de novo methionine biosynthesis 
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is not essential for mycobacterial growth in vitro or that an alternative mechanism(s) might 
exist in M. tuberculosis to generate methionine. Methionine functions as the universal N-
terminal amino acid and so is required for the initiation of peptide chain synthesis (N-
formylmethionyl-tRNAfMet; Adams & Cappecchi, 1966; Webster et al., 1966), as well as 
providing the precursor for the biosynthesis of S-adenosylmethionine (SAM; Figure 5.10), 
the principal methyl donor in one-carbon reactions (Matthews, 1996). Consistent with the 
essentiality of the metK-encoded SAM synthase (Sassetti et al., 2003), SAM has been 
implicated in the synthesis of polyamines (Sekowska et al., 1998; Figure 5.10) – thought 
to regulate transcription (Sarkar et al., 1995) and to stabilise DNA during cell division 
(Marton & Pegg, 1995) – and is also required for mycobacterial persistence as a result of 
its donor function in various methyltransferase reactions during mycolic acid biosynthesis 
(Dubnau et al., 2000; Glickman et al., 2000). Folate metabolism is intrinsically linked to 
methionine biosynthesis, raising the potential for genomic instability and mutagenesis as a 
result of excessive uracil incorporation into DNA (Fenech, 2001). In addition, recent 
evidence suggests that methionine might constitute the preferred sulphur source of M. 
tuberculosis in the host (Wheeler et al., 2004).  
 
Methionine biosynthesis in micro-organisms has been shown to occur via two alternative 
mechanisms  – the canonical E. coli transsulphuration pathway that uses cysteine as a 
sulphur source (Sekowska et al., 2000), and direct sulfhydrylation - that incorporates 
inorganic sulphur (Thomas & Surdin-Kerjan, 1997; Belfaiza et al., 1998). Interestingly, 
actinomycetes are included among the few organisms able to utilise both 
transsulphuration and direct sulfhydrylation pathways: Corynebacterium glutamicum, for 
example, has been shown to synthesise methionine by both routes (Lee & Hwang, 2003), 
and recent evidence suggests that mycobacteria possesses the same ability (Figure 5.10; 
Wheeler et al., 2004, 2005). In particular, both M. tuberculosis (Cole et al., 1998) and M. 
leprae (Cole et al., 2001) encode an O-acetylhomoserine sulfhydrylase homologue (MetZ; 
Rv0391) that, in C. glutamicum, has been shown to catalyse the conversion of O-
acetylhomoserine to homocysteine using sulphide as the sulphur source (Hwang et al., 
2002). Furthermore, a functional reverse transsulphuration pathway was recently 
characterised in M. tuberculosis that enables the incorporation of sulphur from methionine 
into cysteine (Wheeler et al., 2004). However, while sulfhydrylation and transsulphuration 
offer alternative routes for the incorporation of sulphur into the methionine precursor L-
homoocysteine (Figure 5.10), both are futile in the absence of key S-methyltransfer 
activity, suggesting that the ΔmetE/ΔcobK and ΔmetE/ΔcobU double mutants should be 
impaired for growth in the absence of exogenous CNCbl. 
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The energy required for methionine biosynthesis ensures that many organisms do not 
possess de novo methionine biosythetic ability and instead rely on transport and salvage  
pathways to maintain methionine homeostasis (Rodionov et al., 2004). It has recently 
been shown, for example, that both Gram-positive (Trackman & Abeles, 1983; Furfine & 
Abeles, 1988; Myers et al., 1993; Wray & Abeles, 1993; Wray & Abeles, 1993; Cornell et 
al., 1996; Heilbronn et al., 1999) and Gram-negative (Murphy et al., 2002; Sekowska & 
Danchin, 2002; Ashida et al., 2003) bacteria are able to recycle methionine from the 
polyamine byproduct methylthioadenosine. The complete pathway has not been identified 
in M. tuberculosis; however, a functional branched-chain amino acid aminotransferase 
(ilvE; Rv2210c) has been characterised (Venos et al., 2004), consistent with the predicted 
existence of methionine salvage in M. tuberculosis (Wheeler et al., 2004, 2005). In 
addition, the genomes of both M. tuberculosis and M. leprae contain a YagD-type S-
methylmethionine-homocysteine methyltransferase (mmuM; Figure 5.10) which, in E. coli, 
has been shown to synthesise methionine from homocysteine using either S-
methylmethionine or SAM as methyl donors (Neuhierl et al., 1999).  E. coli does not 
encode the enzymes necessary for S-methylmethionine synthesis but is reliant on YkfD-
mediated transport of exogenous supplement; whether M. tuberculosis possesses S-
methylmethionine biosynthetic ability is unknown, and no mycobacterial YkfD homologues 
have been identified. However, coupled with evidence (S. Dawes, unpublished) of strict 
CNCbl auxotrophy in an M. smegmatis mc2155 double ΔcobK/ΔmetE deletion mutant (in 
contrast to the partial CNCbl auxotrophy of the analogous M. tuberculosis mutant), the 
absence of an MmuM homologue in M. smegmatis mc2155 (www.tigr.org) suggests that 
M. tuberculosis MmuM might function in methionine recycling. According to this predicted 
role, deletion of mmuM in the M. tuberculosis double ΔcobU/ΔmetE or ΔcobK/ΔmetE 
mutants should be lethal. 
 
Cross-regulation of B12-dependent and B12-independent methionine synthase 
activity? 
The observation that supplementation of solid media with L-methionine does not restore 
growth of any of the M. tuberculosis strains containing a disrupted metE allele - namely 
the ΔmetE, the ΔmetE/ΔcobU, and the ΔmetE/ΔcobK mutants, raises several possibilities. 
Firstly, growth of both wild-type H37Rv and the cobK mutant on L-methionine eliminates 
any suggestion that methionine supplementation on its own might be toxic to M. 
tuberculosis, consistent with previous reports of methionine supplementation in members 
of the M. tuberculosis complex (McAdam et al., 1995; Mougous et al., 2002; Wooff et al., 
2002; Wheeler et al., 2004). Similarly, the possibility that M. tuberculosis is immune to L-
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methionine supplementation through a failure to access or transport exogenous 
methionine on solid media is invalidated by the differential growth characteristics of the 
ΔcobU and ΔcobK mutants on L-methionine-supplemented media. Significantly, growth of 
both ΔcobU and ΔcobK is indistinguishable on plain as well as CNCbl-supplemented 
7H10 agar, but L-methionine supplementation inhibits the ΔcobU mutant. Furthermore, 
although genes encoding mycobacterial methionine transporters have not been identified 
(Cole et al., 1998), active methionine transport has been demonstrated in M. tuberculosis 
(Wheeler et al., 2004) and is thought to be mediated by any of the predicted ABC amino 
acid transporters (Ayling et al., 1979; Isnard et al., 1996; Seth & Connell, 2000). Instead, it 
is submitted that the differential effects of adding L-methionine to the various mutants 
strains might be better explained with reference to the potential cross-regulation of AdoCbl 
and methionine biosynthetic pathways. Both the ΔcobU and ΔcobK mutants contain 
functional B12-dependent and B12-independent methionine synthases, but are 
distinguished by the respective locations of their AdoCbl biosynthetic pathway disruptions. 
Because CobK activity is required early on in the cobI stage of AdoCbl synthesis (Figure 
5.2), disruption of cobK should result in prematurely aborted corrin ring synthesis, and 
accumulation of precorrin-6x. In contrast, CobU is active during the final stages of AdoCbl 
biosynthesis (Figure 5.2), and modifies the completed AdoCbi substrate. The M. 
tuberculosis genome contains two putative B12-element-binding motifs located upstream 
of a predicted cobalt transporter and the B12-independent methionine synthase, metE 
(Rodionov et al., 2003). It is possible that accumulation of AdoCbi in the ΔcobU mutant 
represses metE transcription by binding to the B12-element, with L-methionine 
simultaneously inhibiting metH expression. Under these circumstances, methionine 
metabolism would be halted, perhaps resulting in cysteine toxicity (Reed, 1995; Wheeler 
et al., 2004), especially on solid media (Chen et al., 2003). 
 
The role of sulphur metabolism in the M. tuberculosis ΔmetE phenotype 
Disruption of metE in Corynebacterium glutamicum similarly results in methionine 
auxotrophy despite the presence of alternative metE- and metH-encoded methionine 
synthases (Rϋckert et al., 2004). In contrast to M. tuberculosis ΔmetE, however, growth of 
the C. glutamicum ΔmetE mutant can be rescued by supplementing media with either L-
methionine or CNCbl (Rϋckert et al., 2004). Significantly, sulphate is also able to restore 
growth of the C. glutamicum ΔmetE mutant but is effective only in liquid media (Rϋckert et 
al., 2004), suggesting that additional pathways of sulphur metabolism might be restricted 
on solid agar. Both Sauton’s minimal medium and solid Middlebrook 7H10 agar contain 
magnesium sulphate as a standard component. Therefore, the unimpaired growth of the 
 193 
M. tuberculosis ΔmetE mutant (as well as the ΔmetE/ΔcobK and ΔmetE/ΔcobU strains) in 
unsupplemented Sauton’s minimal medium (Figure 5.8) but not on solid Middlebrook 
7H10 agar (Figure 5.7A) might similarly indicate that M. tuberculosis is restricted to the 
assimilation of exogenous sulphate in liquid media. A mycobacterial sulphate transport 
system has been characterised, and is encoded by the cysTWA subI genes (Wooff et al., 
2002); however, sulphate uptake on its own fails to account for the ability of the 
ΔcobK/ΔmetE and ΔcobU/ΔmetE double mutants to grow in the absence of a functional 
methionine synthase. Nevertheless, evidence that sulphate supplementation 
complements methionine auxotrophy implies that the phenotypes putatively ascribed to 
impaired methionine metabolism might be dominated by disruptions to sulphur 
homeostasis. In contrast to M. tuberculosis mutants containing ΔmetE deletion alleles, 
several methionine auxotrophs of the M. tuberculosis complex can be rescued by 
methionine supplementation (McAdam et al., 1995; Mougous et al., 2002; Wooff et al., 
2002). However, methionine auxotrophy in those strains mapped to sulphate transport 
(McAdam et al., 1995; Wooff et al., 2002) and reduction (Mougous et al., 2002) pathways 
and not to either of the methionine synthase isozymes. Furthermore, the combined loss of 
both sulphate transport and metC-encoded cystathionine β-lyase activity (Cole et al., 
2001) is thought to result in the natural methionine auxotrophy of M. leprae (Wheeler et 
al., 2004). Interestingly, inspection of the genome reveals that, apart from the loss of 
metC, M. leprae possesses the full complement of mycobacterial methionine metabolic 
genes: there are homologues of MetA and MetZ (required for direct sulfhydrylation; 
Wheeler et al., 2005; Figure 5.10); CysM2 and MetB (required for reverse transsulfuration; 
Wheeler et al., 2004, 2005); MetE and MetH (methionine synthesis); MmuM (putative 
methionine recycling); and IlvE (methionine formation from ketomethiobutyrate; Venos et 
al., 2004). It is proposed, therefore, that M. leprae might require exogenous methionine 
solely to fulfil sulphur requirements and, further, that the presence of multiple methionine 
pathway genes is indicative of the significance of methionine homeostasis in 
mycobacteria.  
 
The differential ability of C. glutamicum – and, potentially, M. tuberculosis - to utilise 
sulphate in liquid versus solid media might also be applied to explain the variable growth 
phenotype associated with the cobU mutant. It is possible that, during growth in liquid 7H9 
media supplemented with CNCbl, excess CNCbl represses metE transcription by binding 
to the upstream B12-element (Rodionov et al., 2003; Vitreschak et al., 2003), 
simultaneously supporting sufficient MetH activity to maintain growth at wild-type levels. If 
a naïve ΔcobU culture is grown under these conditions from a starting OD600 of ~0.050 to 
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an early log-phase OD600 of approximately 1.0, and is then harvested, washed, and 
immediately plated on solid 7H10 agar lacking CNCbl supplement, growth might resemble 
that of the metE mutant as a result of the inability of MetH to maintain wild-type growth in 
the absence of the necessary B12 co-factor. In addition, residual CNCbl-mediated 
suppression of metE might compound delayed MetE activity. Of course, as with the 
ΔmetE mutant, the phenotype is completely absent where solid media contain CNCbl 
supplement since full activity of MetH maintains wild-type growth. If, on the other hand, a 
liquid culture of the ΔcobU mutant is subjected to serial passage and sub-culturing, it is 
submitted that the gradual (or intermittent) depletion of the CNCbl supplement results in 
the utilisation of both B12-dependent and B12-independent methionine synthases so that 
subsequent washing and plating does not necessitate the sudden switch to full MetE 
activity, thereby circumventing the ‘shock’ phenotype. It is vital, therefore, that 
transcription of the alternative methionine synthase isozymes is compared during growth 
in CNCbl-supplemented and -unsupplemented media. 
 
AdoCbl biosynthesis in M. tuberculosis in vivo  
The relevance of AdoCbl biosynthesis to mycobacterial pathogenesis was suggested by 
the attenuation of the ΔcobU deletion mutant in the mouse model of infection (Figure 5.9). 
Although bacillary loads in the lungs of mice infected with wild-type H37Rv and the ΔcobU 
mutant were indistinguishable at 14 days post infection, the ΔcobU mutant failed to match 
the growth of H37Rv and did not achieve wild-type levels at any stage thereafter during 
the infective process, consistent with the prolonged median time-to-death of mice infected 
with the mutant strain. Loss of AdoCbl activity might exert pleiotropic effects on M. 
tuberculosis metabolism over and above the predicted influence on the function of the 
various B12-dependent isozymes. The in vivo growth phenotype of the ΔcobU mutant did 
not mimic the ΔnrdZ mutant, for example (Chapter 4); however, a time-to-death analysis 
was not performed in that study precluding a comparison of virulence attenuation. 
Significantly, the in vivo growth and virulence phenotypes of the ΔmetE strain were more 
profound. However, although not achieving wild-type bacillary loads, the ability of the 
ΔmetE deletion mutant to survive and replicate in vivo suggests that that the ready 
availability of sulphate in tissues and body fluids (Wooff et al., 2002) might complement 
growth. Alternatively, exogenous L-methionine might complement deficient MetE activity in 
vivo; a methionine auxotroph of M. bovis BCG unable to transport sulphate is able to 
survive as well as wild-type in vivo (Wooff et al., 2002), for example, thereby providing 
compelling evidence of the ability of mycobacteria to transport methionine in vivo. 
Specifically, despite the inability of L-methionine-supplemented solid media to support 
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growth of the ΔmetE mutant, it is possible that exogenous methionine might only prove 
inhibitory to the ΔmetE mutant on media (or under conditions) where AdoCbl biosynthesis 
is repressed, consistent with the inability to detect AdoCbl production in wild-type H37Rv 
on solid media (S. Dawes, personal communication). Finally, a potential caveat to the in 
vivo phenotypes of the ΔcobU and ΔmetE mutants is provided by the initial colony counts 
(Figure 5.9A). Lungs of mice infected with the ΔmetE mutant (26 ± 15) contained 
approximately seven-fold fewer CFU than wild-type H37Rv (194 ± 54). Similarly, initial 
counts from ΔcobU infected lungs (69 ± 34) were three-fold lower than wild-type, a 
difference which was statistically significant (P<0.01). Spleen counts confirmed the 
reduced bacillary loads in the mutant strains (data not shown). Stocks of all M. 
tuberculosis strains including wild-type H37Rv were maintained at the same titre, implying 
that the reduced bacillary loads associated with the ΔcobU and ΔmetE mutants reflect 
poor aerosol delivery. Mouse TB is a chronic disease of the lungs (Pierce et al., 1953; 
Dunn & North, 1995; Dannenberg & Collins, 2001); therefore, it possible that the effective 
starting lung CFU might dictate disease progression (H. Boshoff, personal 
communication). Assessments of resistance in different mouse strains, for example, have 
demonstrated the differential infection outcomes associated with inoculum size (Smith, 
1985; Medina & North, 1998). Although the difference in starting lung CFU was 
maintained throughout the course of infection in the case of the ΔmetE deletion mutant, it 
is perhaps significant that bacillary loads in the lungs of the H37Rv- and ΔcobU-infected 
mice were indistinguishable at two weeks post infection. 
 
Transport of vitamin B12 in mycobacteria 
M. tuberculosis H37Rv does not encode BtuFCD-type cobalamin transporters and no 
alternative mycobacterial B12-specific transport mechanisms have been identified 
(Rodionov et al., 2003). The demonstration that CNCbl partially complements growth of 
the H37Rv metE mutant is, therefore, significant since it implies the ability of M. 
tuberculosis to transport vitamin B12 as well as both MetH functionality. In contrast to M. 
tuberculosis, the M. smegmatis genome contains a putative BtuC homologue (MSMEG 
4553), but lacks homologues of the remaining transport components (www.tigr.org). An M. 
smegmatis mc2155 double ΔcobK/ΔmetE deletion mutant is a CNCbl auxotroph (S. 
Dawes, unpublished). Significantly, disruption of btuC in the mc2155 ΔcobK/ΔmetE mutant 
is not lethal (data not shown), reinforcing the likelihood that alternative vitamin B12 
transport mechanisms might function in mycobacteria. Whole-genome transcriptional 
analysis of either M. tuberculosis ΔcobU or wild-type H37Rv strains subjected to CNCbl 
supplementation or withdrawal failed to reveal any obvious transport candidates. In 
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humans, mutations in MMAA - a putative AAA ATPase-type mitochondrial vitamin B12 
transporter - define the cblA complementation group that is associated with methylmalonic 
acidemia (Dobson et al., 2002). Interestingly, a possible M. tuberculosis MMAA 
homologue (Rv1496) was recently identified in the M. tuberculosis H37Rv genome  (S. 
Bosnjak, unpublished). As with a number of sequenced microbial genomes (Dobson et al., 
2002), Rv1496 is located in a predicted operon including the mycobacterial mutAB genes 
(Cole et al., 1998). Although the functionality and regulation of this putative alternative 
vitamin B12 transporter in M. tuberculosis remains to be determined, it was noteworthy that 
expression of the individual genes within the operon clustered under both in vitro and in 
vivo conditions (Talaat et al., 2004). Furthermore, preliminary transcriptional analysis by 
microarray suggests that expression of both Rv1496 and mutAB might be elevated in wild-
type H37Rv as well as the ΔcobU mutant during growth in CNCbl-supplemented media 
(data not shown). It is, therefore, tempting to speculate that Rv1496 and mutAB constitute 
orthologous components of a vitamin B12-dependent system that has been conserved 
through evolutionary endosymbiosis (Margulis, 1975). 
 
An immunomodulatory role for AdoCbl? 
Previous in vitro assays of the relative AdoCbl biosynthetic abilities of pathogenic and 
non-pathogenic mycobacteria reported significant amounts of cobalamin in the culture 
filtrate (Aithal & Sirsi, 1964) and, further, that the distribution of B12-dependent activity 
between culture filtrate and bacterial mass differed according to mycobacterial species 
(Aithal & Sirsi, 1963). The relevance of cobalamin extrusion to in vivo infection is 
uncertain; however, the demonstrated high-affinity interaction between NO and both 
cobinamide and cobalamin in various oxidation states - in particular, the low pH-specific 
interaction of NO with cobalamin (III) (Sharma et al., 2003) – raises the intriguing 
possibility that cobalamin might constitute an indirect mycobacterial immunomodulatory 
mechanism. As stated previously, pathways implicated in tolerance of reactive 
intermediates are thought to have evolved primarily to function in normal cellular 
metabolism and signalling, but may be subject to second-order selection for additional 
roles in defence against host immune mechanisms (Zahrt & Deretic, 2002; Nathan, 2003). 
The possible dominant role of NO as a murine immune effector (Boshoff & Barry, 2005) 
suggests that attenuation of the cobU mutant in vivo might result from an inability to 
modulate the interaction with the host immune system. Evidence in support of this theory 
is scant, although it is notable that maximal cobK expression is observed at 21 days in 
vivo (Talaat et al., 2004) and coincides with immune activation and, further, that several 
genes of the putative M. tuberculosis AdoCbl biosynthetic pathway are associated with 
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survival in immunocompetent mice (Sassetti & Rubin, 2003; Talaat et al., 2004). In E. coli, 
MetE is inactivated by oxidised glutathione (GSSG) during periods of oxidative stress 
(Hondorp & Matthews, 2004). Furthermore, GSSG-mediated inactivation is cysteine 
residue-specific and might represent a deliberate and reversible mechanism to modulate 
MetE activity while preventing damage to the active site. In light of the postulated role of 
cobalamin in mycobacterial defence, it is tempting to speculate that the upregulation of 
vitamin B12 production upon immune activation - to enable MetH to assume dominant 
methionine synthase activity - could simultaneously increase cobalamin export and so 
augment immune tolerance. Significantly, it has been shown that expression of metE is 
downregulated in activated macrophages (Schnappinger et al., 2003), whereas genes 
involved in sulphate assimilation are induced in M. tuberculosis in response to oxidative 
stress (Pinto et al., 2004). Of course, such speculation must be tempered by the possible 
NO-mediated inactivation of the B12-dependent methionine synthase itself (Danishpajooh 
et al., 2001). Furthermore, studies so far have not identified metH among those genes 
significantly upregulated in vitro in macrophage models or during in vivo infection 
(Schnappinger et al., 2003; Talaat et al., 2004); however, it is possible that the higher 
efficiency of the B12-dependent isozyme (Greene, 1996; Bandarian & Matthews, 2001) 
might invalidate the need for increased transcription and that maintenance of homeostasis 
could, instead, rely on increased vitamin B12 biosynthesis. 
 
Future studies 
Possible cross-regulation of AdoCbl and methionine biosynthetic pathways was 
suggested by the data presented in this study (Table 5.2), and demands further 
investigation. Significantly, preliminary follow-up studies utilising transcriptional analysis 
by microarray have pointed to the responsiveness of M. tuberculosis to available CNCbl. 
However, direct quantification of the expression levels of several sentinel AdoCbl 
biosynthetic genes, as well as the B12-dependent and B12-indepedent methionine synthase 
isozymes in wild-type and mutant strains in response to a variety of conditions should 
provide a more definitive view of the possible interaction of different metabolic pathways. 
In addition, expression analyses might enable characterisation of the conditions under 
which MetE and MetH operate, perhaps explaining the apparent inability of the B12-
dependent isozyme to fully complement abrogated B12-independent metionine synthase 
activity in the ΔmetE mutant. In this regard, genetic manipulation of the proposed 
alternative methionine biosynthetic or salvage pathways – suggested by the presence of 
the mmuM-encoded YagD homologue as well as IlvE – in the various M. tuberculosis and 
M. smegmatis mutant strains should prove enlightening. Finally, analysis at the mRNA 
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level of the apparent CNCbl “shock” phenotype might yield novel insights into the 
regulation of AdoCbl, methionine, and sulphur metabolism in M. tuberculosis, as well as 
the specific mechanisms adopted by mutant strains in adapting to biosynthetic 
deficiencies. 
 Appendices 
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Appendix 1: List of abbreviations 
 
Abbreviation Abbreviated term/phrase 
ADC Albumin-dextrose complex supplement for Middlebrook 7H9 
AdoCbi Adenosylcobinamide 
AdoCbl Adenosylcobalamin 
Amp Ampicillin 
aph Gene encoding aminoglycoside phosphotransferase 
ATCC American Type Culture Collection 
BCG bacille Calmette-Guérin 
bla Gene conferring resistance to ampicillin 
bp base pair(s) 
BSA Bovine serum albumin 
CFU Colony forming unit 
CNCbl Cyanocobalamin (vitamin B12) 
DCO Double cross over 
DMSO Dimethylsulphoxide 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphate 
DOTS Directly observed therapy, short-course 
DSB Double strand break 
EP Error-prone 
GASP Growth advantage in stationary phase 
HIV Human immunodeficiency virus 
Hyg Hygromycin B 
hyg Gene conferring resistance to hygromycinB 
IFN Interferon 
IL Interleukin 
kb Kilo base pair(s) 
Km Kanamycin 
Km Michaelis constant 
LA Luria-Bertani agar 
lacZ Gene encoding β-galactosidase 
LB Luria-Bertani broth 
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LJ Lowenstein-Jensen 
MIC Minimum inhibitory concentration 
MMR Mismatch repair 
MTZ Metronidazole 
NO Nitric oxide 
NVB Novobiocin 
OADC ADC with oleic acid, supplement for Middlebrook 7H10 
OD600 Optical density at 600 nanometre wavelength 
OFX Ofloxacin 
ONPG 2-nitrophenyl β-D-galactopyranoside 
ORF Open reading frame 
PCR Polymerase chain reaction 
R Resistant/resistance 
RBS Ribosome binding site 
Rif Rifampicin 
RNA Ribonucleic acid 
RNI Reactive nitrogen intermediate 
ROI Reactive oxygen intermediate 
RT Reverse transcription/transcriptase 
S Sensitive/sensistivity 
S.A. Specific actvity 
sacB Gene encoding levansucrase 
SCO Single cross over 
SDS Sodium dodecylsulphate 
ss Single stranded 
Suc Sucrose 
TB Tuberculosis 
TNF Tumour necrosis factor 
Tris Tris(hydroxymethyl)aminomethane 
Tween Polyoxyethylene sorbitan monooleate 
U Units 
X-gal 5-bromo-4-chloro-3-indolyl-α-D-thiogalactopyranoside 
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Appendix 2: Culture media 
All media made up to a final volume of 1 litre with deionised water, and sterilised by 
autoclaving at 121oC for 20 minutes, unless otherwise stated. 
 
2TY broth 
16 g tryptone powder; 10 g yeast extract; 5 g sodium chloride. 
 
Luria-Bertani broth (LB) 
10 g tryptone powder; 5 g yeast extract; 10 g sodium chloride. 
 
Luria-Bertani agar (LA) 
10 g tryptone powder; 5 g yeast extract; 10 g sodium chloride; 15 g DIFCO agar powder. 
 
Middlebrook-ADC (7H9M-ADC) 
4.7 g Middlebrook 7H9 broth base; 2 ml glycerol. 
100ml ADC supplement added after autoclaving. 
 
Middlebrook-OADC plates (7H10M-OADC) 
19 g Middlebrook 7H10 agar powder; 2ml glycerol. 
100 ml OADC supplement added after autoclaving. 
 
Psi broth 
5g yeast extract; 20g tryptone; 5g magnesium sulphate 
pH 7.6 with potassium hydroxide 
 
Sauton’s minimal media 
4 g asparagine; 0.5 g magnesium sulphate; 2 g citric acid; 0.5 g potassium dihydrogen 
orthophosphate; 0.05 g ammonium ferric citrate; 48 ml glycerol 
pH 7.2; sterilised by filtration. 
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